%PDF-1.3
%‚„œ”
1 0 obj
<<
/Producer (pypdf)
>>
endobj
2 0 obj
<<
/Type /Pages
/Count 8
/Kids [ 4 0 R 64 0 R 122 0 R 159 0 R 188 0 R 226 0 R 251 0 R 256 0 R ]
>>
endobj
3 0 obj
<<
/Type /Catalog
/Pages 2 0 R
>>
endobj
4 0 obj
<<
/Annots [ 5 0 R 6 0 R 7 0 R 8 0 R 9 0 R 10 0 R 11 0 R 12 0 R 13 0 R 14 0 R 15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R ]
/Contents 24 0 R
/CropBox [ 0 0 595 794 ]
/MediaBox [ 0 0 595 794 ]
/Resources <<
/ExtGState <<
/GS1 25 0 R
>>
/Font <<
/F1 26 0 R
/F1-0 29 0 R
/F2 30 0 R
/F3 33 0 R
/F4 36 0 R
/F5 39 0 R
/F6 42 0 R
/F7 45 0 R
/F8 50 0 R
/F9 55 0 R
>>
/XObject <<
/Im1 58 0 R
/Xi0 59 0 R
/Xi1 60 0 R
>>
/ProcSet [ /ImageB /ImageC /ImageI /PDF /Text ]
>>
/Rotate 0
/Thumb 61 0 R
/Type /Page
/Parent 2 0 R
>>
endobj
5 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib79)
/Rect [ 134 269 218 277 ]
/Subtype /Link
/Type /Annot
>>
endobj
6 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib86)
/Rect [ 225 269 290 277 ]
/Subtype /Link
/Type /Annot
>>
endobj
7 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib86)
/Rect [ 51 257 112 266 ]
/Subtype /Link
/Type /Annot
>>
endobj
8 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib52)
/Rect [ 118 257 181 266 ]
/Subtype /Link
/Type /Annot
>>
endobj
9 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib65)
/Rect [ 226 246 284 255 ]
/Subtype /Link
/Type /Annot
>>
endobj
10 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib10)
/Rect [ 209 190 290 199 ]
/Subtype /Link
/Type /Annot
>>
endobj
11 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib10)
/Rect [ 51 179 75 187 ]
/Subtype /Link
/Type /Annot
>>
endobj
12 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib5)
/Rect [ 154 156 209 165 ]
/Subtype /Link
/Type /Annot
>>
endobj
13 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib65)
/Rect [ 113 145 172 154 ]
/Subtype /Link
/Type /Annot
>>
endobj
14 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib14)
/Rect [ 341 269 460 277 ]
/Subtype /Link
/Type /Annot
>>
endobj
15 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib39)
/Rect [ 334 168 424 176 ]
/Subtype /Link
/Type /Annot
>>
endobj
16 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib8)
/Rect [ 433 168 541 176 ]
/Subtype /Link
/Type /Annot
>>
endobj
17 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib82)
/Rect [ 517 123 547 131 ]
/Subtype /Link
/Type /Annot
>>
endobj
18 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib82)
/Rect [ 308 112 327 120 ]
/Subtype /Link
/Type /Annot
>>
endobj
19 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib39)
/Rect [ 334 112 416 120 ]
/Subtype /Link
/Type /Annot
>>
endobj
20 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib79)
/Rect [ 516 89 547 98 ]
/Subtype /Link
/Type /Annot
>>
endobj
21 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib79)
/Rect [ 308 78 353 86 ]
/Subtype /Link
/Type /Annot
>>
endobj
22 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib7)
/Rect [ 469 56 541 64 ]
/Subtype /Link
/Type /Annot
>>
endobj
23 0 obj
<<
/A <<
/S /URI
/URI (http\072\057\057crossmark\056crossref\056org\057dialog\057\077doi\07510\0561038\0452Fbjp\0562008\056307\046domain\075pdf\046date\137stamp\0752009\05501\05529)
>>
/Border [ 0 0 0 ]
/C [ 0 0 1 ]
/Rect [ 519 794 595 779 ]
/Subtype /Link
>>
endobj
24 0 obj
<<
/Length 16370
>>
stream
q
q

0 0 0 rg
/GS1 gs
1 i 
50.797 447.477 496.176 -0.454 re
f
BT
/F1 1 Tf
19.9253 0 0 19.9253 50.7968 696.5857 Tm
0 Tc
0 Tw
(REVIEW)Tj
20.4233 0 0 20.4233 50.7968 659.225 Tm
[(PDE4)-336.5(inhibitor)-8.5(s:)-334.1(current)-337.2(status)]TJ
/F2 1 Tf
10.959 0 0 10.959 50.7968 629.2912 Tm
[(D)-331.2(Spina)]TJ
/F3 1 Tf
8.7174 0 0 8.7174 50.7968 603.4392 Tm
[(Kingí)50.4(s)-335.4(College)-338.2(London)-332.8(School)-337.6(of)-331.1(Biomedical)-339.1(and)-336(Health)-334.1(Science,)-335.8(Pharmaceutical)-342(Science)-334.2(Research)-327.1(Division,)-342.6(Sackler)-334.7(Institute)-335(of)]TJ
0 -1.2617 TD
[(Pulmonar)-17.1(y)-333.9(Pharmacology)69(,)-333.3(London,)-334.4(UK)]TJ
/F4 1 Tf
8.9663 0 0 8.9663 50.7968 562.0534 Tm
[(Phosphodiesterase4)-271.8(inhibitors)-268.9(are)-265.6(currently)-267.3(under)-263.2(development)-270.7(for)-267.2(the)-264.8(treatment)-264.5(of)-268.8(respiratory)-267(diseases)-267.6(including)-261.6(asthma)-265.2(and)]TJ
0 -1.1634 TD
[(chronic)-300.6(obstructive)-310.3(pulmonary)-299.1(disease.)-304.7(The)-296.1(rationale)-306(for)-298.8(the)-302.8(development)-302.3(of)-300.4(this)-302.6(drug)-301.6(class)-300.8(stems)-295.6(from)-301.7(our)-302.3(understanding)-307.3(of)]TJ
0 -1.1697 TD
[(the)-328.1(role)-327.7(of)-332(PDE4)-328.8(in)-322.4(suppressing)-332.4(the)-328.1(function)-333.9(of)-325.7(a)-328.3(range)-328.9(of)-325.7(inflammatory)-334.1(and)-322(resident)-331.9(cells)-329.3(thought)-331.1(to)-324.3(contribute)-335.7(toward)-326.5(the)]TJ
0 -1.1634 TD
[(pathogenesis)-482.4(of)-477.4(these)-482.6(diseases.)-476.1(Similarly,)-484.1(numerous)-480.7(preclinical)]TJ
/F5 1 Tf
29.0348 0 TD
[(in)-477.2(vivo)]TJ
/F4 1 Tf
3.4017 0 TD
[   (studies)-482.1(have)-472.4(shown)-478.7(that)-481.9(PDE4)-480.6(inhibitors)-477.6(suppress)]
TJ
-32.4365 -1.1697 TD
[(characteristic)-266.8(features)-257.4(of)-262.5(these)-261.3(diseases,)-261.1(namely,)-256.6(cell)-259.1(recruitment,)-264.7(activation)-265.3(of)-256.1(inflammatory)-264.6(cells)-259.8(and)-258.8(physiological)-267.2(changes)-255.4(in)]TJ
0 -1.1634 TD
[(lung)-270.2(function)-277(in)-271.9(response)-273(to)-267.4(a)-271.4(range)-272(of)-268.8(insults)-276.2(to)-273.7(the)-271.1(airways.)-267.2(These)-273.6(potentially)-270.7(beneficial)-274.5(actions)-275.3(of)-268.8(PDE4)-271.9(inhibitors)-275.3(have)-270.1(been)]TJ
0 -1.1697 TD
[(successfully)-382.5(translated)-384(in)-379.3(phase)-375.4(II)-377.8(and)-378.9(III)-383.4(clinical)-379.3(trials)-378.9(with)-380.8(roflumilast)-383.2(and)-378.9(cilomilast.)-384.2(However,)-379.9(dose)-380.6(limiting)-379.4(side)-378.5(effects)-384(of)]TJ
0 -1.1634 TD
[(nausea,)-452.6(diarrhoea)-451.5(and)-454.8(headache)-446.1(have)-453.4(tempered)-451.3(the)-454.5(enthusiasm)-455.2(of)-445.8(this)-454.3(drug)-453.4(class)-452.6(for)-450.6(the)-448.2(treatment)-454.2(of)-452.1(these)-451(respiratory)]TJ
0 -1.1697 TD
[(diseases.)-337(A)-328.1(number)-329.2(of)-332(strategies)-331.8(are)-335.2(currently)-330.5(being)-333.5(pursued)-333.1(in)-328.8(attempts)-330.5(to)-330.6(improve)-336(clinical)-328.7(efficacy)-333.9(and)-328.3(reduce)-331.4(side)-334.2(effects,)]TJ
0 -1.1634 TD
[(including)-337.5(delivery)-339(via)-333.7(the)-334.4(inhaled)-338(route,)-334.3(and/or)-337.1(development)-333.9(of)-338.3(non-emetic)-333.6(PDE4)-335.2(inhibitors)-338.5(and)-334.6(mixed)-341.1(PDE)-331.8(inhibitors.)]TJ
/F5    1 Tf
9.4646 0 0 9.4646 50.7968 456.718 Tm
[(British)-336.1(Journal)-332.4(of)-337.1(Pharmacology)]
TJ
/F4 1 Tf
13.7111 0 TD
(\(2008\))Tj
/F1 1 Tf
3.3364 0 TD
(155,)Tj
/F4 1 Tf
2.3421 0 TD
[(308ñ315;)-335.3(doi:10.1038/bjp.2008.307;)-347.9(published)-335.2(online)-334.9(28)-335.5(July)-335.8(2008)]TJ
/F1 1 Tf
8.4682 0 0 8.4682 50.7968 435.5715 Tm
(Keywords:)Tj
/F4 1 Tf
8.9663 0 0 8.9663 96.3212 435.5715 Tm
[(asthma;)-334.5(COPD;)-340(cilomilast;)-333.6(roflumilast;)-345.1(PDE4;)-335(inflammation;)-336(emesis)]TJ
/F1 1 Tf
8.4682 0 0 8.4682 50.7968 419.1306 Tm
(Abbreviations:)Tj
/F4 1 Tf
8.9663 0 0 8.9663 112.5921 419.1306 Tm
[(CD,)-331.6(cluster)-334.6(of)-338.3(differentiation;)-339.5(COPD,)-333.6(chronic)-338.6(obstructive)-335.6(pulmonary)-337(disease)]TJ
/F1 1 Tf
9.9626 0 0 9.9626 50.7968 371.2818 Tm
[(Intro)-10.3(duction)]TJ
/F2 1 Tf
8.4682 0 0 8.4682 50.7968 349.1149 Tm
[(Theophylline)-313.7(has)-309.2(been)-311.6(used)-312.8(in)-310.7(the)-310(treatment)-310.9(of)-309.2(asthma)-311.5(and)]TJ
0 -1.3256 TD
[(chronic)-590.7(obstructive)-593.4(pulmonar)-11.6(y)-592.8(disease)-584.6(\(COPD\))-592.2(since)-589.3(the)]TJ
0 -1.3189 TD
[(1930s)-700.1(although)-697(its)-694.5(popularity)-695.5(has)-690.8(declined)-695.8(due)-698.8(to)-692.3(the)]TJ
0 -1.3256 TD
[(introduction)-549.8(of)-543.5(long)-542.4(acting)]TJ
/F6 1 Tf
14.0657 0 TD
(b)Tj
/F2 1 Tf
6.351 0 0 5.6449 174.5574 314.0787 Tm
(2)Tj
8.4682 0 0 8.4682 178.2425 315.496 Tm
[(-adrenoceptor)-542.4(agonists)-545.8(and)]TJ
-15.0499 -1.3256 TD
[(glucocorticosteroids,)-391.4(either)-385(alone)-388(or)-381(in)-384.3(combination.)-390.9(Theo-)]TJ
0 -1.3189 TD
[(phylline)-260(is)-252.7(often)-251(used)-259.3(with)-249.3(glucocorticosteroids)-267.4(as)-248.9(second-)-255(or)]   TJ
0 -1.3256 TD
[(third-line)-843.7(therapy)-843.1(where)-843.3(it)-839.4(has)-844.8(proven)-840.6(anti-asthmatic)]
TJ
T*
[(activity)-553.1(in)-545(asthma)-552.5(\(Sullivan)]TJ
/F3 1 Tf
14.1729 0 TD
[(et)-545.5(al)]TJ
/F2 1 Tf
2.1423 0 TD
[(.,)-549.4(1994;)-547.4(W)74.6(einberger)-551.8(and)]TJ
-16.3152 -1.3189 TD
[(Hendeles,)-396.3(1996;)-393.4(Lim)]TJ
/F3 1 Tf
10.1627 0 TD
[(et)-391.5(al)]TJ
/F2 1 Tf
1.9817 0 TD
[(.,)-395.4(2000\))-397.3(and)-385.7(in)-391(combination)-400.7(with)]TJ
-12.1443 -1.3256 TD
[(long)-321.4(acting)-323.7(bronchodilator)-324.6(drugs)-322(in)-317.4(COPD)-322.8(\(Rennard,)-322(2004\).)]TJ
T*
[(As)-540.5(an)-541.1(p.o)-540.5(formulation,)-542.6(this)-540.6(drug)-540.5(offers)-543(the)-537.6(advantage)-544.1(of)]TJ
T*
[(improved)-249.4(compliance;)-248.4(however)40.6(,)-244.6(its)-245.9(perce)14.4(ived)-247.9(lack)-245.8(of)-242.3(efficacy)70.2(,)]TJ
0 -1.3189 TD
[(the)-805.4(necessity)-811.5(to)-806.1(monitor)-811.8(plasma)-814.8(levels,)-809(coupled)-809.5(with)]TJ
0 -1.3256 TD
[(numerous)-560.3(side)-554.6(effects,)-555.5(known)-554.5(drug)-560.6(interactions,)-560(and)-553(the)]TJ
T*
[(effect)-335.3(of)-329.3(smoking)-337.7(on)-330.9(plasma)-332.7(clearance)-335.2(\(Boswell-Smith)]TJ
/F3 1 Tf
25.7281 0 TD
[(et)-331.2(al)]TJ
/F2 1 Tf
1.9281 0 TD
(.,)Tj
-27.6562 -1.3189 TD
[(2006a\))-724.1(have)-714.2(provided)-719.6(an)-715.2(impetus)-720.6(to)-719.1(discover)-718(a)-715.1(better)]TJ
0 -1.3256 TD
[(theophylline.)-355.4(Moreover)40.9(,)-345(whereas)-349(glucocorticosteroids)-354.4(are)-352.3(of)]TJ
T*
[(clinical)-303.4(utility)-294.4(in)-297.3(asthma)-298.1(\(Barnes,)-299.9(2006a\),)-299.2(they)-293.6(are)-298.7(of)-295.8(limited)]   TJ
0 -1.3189 TD
[(use)-515.2(in)-511.5(COPD)-516.9(\(Rennard,)-509.4(2004\).)-521.4(There)-511.5(is)-513.8(clearly)-514.9(an)-507.7(unmet)]
TJ
0 -1.3256 TD
[(clinical)-243.1(need)-237.1(for)-232.1(the)-236.4(development)-243.5(of)-235.6(disease-modifying)-238.4(drugs)]TJ
30.3542 25.1456 TD
[(in)-645.4(COPD)-650.8(because)-642.3(other)-650.8(than)-641.5(cigarette)-652.3(smoke)-643.8(cessation,)]TJ
0 -1.3256 TD
[(current)-726.5(drug)-728(therapy)-729.3(does)-728.8(not)-725.8(prevent)-732.6(the)-725.1(accelerated)]TJ
0 -1.3189 TD
[(decline)-335.8(in)-337.5(lung)-333.9(function.)]TJ
0.9975 -1.3256 TD
[(The)-305.3(mechanism)-307.5(of)-302.5(action)-305.2(of)-309.2(theophylline,)-301.8(which)-309.4(explains)]TJ
-0.9975 -1.3256 TD
[(its)-252.6(clinical)-256.5(effect)-261.7(is)-252.7(not)-250.5(entirely)-257.4(certain,)-257.7(but)-255.6(several)-255.9(have)-252.3(been)]TJ
0 -1.3189 TD
[(proposed.)-407.4(It)-402.4(was)-401.8(originally)-408.7(shown)-405.9(that)-400.3(theophylline)-405.4(inhib-)]TJ
0 -1.3256 TD
[(ited)-304.4(the)-310(activity)-305.4(of)-309.2(a)-306.8(cyclic)-309.3(3)]TJ
/F7 1 Tf
5.9275 0 0 5.9275 420.4912 284.9385 Tm
()Tj
/F2 1 Tf
8.4682 0 0 8.4682 422.6455 281.8771 Tm
0.3048 Tc
(,5)Tj
/F7 1 Tf
5.9275 0 0 5.9275 432.5101 284.9385 Tm
0 Tc
()Tj
/F2 1 Tf
8.4682 0 0 8.4682 437.2156 281.8771 Tm
[(nucleotide)-313.6(PDE)-304.3(with)-309.5(a)-306.8(K)]TJ
/F3 1 Tf
11.4213 0 TD
(i)Tj
/F2 1 Tf
0.6025 0 TD
(of)Tj
-27.3013 -1.3256 TD
(100)Tj
/F6 1 Tf
1.8879 0 TD
(m)Tj
/F2 1 Tf
6.7745 0 0 6.7745 328.4786 270.6519 Tm
(M)Tj
8.4682 0 0 8.4682 337.833 270.6519 Tm
[(\(Butcher)-343.5(and)-338.8(Sutherland,)-340.9(1962\).)-347.3(This)-341.7(might)-335.5(account)]   TJ
-3.5415 -1.3189 TD
[(for)-613.8(its)-614.1(beneficial)-617.7(effects)-612.2(clinically)65.2(,)-612.8(a)0(s)-610.4(a)0(n)-614.8(increase)-620.2(in)-612(the)]
TJ
0 -1.3256 TD
[(intracellular)-259.3(levels)-249.8(of)-255.6(cyclic)-255.7(AMP)-253.3(can)-253(reduce)-248.6(the)-256.5(activation)-256.6(of)]TJ
T*
[(a)-326.8(wide)-323.5(range)-326.8(of)-329.3(inflammator)-14.5(y)-325(and)-325.4(lung)-327.2(resident)-325.6(cells.)-327.6(There)]TJ
T*
[(are)-573.2(presently)-576.9(11)-576.5(known)-574.6(families)-575.6(of)-577(PDE)-572.1(and)-579.8(at)-567.7(least)-574.8(21)]TJ
0 -1.3189 TD
[(isoforms)-446.8(with)-450.1(numerous)-446.5(splice)-443.1(variants)-451.3(that)-440.5(are)-446(character-)]TJ
0 -1.3256 TD
[(ized)-492.6(by)-485.1(differences)-491.7(in)-491.4(structure,)-493.2(substrate)-492(specificity)68.1(,)-485.6(inhi-)]TJ
T*
[(bitor)-476.7(selectivity)72.5(,)-478.9(tissue)-473.2(and)-472.7(cell)-475.7(distribution,)-481.5(regulation)-477.3(by)]TJ
0 -1.3189 TD
[(kinases,)-269.9(proteinñprotein)-275(interaction)-266.3(and)-271.9(subcellular)-271.7(distribu-)]TJ
0 -1.3256 TD
0.0001 Tc
[(tion)-795.3(\(Houslay)]TJ
/F3 1 Tf
7.6722 0 TD
0 Tc
[(et)-793.2(al)]TJ
/F2 1 Tf
2.39 0 TD
[(.,)-797.1(2005;)-795.1(Bender)-797.9(and)-794(Beavo,)-802.8(2006\).)]TJ
-10.0623 -1.3256 TD
[(However)39.4(,)-853.8(targeting)-859.4(PDE4,)-860.5(the)-852.3(enzyme)-855.7(responsible)-861.8(for)]TJ
0 -1.3189 TD
[(metabolizing)-833.2(cyclic)-824.8(AMP)-829.1(has)-831.4(been)-827.1(the)-825.5(focus)-828.7(for)-828(the)]TJ
0 -1.3256 TD
[(development)-852.8(of)-851.5(drugs)-850.8(that)-848.9(could)-849.1(prove)-847.2(beneficial)-858.7(in)]TJ
T*
[(the)-256.5(treatment)-264(of)-255.6(respirator)-16.9(y)-258.1(diseases)-258.9(such)-265.1(as)-255.6(asthma)-257.9(\(T)58.3(orphy)72(,)]   TJ
T*
[(1998;)-473.7(Houslay)]TJ
/F3 1 Tf
7.3174 0 TD
[(et)-465.1(al)]
TJ
/F2 1 Tf
2.062 0 TD
[(.,)-469.1(2005\).)-474.5(It)-469.4(is)-467(therefore)-476(of)-469.9(interest)-467.6(that)]TJ
-9.3794 -1.3189 TD
[(plasma)-580.5(levels)-571.1(achieved)-576.6(with)-577.3(a)-574.6(dose)-574.8(of)-577(theophylline)-579.5(that)]TJ
0 -1.3256 TD
[(d)14.9(e)0(m)27.7(o)17.2(n)13.3(s)0(t)31.2(r)0(a)24.7(t)13.5(e)18(d)-346.7(s)17.7(i)0(g)22.9(n)20(if)25.7(i)17.4(c)13.7(a)14.6(n)13.3(t)-348(a)14.6(n)13.3(t)20.2(i-)29.1(in)24(f)15(l)17.4(a)14.6(m)0(m)26.2(a)14.6(t)13.5(o)17.3(ry)-341.7(a)14.6(c)13.7(t)13.5(i)0(v)27.2(i)17.4(t)13.5(y)-345.1(\()12.6(S)18(ul)28.9(li)28.2(v)16.4(a)0(n)]TJ
/F3 1 Tf
T*
[(et)-431.7(al)]TJ
/F2 1 Tf
2.0218 0 TD
[(.,)-435.6(1994\))-430.8(was)-428.6(well)-434.8(below)-427.7(the)-430.5(K)]TJ
/F3 1 Tf
14.4139 0 TD
(i)Tj
/F2 1 Tf
0.7163 0 TD
[(for)-433(PDE)-431.5(inhibition)-434.7(and)]TJ
-17.152 -1.3189 TD
[(suggested)-440.2(that)-440.5(PDE4)-441.9(inhibition)-441.3(alone)-441.6(does)-434.2(not)-444.6(completely)]TJ
0 -1.3256 TD
[(explain)-336.5(this)-326.3(drugs)-335.4(clinical)-330.2(effectiveness)-337.2(\(Barnes)]TJ
/F3 1 Tf
22.461 0 TD
[(et)-331.2(al)]TJ
/F2 1 Tf
1.9214 0 TD
[(.,)-335.2(2005\).)]TJ
/F4 1 Tf
6.9738 0 0 6.9738 50.7968 66.4441 Tm
0.0001 Tc
[(Recei)-10.3(ved)-302(4)-297.7(April)-304.9(2008;)-306.6(revised)-304.4(5)-297.7(J)0.1(une)-308.5(2008;)-306.6(accepted)-309.3(9)-297.7(J)0.1(une)-300.4(20)-10.2(08;)-296.4(publis)-12.6(hed)]TJ
0 -1.2926 TD
[(onlin)-11.2(e)-327.2(2)0(8)-343.5(J)0.1(uly)-337.3(2008)]TJ
ET
q
50.797 124.214 239.131 -48.813 re
W n
0 0 0 RG
1 J 1 j 0.454 w 10 M []0 d
-409.493 124.214 m
546.916 124.214 l
S
Q
BT
6.9738 0 0 6.9738 50.7968 111.2314 Tm   
[(Corres)-13.1(pondence:)-244.4(Dr)-234.8(D)-236.4(Spina)-11.7(,)-229.2(K)0(ingí)-11.3(s)-232.7(Colleg)-13.1(e)-229.7(L)0.1(ondo)-13.5(n)-229.8(S)0(choo)-13.3(l)-232.4(o)0(f)-234.3(B)0(i)-9.9(omedical)-240.5(and)]
TJ
0 -1.2844 TD
0 Tc
[(Health)-319.8(Scienc)-10.7(e)-0.1(,)-312.7(Pha)-9.9(rmaceutical)-322.8(S)-0.1(cienc)-10.7(e)-311.1(Rese)-10.2(arch)-314.2(Division,)-329(Sackler)-319.7(I)0(nstitut)-12.8(e)-311.1(of)]TJ
T*
0.0001 Tc
[(Pulmonar)-14.3(y)-491.7(Pharma)-11.3(cology,)-501.3(S)0.1(t)-494.5(Thoma)-11.2(s)-492.9(S)0(treet,)-505.2(5th)-501.6(Floor,)-495.3(Hodg)-13.2(kin)-495.4(Building,)]TJ
T*
[(London)-340.9(SE1)-342.6(1UL,)-336.4(UK.)]TJ
T*
0 Tc
[(E-mail:)-343.9(domenico.spi)-15.4(n)-0.1(a@kcl.ac.u)-14.6(k)]TJ
ET
q
50.797 767.282 14.91 -14.91 re
W n
0 g
q
15.1199 0 0 14.9039 50.8093 752.3956 cm
/Im1 Do
Q
Q
50.797 749.877 239.131 -0.283 re
f
BT
/F1 1 Tf
5.9275 0 0 8.4682 139.9181 761.8392 Tm
[(British)-323.4(Journal)-334.8(of)-323.7(Pharmacology)-328.2(\(2008\))-324.2(155,)]TJ
/F4 1 Tf
21.2137 0 TD
[(308)-82.2(ñ)-83.4(315)]TJ
/F8 1 Tf
6.9038 0 0 8.9663 75.1181 753.8455 Tm
()Tj
/F9 1 Tf
5.7532 0 0 7.4718 81.8645 753.8455 Tm
[(2008)-333.3(Macmillan)-324.9(P)32.5(ublishers)-329.9(Limited)-1003.2(All)-334.7(rights)-328.3(reser)-30.4(ved)-1005.3(0007)-116.5(ñ)-130.7(1188/08)-993.7($)]TJ
5.2302 0 0 7.4718 275.6976 753.8455 Tm
-0.0001 Tc
(32.00)Tj
5.9774 0 0 7.4718 232.5543 742.9038 Tm
[(www)81.1(.brjpharmacol.org)]TJ
ET
  
 Q
q
q 76 0 0 15 519 779 cm /Xi1 Do Q
Q


Q

q
0.0 0.0 595 794 re
W
n
1 0 0 1 0 0 cm
BT
/F1-0 12 Tf
14.4 TL
ET
1 0 0 RG
n
48 693 78 22 re
S
1 0 0 RG
n
48 653 300 27 re
S
1 0 0 RG
n
47 624 47 18 re
S
1 0 0 RG
n
48 599 486 15 re
S
1 0 0 RG
n
48 589 152 13 re
S
1 0 0 RG
n
48 559 500 12 re
S
1 0 0 RG
n
49 548 499 13 re
S
1 0 0 RG
n
48 537 501 14 re
S
1 0 0 RG
n
47 526 502 15 re
S
1 0 0 RG
n
47 516 502 15 re
S
1 0 0 RG
n
48 506 500 13 re
S
1 0 0 RG
n
47 496 502 14 re
S
1 0 0 RG
n
47 485 501 15 re
S
1 0 0 RG
n
48 474 500 14 re
S
1 0 0 RG
n
48 464 478 13 re
S
1 0 0 RG
n
48 452 476 15 re
S
1 0 0 RG
n
49 432 314 13 re
S
1 0 0 RG
n
48 415 369 15 re
S
1 0 0 RG
n
48 369 62 13 re
S
1 0 0 RG
n
49 347 242 11 re
S
1 0 0 RG
n
49 335 242 12 re
S
1 0 0 RG
n
49 324 242 12 re
S
1 0 0 RG
n
48 313 119 12 re
S
1 0 0 RG
n
178 313 113 12 re
S
1 0 0 RG
n
49 302 242 11 re
S
1 0 0 RG
n
49 290 242 11 re
S
1 0 0 RG
n
49 279 242 11 re
S
1 0 0 RG
n
49 268 242 11 re
S
1 0 0 RG
n
48 257 243 11 re
S
1 0 0 RG
n
48 245 243 12 re
S
1 0 0 RG
n
48 234 243 11 re
S
1 0 0 RG
n
48 222 243 13 re
S
1 0 0 RG
n
48 212 242 11 re
S
1 0 0 RG
n
48 200 243 12 re
S
1 0 0 RG
n
49 189 242 12 re
S
1 0 0 RG
n
49 179 242 11 re
S
1 0 0 RG
n
48 167 243 12 re
S
1 0 0 RG
n
48 155 243 13 re
S
1 0 0 RG
n
49 145 242 10 re
S
1 0 0 RG
n
49 133 241 12 re
S
1 0 0 RG
n
305 346 243 13 re
S
1 0 0 RG
n
306 336 242 11 re
S
1 0 0 RG
n
306 324 102 11 re
S
1 0 0 RG
n
314 313 233 12 re
S
1 0 0 RG
n
306 302 241 11 re
S
1 0 0 RG
n
305 290 243 12 re
S
1 0 0 RG
n
306 279 108 11 re
S
1 0 0 RG
n
435 279 113 11 re
S
1 0 0 RG
n
335 268 213 12 re
S
1 0 0 RG
n
305 257 243 12 re
S
1 0 0 RG
n
306 246 243 11 re
S
1 0 0 RG
n
306 234 242 11 re
S
1 0 0 RG
n
306 224 241 10 re
S
1 0 0 RG
n
306 212 242 12 re
S
1 0 0 RG
n
306 201 242 11 re
S
1 0 0 RG
n
305 189 243 12 re
S
1 0 0 RG
n
305 179 243 10 re
S
1 0 0 RG
n
306 167 242 12 re
S
1 0 0 RG
n
305 156 243 11 re
S
1 0 0 RG
n
305 145 244 11 re
S
1 0 0 RG
n
306 134 243 11 re
S
1 0 0 RG
n
305 122 243 12 re
S
1 0 0 RG
n
306 111 242 11 re
S
1 0 0 RG
n
306 100 242 11 re
S
1 0 0 RG
n
305 89 243 11 re
S
1 0 0 RG
n
306 78 242 11 re
S
1 0 0 RG
n
305 66 244 12 re
S
1 0 0 RG
n
306 55 242 11 re
S
0 1 0 RG
n
168 314 9 10 re
S
0 1 0 RG
n
414 281 8 9 re
S
0 1 0 RG
n
426 281 8 9 re
S
0 1 0 RG
n
306 269 29 10 re
S
0.619608 0.619608 0.619608 RG
n
49 109 241 9 re
S
0.619608 0.619608 0.619608 RG
n
49 100 242 9 re
S
0.619608 0.619608 0.619608 RG
n
48 90 243 11 re
S
0.619608 0.619608 0.619608 RG
n
49 82 69 9 re
S
0.619608 0.619608 0.619608 RG
n
49 73 107 9 re
S
0.619608 0.619608 0.619608 RG
n
49 64 241 10 re
S
0.619608 0.619608 0.619608 RG
n
49 55 64 10 re
S
0.619608 0.619608 0.619608 RG
n
138 760 153 10 re
S
0.619608 0.619608 0.619608 RG
n
52 755 13 9 re
S
0.619608 0.619608 0.619608 RG
n
73 753 7 8 re
S
0.619608 0.619608 0.619608 RG
n
80 752 211 10 re
S
0.619608 0.619608 0.619608 RG
n
534 782 60 12 re
S
0.619608 0.619608 0.619608 RG
n
230 740 62 12 re
S
Q


endstream
endobj
25 0 obj
<<
/SA false
/SM 0.02
/TR2 /Default
/Type /ExtGState
>>
endobj
26 0 obj
<<
/BaseFont /DJCIIA+AdvStone-SB
/Encoding /WinAnsiEncoding
/FirstChar 32
/FontDescriptor 27 0 R
/LastChar 177
/Subtype /Type1
/Type /Font
/Widths [ 291 291 375 572 572 979 781 208 406 406 427 572 291 333 291 458 572 572 572 572 572 572 572 572 572 572 291 291 572 572 572 458 833 666 625 666 750 541 510 760 739 302 302 645 520 958 781 791 593 791 614 552 593 718 656 1000 687 625 604 354 572 354 572 500 354 541 625 479 625 552 354 625 614 270 270 510 270 916 614 604 625 625 395 427 385 593 520 812 531 520 510 354 260 354 572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 572 572 0 0 0 0 0 0 0 0 0 0 0 0 0 572 ]
>>
endobj
27 0 obj
<<
/Ascent 735
/CapHeight 700
/CharSet (\057i\057K\057parenleft\057t\057zero\057eight\057parenright\057T\057u\057one\057A\057g\057B\057v\057two\057colon\057m\057b\057C\057w\057o\057d\057R\057c\057D\057comma\057y\057l\057four\057E\057e\057p\057n\057five\057f\057I\057r\057V\057P\057h\057J\057F\057s\057a\057W)
/Descent -249
/Flags 32
/FontBBox [ -177 -239 1395 770 ]
/FontFile3 28 0 R
/FontName /DJCIIA+AdvStone-SB
/ItalicAngle 0
/StemV 0
/Type /FontDescriptor
/XHeight 510
>>
endobj
28 0 obj
<<
/Filter /FlateDecode
/Subtype /Type1C
/Length 2344
>>
stream
HâÑUkPWÓ¶ªƒﬁË“”dö_ºÇ<PAﬁ‡¿¿Ç<uÑÖ¬àâœUAÉV¨∏´§\|à»ÀA|Ä"FQbX–ò‡#ëÑƒÕF\9=9Ce{0ªk’˛ÿ™ÆÓ∫˜~˜|ﬂ9˜;∑%ÑLJH$íﬂÖÜÖ-q\íQ¢)^üüÈ¨Yjúv8©¿ô[‚2‹aCÈˇL*èJ~›ª˜Õ€ú˘ÿN˚ÿ∆,`∫m˛ˆnBBòJà©1MJ∞¬ö 8ÇòIR¬ï ‹	¬ì Hà•r"JFhH"â ﬁ•2qmÒ!°#z%fí˘í…†T"ıïÓêvJ«Lìπ&&	&€LŒõ¸`bêÕëÌî=#gë´»‰s Ç ß*©+T7=É§7“óÈÂ‰πÚÉÚS+Sçaò¡P¡=Yd^˙Å7( ÏGx‹≠LºH¢´≠z†FÅõÅDG∞∑UäJΩÃÏáËÉ
sDˇQ ˆ4\«øw–(`3í‡Ñˆ„"˙räh3à!ÔÎ÷4fpÈ[äH2–ºïáqò¡Õb1C˝1V$‹0és¿Åˇ^í>1‡€˙ºØØ’}1&}~œ*}
ã2
5'¸·›§a&ÕË,ÖäWÿCÅÃ$ÅáYgª*@n◊ãÊhÍøbEö≤3å<ﬂz≠˛&wªqER`≤˙£?èhA2¬˚z5;õB4$ëë0Ñ†Ñà'ﬂx—¯≠%$¬'d~B1’◊ŸÑ¡ømæ√Å'òøÑi?i¿∑5Ûu0ÉÑ5‘È$Sã>	ã` ≤πQi!Û‘â’µ©<-ΩÏ“ÙŒœøli∏|Ü◊Ω?ñ^Ó-è⁄£çY¬ï˘≥‡¶‡ê¢…Õ∏”¸•„è˚˙EÈsØ‚;®T©—ƒÎZ“Õb•:«'ƒNÅ“q_pUVËUÏ›3I)q©kä¯Ùc—µ=äkÁt›ìEø√jÎs.4÷◊75g’gh≥≤µJ¯E¶≠œÁŒˇwéyMbﬁÿ8°&Å°æ 	Q=(~‹(¸TØ&1¿∞ê≠˚ÆÓI5Ú
™âØ9”≈0»ﬁß‹ŒÚÒSk˝¯@jƒìüüü¬‘qá[˚˘
˙ °ë6ê)~æéfJ¸xBMÅJ¯Ö†n∑DÖ«%¯ÚÈÛHoÆü√ûI9µî√=ËÑQÉZpFwÿ›7xÏ§éœxFnX≥‚ÉxﬂE˙Ô‡ÓØ~ÜY◊ªJ6ûÎÍ=,&0°Üç4|Ûƒcﬂ~ˆ‡âç¸gˆ%Ûª‚lLAOﬁìb“Ñto0üPF±J†tK!∂PLÄêf\õ"FSA˝õÖRÿL1ÿ ≈ñz5™&‘¥8òdT—…€ì∑î(∑o˙pK·π7”û~	.ºﬁéf>ÉbcUUìÅ∆+(®¬_aVÉa+‘£¨˜c/YN1†XcÔP√ó¥ÅŒ⁄–›|nÈQG√¢ó €∆∆°›x,0F¢ò3ìËÍ∆çÇEâπã¯X
U3Vd©{L¡LlÖyß–:»ﬁ¶é[Ø0≈ı.*î∏[$L,Ö1»5Ù;CÆaåf˙Ö©ñP≠∆©U·,>òf]NECZ4GA0:l∞ÇC¡bo∏	Òb>’`HÆîóS©∞:"R yï ¢`6’æWa·Uàç“é±∏∞}Â0ãÇ"]ïå‚ìÇ´Eö8X!ï3ibÄ-ÿó∞T)&π©~◊•f¨§a>í5.¡—•âQJ]$YSﬂ|¥ã”µ‰ß‡—,ãDyNpºì¬•G˝∞ÌbMuÉÚ,ÏbqÓ¡‡∞?pÎ÷◊¥v’5ˆTÒ¢OøÇÿ¡FOO˜<;/◊µOFÄnxÃ„aC÷›TzC{~73üv ç∫-è»KÃ‚À°≠)∆Vc7Êdˇ)ósä}êµVVñÔÆ‰+wWÓ:ºÛÏ´⁄§É´9\¶€’vv∫B∆≈ŒC'/È;E˙G-æs3›¸3G_º®z √‘Iv}Zc[9’ös*úCÖ3NGKÙxf3v¥\®„+(&[ÿ€Y∞?”p>áv(≥«˜–H8v›ØlÓ„3˚…‚úÑ“$Œ;¨t_Ò˚˘ûs∑á∏ﬁ”	ªx?ÄBK!Ã˚–¸+˙éÓ/GˇZU∂ÛàÚx/y$+c∑ÿ>g±CÇh¶I∏&î±h]N]\ø¸L4á6éˇ—e=ÙFWÖtHº{HÏ°ö$e°ô˜ŸPÈ ˆ`9 Ö<f¸o“¢}SÙE,ZMÅ5¥S_∑ÎzÓ’¶.S‚-q<H√Ù®ªhYúú&ﬁa˜˙DÜ2∞ Ë–^ˆJmãÆimcj⁄∫åÃïgµóƒ¥ÓA™•±ÇE4√êbTme‹ó©'M∫;]µ…bÏõF.˙Ys„›ﬁ™Â1JÏ«_—Â@´Ô!πGΩ'<o’jy[^¸…HN^òñÕó˚Ï≠`ˇGËËcÆØA.‡Ö£($Z8£∫ºFÃÁdNÖØøÆ˘i‰˚ÍyﬁÓT9¸€ñColÈòxˇüøŸ“¢O,˝ƒ6ëÁÆhÕé¸€ÿ=[∞iÑhM◊Â·ì÷Ô$Õ€"˜R@\lh;}xÁ÷c ´ﬂë’Î◊}ö«iÛWól‚2å7∫”Ö5ÏŸµÒá„8˚ ı¢®¶ÃÆ˛rvGaäbUˆÜÃµ+Oú»SÆ
&s.µﬂ„@˙`†ø≠§#ËØiI>ﬁ¨8WÛØÕYπxUcÈJ`‰ƒ~/˝)th.ÎoW˜ãø7∞´Ó˙Œ¥}˜¥˘õ‰JŒ≤6UV5ÁI«≠ª+ˇΩÎª¯˘ﬂ‚Ï¿HZÏªƒè`íﬂ föÎì≥Û¢‹˜√@˛5ˆﬂB'}æù⁄≥t◊.9>œÔ˚≈æÁ˝®˝Õ∂ ˆ7{Ïoé∏ﬂÚ¿#Òª|¸wéÑÔÏø%ã%æ'¸©∂  ~∞ √ A!^!Ò∑8∞X ¯.ïˆù9Xè
I|˜¯S…˙åmÎwÊmﬂY∂|ñJ[ãoˇÕ≤Ì73«∂Ô?ö~≥œNˇÕîˆõ9„∑ÿ
ÒÑo	ﬂ8¯<{Tâ~˙Õ˙€2,™–O:”Ë€w±ìﬂ˘N,ìˇﬁ˝cˇoVÏn„‡˚qA‰«=Q ˙‰Ù◊

endstream
endobj
29 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
30 0 obj
<<
/BaseFont /DJCIIC+AdvSTSerif-R
/Encoding /WinAnsiEncoding
/FirstChar 32
/FontDescriptor 31 0 R
/LastChar 177
/Subtype /Type1
/Type /Font
/Widths [ 291 291 375 572 572 906 812 208 354 354 427 572 291 333 291 385 572 572 572 572 572 572 572 572 572 572 291 291 572 572 572 458 760 687 614 739 781 572 520 791 802 354 354 666 572 958 791 812 572 812 635 500 614 781 718 1052 760 645 593 333 572 333 572 500 354 510 583 489 604 500 343 541 656 312 312 552 312 947 656 593 604 604 385 406 375 614 552 791 572 552 468 333 260 333 572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 281 281 0 0 0 500 0 0 0 0 0 0 0 0 0 291 0 572 572 0 0 0 0 0 0 0 0 0 333 0 0 0 572 ]
>>
endobj
31 0 obj
<<
/Ascent 735
/CapHeight 700
/CharSet (\057R\057K\057question\057p\057four\057S\057parenright\057E\057T\057five\057q\057quoteleft\057U\057g\057B\057r\057six\057V\057b\057C\057s\057a\057W\057c\057seven\057D\057l\057comma\057t\057eight\057X\057e\057G\057hyphen\057u\057nine\057H\057f\057I\057Y\057v\057period\057Z\057h\057P\057J\057colon\057F\057w\057slash\057bracketleft\057d\057semicolon\057L\057i\057endash\057y\057N\057zero\057percent\057j\057M\057z\057n\057one\057A\057k\057O\057bracketright\057two\057m\057quoteright\057x\057Q\057three\057o\057parenleft)
/Descent -249
/Flags 34
/FontBBox [ -197 -239 1270 770 ]
/FontFile3 32 0 R
/FontName /DJCIIC+AdvSTSerif-R
/ItalicAngle 0
/StemV 0
/Type /FontDescriptor
/XHeight 500
>>
endobj
32 0 obj
<<
/Filter /FlateDecode
/Subtype /Type1C
/Length 5136
>>
stream
Hâ§UiPTgÌﬁ¢B≥>¥_S˝ûª †,ÇŸ5Ä "0:Ü}i¥hhê–äeiöÕhDBµUh‹W4ã®¡(âgÉ:eƒörnSkÊa∆ôL‘_Û£øÆ∫uŒΩÁﬁÔªÁâE&F"±Xl3oA`HH‡tˇ‘º®Ë(ÖZôÊ9w6»ƒ;#Éù©-.√";ì¡°≠Ñ|á¯üøù¶‘òÉﬁ≤÷n\ªï»H,nÿ® “®ïÀW‰Ú”RÏyó9≥=ÖsŒÃ◊ß+Ôü™JVQöú\EFíô¢Rg©‘IπäTgû˜OOÁ#G∏9|§"G°Œ¢!—Å|TÆ*S¡+s¯$^≠XÆ∏jE*ü´NJUd$©WÒ™4!ìÃL U™2ì“˘hMñ"-)E¡˛;Ωv˛üÓDb)—F"3s/M`E>"ë?+RâDa¬LD&¢u¢œEﬂã^âÌƒˆb?q§∏Z¸çë≠Qâ—„â∆´çwòå1â1)59E∞Ñä∏JN ”…”î1•†.QOi?z?›7*h‘ô—ƒËÖ£Oé;&Lª©ôiÇÈ93{≥OÃ⁄ÃÆõ=ëòJ6H˛jÓh^kﬁk·c—kÈa©±<kegµ¿Í¶µ£ıJÎümfÿ‘Ÿ‹a∆1jÊ†≠±möÌy€ß∂√√ù¯í·Û±wπ›[ﬁÙ≈mFcÚ\]>˜±…≥Ó˚0··R QÇí?#È≤â√	ï7›û…≈ÿ¯nVæ¿Íˇ/k©¿¬	›Óœ∏·ÍZÊ2iX:AÑìl{hò√¥]|ì∞˙ÃÛ≈·q:yM‹Œ˘i	.á_0å¡È0VÓ¬ÇÔ!pˆô|c#ÅÓº+∫cãÎÅ Rπ@ÿèIHü ”a=QÆ‡éÓÉÚçÿ…á–}Y—ºÈ8V¿Ôπé!L[«Î˙˚T÷á«é‘èﬂı[˝8Àò;®õC	ÿ€Á•>≥µUøØµ5CØTfd(Ö¡<ıCwâE$nuóê¿ëBa
l oàƒ Ú∆Ht¿É8∏˝&9h]œ·6XÌ⁄VõÒ6>G´ÕjNœáb¨∞ˇLy¢ë¯j˚ÖÊ vÿõJ´(–f…µπ)Â~≈t6¥P>u
ùv']∫ßb{+1lÅ`fqnNLàíÁ;∫Æ]Ï†Ø]–@≥@:_DÒ\Â¸(9“-‘`˝ï„?…zN,FÕ—∆œóããçè]I/3ÑSù,Ù0û2ß¿gÜ8,Ò˜éIŸr,ìãπ©≠-*ﬂ∏Qö´)*Æ(´*ñÚ˝b}ﬂÍkÂR]v7Ñ_99uM⁄BÎ®ªz:7˝ù¢ƒÛ éí≈yØ…L‡|®˝DÔﬁ£˙NY«Èò¶-ä@S-'1xE0ãI§—Ωpc‹‹≠„†-ê\^±Nõ-◊ÆVîX"Ù›—B}Tõ¶”6”⁄ñä˙/ŸÓ?L§∫Ì©;@A‡ÂNª)	D
π‹©k¶"ÕzEyá+[õ5Ú–[≈õãKJJ•y˘%•UEU%“£^Ñ¶©S›+Ã;‡Q¶∏¢â;S	PëªoÉf‰N¥kÑã\UÜÈ4îøú„e }¸$ïÿW:^/ÛãœHSpÂ∫}‡ˆ∆CòVäΩ√ûLˇw?=:9k¢oäì˚å∞{¿÷…%Ü‡!Ç	¿pÙ¿Ø\–Å~L¬xyÇoÄ}|ÿmZ®o´ªJvÀ$0€pôπrÏbOœ±Hˇyäe	yr∑∂˘'~daÙ1∆#‚nˇù÷„ﬂ‰Ó&ÅqÍ÷sÈ¢ôÚ °°8p“¸s·}…\®⁄-IMû| »^ˆÄ;ùü”.?”ÀŸßÏãôg—H.y º€ z Ud“Z≈˜£µ'OüàaÁÌ7Ωî›:©o˚í”ï´–Õ9”I°◊‡…∏á˝)¿)æˇyœ·G=]û(+ëøgc"•>CàÈøE{æGø◊F0IXƒÃoQ0ÇIÙ√Hû?rxPA,”Ww†Îí¸õ≥W:˙Xyt°Ÿä†uÖ˘rÂ¬≤“ä“⁄2©>Ø∂¨¶≤¶FzˆQø≠©I/˚∫5‘/~MjRÏ\îX5ãNƒiÔÿlê¢†Ä9Üë–P≤rë,÷µPâk\ZÕ)LÜÀAGGë≥1G·_›Ëïk3◊d	®-TB˛¡√€∏ì¿€€ΩÑé¸ˆí3ê34ì˘ö8≠òÜt– HŒó\erï¸ıÁD4õñÌ2[≥˚>áÖé≥©áÖ⁄gvx	Â\]„R(œ=Sø˛•«„´8u{ÁµN°m“≥ù¡Cæ!3wU®/Jeò8xàûgpÂC¡	¬e‡vŒ›´äkÜl(¨W}*o¯(Æ—AÜÕ8—w@®$ıﬂhÿ÷ŒÌ˝¥±∫ô’É•‡ÈØ5í˝LxUëXÉÊûËÍ®ÆÒà“}Ã[:/QP	S¡b!-¿K9ºGJéÿ
IΩ‡/Ÿ$Wóåìe.©u˜8»Î£∫vÆà–	“îŸdhyñzëÃÉŸ›ÌøEœé &ˇPFˇZ◊ÍÛhˇmÔAeCsÂ≤µ∫ÙIè©ÆÊÂ##X˘¶é#)Å<√ÇBÊo}MªØr@=“ñ>‹*o¡£ŸΩNFy∆°%&xA∏V ¡∑Ú:L≈{'∫m7Q¡’7@ºb‡ío…2,˘O…Ê7wé˛¯¸ﬂéø´≠ëœdé°õ˘?¡qÊŒO»’|VøZÆl,¸Q´ïÊÁïï◊Kèƒü¸ãÒ*äÍ ¬£·Ω€å⁄ñåO°ª|œ=íà†8$.qCYei6K£t£‚∞à¢,ç6›@îUˆl6Çó†£&#â«â3c•f h‚y‰t¶Êvì*k˛ºWØÓªÁú˚›ÔúÛùcGäÂyóåï«$u≈_]Ä(ôÙ1ÿ¿ÓE¨ìkƒc%≥µ´&Ê¥¸õ2ˆÕK∏ ∂ÃÅ◊®Zÿn€’’q∫©XbD/5i?zıPx,“V£Ÿó° ï@»ãG∑∞'„ˆh({
,ÏYU8"à;^ìTú!dsÂ,‘ã=åŒ¸ˆK‡˜#◊:o—Ì.ªÃ±Yº»†ØöÌÌã
≠Ã¡doNä6ïœV∆¶áf”.¥«HB±•ŸÌmynEµL¥◊—Æ≥wl„4Ò*©÷WË yC{kièÅûN´&7≤[”Jâ.Uü≤Wfv‘¥7tOÀ[ÇÓjˆí)^Ÿ(ò„ü;äKﬂfq§5∑üÂXyx`É3˙H§pD¥•5[M5—jP¬"¥ÅÕòÄQ∏ùQÖÅ`èã¿_hhÂê≥§!d”&i^JÅ{°,=—õÚ”íHC,X]B+ÔªßËÑdô0Ì.Ãï¡ƒe7p9èeØJ/Œw„q:w∏Bù_∞≥–.Æ(¨dS3Nπl;ÅjàêÅN‹âë∏ùp˙√|\Å¸Yv·ƒè£⁄≤´ãÏÃì«Ósñ Ì1Ç˛ËãSÈ∆…ê”áa1¨§#?˝){Î√háÃªnKÖ∑YÙÄ˚/ñ£_XÈıà†&5„∏+Ú'%lLµˇH-{∞∑˝Ù‰µ??ëÅı¸ÛÛy<√J›E'±óÉÈƒêßœ“Ò•Ô˙"‰H^_ø«G]P
∆Ç∂@wŸ:ﬂ-ÎW≠;ØQ?8ó•9£◊Ú…É˛$áâ Ω˛€?kTx˝ìÔè»núº¸YáˇÜ"û6Çg4¸áÏÉ™ ∑°ûM∆|éMD¶ûΩ—R5¯@˛–‹˘"]-ÂX˘≤∆~Çn7fB,p0c‚yh{Œ∆ñ“^®IœØŸà&ÇK]q⁄G?Éô¥É8¿i™û∞û≤ﬂ§öyJ¬U7qÀÆïÙ≥_@‰}à†O…πÍñcMr#™‘‰¶QÂ©º–¡y†C,ÙÖ5Q[…WqùÂÉr©ò
Mãî9Á[∂€7
¶πôÈf!TÏÖπì°˜Ó-˛ì¨Ë¨=IM&™…Áy	˚º¬qv$Œ√ô-ã!¢ââfQaÓ`Ë◊qs3π÷xç™£ ÒŒòw≤ÊTU›Ì´&≠-…€b ˜u≥asyGKe]ÿØ&g™vá5	4I2—á÷•‡ç:Ñ6Î#â⁄eÍ¶*éBÁÑfcODz4])4íÄÉ•ü
4›⁄Èg‡;ç^˚ì¨HΩÆÒX+‡"”€–P“H›lWì+Õ;Ωc‰Qèì@œhw‹°+Ejr∂Q„ﬁb	‡2Éã~ÆOçbÖ«áNFv‰h]˜®ˆ∞fóÔ«◊ƒ0b¨W≥NyQë+‰ÿ∆äK∆&0ñôƒz,â˚è3®åÆ$8˝¯ya,á|P|ºóøc§U⁄Xíï˙È;~ L¯>áÓ?∞ïwUÉÍ;gÀ∏>tÔéÄÖ8/^ñ–TV¯·Ÿ2-ü}v˜»˝ßi ‹á∂^±A
UGœ◊OÍ˛÷¬√r,Â≤ôMÍ‹Ó~hå€:Ä÷·±áˇ®‡3r ⁄óhõw8?ß@€z»∂ O$ﬂ iØ´í_≠ı]*‡o"¥V¯',î≠Ùªaj<^VÀﬂ`äTe)ºÙ≠]Ÿ\˛•“æµ∏∑˚Ç¸ˆÌ-8›Ôµ|Gd¡ât!µ2∑ßIFHÆ¸⁄`‚ór™a•0ú¿Õq%û™≠ïZ]x™GÜè÷N›Eéß$
“’¢◊=nø&>)@és∑ÅÏ[ò˜eœïéÜ‘‘R°ﬂGü[p‘êo◊VìØ;¢œ’€≈3ïqÅÖ;‰∏ 'Õ√%k€ﬁiéúGAR\Oµ˛UFzZ\
<‚àR»üﬁ=CÁéÒWªR"å&Û‘_`ˇŒÊ√)¶·‡LR¶”≈ÀQé”úp≤#8ñ’ïUüÜ;è&Ï)K±£ïGM\#õu˜Ë|∂ Á†ıöS+O∆ÚŒüQR/7±0}(’ƒd$≈Y6'¨Å⁄¨¿ÊzÁ≈æpè]È{®§÷¿?ƒDò∆vm9U^ïôYÀ∑ßhã¥Tó◊ÂÁ
≥
ÏB;3ﬁK—Ó◊⁄Ì Ÿóú&Q™ïJŸÚçäè2Yl»w…†Âß÷H¸J]Nµ$ßÓHiã.ˇãtU1“$ËŒÁÜé|K‡ÁÎ8◊Ô‚ÌÅÆ¶ŒZÜ≈?pgñÑf¯fπÎÏä5*ΩRÓ0œo÷äS€ÓDﬂ…k‘|êeß%≥ò¥L›ﬁ4éÊFãó›„˚_‘∑æîw<¡l>æ›P'´(+-9∆ÁïÊU a“≠w˙ìœÌÆ–°âªÆk_Î(S§πn Â]rì˛=,Î´˘(üó˛B(◊ºâ˙}b¥‹Åπ˘ëÚçƒ•ÿê˚PRÚ§
∆√‘oıŒû<zæ‰è‰i“-î.uçé‡·*ëbÑàÔqä]õ2®u“g“+<˘‚Vë#»Ç◊†n654öLâÒ™Du<o11…üã» ⁄Àå—§Ï…ëÏ%££Ω∞J;({,∂∑Pˆê^ãÌ4»xâç˝b_	∑•'√óG:bkjj´™¥Ë*W™´ÆQY%DÑª.€$7˝äêØÉäÿÉLa8Âˇá°¯ëä6TÓgq∞æß˚ﬁ#√™5<zºƒæÑ¿ Ó˛ø˛Ô¢…”ù∑—jÖ˜+/◊ò(Æ(é◊¬ùª%B¥e*≤:∑QÍT4-ı1‚+h’uY¥qõÆå »"ë›Ú÷a1«ÆîZ≤∞(≤Ó˙åÚa£ÿJM∞±h¸`L4÷¥göª<£“–ê&˙mÓúô3sŒ=˜w˛gó1CÍ……ÌH‘œ_πÀ¯-≥
o≤≤QÀ ˇf7>*ƒ˜⁄“A˙NûÄî[sˇ∆ŒK¯ò?p&¯j*ˇÑ3æ¬ÁA$kD©5j√3àÑ¯[ø¬Gp4·	+ñ…"‹∞loA◊›Ëq˘ıøıx¸Ï|>ï«§g:ZÕ,%‘⁄›Zﬁ•á% tu‹M˛·úâŸFDl˘˜œ(tÕÛ©°äèÕÖÂŸRyÓ7ˆ’ö†lä‰ü0j,û’∞ÆJ«'h,ZŒÈpµì°∆∑îõÚ^R.§∑Û R.ÇØÑªÍd±÷VcØ´q9£Íjjë£_î´†®≤Do-<¥/õ6ë«#*xXFõ∫È?4ôE9r´”qºÚ1¸D¢ﬂ!Z€ªJÆË>9ˇ≤ª®}fÄ-ıoQz¢›gOyÆùŸ∂ßZRûéÌ&Ñi“¬‘/í€
Óß∞È˛úU—;˜ÏXøﬁS_•$coÄ?5ŒÄyY¬æy˘˘tìÊo‡ÌîOºö◊'ÅÓ|ôBä≥e{ñ>Ÿ>‡f–!Ø…ÊUo∆Û±#+d6Âq;åÒâE}˝‹A{ÍPºoÏ{)mMÍ:Y’‚ë˘à^ZHVÁàó˜_Ø;á¬†^¶õ∂ZÍ,~F⁄4ä§”Ÿ‘”ÉFìL˝W ñYˇòˇHp»®U-‚πÛf!E:òÆÜ√î`∏v˘)æŸ€|‚¥Ê6M¶ûke”,l∑iöIR√Hö¿cÉW…PGeˇ\¿èPmå¯\º`©:È√u°L;\y&Ö˝≈ÁÚ0O∂d 9È(áV)tsâ±{œ˙9!Ü≥69o*4-´æm?„1∞˚)å&7ºM«=Ë(	%Wµ5›Ãƒå˘2ËD>º§OæTz	ÌhØ∑Æ;Õ`ApºÅP`ﬁõìyp|J.)*Ø(-ç∂“íÍ‚£“]¡›p Ìd‡Tòß◊;îó“eﬂ±àiÍ"’&Ú|ú"¯*õ;zà¯Ì`“âL¢∆¬8Y0~oÕX®ÁFÆ™	€´Lbo–∂âu;RÌ_K”ä

endstream
endobj
33 0 obj
<<
/BaseFont /DJCIIE+AdvSTSerif-I
/Encoding /WinAnsiEncoding
/FirstChar 32
/FontDescriptor 34 0 R
/LastChar 177
/Subtype /Type1
/Type /Font
/Widths [ 291 312 375 572 572 906 760 281 333 333 500 572 291 333 291 333 572 572 572 572 572 572 572 572 572 572 291 291 572 572 572 458 760 687 614 708 770 572 541 739 760 333 333 666 572 885 760 739 572 739 614 479 645 697 718 1072 739 645 645 333 572 333 572 500 354 541 541 416 541 427 333 458 572 291 281 500 291 854 572 500 520 520 354 406 333 552 479 739 520 479 479 333 281 333 572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 281 0 0 0 0 0 0 0 0 0 0 0 0 0 291 0 572 572 0 0 0 0 0 0 0 0 0 333 0 0 0 572 ]
>>
endobj
34 0 obj
<<
/Ascent 735
/CapHeight 700
/CharSet (\057a\057L\057t\057M\057T\057u\057H\057k\057A\057g\057B\057O\057v\057m\057colon\057b\057x\057C\057w\057o\057d\057c\057R\057l\057comma\057D\057y\057four\057E\057e\057S\057p\057N\057n\057f\057U\057I\057period\057quoteright\057r\057h\057P\057J\057F\057s\057K\057i)
/Descent -224
/Flags 34
/FontBBox [ -208 -250 1291 760 ]
/FontFile3 35 0 R
/FontName /DJCIIE+AdvSTSerif-I
/ItalicAngle 0
/StemV 0
/Type /FontDescriptor
/XHeight 512
>>
endobj
35 0 obj
<<
/Filter /FlateDecode
/Subtype /Type1C
/Length 3658
>>
stream
HâîUkTT◊æÉúÀ8jõÀöawT®hQA%(B	‚£((/%¬Â1¬ 20Ä C º∆áƒF—£Q⁄Äè‘–¯k!Ö`çµÀh„“â˚N7©=#&Í™]m‹˚cÔ≥ø˝Ì«˘éà±∂bD"—KW.˚π‚ÊàpïVΩqv†≈>GêãÑ)V¬{LƒÍ)ƒŒºÉ8Ì=≠™˚€€@ÕDËú\;eÚıü0V"—ûˆ MFÆVùîú≠pMò©X¥–Àç˛π?˚œS¯'j‚Uä‹¨l’¶,E`zÇFõ°—∆e´Á(˛iiä0Klñ"Lï•“n¶÷¿à Ex∂&]•Pg)‚ZUíö∆jUâälm\¢jSú6U°ŸHë®1=.[≠IèKSD‰f®6∆%®œ·©yŒ+’1"FÃ0f"√p#gòiÑô)fÊècñàô ¬Ñ€0Ó¥9å5„¬,g¢ô.Êñh°hØËûïó’>´åÀ◊6ÓÎ Î*"&È§ì|œ&∞∞!6…6gƒrqº¯∆¯È„5„ü⁄&Ÿ^≤s±SŸ=µO∑?4¡aB¸ÑÓ	ˇîdHŒM\:qxRËhΩ@*xs'/Ç8wl)Ωê_]PÈ§ã©Z6ÕY,iƒ@ÓDLó∫#‚Cµπ=Ú≤e ÇJ^≥sπ3=pµõÀiLÈ:Ÿˆ~W{æ)yCJFåì‰º`2ápa,∫¢ŒEoúÜÓ∆t)úa í∂o{7SVöì®_V^ë)Ö∂∆D¢kì˚¶Í¶∫éÊÎ“«l”U2ù≈aá{¿|Ï»∑Ωt9…Ò◊‰˚B`®QMçá_"K å≠5ëÑ-/~¿bF∂	•∆¯\mîNVûI ü&èÿ˘n}Ò-Ÿ·èdãÊ¢∂πãc”∂$ØïÉ 8àÄƒ¿≈DÚä‡	wôΩÛY‰B¥@[∑ánÔÂ˚—ÖÉ7¡µúˇtc¡nﬁ`3–˙,X9˛9Ù,Jú([û9T≤kgæül÷hIæOE„¢‚g$Æò=∏´Ï˝ΩÎ¢ßﬁÎ¸x_VëÊ`≥w¥õ‰Ñîÿ)ú„g	„∂µÓ‚?ÖÈŸ;âœ⁄Xwtì„Ãu0l!¨a5§¡‘ñp$ïºâb’æÊx^@+tFÔY®¡"îÈé|Ÿ¬?Z	ˆ}OΩ,¸fC:¨ÉUSG0ö«! wpåØÎhIûèÆ—ªX&9õgq0ÖΩV∑˛m=≈ˇ º»h8[ë9TNœ˙<;ª®¢qq©•6°òΩ+I&õ´&Œkïe≥Â™Í¡=|7dìø∞ókã¸ébbª çû ã%iÖ[ãWÀΩXIªpâ.E÷Ω¬¢¬¬¢Çv≠ïéŒgWIŸû~ŸqPS¥œw%ÚÒ&õ.ÿD°Ú)‘∂‹‚`
u.êóK† -‹„ZçÖ7jMR<¯º“?YFº≈vB‰ò[F˜M/&˜ÇÉÓáZ”‚1ü@Å[l$6X&ªpl≤¶~	˛:^…˙ø†“®$ÂÄ?◊Œ-∑
:Èÿ‚7;ÿO&°Cº#∏r† 1àøÈÿ¢Y∂˚ÒdìTòéÔxä∑≤øÖıˇguß°ûº«¬$!HnÈñﬂ•Œ_U~‰≥ÈRlu
üO:kqW*À‹‰ÛT’˝Õ¸}!Áıπf˛òK"àoõﬂ‚öŸ∂c9Àn£⁄mAy€ñÍüë»•yñ≤w_ï]Ê–KÿÉ˛„íSË/>»¬ﬂÖO©…k4˙ıMø)$ì°∆Ó÷√Ú£!¿U,éåˆÆá–	áPz[∂aò&héâm„gå¶Â˘§Íb«ƒaçÒ7jd7?`1&¢Ê
*dX_ë/[:åøë[Ä+i]‰n[·/
yˇ—¢g—
BÈ‚
kƒ@≥lﬁ1+9L≈ïËãuxR ÔÙCgü`hw]˘¸MtŒ¢N¡’~∏#qR8Ç¢A4,·È’;iû«ùaGé,ZáŒ”BúıºÂ"L›˛O@·ÿß¸Ær¬2Je¯ø≠’£ø~ÀçπtTÇ_ÚtC&dø√:¢n˙u“iy?[Ω'•=Ω{√]ô7xíÎÕ ∫ìØá‡T'4æ»¢>Æó˝ ¥"⁄g=≠¡ñ_¡J‘B∫Ÿá€Q£Ø+7àõ¢÷7»]oM;:¥åø∂∫sE¥„|ø®Uouip d5Ë¨/≠÷UÎe[NııÀ¡}¯…`oÈYØõºÁÌ»Œ^«ÅÛ{ªT:'À5ñö-
af7¢ïêØè¥π+;≠Gœ‰Ωê◊óˆ¨Ö3˚uÕR≠ˇv)KÍ-≠ƒ·“∏Ì™ÍdôÀÆK¡0C„aÚ¨Í‡Ø¿˝Ω√5Ö√c;ΩuL=ÍÚ}i» Aè¥ê5h/GYÊ›«ÔÒT«™ÑÌ‹À–C1:fóÔπœÅ ˆ˝ºAüÜˆEJ]û±@f(™+l)ü;“í˝ lu^QC√IY|√açíæ†Sïre’≈cïº~Ëw†£òBãÖµ‹ÈöÂ)òÖsÁ/»…1÷ÁÚ~’ …y9Ç=\yÊ'5§¡–Z©q,÷óËÚùPÒ=}ﬂda}H<!„\Nﬂ™ihãS„≥yΩ·û0ÉHf	ûÇ/◊tô4oâ´Këß*Ûµ1<Ã¨¿‡˘‚Öágå»˜}∏˚–I~‰r—íñ+˜€‹	l˚¿l:⁄”4{-ïœb(˚ç8«¬~CÂ˚è({w£¯4‘Qr=Øí€Ño‹çìü5™ﬁ˜Ïèç™k‘ˆºÍYuQm·ﬁrX|GZJï<÷(PòED‚	O¡éKä
ßÑÊgÉËÒ% ˜¡ø¯¨“†&Ø(Íˆ>”Œòi≈`íoöØqï⁄3h«\QAà¢hL!	1aIà¢D$,"õ◊äNQkup¨c;qä∂Nù∂æÿ´3}†L´UˇæÔ‹{œπÁ˛eq}$¬4Ü¿%áaÙØÓ°]E†¡ëú>˚}Ïuá>X)€∂º ÿÕÛı¯Ó`:e˝ö‘·ÍjªL∑7ÏI≥356€5dﬂkñ–âú	ª¢?JôàR‡Û"
uQÒúª¯˚n¨d·…îÎbG‡–úñΩ∑√Ñ¸’ãwÑ≠\Ÿ¸›ùáﬂ‡ãd÷G›Ÿˆ›˘T&^ôL\$¶a‘åY>°ùâóLôﬁj≤ÍY)ª#D;¯“™lGæ`YL›4õà«Jn·±òπåYÇ{t°óﬂ‹S’^+8^””{ó_°s ´†Ä)úﬁÜﬂÓû±n‹≤v€Ã–Õ≤Û]$£µxﬂß∑NÈ ßb¡=∫-;<A¡¨Ü¢ˇ»ÒÂîïáÖ§U*¥j:G_Uoan‚cË¡aIMÌ<ˆè ¬yÏ	É5ôôg^'îd¡ NßôJKL•tµF,/`B‡õ¸˜c43?‡'E’¶J©ë!ÀûágsZk‹Ó"¶°hø;âﬁ*Ì÷2"≠C‘L≥sû	9ôo
]b∫OÆ±Ìçhì˚`Z-Ò≥2á∏V‘wÖ„lÏè'Vÿù÷ ^mô≠-£íì}˝ØbI©œàç;ûâ9√}µöF«Å%œößñh•0˛˘1ÓP¶˝¶ó{˚JéH´i¬¬∞Ò‡ò˚v^¬sÿ3t£^∏S…Ã|N°~™äºW^«Fù√Ô˘ÃJp)Ü?ÂΩÎW2˛Î∏∫dıët `Ú‹h2~Ù¥µS~Ù\¯xÛcù±Ø¯wÄŸºóˇ∑lŸHÖUı≈Ãç!˛´%5—¥?_ÒﬂˆNF‡BG‡JM%√pZÜùã£ﬁèsòÅ‘"õ @ì˝ö|Ò$∆vî≥D9x{ﬂ$˘sî£WÎK◊APª¯4˛ôsªXœ[’)π9$WfÀHË1¬& ‚B_ÈJ,:Fc5⁄ÕïMx!ØP[˜√J˛Q√ÔÅ≤ZÒf¡¬‰z<—o[*xmG8®ã„j?Ìl§õ™Ñ±∞FAÄÔæl£9ó¨¸Áx¢˜	º∂Úß¥µlÂU]ZÆRZôZª„>
ŸV0ÖT˛¯=„]|bÍ˘–£‰8Ñ∆dzÕ¢∏Â
F“öp.ñu1∫*#ÇøgÁ∆5zAÑ>≤Õ~É%¶2aíª;Ú/“O~Èª}-˛‰ˆf&ÊTÚ±˛Ö≥’µÁ\Ò	FÅãÚ$oèÑcv"bK«Ò<îBI%iôÈ
Ètn¿êıS·o¥*∑^ÿB„®KÍ£(?#.'ïNŸkøW¡\√=@±[=5ƒŸ(˘"Ö[a
∞"ÈÙl«+Yº¡∑7¶"r‘#`e∏•-Ùèx*ûqÆë‹0Y¿[Oÿk¢eÔ¬Îâå¯Å≥ÆªWÂ‰â{êEWPñGÀ
PûN©ïÛ◊èœ2&$Ö¿Dû—Ë`°±>ãÜÄ“Lõ©‘d7ŒõıI≈¡V`ôaº∆≥H¨¬Î»Ø"¸àƒ¿6xÑö("†æ#]ßØ…ÑtBA åÎQñ>&%F „ úƒ4°Á≥YâEY∆lC6œïõæ≈æ‰R©¯O‰–¡´Ûµ:%Ç®í}Âªy∏”RÛˆFxÃeªØr‰Ze°^≠I‚™Mã†õr:ÌŒ
Ü,ıÇnKdã§ú.≥ôL•ˆÍVWÁ‰hsÙº(≠¸∏ÏÍûß\bﬂπé4◊Â◊ÚÍHπk-◊†‹·rU·™,UVöà'ﬂÜÁ£:µ¶VI´‰*ùänºE\QÙ™¢‚µß`v‡n Æ-“%ãΩKyÉ∆†∞ÈXN™\o3ò+l‹“c5ùç'Ò)è/˜%‚ÓˇI0≈oãÄ/ƒÔÒåz'	u–œMNLOﬁô¥{ß(’(&\tNÚîq˛ π–np

endstream
endobj
36 0 obj
<<
/BaseFont /DJCIIG+AdvStone
/Encoding /WinAnsiEncoding
/FirstChar 32
/FontDescriptor 37 0 R
/LastChar 177
/Subtype /Type1
/Type /Font
/Widths [ 291 291 375 572 572 927 812 208 354 354 427 572 291 333 291 385 572 572 572 572 572 572 572 572 572 572 291 291 572 572 572 458 791 614 572 687 739 500 479 739 708 260 270 593 479 927 781 791 541 791 552 520 552 687 593 927 645 541 614 333 572 333 572 500 354 500 593 479 593 510 291 593 583 239 239 479 239 895 583 572 593 593 343 385 343 572 489 781 520 500 447 354 260 354 572 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 281 0 0 0 500 0 0 0 0 0 0 0 0 0 291 0 572 572 0 0 0 0 0 0 0 0 0 333 0 0 0 572 ]
>>
endobj
37 0 obj
<<
/Ascent 735
/CapHeight 700
/CharSet (\057R\057K\057p\057four\057E\057parenright\057S\057at\057T\057five\057q\057U\057g\057B\057r\057six\057b\057C\057seven\057s\057a\057c\057W\057l\057D\057comma\057t\057eight\057e\057G\057hyphen\057u\057H\057f\057nine\057I\057v\057period\057colon\057h\057P\057J\057F\057w\057slash\057bracketleft\057d\057endash\057semicolon\057i\057L\057y\057N\057zero\057j\057M\057z\057n\057one\057A\057k\057O\057bracketright\057two\057m\057quoteright\057x\057Q\057three\057o\057parenleft)
/Descent -249
/Flags 32
/FontBBox [ -177 -239 1291 760 ]
/FontFile3 38 0 R
/FontName /DJCIIG+AdvStone
/ItalicAngle 0
/StemV 0
/Type /FontDescriptor
/XHeight 510
>>
endobj
38 0 obj
<<
/Filter /FlateDecode
/Subtype /Type1C
/Length 3334
>>
stream
HâÑU	PgÓÅÈÉÅiØ4 ¥N£x 
äÉÀ%á¿†¿pâ   $†(‹BçÎV¢®cL%õ*R∆M$ä(Ç`#,(ÒBt‚ÅBÜàoÀ7≥o®Ï?¶6ªU…÷VWuWΩ~Ôˇﬁ˜ˇﬂ˚~%∑°d2ŸÿË0≠6rvHnibI—∫<kÃ›$⁄òDG\åùL€õ˜–ÍØdøÏﬁ˝Î€ÅΩ7l∆}2yÃ¨Ò÷lªﬂJ)≈ŸP 1‘TÅÚ£® ä
¢®P'™à¢¢%ß$*é⁄J}AUS≠‘5'õ"[.kîıÿ6y6õmÓ€˙⁄fŸ~"wëßÀ´‰√Ù$z>Ωî˛åÆßœ–˝åå·ôX¶úÈ`û≤°l9{ëÌÂX.á+Âvq√v3Ì2Ìÿ(îä˜˚äáˆ
{G˚t˚Ì€‰·ÎZû('(˝ïü+œ)ëw‚gX∂Ò¯ﬁìN0B}πn{Gûò≥yç∂D“·"öG5ú6op¢; —ÀU∏Ï˙ÄRÍ∆F⁄ÂÜAî
ı¬BP<Uì¸ò#¿D#»aî´`ôÃ#î:7ó~ˆÉ1JÖã–Æ$=√Äa» ñ<õ˙’F1w€∆∞˜%-ÜËy–©B?Í≤$±∑M»Ø)™´≠©©=æ∂¶†`Ì∫|5Ô¸–YÄÉÊ:ö¡™—öáì€ò˙f¬ü¡'0C0ÁcŸú	S•ÎrM“SX⁄„‡`á;jqUí´F‚aƒú.D1ò\•É)ÁËQ•ëÂõM=¯ê— ¡Ù⁄KwUo4∑—~jDjJé∫%ã>^ﬂ÷–%^kN–≈o[éi∏JB7Ù$ç√C°$ﬂyalÇolZÂ˛B©(ˆ»ñ˙w9Å¶‚'∞≠xæ\ù£πürz∂˛ã«ù;Ê`⁄ø\&∆≈îÆéóéËË™⁄ˆ≠b”ï27Ô,∑R<Àõ¥fùœ Z“ËLË¡å«êqœ∞Ä≈Àé∞”z<ÃêLíÊc)/ò£
]·áÚ%I’’9ÍÇ•t⁄˘[[/â‡˜h∞Hg,?,5ÉqÃ°ö7m$õÅÂ0	3v‚^gWå∏√L∆øy{$p€3˚&≤brzyÈªR(@ˆ
<ø·0¡2$D.iˇ®≥m?4G¯dÜŒìx”A“ç%0˙|j˘Á&xmÊ≠áuN–§t˛p˚L≥°Nj*:£¬áã®X°Û+¢_ﬁÅ±`„⁄wPjo∏’qW5“É„–I‚p&˘Jë:æ0`â≥ y‰O ©?6œnMM—≠»IY#•~≠˝∂Kuı‰…õj˛—D˘AHÇÃΩ†Á¿KÔ˝ßâ®vqFá]⁄Ï2†$±˝LeM≥§Ø» 2Ù,vÇ”ê–◊í=«•¨Z†Yy˝ŒÉ÷õC“ˇP£âíÁ◊¨#±£ˇ•PÃ∏ä°¨k¶n·˜–f™2})lÀ¶m)>í&¢"ëÚ;ïx˘“ÈTVJe«‚˚Ä2>G8·Z‹ÑËâe8\’wW_Sù°7dƒîÃ19≤èæêû†$eÎ/¢è∑g≤KS∂ü¨‹']á*˝”ÖÚ≥wJ»oOÀﬂ_øøÛY˜ÕV2<'Áá'FuÙ#Ê6‰–wÊíèú¡J≥éFç%@h0û0÷√xNœ‘·¯„ÓuÓZÓ2ΩÉ˘nö»¨ …Éy∂XÄœ~;`<Œœ›+ÈŸˆø›oFı ∞ÕEçkGuå—¨˙ôæ¶¸òE°Òi—räy™YÍ3◊ÕÒcT„R«dòÄA∞wx‡Ë±)Øì. â€,è‚¡[µ=Bnﬂ.X_KÏ$FuêÀ¬p%ìº‹¿Î$ú@ZX:4Ω0{é¶JH1¸ß¶+Á'£:”$6√~ÿa¿P
{~Îoˇå–Úk¸Ä5ªM›pS¿ø∞õrW~®q*ˇ”LÙù+Î◊ùíNv“uŸ˛µ3D‹Gò,!∑KºÉ¡†øÔÎ™k4∞<ö)‡éu8uÓVòÁ0ÇœçèõAÎh÷ëÒƒ‚VVÅlÓˆîJ’€À7ó}ƒÈÿ·æVò.ô£Y˛9XΩ‚ÌøË∏h·FÍÒ TAÉ∂	œ!ôı≠ÉéoöÓoä4ﬂ#^å∆∫bú+¶˙@™7ƒyC,Á2™Î3uÎô√sa∂a$◊»<ÜHòó™˚9Ω•õ¥ßÃ1§ﬁﬂ“Q¡§s¯=!ö≥ñ∂ÎôS±Pâ›0£π∆™Ùid2A~êÀ—<1ì<ÆDÃÀ1TËÖƒ±Q˛0&¿B ƒ@,v"NâA‘J¸wÑ§BËf^5%πËR=>í÷Ï¢óe¡˚˘‚LìΩÆ¢´Ñ·d˛Ÿ»¿%ÙlÓ¬œ@I˜÷Ä¯÷©~áøÖ‡;C°˙ˇ·_xã?¿tµØˆ’ïÃ≈±R„érü6Ωd`∂?9Ç°–Jw7ùÌ|©•œ˜»®1ù·´MôfG°97ˆP®à2Øp◊Æ¨ŒLÈ|ˆÎÑy™¿eÔFh3è…Qg≈”ig˚J∫Eêø˛láØÃ6Hﬁ]Y'Œ™⁄ø5ú:]\|\M∫Ëu4+`£¡“¥JFDE)∑¨Æªà≈®ﬁÈê
ÅF∞oµ)ŒÀ√ŒZÈB(åKÓÅjS πT"M¡$;„„1>∏
&
ì 9	íº &Aˆh˝„ø¯¨ˆ†®Í(l ΩK	+!ç´˜:¢b	…ä)5ÀL∆+wï›Õ]vEtYyâ∞≥d§âòπ4ë2fæ∆≠´∏,"≤±@ùÚÅ÷&ôç:‰+∆Œ•≥8˝÷¶öi“ôﬂ?˜ŒΩøÛ}Á|Á;áÓ ˘ê∑Éûty;Í€QﬁÅÚ¿õ4ŒKÿëé*æ£¿Çó*i%‰* ùú@2«ø'ƒ„80çÏ`∞ßât„¨‰›B`á⁄êïÉ˘è8ëxÙ˝ƒ‰WÂo+ÂÓ“euµ÷G¿JL¡·˚ﬂL÷º´À‡lã)kù}'Î8ï-ﬂƒc2*≤`éjfDLÁÇ-ÕVõç;Îå›ˆ∫4ç5k››çıû˝<ÈÉKn≤˙˙Åi˜<º›Újll>„0?V3ﬁU¥Œﬁ∂¢õÖ(/i‘ËÀ˘êàjeR·¸æ.H¸üÏeJ≤ÂKX^xw ∆›nÎµ€◊Æ9¬[]‘·úÃÌƒ„8|1≈J¨i›â≥ªl‡£n&:Û¡ÔèNÙ‹u≈≈‡àÃI¯”IÿAìùïtkÅ¸`*ã„c0î˝ÃõÄÌ=›Ë∞ÒU¥x∑ê≤Nm’¿xåfë¬)Œ¡§ﬂ¢!÷›UcwÛ≈™xπ≤,ìùö‘wˇæ˙+Ê‹ßı?Ù≥û⁄π	˛A	·Ç
Ç‹‰]wm⁄Y≥√≤q'W”BÌ2l.fïFr©⁄„Sâû∑RP1íîJ⁄Uîfùœb‰¥∞rûø∞¶“>oÓ$ôr´MŒï,†åù=kzX`a‰w†‡≈ø¿lRC&/¥—˝ÁóÆ7hc8Ï¬UÑ Œ°Hùh XDÊeuè`a|Ø`-`ö∑?t†Ù∞—XZT≤r{n3°T]çUå«”R^8&Ò’â+r Õ\≈™≤µÊçÅ@:ˇÁØz¬Ωpêx‡J¥›j@#lÅêø]O˙|9µZòKjå’Nj2d"Ì≥	å8È~á„⁄ïÜÇ◊E‡ã∏ÆıÌNL|Ú¯≥ËëEyG∞ ‘¬,ﬂX†≠ï≤™˘≈:˝“_Úl“%Ò¡©˜»Œ<ùFí›Pä¡Y8˝@/d eü,â…«·¯>ü√ÔxÌ!¿/±+O”v¨øjCÎºÕ≥Nì+Í…óˇ÷;zQ@sÔ nF"{ñDÒ∫ódÓeòEà∆˘âÓ•aD}KÀæΩÎ ˜rçùTmQﬁ.3[ö∑∫¥î7.£ƒ‡W!á9X¨´—≤q	“TgÓ=*◊]í°]b^j»ﬁwhó•°ñ’û3ùa˚~Ï∏qqicöÉWú»‹”—‘∏Ûÿ°#ÎMuú?™lêc$Ö%´/‚i—‰V≈˝„ˆœkérf'UQ∂j}´Z”tëá:„∆1§¨—·∑ãO“Ø()oúw8hó‡UÜvÕ—˘ìö]úÿ{¬°P(óÓ^à£’¶∆iƒ—2`ö¬40Zb_Y_õÑaÑ∂Gj1Háëƒ3µƒzgs|´©≥¥B»iÖâƒ38—Ö!N	Ï¶!I¯0~áGÈQúçQ$Ç"µ§ÖëÅd4TXî¡ò	Ÿ…Gq,Y¬ Ì5ƒbY÷^“©Åã(ÒñœÑ˜–¯2)ÃH z_∆Ê¶5”7ª:ù‚a´pU˙≈h®ü–/ﬁ"Òq:l¶±€'°VÒg±U≠¬r´`”Â≥»Hﬁæ ô? kúh

endstream
endobj
39 0 obj
<<
/BaseFont /DJCIJI+AdvStone-i
/Encoding /WinAnsiEncoding
/FirstChar 32
/FontDescriptor 40 0 R
/LastChar 177
/Subtype /Type1
/Type /Font
/Widths [ 281 291 375 572 572 833 739 208 354 354 427 614 281 333 281 385 572 572 572 572 572 572 572 572 572 572 281 281 614 614 614 458 760 572 520 614 697 458 427 708 666 270 270 541 447 875 739 739 520 739 541 500 541 666 572 885 604 520 593 333 447 333 614 500 354 541 552 427 541 458 281 541 552 229 239 458 229 822 552 520 541 541 333 385 333 541 458 718 458 458 479 333 260 333 614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 281 0 0 0 0 0 0 0 0 0 0 0 0 0 281 0 572 572 0 0 0 0 0 0 0 0 0 333 0 0 0 614 ]
>>
endobj
40 0 obj
<<
/Ascent 735
/CapHeight 700
/CharSet (\057t\057u\057O\057g\057B\057v\057m\057b\057C\057o\057c\057R\057l\057D\057y\057N\057p\057E\057e\057four\057S\057n\057q\057f\057r\057quoteright\057h\057P\057J\057s\057a\057i)
/Descent -249
/Flags 32
/FontBBox [ -187 -239 1208 760 ]
/FontFile3 41 0 R
/FontName /DJCIJI+AdvStone-i
/ItalicAngle 0
/StemV 0
/Type /FontDescriptor
/XHeight 510
>>
endobj
41 0 obj
<<
/Filter /FlateDecode
/Subtype /Type1C
/Length 1778
>>
stream
Hâ¨UkPWÓÊﬁôr…¯X{ÑiwöáQA—Dæxâ†2º	>`xäÑ ‚ ≤FçBD#‚Ñ˜&<"Ab–$j|ÄË&∆•∂‹-7¡≠”Sk∑—›™¸IRµµ?∫´n˜wÍ;Á;ﬂ9W¬»§åD"ô„≠›‡´ı]≤>>Kóë≤oóì~˙´£¿IŒRÖAX4_v…|Ñh™%ˇ*+{˝∂î?,gõØHü3ç˛ÕOÇ	£`ñaÏ-ò%≥\ 8K/)≥Q∆Ã`"∆V§edÃ"&Ç11kâèdØ§YÚ£‘Aö mïNY¨∑»±¯J&ì%ÀZd˜eƒü|@n“πt=F«‰ÛÂ€ÂÖÚˆ©%&BåÃÇ%¨ØÆØ®;rﬁ∫∫ºË£\¬˛›æ…¸;ËIî£¬9s0AßñNEÌ –A0ö<¢üB4°ïwà;≈z·byi8^ Jd¿cˆ˝¶'r*V&{Û.ÙëñÖ˘`˘TcQ∑]NÚêwúE;ÃQèoΩÖñt¶8Ôe0ÅwÕ3Ÿ⁄}%Àc·€ª<˘ùT	J≥ãy!{.S€¥é√0‹É6XâY∞“ñ›∏w¶¶á7Ùìúò–¸pïˆO¡A6‡vß);ØÅWBÏQ∏J¿T·∞Kxå†ƒ§§f?÷‚RÙBäõ0ôw†JΩP)VåˇIÈZqì‡iz.HyuÿG; è@:Uböò≤˛ÌK∑¢¯úº,Î¸‹‹‹¥íÇ`´—±+∞‡"*≥ñ(°Ã\.‚‹i˙„`±á¢î¶ˆ£∆ë?ÖÓ5◊mÑçM∞ÈàVî”∆5àΩ/–[1  P&dö∑≥bÈ≥–àﬁ(Ωä[!éÄä ñ:ÄWÛN/ÌXúÂÛwp}⁄˚!Ì˘C7¥C« L∆H^ÏLì(Ô5˙ÁœV«ÊÒM#√fŒ@!…¯7†áa¶5ÿFy˜ΩNÈ;ë∫Qå∫IGk#l=tŒ|Öê)9˚§Âpô7›©z– R|KÉˇ˚∫»Uû>6/`MªL.Jù=ﬁˆh€⁄±çoçæª¡MΩA∑›'(¶ﬁî®I‘ΩÈ÷û˚Ñ6 ﬂ3Òu‡M^{{À%ıçÓK◊˚Í“Úk4JAˇ`Q˚ûJ◊ra{>œÔ'∏⁄}êX Æ°Ö:RJ€≥¢jc9\Ü≥qjë˘v‰A√yæº4«âåQÂuX5…¬”$Háπ·*ü(±ˇ2{ø»Ë]˚¯7ÌŸ1zºïË;|¡Å◊sà´ÁÒvÆC¸‚¯“ÚAxF\©R+®û∞Ÿ˙¯ú8ô<êˆ¿Çœ&Z:s
+˘ñ.Rì[%&ë±wÿØ´«ﬂ¡äæû3}ºË/ı6œ†3Dpãû›: √ÍBpKı∏C(˙àY£#Jª=ˇ98TŸ2§¡„˚º˙ªÒ[\À≈îX#_¥‹˘
≈Ù¸.Q=tz≤ó Cœ<%cß;è~ƒù≠0™‡k;IEÆ·√t.»5m”¯Ç@≤ÅÜëªt’îé(ÖÕø ®Ùï†øˇAsWT•˘¯.„B#O6GÒ˙`íÿ9ò7ƒÅ8∫#∞•Ö’n0ß≥Î(j^¶ìQ⁄°‘5¿ÄÂ8◊u>-!Ω$©$õ˜«~±5põo<V€¨˛SD€|√ﬂ#$VSZNîXÀ#Î4eQå$sím≠i´;]hJﬁ≥;%˛˝r}+?ç≤SÅ∆úN÷æ¶S¬#»„‹Ët‰®8`Z[õA˛M77PÖŸ|∂˛“è^h#‡’∞∑€ûÛXÂñ*Ä‹?ñŸ∑ösˆNú>ä˛î„+–OÑYt[ào·bák¯,Ä≈/`¨ +óoÚEAÏ‰Qúïàs6„ª<ò—ñÉ0d‚ís˙y;ﬂlXQõóÖ"{/¥ˇºØ…ˇc¿|Ò£3º/J‚J_7¨ñ|“{˝*wÒ„ÉáNÌWIUNˆŸTnKä>`€+r¡VHfœ‚jB8€pﬂøÓùç	|OHuÓ6ut¥!6.© î§I
!)ü]>pÖÚıÌª˝ª.ÌºÃø˚Öæ∂C›Ù«ö∫Ü¶‹ÏöiˆÆÏ¡Ïî¢TnW~√Wß¯k0@`=%…j«ï{3—í¯”Ç02@C∞è,›_î´o9YŸƒ+ÖÍ·+ì≠£{–ù õaãã‹∏√πˆö£Õú„†_tò?ﬁ&≈…∆Ã$u‡Á1˝è¸§möÚR¢‘√>	YZì∏Æw˙¢,Œ«∫îÊMˆ≈BÒ;yVìS≈"ËëPÃ˛e*≠0Hs≈;t1£µ÷‰éÛ‹— Ì≈∏˝`üVô0O°>ù+∞ˇ |ˆØ

endstream
endobj
42 0 obj
<<
/BaseFont /DJCIJK+AdvPi1
/Encoding /WinAnsiEncoding
/FirstChar 33
/FontDescriptor 43 0 R
/LastChar 126
/Subtype /Type1
/Type /Font
/Widths [ 1000 437 1000 385 1000 1000 0 1000 1000 1000 1000 1000 0 500 1000 1000 1000 0 0 1000 1000 1000 1000 385 1000 1000 1000 666 1000 666 1000 385 0 437 822 666 437 718 666 666 0 0 552 718 0 0 718 822 0 552 666 0 718 1000 552 666 822 666 437 822 437 1000 1000 0 552 552 666 500 437 666 500 885 333 666 552 552 552 500 666 552 500 552 666 437 500 0 552 500 500 437 500 0 385 822 ]
>>
endobj
43 0 obj
<<
/Ascent 712
/CapHeight 0
/CharSet (\057m\057b\057four\057a)
/Descent -207
/Flags 34
/FontBBox [ 13 -323 958 824 ]
/FontFile3 44 0 R
/FontName /DJCIJK+AdvPi1
/ItalicAngle 0
/StemV 0
/Type /FontDescriptor
/XHeight 714
>>
endobj
44 0 obj
<<
/Filter /FlateDecode
/Subtype /Type1C
/Length 1091
>>
stream
Hâ,ìÕ´5∆œmõ…¬r•‚qS¡Ö](∏È¢Uä∏ëÆ°ä“œ€”sf&ÛôI“L2…d&ÛqÓ’R€Z¸∫q_,∏≈ïˇÅ‚9Ì≠hö≤Û<ì7ø˜›ö:0Ÿ⁄⁄⁄>yÍƒªßﬁ{˘ÿ';ú}usÚ“˙ËÅı—√œt˚ø<˙·=‹◊[ˇ\ªˆﬂ~˛˙‰G™g¡˚Om>Öˇª‹öNéONLNOÄKùúºæu˜‡ùC>ø˝Ë»√3´j˙x‹ˇúùÈ´ÆÍÂè◊Ô˚”Ìı´7¿¸{≤j)‘#ú¥ﬁ›ˇlØ&Îw¶Qâü-≤YæÉ/ìK‰˚íü,wƒé‹©fjÆµo÷∑Åç€ƒf]nIÁ¨◊∞ûwºVZŸÍ¶nç∂k3ö—ﬁ,YÛôæ¢g2©b´‘d@cMSOÛZh°e≠M´öj1ñCy,<|ë¶EJ≤<«Màº¥L]PbrCdj≥>Ôãè´'V˜^c'˜Oπ“ÇÔ”oíEùéi˜Q7Qç4™î ‘/Fyòı ‘÷≠j•ñ[^1Wã•ñ¥ÿfMfR5°	Ã\œ€ãú¯ÒãÈ,ΩJä,L√$âì8èpDKX∆sûÒT¢*QÖMd#õˆ¿›pƒÀbIG:∞Å@¬≤+mi´^™◊V7¶qﬁ~x|ä#î∏Ë,¿A·DS;% Ü¸ÒÔÏ<;G/êã1Dç¿oû\
'ﬁî∑ƒm˛∏ÔCŒ¿5o˙Àd/©hG˙¢£=ΩÁTébOÓÍ¡t¶k⁄VänhwÖ0ÀzWÌ ë´≤-[nÅÖ
2wg2‚ë©º√]÷%vSR!É&l∞àuTEjÏá~õﬁt∫’ mŸ8wd#uﬁlHG48MR«*r K$:w4|/`)sL∞è√‹˛tjÍFµ éÜaÜVì¶h3ë®§J™Ê“ﬂÙfƒ#¡≤úÜ, »e,r?æ‡öÄzÃK®Àê«<e)ÕhV‰ò¶ CûóÖ ÇJZ”ñZZo‰ÀrîÓêï‘^µãf^œÎôH™Y5ì≥r∆#~\Å“ÄÖƒ…ıPîEI‰VÇrÑC0zÓ"îÅ
¥oBsÓ+∂>Àw—À°ÍÍN∑`˚Ác”bQ¯—ê"Ä`K◊;"ìπƒ≤®pEïìfö+ÆD%ÑT™R¢57‹∏1ñêI∞Ÿ¢ªtÿåêÓ·-cÉ;lHÕjjOzùk∂Nv’hÜv0≠cﬁ∂◊o Óq@Ü“aõ¨vMj
¥ßô‚Ó9Z—T∆Me]ÎFY5T∑e∏`ëà ídiVd$g ˜0Öá›„ çvM0–ÅkÄÜ#\B∂∫ﬁÚË˛ÉK3?Ú„å$Eåc9‰!ûî±ÿêÕù;wn‚¶êılÈ b´¿õèO{W πLgd∂◊wü˛k˙Ô  å

endstream
endobj
45 0 obj
<<
/BaseFont /DJCIKL+AdvP4C4E74
/Encoding 46 0 R
/FirstChar 1
/FontDescriptor 47 0 R
/LastChar 2
/Subtype /Type1
/ToUnicode 49 0 R
/Type /Font
/Widths [ 270 770 ]
>>
endobj
46 0 obj
<<
/Differences [ 1 /zero /thorn ]
/Type /Encoding
>>
endobj
47 0 obj
<<
/Ascent 750
/CapHeight 717
/CharSet (\057zero\057thorn)
/Descent -249
/Flags 4
/FontBBox [ -20 -958 1114 770 ]
/FontFile3 48 0 R
/FontName /DJCIKL+AdvP4C4E74
/ItalicAngle 0
/StemV 0
/Type /FontDescriptor
/XHeight 705
>>
endobj
48 0 obj
<<
/Filter /FlateDecode
/Subtype /Type1C
/Length 210
>>
stream
Hâbd`ad`ddrÒrˆÙˆ—vL)0q6q57âj¸êf˙!Õ#V˛/Ë◊ªü”XÂ0˛ÔÓÜê<ÏèûÒøÏ˛û&RÀç§ïÅÅ…†ùÅAêa3##≥^N7ﬂ˜EkÓàv∂t∂¥I5¨lÈù‹7yJø‹w∑f¨}˚¶Mñ⁄ñ4≠&π1≥ÆCéÔÁ¥∫ﬂ´DøØfõ9Ø{˛¸äÓZ˘ﬂ´øØaõŸ=Øººª¢VÓ˜öﬂkÿk+∫ÀÀÁuœîˇ‰±’vWÃüﬂ=o¶@Ä ∫So

endstream
endobj
49 0 obj
<<
/Filter /FlateDecode
/Length 228
>>
stream
HâTêAkƒ ÖÔ˛ä9nÈAìÙÑín!ámó¶Ì›’Iïâ)ÏøØ∫È“|0æy„ÁÆÍùç¿O‰ıÄFÎ·‚W“gú¨É™cu‹™¢zVx
ó%‚‹ª—C€2˛ñÃ%“vèÊ˚‘tÕ·°πw¿_… Y7¡ÓΩ˙¯L√¬ŒË"êéåwG^‘å¿ˇ∆ãWm{ÉKPIπ	°ïLRK@g˛{¨æ&Œ„µ‹ZãàΩê¨ƒ6œ…“àﬂÊ<-Ò§W¢ƒZˆP03îux[U!3‰√~ içmE

endstream
endobj
50 0 obj
<<
/BaseFont /DJCIMN+AdvTA42
/Encoding 51 0 R
/FirstChar 1
/FontDescriptor 52 0 R
/LastChar 1
/Subtype /Type1
/ToUnicode 54 0 R
/Type /Font
/Widths [ 708 ]
>>
endobj
51 0 obj
<<
/Differences [ 1 /ampersand ]
/Type /Encoding
>>
endobj
52 0 obj
<<
/Ascent 638
/CapHeight 631
/CharSet (\057ampersand)
/Descent -38
/Flags 6
/FontBBox [ -72 -145 875 718 ]
/FontFile3 53 0 R
/FontName /DJCIMN+AdvTA42
/ItalicAngle 0
/StemV 0
/Type /FontDescriptor
/XHeight 535
>>
endobj
53 0 obj
<<
/Filter /FlateDecode
/Subtype /Type1C
/Length 240
>>
stream
xúcd`ad`dd‰wÒrˆÙı”vL)q41	i¸êf˙!Õ#Ê¸[ıÁˇüI¨rˇwwCHˆ;˜˘	vo©ÂÄÈc``Tc``g`bddû–Õ˜3‚˚≥3E´‘[˝∂Ω˛[‰Êo—Ôaù∑æ+G,ïp¸Õˇ€s}Ìw˘⁄Ô“ﬂïØ}g1ﬂ∞I"~[‰œVé¶á¢ﬂmg}Wˇ-2·∑’ƒﬂnøu+˛vü˚€qŒoæÔûªø€Ø˘Œ˛Ò·wŒ©kX~ã7¸f◊Mˇ-Ú;Ùª»ÔËÔ°eﬂKø[|WÓ˘ﬂÛ›Ô∑’w≠ﬂÅ’|\ ˇf“
endstream
endobj
54 0 obj
<<
/Filter /FlateDecode
/Length 213
>>
stream
HâTêAã¬0ÖÔ˝stÒê¥àßRΩÙ‡Ób’{L¶%`'aö
˛{ì™30yÛÒﬁDlÎ]M6Ä¯gß–Z2åÉY#\∞≥y∆Íö¶Æ{ÂAD∏π˚öZeôâCá¿wXlÃÌ∏YK˘‚è≤•«¸téÕË˝{§ ™
∂ôÿÓïˇU=ÇòŸI»_ñŒ‡‡ïFV‘!î2Øû…|ko‚“>«œj)e±Æ≤Hºµß[fs=2«\”¡S§î¡Œ‚ùOñ©≤á  whÅ

endstream
endobj
55 0 obj
<<
/BaseFont /DJCIMP+AdvNewsGothicR
/Encoding /WinAnsiEncoding
/FirstChar 32
/FontDescriptor 56 0 R
/LastChar 177
/Subtype /Type1
/Type /Font
/Widths [ 302 312 291 770 604 854 635 145 322 322 500 833 302 333 302 270 604 604 604 604 604 604 604 604 604 604 312 312 833 833 833 437 1000 604 645 604 677 572 541 656 718 281 437 625 520 833 718 666 604 666 656 562 552 708 593 906 552 552 541 322 270 322 1000 500 500 500 541 468 541 479 281 489 552 250 250 489 250 833 531 500 541 541 322 437 302 531 458 729 437 458 437 500 500 500 833 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 500 0 0 0 0 0 0 0 0 0 302 0 604 604 0 0 0 0 0 0 0 0 0 333 0 0 0 833 ]
>>
endobj
56 0 obj
<<
/Ascent 723
/CapHeight 723
/CharSet (\057seven\057L\057slash\057t\057zero\057eight\057j\057M\057u\057one\057A\057nine\057g\057v\057two\057m\057b\057dollar\057w\057three\057o\057d\057c\057endash\057l\057D\057p\057four\057e\057S\057n\057five\057period\057r\057h\057P\057s\057a\057i)
/Descent -189
/Flags 32
/FontBBox [ -156 -229 1218 812 ]
/FontFile3 57 0 R
/FontName /DJCIMP+AdvNewsGothicR
/ItalicAngle 0
/StemV 0
/Type /FontDescriptor
/XHeight 523
>>
endobj
57 0 obj
<<
/Filter /FlateDecode
/Subtype /Type1C
/Length 2262
>>
stream
Hâ\î{PW∆{ÜÈÓ±‘Vî±{ËvU‘Ä¢∏Ä‘Gë˜”ÅA@‰µ®†±‘ƒ§≤æà∆hi‚ì®Ë»F1EÉ<ÇàËQƒGpùçÎsfˆåª;ò≠⁄™˝Áû[uœΩﬂÔ÷˘Œë2)!ëH*u‡≤–pwˇÙèVÆŸ\∞t›∆Ã¨¥»·7/µ£8∑(e÷zR8-˘˜ﬁΩøØ£hÛpq<®0n8{Ãˇ=@Hí ∆–Ñ≥îòLÆ1KBxÑA»à"TFDëƒ:ÇòaÁ dƒ&‚S‚ —N¸M2OÚï‰∫ƒ*%Õó∂Hˇ·‡Â‡ÔêÌpƒ¡*ììuí"ôBæ•îîï@•Q%T;Ì@/•≥i==$wîª…Âkle\pg˛JÅÚ}8pøµ°ÎeN–-ª+≥/-o,s^’z≈˚†¸NÙ2ù>TM‚‹o≈ÄKäÄWh’°Ë´k:"Súk}ª¥/w öY8Eõ◊WkÉ9UT‹‹›B4XŸπV_iÂ:ÙèÓz≠0É‘çb<\µ∞·ûz◊A6QLºc±)éy
„°
ÁÇ˙†œ\t¬B°[)≠oÄ∫y
¶`J¯§ë{)C÷|6ÇJﬂö∏5|õ<ÅÓ8i{Äånﬂ∆ë4S£∞d‹±)©sMÜÊ-=?´*€‰∫ÀG j8π∞ùQ1?'Ê	˜>&_ùnix¬‘«œ”l\≠MSSVdFƒ,èUg˚…ôK‡ÃŒl\”û¿Ñ¡§∂?^;/¸c˜Î¢{Ë4À?ma∏–îBvËk/ﬁÂ÷jÉÊ™qÏ'[ˆÌ€$”_ñÌ=ÃÉ`åuù3m°∫ÏA≤»X§	ã_PÖ≈ó4∂≥S)¨≤Ì!„°’FP√»÷·t ÀzTﬁ◊Äî◊Wo¿‹<^†Û
Ìñd≠¯-l&°Âéç¢rm‹Ìm§Èl˝5ˇ‚v86ƒojp‰µÓ4ëóœÿá4[˝…j[BàÖ¢H≥ågß¶G´º93‰û0ˇE'å2'¥M*K+öÓsøyõ–oøIã+#gØ/±(˘>Æ≤ïkk©yfnN
Ri◊∫fõ’,L–∂¨ˆÂÜƒ£|Ú“¶ü:µ Ω.0ñ¯'ãQ>(C«ÿ’«Œf
9°d^ôa˚mT0‹·k»˜
‡$7w‰p˙”90—ÿz°µ^‹Îô™ÒÁ=B€ﬂö;åœ_u¯°”ë9©†⁄`	g®€∏â|Daæu-âmdAbM~CaM20—¨ 
ˆ¬X``Io›+√TG‹xÙ£¿#ÑÌo›µ⁄ ∂Æ*ùár•YÛ√4Bj|»Á≥˘Âñ~ä)x≠∞|pª≠ìP\7+z¨é‰Ωs$ˆ`u$ﬂ9ˆX◊¢úF≠0Ÿ$é°≥¢∫a6”u -¯°àT/∞P#hﬂú„ÊìÖ„D¶Ë,c—È⁄‡r`ypÏÉë ã∏Åcıb∞.ÊDÓYyÓπm%ﬂs¶UΩöíΩœ
¶”ˆñ»ÚmEèÏ¸%(üeHôVl-hﬁ¶œëón:ëùÃ˘Eƒ{,X⁄8¥A`¥´ë=§"˚Q;äwÎJ8®§Q7¢‘sYÜ∫p+ã4úØ,i‰o]œ‘àkhÃJùâ4Á”1p´AWW-Ïogc√÷'Ò±9Ù]ΩWa^©»ÏÈV4R'oëâ•õZÏ‡=C ™Ef‰"R
49"¥Ëÿ¬®]ë¬}ò¿¬1∫ÓbÖÆé©W·Ttéúï¢3dàÃáñH«ÆºHÁ$¨ç·=W›\nôÀNã¶bÚYÓ“ZOæ3–É∫<@˘¨Ω¸yπ¬¢±ÆeÒ(Uïó\ „ƒ%3—z›¿©≠¸t›UÒ‰2≤ë⁄—∞◊`‡aã«Ë∏ÌÜ8ﬁ]cÇ©‡\g|ÿXæ!Êä»®-3`:ª276[ÕœãhÒ$<>C√‚%/p<éı˝¿.¸”l‡_u¸®L¿ó«æ˘™∫©áÔ™âò˙•»D€=œÜ¨œãÁ|L´a
ÃÈ´y˛*‰<äGÖá„wñqE«ã˛Úç∞Cß€≠„AﬁyÆ˝πÙ£Ôƒ£_ü⁄Å?ﬁ±ù Œ€ˆß,Qóùz4ë«—Å*î-/÷îÁäöı7fpÈßÚÀ?Ck™™2ıËW}Ëüú‰∑X[’'l∞Õd´kJÜÄ4ƒ≈DÁ£√ÃƒíZÅ9‘Ø0Y8™æ¶N◊»∑g˘âh3Z&–CÒuû!±Î√#¯.êfP?®Ë≤úÚßvÇå}¸ƒ€>Æı8JJÔ:vº$ˇ˜ì7~--˛∂^:È≥Õi€∑Ô€ø]xd›Õ>Ò¢ﬁ_Ó¥ÆÓêæﬂÂ™+t˛fqVÄàˇ∫k·ËzΩ^Wœﬂ<ì(⁄”∞~bùè:n]XîP∑5˝rØN∞Ô≈˚!4≥˝øƒ’7Ï^i=Û?‚Ñ:Ô1y·Q¬pñˆg1†ﬂî†Ïi∑^¿Çó®DÂw∫‡Rg¸˘ÁZ
Ë8gvú	ÅŸ”è¨	
)mi˘Êf&ıæ7≠Ø]V§m–dàü∂ëQî…¶|Ô÷“*;≥˘Ü
ˇÄ||†WD πÜtë¡¸~ETÿGÃ≈∆&#ÿDÌ€πkÔN>Xì:/SÑë˛43È€gÏäÚŒÃ~{ïç∑Ü:”*ºJƒË¢ƒÉˇY∆é™ÈMÛJÌ\ªÚ‡˛Eëõ‰vÔf=È∑‹NZœ+–Ãm[Ãì˘è9«⁄\•¬í2º¢ñNU¢ﬂ∑ûmØÆi/óˆkû{@˛˚cpı›÷˛∑≠≠ÔÕ?,ÏÓõ≥n≠X“7ië_›è»ÛEùˇH±ÖEGS∫oÈ⁄kÚﬂˇ8ˇg◊€Ò‘°Â«ÀŸúeÁ3˝Ó)ˆíÌª˝è˘¨éløU˛Ñ¸V˘dÚ}˜˝n-ˆòXñ |g¸#√˙ÑÌª
Pë+€oÓ?^øyx±˙∞˝Ê2πÅL6`SœÚ£cˇü6æD~l §[ò

endstream
endobj
58 0 obj
<<
/BitsPerComponent 1
/DecodeParms <<
/Columns 63
/K -1
>>
/Filter /CCITTFaxDecode
/Height 63
/ImageMask true
/Subtype /Image
/Type /XObject
/Width 63
/Length 144
>>
stream
ï ºp@·NtË:–tÎOußÈ˙3êŒ9∏≥¯)®G∞D~_ªÉ/íb<&ÿA“fÍ›€™”ÌˇÔßÙ˝jÆóˇØˇm/ˇkˇÿØ˝KÉˇı˛“	“_ß$√≈ß4tr‡†ƒ~ÖóØIçÈ?]ˇ◊jÎª∫Ωä·6	Xäµj’®j’Ö(aH@bQÄ Ä

endstream
endobj
59 0 obj
<<
/BitsPerComponent 8
/ColorSpace /DeviceGray
/Filter /FlateDecode
/Height 45
/Subtype /Image
/Type /XObject
/Width 228
/Length 32
>>
stream
xúÌ¡   ¬†˛©o         `©Ó6
endstream
endobj
60 0 obj
<<
/BitsPerComponent 8
/ColorSpace /DeviceRGB
/Filter /FlateDecode
/Height 45
/SMask 59 0 R
/Subtype /Image
/Type /XObject
/Width 228
/Length 4086
>>
stream
xúÌö	sTU«?ƒLMM’|g‘“±\F«óuF≠â(à,"à ã(*´+˚™(ÉÄÇ¨I»“Ÿ“	È%›Èt“IË$tvBpôEù}™èÓ˜:Ñ´ﬁøn•ÓΩÔú{œ=Ôœ=˜u¬πŸŸ%EEv±À[†h8J‘_lÿ∏·!ız[a√∆–ê {Ω≠∞achÿ\µÒ[ÅÕUøWæRúøp!rÊ;wÔ©ºÆ„˘]'®¥û˘Ó¸ÖüÆx@6¨ Qã/gœùœjÔõÂ?Ï›üUSÕÒø·	;⁄˚æ=˜√pG∂a√
ïÚc“¯Ó‹˘≠ç]èÁV≈S4æ<ôWµΩÒË˜Áœ'?æVÆûO¡˛S#ãÇ…∞‘XF◊‘ùLr
6¨ Qã

Œ%Ååñû≥MN¸∂fœ_ˆ≈≤ÖÎ(TFosƒÀå»ˆ9⁄zìô≈Ü+@T ˇÜ¬Ó¶Æ˙=Ω´xÎÃ≈-==x«C1•eƒ3[f-E F%=“=‰D6lXA∏˙}BîtÙ)˜@VÂ∆π˜ﬂ˝X<Kç•Ôû«÷Œ_˘ÄQ1ª≤¨´/Ò\6lX·"WÛÛøµF˚¿†Ò&ıœ\iV^bñKqV˛#ø™ˇ+Ø™Û‰È”%@ooonnÓgü}∂vÌ⁄-[∂îññû:u (
Ö ÀÀÆl¸d–››]≈∞¥Nú8·ız1ØëaW,ÀåÒıD•|cçyû∞2÷˘∫˚23íÁ*¬ûÆæÜO[*Lgä≥gœÓ›ªwÙË—)óc¬Ñ	≈≈≈*ˆ·á“	ìá;~Ú‡ı…‘…´tuuΩ¸ÚÀ¢ı˙ÎØ_3”Æ&>,∑∑∑'©íóóóûûN†∏vVA‘¬ºº3®:⁄sY¬Ÿ‹IÁÒå…saTˆ6v«©9÷o5£)÷Ø_/Æ{ı’W∑oﬂéOàÆ/æ¯¢tâÿ|@sÕö5√|Xp:ù2iÚ*;vÏ@˛˘Áüﬂ∞a√Ó›ªØùmWııı≤Ã÷÷÷$U^yÂ‰”““ÆùUïr⁄AÔÙ=Á<ñ}ÇÕ8T/ù˝√·*¬®û>=µ¨Nπ∫®2l5c<îÀñ-–˛∂∂6âW„«èÁÃ¢G∏∫zıÍ‰.‘ò‰U∞˘è>˙Ë⁄Yu’QWW'ÀliiIRE∏ööözÌ¨Æû2Cwﬂ—<∑˝‚Ωπœı‡‹¸/|ù=“ﬂüû6Æ¶ßâñ´˝ÿ•∂æû¶ì∆És'Lû<πøø?ÊQFFÜ∏Ù–°C4ﬂˇ}·jggÁW_}EJ∞b≈
íÑì'O^∂ÆÓÓ={ˆ|≈Œù;9ÊbÜE}ﬂæ}Ë"@b\[[´è<(3jëg1„477”ˇÊõo"?oﬁºúúúÍÍjyƒ¶+(( ]yÔΩ˜V≠Z≈#„ÍòE±<??üM
‚=s‡¿ƒ8v„ç9~¸8Õ  J1å}ÕJá≥≥≥„=6m⁄ƒÜ‚oUUyµ,3â®¡%%%7nƒ`ªyÛfu„3Àÿ±cë_æ|9kA]GÊ’p,Új8V‹nwÃºèÁÛœ?«œx˚À/ø4Æ%µ 7˜§©UJ∑˚qÌÔKKMû´´‚ò‚Kø#E∫L'çASSì8W«?Â∂ÂâÇwDS∏:˛¸ó^z…ò÷‚•Kã
»rçO…%\.ó
‡€1c∆ƒ$∆§ÚTπ*M¬i	Õ9sÊêó∆òß¬
ò@GGáÿ∆	á√¢»N°ÁÌ∑ﬂÊ S¯ø|…Çáˆ‡
ë?zÙ(M¶€ÑHä◊^{ÀUíƒ#ûGéA nø˚Óª12œ>˚,õÖßÿÛàEKnF Ã!(Û≤qbûé9íΩiEàJ9aÜJﬂbÂj¿øD˚{Rá¡UÑUq]u≥ru}u≥È§1¿rY˜Ë!ÖŸÚ"º`¡‰˝~?ÈÅÛ@!Í‚≈ãyWÆ\IÛÖ^‡• @$§Nœ;Ôºi	ÉÏzÅ¨bù4©£"D%fB‘x{ç &Á¬[oΩEùêEøX≈é‡¬H˝íÃ0ZOOÙ”5jgŒúâπfÔH∏ä∫ˆ∏ƒ<éöü~˙©4'Nú»¨óìh‹∏qB`Qaô"CP%˚|>¢úíG¸&ˆ@$*ÑæööIlXÑƒ’ÿ √∫©3Z‚:24Æ]\÷≤≤≤$l€∂çß¯V¶`cí.p£å…¡g˙~Ö´«ÕPÁû®\≠mÿß˝«≤2O›Ò`í\Ìu8T1∑©]π:∑¢ﬁt“HÑƒú!ÖÖ´8á≈Jéu8FìƒÄ˙¥i”†Ñ‡jq—'ü|Bì¯I}“§I:X∫t)ù$√‘ï´ú™”ßOßB¿1
[Y≈¶ê&{DF Í™˘·sœ=G'/î¶p0u__ü’»¬UQ∆ï´4ï´L™2eee“	3iJeo‚
ı	Mëill§á˚,ßÁæ¢
d"@íFÀ•If≈uíûÚÚr’"=†gÙË—Ñ}Ò$¡Y¶ê1∑EA0]/DÕœ…È3CƒıÂjcã[˚ª\e¡ø¸©˜ˆªì W=>UÙµ]˙ÒkJi≠È§1‡^)>a/)¨§“íQ/,,§)¥D†¬ 9âàiƒR¢'µqXãÁy)‘Gú1cÜÑÇg2V¡Ui~˝ı◊Ëbƒ‰ê%ﬂ£N:-≥¿·#W333µáÂà"”dRü={vå¢äìö∫4C£Äg«ÿOÊ¿v‡Ëá∫∆âtL,ó&Ÿ∏ƒmu5Øhïññ‚7!3‘%U (ëûÒæ¨¢RzÕ–Â~Rπ⁄‘–˛Œ
ß˜¶ﬂUﬁÙ˚#∑ﬁ4dÄÌwW™b]«QÂÍÿ‚†È§1`Q≤:Œë¯ß8jk≤La9ûQFπJ]Ó™¶`É# ~≥≤Gπ**¸ÂƒLºÑ´Ñ?§1b≤e»Q©ÔﬁΩ;%öH'Y∏ ±Æ=z†ˆiräw`˙πÚPóUlçd&2So‘œÛ|˝÷-·*ñKS∑õ)ƒfN—R∞ÖâNVÎÖ®y99«Ã–‰©\7Wh˚°R∏*e» €ÎÚ®¢'“aà´5¶ì∆ W»·»÷ãJ)kƒ’4ó,YíMF PPÁNëç´˘f@@.e+{4‡@—]ªv∑BåUú§)—∞#&◊êEãQóëyèâù#\% ièûÔ@ö¬UàQîÏÖ]C]rHNd£Äﬁ
…$i v#ì«x&©¶∆ôÎ∞\ö˚˜ÔóÌfÍj∂Äàë>ëäp÷0ÖÚ?«ÇêyQÆvõ°∆=YπZ⁄•˝ÌÂï´`#∑˛Ÿ*¿ˆT∏U1´!¢\}≥<d:i<$’g˚4å˝Õrn‚.MÙ(+åbJ'ÍÚñ“(¿m"==⁄SóÄ√ÕÀ( √‚LÍ URêÎ<áÀ ˛´$g#y OS˝m2–î<Å∑üÿ3¬URDÌ—èxëHÑÊÜ®sXUSe˚s|–|„ç7®s2é,y{J4	AWbojj™
Ë˘"·*ñKS3gŒz’b®Ù(–ä:}ä$7ÖîËA`∫^·jó\ﬁ% ’™ Ö⁄ﬂÍ,6rUJ˝˜<5*û´›Â.U\UŸ†\]Ì;l:i<B°êÏ}ˆ5ªµµµïNÚ(Æú‚r ëÑc)—´®Q]d∏S'ë⁄„jy 8S¶L°ìkMâ=DÄ,Kﬁ,4†…82†<ÖÁ∞.~R#b¨"I¶Aïµ@{!Ûr¯“≥sÁŒîË/±g∏$¶DøB∞UiBB˘Ê °GÔìoŒÙ¿	‡òMÃ‘π≠€Ì÷%kà´≠≠≈`©Ôÿ±Có†ó/"§t
W·º4ôN2.Óné∆e≤µ1ñ¶Ds	Ú7vÍ‘©)—oå¶ÎÖ®πGß\5˚î´«‹ˇ–˛g—eqıñ?6,_‘Ÿ÷FÈ[±~ÆG.„jYÖ*é.(W≥ÎèòNj
N(ıN&û»Nó7.†¨0ÍÍ±Bùw*«YJÙ[˘.Ñüâr0î‹üòIV)T§Ç.%Æ
4rMçè∑
I·ˇ¯Ò„94ãf”âÄr5±[∏2ã"ˆ√X‹"‹R¢ﬂöÆJ'4 ¬k~»˝QaøË=ëeŒù;óµÎ8\ië—õ‘¨Y≥,X†ønº$2Ë  Ï ∂<=‹§dôdVX25ÉÀªPf ºê_∂0oƒÔ˜õÆ¢R⁄Õé4ÔπSÈeHˇëÉÖJ‘¿Sèîïµ∫úÂœéSÆ“î˛ÇÜKWq¯öZ€L'µ9;Tné<∞}˚v\≠2úº_v•QqRRi‚"ˆæ~«QKËVyé'9}Ã∏j’*ò,OG4 så“√[£o9âÁëÕÿÈt:ë◊«[„d‘ßd}®êU&ˆ	kaXŸM öeffäyb∫uÎd£q|Îˇœ∞ÎŸ_Fø…!•æÖ∫∫L‚*D`vúXÀ_÷À	•øx<d»–`2É Ä˝22˘≥ê_$gœûMÿ—yq;˘ò⁄èõÇ‰¡jΩ¬’6¯\”ï´-n.}≠t))∏H‘õˇPˇÒ¬∂HƒD-È]∂vŒá·jgiY[TmrIµru~y≠’åâA∏‡®b√r¯‚Ì+ñŸº^Øó≠ÿÃ¬¡z≈≥âp8Ã°~Õ 0ç˜„	Wau‹≈ä»IL«a•CÇj5¸g£«ò4„QAë≈ZÕãüyC∫¢Êdg∑X¿*˛Ÿ{ã“µ“øÜŒ¶¢º™'Ô·Øïñ†£®d‡ô1%NÍ_¯/e™î“Ü¶ƒ∫6Æ
‰;\ΩﬁÜ\@TJƒ~◊4ÂÍèﬁ€¸¡‘#ıuë¶∆*äñpcKCCE0Áﬂßué3òåÆç_è5k÷WØ∑!Wπöï’lç™zˇ†˚^•Î9œ_ΩÅù	‰c‡	Ï@Â§˚æÖõ Í9>ﬂ·∆‰’m¸ê7.\∏êÙ˚zru Q)M	·¨⁄{¡{´“ı'Ô->œº√·öƒZák|Óπ∆¢¢l\Zu(±ñVÆÜáBëg”O÷QNªÔıxñVá ‚Ö!ß«Ω‰œ=Fy !Ô⁄!'≤a√
’ëôy8	îx7üÛ‹CøãˇâÌ~∏ﬁ5>‡öQÂöYÔ◊Ô/C¢[Ê›îÃ,6lX¢RÍìÉ”ü›·z"ûäâÀ1◊£U…Na√ÜÑ´uI£:TS‚Z6Ëæ/ñûqˇÕÈ˙0™N~|6¨ Q≥32jáâ `†»˝Yı°	ﬂzÓäßË˜û;k+∆ï∏?≠™©Ó»6lX¢RjÆU¡†”_XÏŸYË˛/•ƒ≥√È/ÉW<†VÄ®Y’6l‹»är5`√∆·™ﬂÜç5Û¿ü7< j⁄˛˝^6nx@‘˙Pàøê÷.vπaãıˇrwg
endstream
endobj
61 0 obj
<<
/BitsPerComponent 8
/ColorSpace 62 0 R
/Filter /FlateDecode
/Height 99
/Width 74
/Length 360
>>
stream
HâÏW	√ ‰ˇ‰;ùF£¢h‘…!”L”$ÆÏ∫Bä¯ÅÄx∆DÁŸt'íH;l1N‹ΩJ∂"π-ÇT-8?6$øÌ»ÒË·ÚxèØ”KC©ôlÂ˜ÍÆ∏∂ËPº¢È8§«∞≥„['i®àƒøÕÒC{r2•ªLq´x„÷n
µã9Aóüf1ic∑€Œ›„›´¢mí‹§°»oïí≠Q/U∆ú
§ı:q}&>QÈ˚6v·/åÙ¿\vÏú3®π ≥É«hÈÊX˝°$5Vß˙Ã‘úûAbQÒõ∞´' ÂÑ–ËqL∆IÏ$€)9eHstbíTÈÑZ,5ë]Êﬁbnùú≠™ ∑êys1!•xzﬂ
vò~Ykãî_[·Çñú»˝…˝åŒWN¬¢≥JH '‡1ëÇRàmíNÅ¢œ)YÉéÑJy*™$Ñ8‰ª†.a§yüS\&ß¡]!±„UÒ rÊ§k
endstream
endobj
62 0 obj
[ /Indexed /DeviceRGB 255 63 0 R ]
endobj
63 0 obj
<<
/Filter /FlateDecode
/Length 337
>>
stream
Hâ¥R[ïBA´,`°∞ÄÖX∏∞X¿B,`Ÿd<lˇz¶MÛòô‘Œ`Ü3öqª›YÃrV≥Ó#vÄ∏≥‹!ÜjËÆjGq§ëÉ4ﬁ1∆kÏ:XYŒ¥{ßÖ]Ój◊=õXp°ÖÀ"èƒíK-]RôV\iÂpÃÍkÆµv)WCHáehπ
z)–¡ ≤+®}äÄ W_Œ¶#AÅÆ‹∞»£	r‘áTfa¬Ç]3jV∂cGÙªﬁTR¿B:,]´z8ÿÅñÎ\ü”ßD∫FF_Œ¶ì(«◊»ã<“¢]õõ
:[£]◊Î∫Z;‹™E*i7ìÚ@ÅÌF‘iÙNÀI,FF_Œ¶ìÌÛ|ÚˆI‘'3üT||˜q÷«;w|Ù˚(Ù—‡√“ááœ%,üiü˛vª›Ô˜«„Ò|>ØÎzΩ^Ô˜˚Û˘|øﬂﬂÔÁ´? q´c
endstream
endobj
64 0 obj
<<
/Annots [ 65 0 R 66 0 R 67 0 R 68 0 R 69 0 R 70 0 R 71 0 R 72 0 R 73 0 R 74 0 R 75 0 R 76 0 R 77 0 R 78 0 R 79 0 R 80 0 R 81 0 R 82 0 R 83 0 R 84 0 R 85 0 R 86 0 R 87 0 R 88 0 R 89 0 R 90 0 R 91 0 R 92 0 R 93 0 R 94 0 R 95 0 R 96 0 R 97 0 R 98 0 R 99 0 R 100 0 R 101 0 R 102 0 R 103 0 R 104 0 R 105 0 R 106 0 R 107 0 R 108 0 R 109 0 R 110 0 R 111 0 R 112 0 R 113 0 R 114 0 R 115 0 R 116 0 R ]
/Contents 117 0 R
/CropBox [ 0 0 595 794 ]
/MediaBox [ 0 0 595 794 ]
/Resources <<
/ExtGState <<
/GS1 25 0 R
>>
/Font <<
/F1 26 0 R
/F1-0 118 0 R
/F2 30 0 R
/F3 33 0 R
/F4 36 0 R
/F5 39 0 R
/F6 42 0 R
/F7 45 0 R
/F9 55 0 R
>>
/XObject <<
/Xi2 119 0 R
>>
/ProcSet [ /ImageB /ImageC /ImageI /PDF /Text ]
>>
/Rotate 0
/Thumb 121 0 R
/Type /Page
/Parent 2 0 R
>>
endobj
65 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib9)
/Rect [ 262 672 290 680 ]
/Subtype /Link
/Type /Annot
>>
endobj
66 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib9)
/Rect [ 51 661 94 669 ]
/Subtype /Link
/Type /Annot
>>
endobj
67 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib38)
/Rect [ 229 581 290 590 ]
/Subtype /Link
/Type /Annot
>>
endobj
68 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib38)
/Rect [ 51 570 70 579 ]
/Subtype /Link
/Type /Annot
>>
endobj
69 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib38)
/Rect [ 118 514 196 523 ]
/Subtype /Link
/Type /Annot
>>
endobj
70 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib88)
/Rect [ 417 672 474 680 ]
/Subtype /Link
/Type /Annot
>>
endobj
71 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib16)
/Rect [ 479 672 544 680 ]
/Subtype /Link
/Type /Annot
>>
endobj
72 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib85)
/Rect [ 308 661 377 669 ]
/Subtype /Link
/Type /Annot
>>
endobj
73 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib88)
/Rect [ 438 616 497 624 ]
/Subtype /Link
/Type /Annot
>>
endobj
74 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib16)
/Rect [ 503 616 547 624 ]
/Subtype /Link
/Type /Annot
>>
endobj
75 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib16)
/Rect [ 308 605 327 613 ]
/Subtype /Link
/Type /Annot
>>
endobj
76 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib85)
/Rect [ 332 605 400 613 ]
/Subtype /Link
/Type /Annot
>>
endobj
77 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib16)
/Rect [ 311 537 376 546 ]
/Subtype /Link
/Type /Annot
>>
endobj
78 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib85)
/Rect [ 381 537 450 546 ]
/Subtype /Link
/Type /Annot
>>
endobj
79 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib6)
/Rect [ 311 470 369 478 ]
/Subtype /Link
/Type /Annot
>>
endobj
80 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib37)
/Rect [ 376 470 434 478 ]
/Subtype /Link
/Type /Annot
>>
endobj
81 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137tbl1)
/Rect [ 338 392 366 400 ]
/Subtype /Link
/Type /Annot
>>
endobj
82 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib27)
/Rect [ 382 297 454 305 ]
/Subtype /Link
/Type /Annot
>>
endobj
83 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib35)
/Rect [ 459 297 542 305 ]
/Subtype /Link
/Type /Annot
>>
endobj
84 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib35)
/Rect [ 380 288 397 296 ]
/Subtype /Link
/Type /Annot
>>
endobj
85 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib74)
/Rect [ 401 288 461 296 ]
/Subtype /Link
/Type /Annot
>>
endobj
86 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib62)
/Rect [ 466 288 524 296 ]
/Subtype /Link
/Type /Annot
>>
endobj
87 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib25)
/Rect [ 382 279 450 287 ]
/Subtype /Link
/Type /Annot
>>
endobj
88 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib74)
/Rect [ 455 279 514 287 ]
/Subtype /Link
/Type /Annot
>>
endobj
89 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib35)
/Rect [ 382 270 483 278 ]
/Subtype /Link
/Type /Annot
>>
endobj
90 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib74)
/Rect [ 487 270 545 278 ]
/Subtype /Link
/Type /Annot
>>
endobj
91 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib60)
/Rect [ 380 261 455 269 ]
/Subtype /Link
/Type /Annot
>>
endobj
92 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib35)
/Rect [ 382 252 483 260 ]
/Subtype /Link
/Type /Annot
>>
endobj
93 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib74)
/Rect [ 487 252 545 260 ]
/Subtype /Link
/Type /Annot
>>
endobj
94 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib41)
/Rect [ 380 243 438 251 ]
/Subtype /Link
/Type /Annot
>>
endobj
95 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib35)
/Rect [ 382 235 483 242 ]
/Subtype /Link
/Type /Annot
>>
endobj
96 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib74)
/Rect [ 487 235 545 242 ]
/Subtype /Link
/Type /Annot
>>
endobj
97 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib36)
/Rect [ 380 226 446 233 ]
/Subtype /Link
/Type /Annot
>>
endobj
98 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib41)
/Rect [ 451 226 509 233 ]
/Subtype /Link
/Type /Annot
>>
endobj
99 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib26)
/Rect [ 382 217 454 224 ]
/Subtype /Link
/Type /Annot
>>
endobj
100 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib35)
/Rect [ 458 217 516 224 ]
/Subtype /Link
/Type /Annot
>>
endobj
101 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib35)
/Rect [ 380 208 425 215 ]
/Subtype /Link
/Type /Annot
>>
endobj
102 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib74)
/Rect [ 429 208 489 215 ]
/Subtype /Link
/Type /Annot
>>
endobj
103 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib4)
/Rect [ 380 199 442 206 ]
/Subtype /Link
/Type /Annot
>>
endobj
104 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib35)
/Rect [ 382 190 484 197 ]
/Subtype /Link
/Type /Annot
>>
endobj
105 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib36)
/Rect [ 380 181 446 188 ]
/Subtype /Link
/Type /Annot
>>
endobj
106 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib87)
/Rect [ 382 172 448 179 ]
/Subtype /Link
/Type /Annot
>>
endobj
107 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib73)
/Rect [ 452 172 519 179 ]
/Subtype /Link
/Type /Annot
>>
endobj
108 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib22)
/Rect [ 382 163 457 170 ]
/Subtype /Link
/Type /Annot
>>
endobj
109 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib32)
/Rect [ 462 163 528 170 ]
/Subtype /Link
/Type /Annot
>>
endobj
110 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib41)
/Rect [ 382 145 440 152 ]
/Subtype /Link
/Type /Annot
>>
endobj
111 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib72)
/Rect [ 445 145 501 152 ]
/Subtype /Link
/Type /Annot
>>
endobj
112 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib44)
/Rect [ 382 127 454 134 ]
/Subtype /Link
/Type /Annot
>>
endobj
113 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib74)
/Rect [ 459 127 519 134 ]
/Subtype /Link
/Type /Annot
>>
endobj
114 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib54)
/Rect [ 380 118 468 125 ]
/Subtype /Link
/Type /Annot
>>
endobj
115 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib21)
/Rect [ 473 118 542 125 ]
/Subtype /Link
/Type /Annot
>>
endobj
116 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib78)
/Rect [ 382 109 441 116 ]
/Subtype /Link
/Type /Annot
>>
endobj
117 0 obj
<<
/Length 20705
>>
stream
q
q

BT
/F2 1 Tf
8.4682 0 0 8.4682 50.7968 718.7526 Tm
0 0 0 rg
/GS1 gs
0 Tc
0 Tw
[(Nevertheless,)-520.5(highly)-525.8(potent)-518.7(and)-519.6(selective)-519.3(PDE4)-515.6(inhibitors)]TJ
0 -1.3256 TD
[(have)-325.9(been)-331.7(developed)-325.5(to)-330.8(target)-326.5(inflammator)-14.5(y)-325(air)-11.4(way)-329.4(disease.)]TJ
T*
[(This)-589.4(strategy)-587(is)-594.2(not)-585.2(unique)-589.5(and)-586.5(is)-587.5(exemplified)-592.7(with)-590.7(the)]TJ
0 -1.3189 TD
[(development)-752.3(and)-747.2(clinical)-745.2(success)-753.6(of)-744.4(a)-748.6(PDE5)-749.9(inhibitor)40.1(,)]TJ
0 -1.3256 TD
[(sildenafil,)-389.2(for)-386.1(the)-383.7(treatment)-384.5(of)-382.8(erectile)-382.6(dysfunction)-391.6(\(Boolell)]TJ
/F3 1 Tf
T*
[(et)-337.9(al)]TJ
/F2 1 Tf
1.9281 0 TD
[(.,)-335.2(1996\).)]TJ
/F3 1 Tf
-1.9281 -4.0437 TD
(PDE4)Tj
/F2 1 Tf
0 -1.3189 TD
[(PDE4)-455.3(catalyses)-458.8(the)-457.3(hydrolysis)-457.1(of)-449.8(cyclic)-456.6(AMP)121.6(,)-452.1(which)-456.7(termi-)]TJ
0 -1.3256 TD
[(nates)-418.3(the)-417.1(downstream)-425.4(signalling)-422.7(of)-416.3(this)-420(second)-413.9(messenger)67.8(.)]TJ
T*
[(There)-357.5(are)-359(four)-361.2(gene)-360.3(families)-354.6(\(AñD\),)-360.2(although)-362.2(there)-355.5(is)-359.8(added)]TJ
0 -1.3189 TD
[(complexity)-628.5(with)-630.9(over)-627.8(20)-623.4(splice)-630.6(variants)-625.4(\(Houslay)]TJ
/F3 1 Tf
25.4335 0 TD
[(et)-625.8(al)]TJ
/F2 1 Tf
2.2227 0 TD
(.,)Tj
-27.6562 -1.3256 TD
[(2007\).)-327.2(Hydrolysis)-317.8(of)-322.6(cyclic)-322.7(AMP)-320.2(is)-319.7(a)-320.2(common)-327.3(feature)-321.1(of)-315.9(this)]TJ
T*
[(family)70.6(,)-351.7(and)-345.5(it)-350.7(is)-346.5(clear)-347.9(that)-346.8(these)-347.9(isoforms)-353(can)-346.7(be)-349.7(targeted)-347.2(to)]TJ
0 -1.3189 TD
[(different)-273.2(domains)-276.6(within)-272.1(the)-269.8(extracellular)-262.4(compartment)-273.3(and)]TJ
0 -1.3256 TD
[(their)-416.4(activity)-419.2(differentially)-424.1(regulated)-418.8(by)-411.5(kinases,)-417.2(suggesting)]TJ
T*
[(that)-326.7(these)-327.9(isoforms)-326.3(have)-325.9(specific)-327.4(functions)-329.2(in)-324.1(the)-323.4(control)-332.5(of)]TJ
0 -1.3189 TD
[(cellular)-335(activity)-332.2(\(Houslay)]TJ
/F3 1 Tf
12.0573 0 TD
[(et)-331.2(al)]TJ
/F2 1 Tf
1.9281 0 TD
[(.,)-328.5(2007\).)-333.9(X-ray)-332(cr)-16.4(ystallography)]TJ
-13.9854 -1.3256 TD
[(has)-389.5(resolved)-392.3(the)-390.4(catalytic)-394(domain)-394.7(of)-389.5(these)-394.8(enzymes,)-392.9(which)]TJ
T*
[(are)-419.2(comprised)-428.6(of)-416.3(three)-422.5(important)-424.5(domains,)-420.7(consisting)-428.9(of)-416.3(a)]TJ
T*
[(bivalent)-290.3(metal-binding)-294.5(pocket)-294.5(\(Zn)]TJ
6.351 0 0 5.6449 186.5763 486.5385 Tm
(2)Tj
/F7 1 Tf
0.7409 0 TD
()Tj
/F2 1 Tf
8.4682 0 0 8.4682 197.2346 482.7401 Tm
0.2914 Tc
[(,M)291.4(g)]TJ
6.351 0 0 5.6449 214.8661 486.5385 Tm
0 Tc
(2)Tj
/F7 1 Tf
0.7409 0 TD
()Tj
/F2 1 Tf
8.4682 0 0 8.4682 225.5244 482.7401 Tm
[(\),)-285.6(which)-296(forms)-291.7(a)]TJ
-20.6333 -1.3189 TD
[(complex)-314.4(with)-309.5(the)-303.3(phosphate)-311(moiety)-309.3(of)-309.2(cyclic)-309.3(AMP)121.6(,)-304.8(a)-306.8(pocket)]TJ
0 -1.3256 TD
[(containing)-563.6(glutamine)-568.5(\(Q)-554.5(pocket\),)-566.7(which)-563.8(forms)-559.5(hydrogen)]TJ
T*
[(bonds)-471.8(with)-463.5(the)-470.7(nucleotide)-467.6(\(purine\))-472(moiety)-469.9(of)-463.2(cyclic)-470(AMP)121.6(,)]TJ
0 -1.3189 TD
[(and)-291.9(a)-293.4(solvent)-294.7(pocket.)-298.1(PDE4)-294.6(inhibitors)-297(occupy)-294.1(this)-292.8(active)-294.6(site)]TJ
0 -1.3256 TD
[(through)-518.1(a)-514.3(number)-519.2(of)-510(important)-518.3(interactions)-523(and)-512.9(prevent)]TJ
T*
[(cyclic)-456.6(AMP)-447.4(metabolism.)-456.6(These)-450.4(include)-456.1(indirect)-450.7(binding)-453.1(to)]TJ
0 -1.3189 TD
[(the)-484.1(metal)-489(ions)-483.2(by)-485.1(the)-484.1(formation)-494.3(of)-483.3(hydrogen)-487(bonding)-486.8(to)]TJ
0 -1.3256 TD
[(water)37.2(,)-271.4(whereas)-282.1(hydrophobic)-279.2(interactions)-275.3(between)-279.1(the)-276.5(planar)]TJ
T*
[(ring)-442.4(structure)-442.8(of)-436.4(these)-441.7(inhibitors)-437.6(and)-439.2(hydrophobic)-446.6(amino-)]TJ
0 -1.3189 TD
[(acid)-374.6(residues)-376.7(such)-372.2(as)-369.4(phenylalanine)-373.6(and)-379(isoleucine)-373.7(ser)-7.7(ve)-374(to)]TJ
30.3542 41.0993 TD
[(ëclampí)-472.2(the)-484.1(inhibitor)-495.5(within)-486.3(the)-484.1(active)-482.1(site)-482.3(and)-486.1(hydrogen)]TJ
0 -1.3256 TD
[(bond)-583.3(interaction)-587.6(between)-587(the)-584.5(aromatic)-592(ring)-583(structure)-590(of)]TJ
T*
[(these)-247.5(inhibitors)-250.1(and)-251.8(the)-243.1(invariant)-250.8(glutamine)-253.9(residue)-247.2(in)-250.4(the)-243.1(Q)]TJ
0 -1.3189 TD
[(pocket,)-385.1(the)-383.7(site)-381.9(which)-383(is)-379.9(normally)-385.7(occupied)-380.7(by)-384.7(the)-383.7(nucleo-)]TJ
0 -1.3256 TD
[(tide)-324.5(moiety)-322.7(of)-322.6(cyclic)-329.4(AMP)-320.2(\(Xu)]TJ
/F3 1 Tf
14.5411 0 TD
[(et)-324.5(al)]TJ
/F2 1 Tf
1.9147 0 TD
[(.,)-321.8(2000;)-326.4(Card)]TJ
/F3 1 Tf
6.3734 0 TD
[(et)-324.5(al)]TJ
/F2 1 Tf
1.9147 0 TD
[(.,)-328.5(2004;)]TJ
-24.7439 -1.3256 TD
[(W)74.6(ang)]TJ
/F3 1 Tf
3.0193 0 TD
[(et)-337.9(al)]TJ
/F2 1 Tf
1.9281 0 TD
[(.,)-335.2(2007\).)]TJ
-3.9499 -1.3256 TD
[(There)-678.9(are)-680.3(considerable)-677.2(challenges)-681.2(to)-678.9(the)-671.5(synthesis)-678.3(of)]TJ
-0.9975 -1.3189 TD
[(subtype)-717.5(selective)-713.4(inhibitors)-718.8(due)-712.1(to)-712.4(the)-711.7(high)-713.7(degree)-712.3(of)]TJ
0 -1.3256 TD
[(sequence)-731.8(and)-727.1(structural)-729.9(homology)-736(within)-727.3(the)-731.8(catalytic)]TJ
T*
[(domains)-390.4(of)-396.2(the)-390.4(PDE4)-388.4(subtypes)-391.8(\(Xu)]TJ
/F3 1 Tf
17.1119 0 TD
[(et)-384.8(al)]TJ
/F2 1 Tf
1.9817 0 TD
[(.,)-388.7(2000;)-393.4(Card)]TJ
/F3 1 Tf
6.5743 0 TD
[(et)-391.5(al)]TJ
/F2 1 Tf
1.9817 0 TD
(.,)Tj
-27.6495 -1.3189 TD
[(2004;)-299.6(W)74.6(ang)]TJ
/F3 1 Tf
5.8646 0 TD
[(et)-291.1(al)]TJ
/F2 1 Tf
1.8879 0 TD
[(.,)-295(2007\).)-300.5(One)-294.8(possibility)-300.7(might)-295.3(be)-296.1(to)-297.3(exploit)]TJ
-7.7526 -1.3256 TD
[(subtle)-262.7(differences)-264(between)-265.7(the)-256.5(interaction)-266.3(of)-262.3(these)-260.9(inhibitors)]TJ
T*
[(to)-270.5(the)-269.9(catalytic)-273.5(active)-267.9(site,)-271.6(or)-267.2(alternatively)67(,)-271.4(b)0(y)-264.2(non-active)-272.5(site)]TJ
0 -1.3189 TD
[(inhibition)-267.3(by)-264.2(targeting)-263.5(the)-263.1(N-terminal)-268.1(region)-259.9(of)-269(the)-256.5(enzyme,)]TJ
0 -1.3256 TD
[(which)-269.2(contain)-278.4(phosphory)-12(lation)-267.9(sites)-270.5(and/or)-274.5(protein-binding)]TJ
T*
[(sequences)-607(and)-599.9(so)-601(indirectly)-604.2(interfere)-609.7(with)-597.4(PDE4)-609.3(activity)]TJ
0 -1.3189 TD
0.0002 Tc
(\(Card)Tj
/F3 1 Tf
2.9256 0 TD
0 Tc
[(et)-337.9(al)]TJ
/F2 1 Tf
1.9281 0 TD
[(.,)-335.2(2004;)-339.8(W)74.6(ang)]TJ
/F3 1 Tf
6.8555 0 TD
[(et)-331.2(al)]TJ
/F2 1 Tf
1.9281 0 TD
[(.,)-335.2(2007\).)]TJ
-12.6398 -1.3256 TD
[(W)21(ith)-484.6(well)-481.7(over)-487.2(100)-479.8(mediators)-489.3(including)-484.7(prostaglandins,)]TJ
-0.9975 -1.3256 TD
[(leukotrienes,)-444.1(chemokines,)-444.4(cytokines,)-442.2(proteases)-447.3(and)-439.2(growth)]TJ
T*
[(factors)-795.2(and)-787.3(numerous)-801.3(cell)-790.4(types)-789.8(including)-792.7(mast)-794.7(cells,)]TJ
0 -1.3189 TD
[(neutrophils,)-555.4(eosinophils,)-551.4(macrophages,)-557.1(DCs)-551(and)-546.3(lympho-)]TJ
0 -1.3256 TD
[(cytes)-422.8(implicated)-424.1(in)-417.8(the)-423.8(pathogenesis)-421.3(of)-423(asthma)-418.6(and)-419.1(COPD)]TJ
T*
[(\(Barnes,)-581.1(2006b;)-580.2(Holgate,)-581.4(2007\),)-581.6(suggests)-582.5(that)-581.1(a)-574.6(chemical)]TJ
0 -1.3189 TD
[(strategy)-399.5(designed)-409.2(to)-397.7(target)-400.2(a)-400.5(single)-406(mediator)-399.9(or)-394.4(cell)-402.1(type)-399.1(is)]TJ
0 -1.3256 TD
[(unlikely)-688.7(to)-678.9(be)-684.4(successful)-689.6(particularly)-685.2(as)-684(many)-682.3(of)-684.1(these)]TJ
T*
[(mediators)-335.3(and)-332.1(cell)-335.1(types)-334.5(have)-332.6(overlapping)-335.6(and)-332.1(complemen-)]TJ
0 -1.3189 TD
[(tar)-8.7(y)-653.1(roles)-655.9(in)-652.1(disease)-651.5(pathology)69.9(.)-653(PDE4)-649.5(is)-654.4(expressed)-651(in)-652.1(a)]TJ
0 -1.3256 TD
[(number)-264.8(of)-262.3(cell)-254.8(types)-260.9(that)-259.7(are)-265.3(considered)-259.7(suitable)-264.1(drug)-259.3(targets)]TJ
T*
[(for)-325.9(the)-316.7(treatment)-324.2(of)-322.6(respirator)-16.9(y)-318.3(diseases)-325.9(such)-318.7(as)-322.5(asthma)-324.9(and)]TJ
T*
[(COPD)-269.2(\()5.9(T)58.3(able)-264(1\).)-262.5(It)-268.5(might)-261.9(reasonably)-268.3(be)-262.6(argued)-266.9(that)-259.7(targeting)]TJ
0 -1.3189 TD
[(PDE4)-408.4(could)-413.9(potentially)-415.3(suppress)-406.4(the)-410.4(function)-413.9(of)-409.6(numerous)]TJ
0 -1.3256 TD
[(cell)-274.9(types;)-271.1(however)40.6(,)-271.4(i)0(t)-270.3(i)0(s)-272.8(well)-267.4(known)-273.3(that)-273.1(other)-269.2(PDE)-270.8(enzymes)]TJ
ET
1 i 
50.797 329.783 496.176 -0.737 re
f
50.797 97.625 496.176 -0.737 re
f
50.797 310.11 61.285 -0.283 re
f
112.082 310.11 61.285 -0.283 re
f
173.367 310.11 61.228 -0.283 re
f
234.595 310.11 144.964 -0.283 re
f
379.559 310.11 167.414 -0.283 re
f
BT
/F1 1 Tf
7.4718 0 0 7.4718 50.7968 335.5653 Tm
0.0001 Tc
[(Table)-339.9(1)]TJ
/F4 1 Tf
4.4918 0 TD
0 Tc
[(PD)-9.8(E)-327(d)-0.1(ist)-10.5(ribution)-339.9(w)-0.1(ithin)-335.1(human)-341.9(cells)-333.1(of)-335.8(interest)-347.8(for)-334.2(t)0(he)-331.8(treatment)-349.1(o)-0.1(f)-335.8(respiratory)-344(diseases)-339.6(such)-333(as)-336.5(asthma)-337.1(and)-334.6(COPD)]TJ
/F5 1 Tf
-4.4918 -2.3066 TD
[(Cell)-336.4(type)-4568.2(PDE4)-340.2(Subtype)]TJ
/F4 1 Tf
5.6038 0 0 4.9805 156.9259 321.6188 Tm
(a)Tj
/F5 1 Tf
7.4718 0 0 7.4718 178.1858 318.3306 Tm
[(Other)-339.1(PDEís)-2454.1(Biologi)-11.6(cal)-312.8(consequence)-318.1(of)-306.7(PDE4)-317.4(inhibition)-1804.4(Reference)]TJ
/F4 1 Tf
-17.0492 -2.5646 TD
[(T)-237.1(lymphocyt)-15(es)]TJ
0 -1.2064 TD
0.0001 Tc
[(CD4)-338.7(CD8)]TJ
8.2021 1.2064 TD
0 Tc
(B)Tj
/F6 1 Tf
0.5766 0 TD
(4)Tj
/F4 1 Tf
0.994 0 TD
[(A)-8331.7(3)-0.1(,)-335.8(7)-4109.5(Inhib)-10.5(ition)-338.1(o)-0.1(f)-335.8(p)-0.1(roliferation)-346(a)0(nd)-334.6(cytokine)]TJ
14.8261 -1.2064 TD
(release)Tj
19.4013 1.2064 TD
0.0004 Tc
(\(Gantner)Tj
/F5 1 Tf
4.2946 0 TD
0.0001 Tc
[(et)-339.4(al)]TJ
/F4 1 Tf
1.9045 0 TD
[(.,)-328.4(1997b;)-340.7(Hatze)-10.8(lmann)-333.3(a)0.1(nd)-334.5(Schudt)-12.9(,)]TJ
-6.199 -1.2064 TD
[(2001;)-341.9(Smith)]TJ
/F5 1 Tf
5.8424 0 TD
0 Tc
[(et)-331.9(al)]TJ
/F4 1 Tf
1.8969 0 TD
[(.,)-336.1(2003;)-334.4(Pet)-9.6(er)]TJ
/F5 1 Tf
6.4191 0 TD
0.0001 Tc
[(et)-339.4(al)]TJ
/F4 1 Tf
1.8969 0 TD
[(.,)-336(2007\))]TJ
-60.0554 -1.1988 TD
0 Tc
[(B)-338.5(cells)-5439.5(B,)-335.8(D)]TJ
/F6 1 Tf
10.1445 0 TD
(4)Tj
/F4 1 Tf
0.994 0 TD
[(A)-7565.4(7)-4708.9(Incre)-10.1(ased)-333.7(proliferation)-9526.9(\()-2.6(Gantner)]TJ
/F5 1 Tf
37.1562 0 TD
0.0001 Tc
[(et)-339.4(al)]TJ
/F4 1 Tf
1.9045 0 TD
0 Tc
[(.,)-328.5(1998;)-342(Smith)]TJ
/F5 1 Tf
6.7529 0 TD
[(et)-331.9(al)]TJ
/F4 1 Tf
1.8969 0 TD
0.0001 Tc
[(.,)-336(2003\))]TJ
-58.849 -1.1988 TD
[(Eosinophi)-12.9(ls)-3298.6(A,)-331.6(D)]TJ
/F6 1 Tf
10.1825 0 TD
0 Tc
(4)Tj
/F4 1 Tf
1.0016 0 TD
0.0001 Tc
[(B)-7561.7(7)-4708.8(Inhib)-10.4(ition)-338(o)0(f)-335.7(s)0.1(uperoxide)-344.8(a)0.1(nion)]TJ
13.4148 -1.1988 TD
0 Tc
[(gener)-10.2(ation;)-339.9(delayed)-333.3(apop)-10.5(tosis)]TJ
19.4013 1.1988 TD
0.0001 Tc
[(\(Hatzelmann)-260.7(and)-251(Schudt,)-260.6(2001;)-258.4(Smith)]TJ
/F5 1 Tf
17.1706 0 TD
[(et)-248.3(al)]TJ
/F4 1 Tf
1.8134 0 TD
[(.,)-252.5(2003;)]TJ
-18.984 -1.1988 TD
0 Tc
(Parkkonen)Tj
/F5 1 Tf
4.9319 0 TD
0.0001 Tc
[(et)-339.4(al)]TJ
/F4 1 Tf
1.8969 0 TD
[(.,)-336(2007\))]TJ
-50.8289 -1.1988 TD
[(Neutroph)-12.3(ils)-3029.3(A,)-331.6(D)]TJ
/F6 1 Tf
10.1825 0 TD
0 Tc
(4)Tj
/F4 1 Tf
1.0016 0 TD
0.0001 Tc
[(B)-7561.7(7)-4708.8(Inhib)-10.4(ition)-338(o)0(f)-335.7(s)0.1(uperoxide)-344.8(a)0.1(nion)-337.7(and)]TJ
13.4148 -1.1988 TD
0 Tc
[(neut)-10.1(rophil)-336.8(elastase)-338(release)]TJ
19.4013 1.1988 TD
0.0001 Tc
[(\(Hatzelmann)-260.7(and)-251(Schudt,)-260.6(2001;)-258.4(Smith)]TJ
/F5 1 Tf
17.1706 0 TD
[(et)-248.3(al)]TJ
/F4 1 Tf
1.8134 0 TD
[(.,)-252.5(2003;)]TJ
-18.984 -1.1988 TD
(Jones)Tj
/F5 1 Tf
2.6632 0 TD
0 Tc
[(et)-331.9(al)]TJ
/F4 1 Tf
1.8969 0 TD
0.0001 Tc
[(.,)-336(2005\))]TJ
-48.5603 -1.2064 TD
[(Monocyte)-3715.7(B)]TJ
/F6 1 Tf
9.1051 0 TD
0 Tc
(4)Tj
/F4 1 Tf
1.0016 0 TD
0.0001 Tc
[(A,)-339.2(D)-7227.8(7)-4708.8(Inhib)-10.4(ition)-338(o)0(f)-335.7(TNF-)]TJ
/F6 1 Tf
22.4212 0 TD
0 Tc
(a)Tj
/F4 1 Tf
0.8877 0 TD
0.0001 Tc
[(release)-7587.3(\(Hatzelmann)-260.7(and)-251(Schudt,)-260.6(2001;)-258.4(Smith)]TJ
/F5 1 Tf
27.7552 0 TD
[(et)-248.3(al)]TJ
/F4 1 Tf
1.8134 0 TD
[(.,)-252.5(2003;)]TJ
-18.984 -1.1988 TD
0 Tc
[(Heyste)-10.5(k)]TJ
/F5 1 Tf
3.7786 0 TD
0.0001 Tc
[(et)-331.8(al)]TJ
/F4 1 Tf
1.8969 0 TD
[(.,)-336(2003;)-334.3(Jones)]TJ
/F5 1 Tf
6.4949 0 TD
0 Tc
[(et)-331.9(al)]TJ
/F4 1 Tf
1.8969 0 TD
0.0001 Tc
[(.,)-336(2005\))]TJ
-58.0675 -1.1988 TD
[(Macrophage)-14.2(s)-2202.3(A)0(,)-331.6(B)0.1(,)-335.7(D)-6742.2(1,)-335.7(3,)-335.7(7)-3510(I)0.1(nhib)-10.4(ition)-338(o)0(f)-335.7(TNF-)]TJ
/F6 1 Tf
32.5278 0 TD
0 Tc
(a)Tj
/F4 1 Tf
0.8877 0 TD
(release)Tj
5.6038 0 0 4.9805 322.866 221.7826 Tm
(b)Tj
7.4718 0 0 7.4718 379.559 218.4377 Tm
0.0004 Tc
(\(Gantner)Tj
/F5 1 Tf
4.2946 0 TD
0.0001 Tc
[(et)-339.4(al)]TJ
/F4 1 Tf
1.9045 0 TD
0 Tc
[(.,)-328.5(1997a)-11.6(;)-331.2(H)-0.1(atzelmann)-344.3(a)0(nd)]TJ
-6.199 -1.1988 TD
0.0001 Tc
[(Schudt,)-344.1(2001;)-341.9(Smith)]TJ
/F5 1 Tf
9.5603 0 TD
0 Tc
[(et)-339.5(al)]TJ
/F4 1 Tf
1.8969 0 TD
0.0001 Tc
[(.,)-336(2003;)]TJ
-11.4572 -1.1988 TD
0 Tc
[(Barb)-10.2(er)]TJ
/F5 1 Tf
3.2019 0 TD
[(et)-339.5(al)]TJ
/F4 1 Tf
1.8969 0 TD
0.0001 Tc
[(.,)-336(2004\))]TJ
-49.099 -1.1988 TD
[(DCs)-6390.9(A)]TJ
/F6 1 Tf
8.8167 0 TD
0 Tc
(4)Tj
/F4 1 Tf
1.0016 0 TD
0.0001 Tc
[(B,)-335.7(D)-6962.3(1)0(,)-335.7(3)-4109.4(Inhib)-10.4(ition)-338(o)0(f)-335.7(TNF-)]TJ
/F6 1 Tf
22.7095 0 TD
0 Tc
(a)Tj
/F4 1 Tf
0.8877 0 TD
0.0001 Tc
[(release)-7587.3(\(Hatzelmann)-344.2(a)0.1(nd)-334.5(Schudt,)-344.1(2)0(001;)]TJ
10.5846 -1.1988 TD
0 Tc
[(Heyste)-10.5(k)]TJ
/F5 1 Tf
3.7786 0 TD
0.0001 Tc
[(et)-331.8(al)]TJ
/F4 1 Tf
1.8969 0 TD
[(.,)-336(2003\))]TJ
-49.6756 -1.2064 TD
0 Tc
[(Mast)-341.1(cells)-20250.4(Littl)-11(e)-332.2(i)0(f)-335(a)0(ny)-336.5(mast)-335.2(cell)-338.7(stabilization)-4633.8(\()-2.6(Weston)]TJ
/F5 1 Tf
48.014 0 TD
[(et)-339.5(al)]TJ
/F4 1 Tf
1.8969 0 TD
[(.,)-336.1(1997;)-342(Shichijo)]TJ
/F5 1 Tf
7.6331 0 TD
0.0001 Tc
[(et)-339.4(al)]TJ
/F4 1 Tf
1.8969 0 TD
[(.,)-336(1998\))]TJ
-59.4408 -1.1988 TD
0 Tc
(Airway)Tj
T*
[(epithelial)-344.7(cells)]TJ
16.4043 1.1988 TD
[(1ñ3,)-325.9(4,)-320.6(5,)-328.2(7,)-328.2(8)-1795.3(I)0(ncre)-10.1(ased)-235(production)-247.4(of)-237.1(PGE)]TJ
5.6038 0 0 4.9805 327.4582 163.389 Tm
(2)Tj
7.4718 0 0 7.4718 330.633 164.6362 Tm
0.0001 Tc
[(;)-232.4(i)0.1(nhi)-9.9(bition)]TJ
-12.8533 -1.1988 TD
0 Tc
[(of)-335.8(IL-6)-336.3(produ)-12.8(ction)]TJ
19.4013 1.1988 TD
0.0003 Tc
(\(Fuhrmann)Tj
/F5 1 Tf
5.2354 0 TD
0 Tc
[(et)-331.9(al)]TJ
/F4 1 Tf
1.8969 0 TD
0.0001 Tc
[(.,)-336(1999;)-341.9(Haddad)]TJ
/F5 1 Tf
7.6634 0 TD
[(et)-331.8(al)]TJ
/F4 1 Tf
1.8969 0 TD
[(.,)-336(2002\))]TJ
-60.6927 -2.3977 TD
0 Tc
[(Endothe)-10.8(lial)]TJ
0 -1.1988 TD
(cells)Tj
17.5196 1.1988 TD
0.0001 Tc
[(2,)-335.7(3,)-335.7(4,)-335.7(5)-2910.6(I)0.1(nhib)-10.4(ition)-338(o)0(f)-335.7(a)0.1(dhesion)-336.7(molecule)]TJ
7.0792 -1.1988 TD
0 Tc
[(expre)-12.5(ssion)]TJ
19.4013 1.1988 TD
0.0006 Tc
(\(Jones)Tj
/F5 1 Tf
3.0123 0 TD
0 Tc
[(et)-339.5(al)]TJ
/F4 1 Tf
1.8969 0 TD
0.0001 Tc
[(.,)-336(2005;)-341.9(Sanz)]TJ
/F5 1 Tf
6.2294 0 TD
[(et)-331.8(al)]TJ
/F4 1 Tf
1.8969 0 TD
[(.,)-336(2007\))]TJ
-57.0355 -2.3977 TD
0 Tc
[(Fibroblasts)-3530.7(A,)-331.7(B)]TJ
/F6 1 Tf
10.3494 0 TD
(4)Tj
/F4 1 Tf
1.0016 0 TD
[(D)-5429.7(1)-0.1(,)-335.8(4)-0.1(,)-335.8(5)-0.1(,)-335.8(7)-2910.7(Inhib)-10.5(ition)-338.1(o)-0.1(f)-335.8(fibroblast)-340.4(chemotaxis;)]TJ
13.2478 -1.2064 TD
[(inhi)-10(bition)-336.8(o)-0.1(f)-335.8(p)-0.1(ro-MMP1,)-340.8(2)-338.5(release)]TJ
19.4013 1.2064 TD
0.0004 Tc
(\(Kohyama)Tj
/F5 1 Tf
4.8408 0 TD
0 Tc
[(et)-331.9(al)]TJ
/F4 1 Tf
1.8969 0 TD
0.0001 Tc
[(.,)-336(2002;)-341.9(Smith)]TJ
/F5 1 Tf
6.7529 0 TD
0 Tc
[(et)-339.5(al)]TJ
/F4 1 Tf
1.8969 0 TD
0.0001 Tc
[(.,)-336(2003;)]TJ
-15.3875 -1.2064 TD
0 Tc
[(Martin-C)-13(houly)]TJ
/F5 1 Tf
6.7681 0 TD
0.0001 Tc
[(et)-339.4(al)]TJ
/F4 1 Tf
1.8969 0 TD
[(.,)-336(2004;)-341.9(Dunkern)]TJ
/F5 1 Tf
7.9897 0 TD
[(et)-331.8(al)]TJ
/F4 1 Tf
1.8969 0 TD
[(.,)-336(2007\))]TJ
-62.5517 -1.1988 TD
0 Tc
(Sensory)Tj
T*
(nerves)Tj
5.6038 0 0 4.9805 71.9433 105.222 Tm
(c)Tj
7.4718 0 0 7.4718 112.0819 110.8347 Tm
0.0001 Tc
[(D)-9777.2(1)0(,)-335.7(3)-4109.4(Inhib)-10.4(ition)-338(o)0(f)-335.7(n)0(europeptide)-343.6(release)-4317.1(\(Spina)]TJ
/F5 1 Tf
38.9317 0 TD
0 Tc
[(et)-331.9(al)]TJ
/F4 1 Tf
1.8969 0 TD
0.0001 Tc
[(.,)-328.4(1995\))]TJ
6.9738 0 0 6.9738 50.7968 84.189 Tm
0 Tc
[(Abbr)-11.1(eviations:)-344.2(CD,)-331.5(clu)-10.6(ster)-337.4(o)-0.1(f)-332(d)-0.1(ifferen)-13.4(tiation;)-336.6(CO)-9.6(PD,)-331.2(chr)-9.4(onic)-338.1(obstructive)-342.5(pulmona)-12.8(ry)-335.7(disease;)-342.5(IL,)-335.7(interleukin;)-344.5(TNF,)-335.6(t)0(um)-10.9(our)-333.9(necrosis)-340.8(factor.)]TJ
5.2302 0 0 4.6485 50.7968 78.3496 Tm
(a)Tj
6.9738 0 0 6.9738 53.4047 75.2315 Tm
[(PDE4)-338.7(s)0(ub)-10.8(type)-338.2(mRNA)-336.4(expression)-342.9(illustr)-13.6(ating)-335.1(relative)-338.6(abun)-11.8(dance)-334.5(i)0(n)-340.5(cells.)]TJ
5.2302 0 0 4.6485 50.7968 69.3921 Tm
(b)Tj
6.9738 0 0 6.9738 53.9149 66.274 Tm
0.0001 Tc
[(In)-335.6(the)-336(p)0(resence)-346.4(o)0(f)-331.9(a)-337.2(PDE3)-338.6(inhibitor.)]TJ
5.2302 0 0 4.6485 50.7968 60.3779 Tm
0 Tc
(c)Tj
6.9738 0 0 6.9738 53.2913 57.3165 Tm
[(Gui)-10.7(nea-pig)-339.5(sensory)-339.3(nerves.)]TJ
ET
307.842 749.367 239.131 -0.227 re
f
BT
/F1 1 Tf
5.9774 0 0 7.9702 307.8424 761.8392 Tm
-0.0001 Tc
[(PDE4)-332.8(inhibitors)-335.3(and)-325.8(respiratory)-335.9(disease)]TJ
/F9 1 Tf
0 -1.2519 TD
[(D)-328.5(Spina)]TJ
7.0982 0 0 9.4646 534.1038 751.8612 Tm
0.0001 Tc
(309)Tj
ET
307.842 40.932 239.131 -0.283 re
f
BT
/F4 1 Tf
6.0123 0 0 8.4682 405.2408 31.2378 Tm
[(British)-322.5(J)0.1(ournal)-334(of)-334.4(Pharmacolog)18.7(y)-339.1(\(2008\))]TJ
/F1 1 Tf
17.5955 0 TD
(155)Tj
/F4 1 Tf
2.0462 0 TD
(308ñ315)Tj
ET

 Q
q
q 1 0 0 1 0 0 cm /Xi2 Do Q
Q


Q

q
0.0 0.0 595 794 re
W
n
1 0 0 1 0 0 cm
BT
/F1-0 12 Tf
14.4 TL
ET
1 0 0 RG
n
48 716 243 12 re
S
1 0 0 RG
n
48 705 242 12 re
S
1 0 0 RG
n
49 694 242 11 re
S
1 0 0 RG
n
49 682 241 13 re
S
1 0 0 RG
n
49 672 241 11 re
S
1 0 0 RG
n
49 661 52 10 re
S
1 0 0 RG
n
48 626 26 12 re
S
1 0 0 RG
n
49 616 241 10 re
S
1 0 0 RG
n
48 603 242 12 re
S
1 0 0 RG
n
49 593 242 11 re
S
1 0 0 RG
n
49 581 241 12 re
S
1 0 0 RG
n
49 570 242 11 re
S
1 0 0 RG
n
49 559 241 11 re
S
1 0 0 RG
n
49 547 242 12 re
S
1 0 0 RG
n
49 536 242 12 re
S
1 0 0 RG
n
49 526 242 11 re
S
1 0 0 RG
n
49 513 241 13 re
S
1 0 0 RG
n
48 503 243 11 re
S
1 0 0 RG
n
49 492 242 10 re
S
1 0 0 RG
n
48 479 123 14 re
S
1 0 0 RG
n
227 479 64 14 re
S
1 0 0 RG
n
49 469 242 11 re
S
1 0 0 RG
n
49 458 241 11 re
S
1 0 0 RG
n
48 446 242 12 re
S
1 0 0 RG
n
49 436 241 10 re
S
1 0 0 RG
n
50 425 241 10 re
S
1 0 0 RG
n
49 413 242 11 re
S
1 0 0 RG
n
49 402 242 10 re
S
1 0 0 RG
n
49 391 241 10 re
S
1 0 0 RG
n
49 380 241 10 re
S
1 0 0 RG
n
49 369 242 10 re
S
1 0 0 RG
n
306 716 241 12 re
S
1 0 0 RG
n
306 705 243 11 re
S
1 0 0 RG
n
306 694 242 12 re
S
1 0 0 RG
n
305 683 243 11 re
S
1 0 0 RG
n
306 671 242 12 re
S
1 0 0 RG
n
306 660 77 11 re
S
1 0 0 RG
n
315 649 233 11 re
S
1 0 0 RG
n
306 637 243 12 re
S
1 0 0 RG
n
306 626 242 12 re
S
1 0 0 RG
n
306 615 241 12 re
S
1 0 0 RG
n
306 604 241 11 re
S
1 0 0 RG
n
306 593 241 11 re
S
1 0 0 RG
n
306 581 241 12 re
S
1 0 0 RG
n
306 569 242 13 re
S
1 0 0 RG
n
306 558 242 13 re
S
1 0 0 RG
n
306 548 241 11 re
S
1 0 0 RG
n
306 537 151 11 re
S
1 0 0 RG
n
314 525 234 14 re
S
1 0 0 RG
n
306 514 241 12 re
S
1 0 0 RG
n
306 503 241 12 re
S
1 0 0 RG
n
306 492 241 11 re
S
1 0 0 RG
n
306 481 242 11 re
S
1 0 0 RG
n
306 469 242 12 re
S
1 0 0 RG
n
305 458 243 12 re
S
1 0 0 RG
n
306 446 242 13 re
S
1 0 0 RG
n
306 435 242 12 re
S
1 0 0 RG
n
305 424 244 12 re
S
1 0 0 RG
n
306 413 242 11 re
S
1 0 0 RG
n
306 402 242 12 re
S
1 0 0 RG
n
305 390 243 13 re
S
1 0 0 RG
n
305 379 244 13 re
S
1 0 0 RG
n
306 369 242 11 re
S
1 0 0 RG
n
49 333 417 11 re
S
1 0 0 RG
n
49 83 423 9 re
S
1 0 0 RG
n
47 72 229 13 re
S
1 0 0 RG
n
60 62 107 14 re
S
1 0 0 RG
n
48 53 90 14 re
S
0 1 0 RG
n
172 480 55 12 re
S
0 1 0 RG
n
48 65 12 9 re
S
0.8 0 1 RG
n
48 97 502 236 re
S
0.619608 0.619608 0.619608 RG
n
404 28 143 12 re
S
0.619608 0.619608 0.619608 RG
n
531 749 18 13 re
S
0.619608 0.619608 0.619608 RG
n
305 760 114 11 re
S
0.619608 0.619608 0.619608 RG
n
305 749 25 12 re
S
0.619608 0.619608 0.619608 RG
n
577 15 8 382 re
S
Q


endstream
endobj
118 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
119 0 obj
<<
/BBox [ 0 0 595 794 ]
/Filter /FlateDecode
/FormType 1
/Matrix [ 1 0 0 1 0 0 ]
/Resources <<
/Font <<
/F1 120 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Subtype /Form
/Type /XObject
/Length 286
>>
stream
xúuP=o¬0›Û+ﬁ¯#)$¥SKÀÑƒ–HJ'π£ƒéÏ ‚ﬂ◊.jßvy:›È}‹{*æëX∞eõÃ%$˘ä»ÛÇ…pËì	‰]æ\dÖú!¢ò!õ·Ÿ^LgUCZg{∆q˜úWÉNïg÷t⁄Pß+ß‹ï]tGWV€û7Vs)òY¡´„¿¢ ÀDéÍäµ≠N¬&`M3ºEvﬂRÿﬁ¥`ﬁÂíãOEö}0ºa<JrΩá2M2çµ5˚…O≤ˇçë6¥y˝K€O£Õüˆ≠upßé<lãìßÏ°‹®Î∏Séiœ‰L(&ºs©aËt≠™é∞v§F}ÉÌ˚o´k2û¶Â1â’‹0¥˛R&_¸TÑ∏
endstream
endobj
120 0 obj
<<
/BaseFont /Times-Roman
/Encoding /WinAnsiEncoding
/Subtype /Type1
/Type /Font
>>
endobj
121 0 obj
<<
/BitsPerComponent 8
/ColorSpace 62 0 R
/Filter /FlateDecode
/Height 99
/Width 74
/Length 498
>>
stream
HâÏóí√ ÜπˇπŒŒtÂ°˛àQõ¥3e∫MW¸xÜ˘'TÀ¶¶¡‰:S+åwHFüÃ<¿ÙögcËnÔ5ıY>…RÔ≥2¡Ò)£OÊ S»Ã‡°«ehÛ∫ûÉUf∏fŒƒàT}<Ø£›ö±0¯uáüÊòÇ˘Vû·ﬁ◊_h›ùöÿ]|9~ŒOM@ó4Ò∏-<h›”å¶AŸ\eµ‡É=r√™Ì5eµ3∫ÎÛ¢u—È ¶Ó4Ö∆∞%\a!Ω5†ÿ_Ìú\ßò˜≠KÇ
ò≤;œYwäÈÑüŒ[˜›‚ú!ÔµØ]@ÂÚÍx¸ˇÕRn`⁄êg*Óe,«ä‚p‚‚wrµòÂ‰—1!VØoË1Ql+ê|˚U=Ù6…_£Im®ò˙w´)πiêæÅF˜áò4kL«DS@ˇ/áò¯ToùOôs÷πd¬'CÀA*)òö_·)ö≠l√Å«-Ò»çdﬂ@™<˛f©7º{[dDçÜ≈®À
fÈ7ZÈÏ|	3
⁄nMk⁄∫Vy3¨€YØ_~éÖB‘kÍTLÆê471ªBmáÂiªØ›“\Î.≈UÀÔñO⁄ìJìãHâä‘l=6â≥ÌÂéji¶ÕSõq˘™®ûñ˘,¯I& ®Øyñ
endstream
endobj
122 0 obj
<<
/Annots [ 123 0 R 124 0 R 125 0 R 126 0 R 127 0 R 128 0 R 129 0 R 130 0 R 131 0 R 132 0 R 133 0 R 134 0 R 135 0 R 136 0 R 137 0 R 138 0 R 139 0 R 140 0 R 141 0 R 142 0 R 143 0 R 144 0 R 145 0 R 146 0 R 147 0 R 148 0 R 149 0 R 150 0 R 151 0 R 152 0 R 153 0 R 154 0 R ]
/Contents 155 0 R
/CropBox [ 0 0 595 794 ]
/MediaBox [ 0 0 595 794 ]
/Resources <<
/ExtGState <<
/GS1 25 0 R
>>
/Font <<
/F1 26 0 R
/F1-0 156 0 R
/F2 30 0 R
/F3 33 0 R
/F4 36 0 R
/F6 42 0 R
/F9 55 0 R
>>
/XObject <<
/Xi3 157 0 R
>>
/ProcSet [ /ImageB /ImageC /ImageI /PDF /Text ]
>>
/Rotate 0
/Thumb 158 0 R
/Type /Page
/Parent 2 0 R
>>
endobj
123 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib75)
/Rect [ 54 683 128 691 ]
/Subtype /Link
/Type /Annot
>>
endobj
124 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib11)
/Rect [ 134 683 245 691 ]
/Subtype /Link
/Type /Annot
>>
endobj
125 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib71)
/Rect [ 113 571 178 579 ]
/Subtype /Link
/Type /Annot
>>
endobj
126 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib18)
/Rect [ 100 436 179 445 ]
/Subtype /Link
/Type /Annot
>>
endobj
127 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib27)
/Rect [ 86 403 168 411 ]
/Subtype /Link
/Type /Annot
>>
endobj
128 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib49)
/Rect [ 54 358 135 366 ]
/Subtype /Link
/Type /Annot
>>
endobj
129 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib42)
/Rect [ 54 324 128 333 ]
/Subtype /Link
/Type /Annot
>>
endobj
130 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib82)
/Rect [ 73 235 125 243 ]
/Subtype /Link
/Type /Annot
>>
endobj
131 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib76)
/Rect [ 131 235 177 243 ]
/Subtype /Link
/Type /Annot
>>
endobj
132 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib33)
/Rect [ 129 156 206 165 ]
/Subtype /Link
/Type /Annot
>>
endobj
133 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib46)
/Rect [ 122 111 192 120 ]
/Subtype /Link
/Type /Annot
>>
endobj
134 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib43)
/Rect [ 199 111 284 120 ]
/Subtype /Link
/Type /Annot
>>
endobj
135 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib33)
/Rect [ 390 705 464 714 ]
/Subtype /Link
/Type /Annot
>>
endobj
136 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib57)
/Rect [ 469 705 541 714 ]
/Subtype /Link
/Type /Annot
>>
endobj
137 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib33)
/Rect [ 489 672 547 680 ]
/Subtype /Link
/Type /Annot
>>
endobj
138 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib33)
/Rect [ 308 661 327 669 ]
/Subtype /Link
/Type /Annot
>>
endobj
139 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib46)
/Rect [ 441 593 506 602 ]
/Subtype /Link
/Type /Annot
>>
endobj
140 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib43)
/Rect [ 511 593 547 602 ]
/Subtype /Link
/Type /Annot
>>
endobj
141 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib43)
/Rect [ 308 582 351 591 ]
/Subtype /Link
/Type /Annot
>>
endobj
142 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib45)
/Rect [ 357 582 429 591 ]
/Subtype /Link
/Type /Annot
>>
endobj
143 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib34)
/Rect [ 505 504 547 512 ]
/Subtype /Link
/Type /Annot
>>
endobj
144 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib34)
/Rect [ 308 492 351 501 ]
/Subtype /Link
/Type /Annot
>>
endobj
145 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib83)
/Rect [ 418 470 522 478 ]
/Subtype /Link
/Type /Annot
>>
endobj
146 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137tbl1)
/Rect [ 442 403 471 411 ]
/Subtype /Link
/Type /Annot
>>
endobj
147 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib11)
/Rect [ 460 380 547 389 ]
/Subtype /Link
/Type /Annot
>>
endobj
148 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib11)
/Rect [ 308 369 332 378 ]
/Subtype /Link
/Type /Annot
>>
endobj
149 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib53)
/Rect [ 372 336 438 344 ]
/Subtype /Link
/Type /Annot
>>
endobj
150 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib20)
/Rect [ 500 235 547 243 ]
/Subtype /Link
/Type /Annot
>>
endobj
151 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib20)
/Rect [ 308 223 327 232 ]
/Subtype /Link
/Type /Annot
>>
endobj
152 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib81)
/Rect [ 423 145 499 153 ]
/Subtype /Link
/Type /Annot
>>
endobj
153 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib34)
/Rect [ 311 78 404 86 ]
/Subtype /Link
/Type /Annot
>>
endobj
154 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib83)
/Rect [ 411 78 524 86 ]
/Subtype /Link
/Type /Annot
>>
endobj
155 0 obj
<<
/Length 21343
>>
stream
q
q

BT
/F2 1 Tf
8.4682 0 0 8.4682 50.7968 718.7526 Tm
0 0 0 rg
/GS1 gs
0 Tc
0 Tw
[(are)-245.2(also)-240.9(expressed)-242.6(in)-243.7(these)-240.8(cells)-243.8(and)-238.4(the)-243.1(contribution)-249.4(of)-242.3(other)]TJ
0 -1.3256 TD
[(PDEs)-581.1(to)-578.5(cell)-582.8(function)-581.2(\(for)-581.1(example,)-584.1(PDE3,)-586.1(PDE7\))-583.3(in)-578.5(the)]TJ
T*
[(context)-383.1(of)-382.8(benefits)-381.9(in)-377.6(respirator)-16.9(y)-378.6(diseases)-379.4(is)-379.9(being)-380.4(explored)]TJ
0 -1.3189 TD
0.0001 Tc
(\(Smith)Tj
/F3 1 Tf
3.6286 0 TD
0 Tc
[(et)-478.5(al)]TJ
/F2 1 Tf
2.0754 0 TD
[(.,)-482.5(2004;)-480.4(Boswell-S)-10.5(mith)]TJ
/F3 1 Tf
11.2673 0 TD
[(et)-478.5(al)]TJ
/F2 1 Tf
2.0754 0 TD
[(.,)-482.5(2006b\).)-480.6(It)-482.7(would)]TJ
-19.0467 -1.3256 TD
[(seem)-405.2(prudent)-405.9(to)-404.4(develop)-405.3(subtype)-409.5(selective)-405.4(PDE4)-401.7(inhibitors)]TJ
T*
[(in)-364.2(attempts)-359.9(to)-357.5(maximize)-365.9(therapeutic)-363.6(benefit)-366.1(at)-360.2(the)-356.9(expense)]TJ
T*
[(of)-409.6(adverse)-405.7(effects,)-414.9(whereas)-409.3(there)-402.4(is)-406.7(also)-408.3(the)-410.4(possibility)-407.9(that)]TJ
0 -1.3189 TD
[(nonselective)-294.6(PDE)-290.9(inhibitors)-290.3(might)-288.6(offer)-292.9(a)-286.7(better)-287.8(appro)-8.6(ach)-286.4(in)]TJ
0 -1.3256 TD
[(targeting)-310.4(multiple)-301.8(target)-306.5(cells)-304(in)-304(the)-303.3(disease)-303.4(process.)-302.5(Indeed,)]TJ
T*
[(it)-250.3(has)-255.6(been)-251.4(suggested)-252.7(that)-253(clozapine)-255.5(is)-252.7(a)-253.2(better)-254.4(anti-psychotic)]TJ
0 -1.3189 TD
[(than)-346.9(newer)-347.9(generation)-347.7(atypical)-352.7(anti-psychotics)-349.5(because)-347.8(this)]TJ
0 -1.3256 TD
[(drug)-600.8(targets)-603.4(numerous)-600.5(receptors,)-600(and)-599.9(as)-597(such,)-603.4(has)-597.1(been)]TJ
T*
[(described)-818.7(as)-811.2(a)-815.6(ëmagic)-816.2(shotguní,)-815.4(for)-814.6(the)-812.1(treatment)-819.7(of)]TJ
0 -1.3189 TD
[(Schizophrenia)-341.4(\(Roth)]TJ
/F3 1 Tf
9.9284 0 TD
[(et)-337.9(al)]TJ
/F2 1 Tf
1.9281 0 TD
[(.,)-335.2(2004\).)]TJ
/F3 1 Tf
-11.8565 -3.9767 TD
[(Asthma)-335.9(and)-341(PDE4)]TJ
/F2 1 Tf
0 -1.3189 TD
[(Increased)-583.4(PDE4)-589.2(function)-587.9(due)-578.2(to)-585.2(either)-585.8(increased)-585.3(protein)]TJ
0 -1.3256 TD
[(expression)-341.3(or)-340.8(activity)-338.9(might)-335.5(provide)-339.5(a)-340.2(plausible)-339(mechanism)]TJ
T*
[(to)-263.8(account)-263.9(for)-258.9(the)-256.5(pathogenesi)-10.5(s)-256.8(o)0(f)-262.3(asthma.)-261.5(The)-258.5(expression)-267.6(of)]TJ
T*
[(a)-634.8(novel)-640.6(and)-633.4(distinct)-641.7(cyclic)-637.3(AMP-PDE)-639.6(was)-636.1(isola)-9.3(ted)-629.8(from)]TJ
0 -1.3189 TD
[(monocytes)-251.3(obtained)-245.2(from)-249.2(individuals)-248.6(with)-249.3(atopic)-250(dermatitis.)]TJ
0 -1.3256 TD
[(This)-549.2(enzyme)-547.7(had)-539.6(increased)-551.8(PDE)-545.3(activity)-546.4(and)-546.3(as)-543.4(a)-547.8(conse-)]TJ
T*
[(quence)-305.6(monocyte)-302.5(function)-306.7(was)-301.4(increased)-304.1(and)-305.3(thought)-300.4(to)-304(be)]TJ
0 -1.3189 TD
[(the)-256.5(underlying)-257.1(basis)-253.3(for)-252.2(the)-256.5(pathology)-258.1(associated)-255.6(with)-256(atopic)]TJ
0 -1.3256 TD
0.0001 Tc
[(dermatitis)-756.7(\(Chan)]TJ
/F3 1 Tf
9.1518 0 TD
0 Tc
[(et)-759.7(al)]TJ
/F2 1 Tf
2.3499 0 TD
[(.,)-756.9(1993\).)-755.7(However)39.4(,)-753.4(soluble)-757(PDE4)]TJ
-11.5016 -1.3256 TD
[(activity)-513(was)-508.9(not)-511.6(increased)-511.6(in)-511.5(a)-514.3(range)-507.6(of)-510(peripheral)-514(blood)]TJ
0 -1.3189 TD
[(leukocytes)-603.2(from)-597.3(atopic)-598.2(patients)-600.1(of)-597.1(either)-599.2(mild)-596.6(or)-601.9(severe)]TJ
0 -1.3256 TD
0.0001 Tc
[(severity)-240.5(\(Gantner)]TJ
/F3 1 Tf
8.2881 0 TD
0 Tc
[(et)-237.5(al)]TJ
/F2 1 Tf
1.8344 0 TD
[(.,)-234.8(1997b\).)-246.3(Similarly)71.7(,)-237.9(increased)-243.8(total)-238.3(PDE)]TJ
-10.1225 -1.3256 TD
[(catalytic)-494.4(activity)-492.9(was)-488.8(obser)-16.7(ved)-486.3(in)-491.5(peripheral)-493.9(blood)-494.9(mono-)]TJ
0 -1.3189 TD
[(cytes)-704(from)-711.1(individuals)-710.6(with)-704.5(mild)-703.7(asthma,)-710(whereas)-703.9(this)]TJ
0 -1.3256 TD
[(was)-542.4(associated,)-540.4(paradoxically)65.9(,)-532.5(with)-543.8(reduced)-535(PDE4)-542.3(activity)]TJ
T*
0.0001 Tc
(\(Landells)Tj
/F3 1 Tf
4.6596 0 TD
0 Tc
[(et)-425(al)]TJ
/F2 1 Tf
2.0151 0 TD
[(.,)-428.9(2000\))-424.1(and)-432.5(the)-423.8(expression)-428.3(of)-423(PDE4AñD)-435.4(was)]TJ
-6.6747 -1.3256 TD
[(not)-431.2(increased)-438(in)-431.2(peripheral)-433.6(blood)-428(cluster)-433.6(of)-436.4(differentiation)]TJ
0 -1.3189 TD
[(\(CD\)4)-346.4(positive)-342.6(T)-343.4(lymphocyte)-9.9(s)-337.1(i)0(n)-344.2(patients)-345.7(with)-343(mild)-348.9(asthma)]TJ
0 -1.3256 TD
0.0001 Tc
(\(Jones)Tj
/F3 1 Tf
3.4679 0 TD
0 Tc
[(et)-605.7(al)]TJ
/F2 1 Tf
2.1959 0 TD
[(.,)-603(2007\).)-608.4(T)65(ogether)-607.3(these)-602.3(studies)-605.6(indicate)-600.1(that)]TJ
-5.6638 -1.3256 TD
[(the)-658.1(underlying)-665.5(pathogenesis)-662.3(of)-664(mild)-663.5(asthma)-659.6(cannot)-664.1(be)]TJ
0 -1.3189 TD
[(attributed)-341(to)-330.8(enhanced)-336.1(PDE4)-334.8(expression)-341.3(or)-334.1(activity)69.5(.)]TJ
1.0042 -1.3256 TD
[(Numerous)-539.1(preclinical)-548.2(studies)-538.6(in)-538.3(models)-540.9(of)-543.5(allergic)-541.9(pul-)]TJ
-1.0042 -1.3256 TD
[(monar)-15.3(y)-720(inflammation)-730.3(have)-727.6(repeatedly)-727.9(documented)-725.5(the)]TJ
0 -1.3189 TD
[(ability)-525.2(of)-523.4(PDE4)-522.3(inhibitors)-524.6(to)-524.9(inhibit)-522.9(two)-523.9(important)-525(char-)]TJ
0 -1.3256 TD
[(acteristic)-593.4(features)-584.6(of)-590.4(asthma,)-582.8(namely)69.5(,)-586(the)-584.5(recruitment)-594.2(of)]TJ
T*
[(eosinophils)-454.1(to)-444.6(the)-450.6(air)-11.4(ways)-445.6(and)-445.9(bronchial)-451.2(hyperresponsive-)]TJ
0 -1.3189 TD
[(ness)-314.8(\(T)58.3(orphy)72(,)-318.2(1998;)-319.7(Spina,)-313.6(2003\).)-320.5(One)-314.8(disadvantag)-9.9(e)-310.1(o)0(f)-322.6(these)]TJ
0 -1.3256 TD
[(studies)-297.6(is)-299.6(the)-296.6(inability)-300.2(to)-304(ascertain)-295.5(the)-296.6(role)-298.7(of)-302.5(PDE4)-301.3(isoforms)]TJ
T*
[(because)-468.3(of)-463.2(the)-464(nonselective)-461.9(nature)-467.9(of)-463.2(the)-464(PDE4)-462(inhibitors)]TJ
T*
[(currently)-431.6(under)-427.6(development.)-434.6(The)-425.8(use)-428.1(of)-429.7(genetically)-430.5(mod-)]TJ
0 -1.3189 TD
[(ified)-519.8(mice)-523.6(has)-516.7(revealed)-521.9(some)-519.7(interesting)-525.1(findings.)-518.3(Air)-15.2(way)]TJ
0 -1.3256 TD
[(inflammation)-281.8(characterized)-277.2(by)-270.9(recruitment)-272.8(of)-275.7(eosinophils)-273.4(to)]TJ
T*
[(the)-377(air)-11.4(ways)-378.7(of)-369.5(mice)-376.3(deficient)-380.9(in)-377.6(PDE4D)-377.2(was)-375(no)-371.1(different)-380.3(to)]TJ
0 -1.3189 TD
[(wild-type)-350(controls)-348.3(\(Hansen)]TJ
/F3 1 Tf
13.1218 0 TD
[(et)-344.6(al)]TJ
/F2 1 Tf
1.9415 0 TD
[(.,)-348.6(2000\).)-347.3(This)-348.4(indicated)-344.3(that)]TJ
-15.0633 -1.3256 TD
[(other)-684.3(PDE4)-682.9(subtypes)-679.6(contributed)-686.4(in)-678.9(the)-684.9(metabolism)-687.4(of)]TJ
T*
[(intracellular)-433.4(cyclic)-436.5(AMP)121.6(,)-432(a)0(s)-436.3(cell)-442.2(recruitment)-433.5(to)-437.9(the)-437.2(air)-11.4(ways)]TJ
0 -1.3189 TD
[(was)-361.6(inhibited)-369.5(when)-362.7(animals)-363.7(were)-361.2(treated)-366.1(with)-363.1(nonselective)]TJ
0 -1.3256 TD
[(PDE4)-468.7(inhibitors)-464.4(\(Kung)]TJ
/F3 1 Tf
11.3142 0 TD
[(et)-458.4(al)]TJ
/F2 1 Tf
2.0553 0 TD
[(.,)-462.4(2000;)-460.3(Kanehiro)]TJ
/F3 1 Tf
8.8304 0 TD
[(et)-458.4(al)]TJ
/F2 1 Tf
2.0553 0 TD
[(.,)-462.4(2001\).)]TJ
-24.2552 -1.3256 TD
[(However)39.4(,)-485.6(air)-18.1(way)-483.4(obstruction)-490.1(caused)-492.1(by)-485.1(methacholine)-496.5(was)]TJ
T*
[(enhanced)-496.8(in)-498.1(wild-type)-497.3(allergic)-501.7(mice)-496.8(but)-496.6(was)-495.5(abolished)-498(in)]TJ
0 -1.3189 TD
[(PDE4D)-471(gene-deficient)-468.5(mice.)-473.5(These)-463.7(mice)-470(were)-461.7(hypor)-8.3(espon-)]TJ
0 -1.3256 TD
[(sive)-760.6(to)-752.5(this)-761.5(stimulus,)-757.3(even)-757.7(in)-759.2(the)-751.9(absence)-761(of)-757.8(allergic)]TJ
T*
[(sensitization)-478.8(and)-472.7(appeared)-475.9(to)-471.4(be)-476.9(related)-469.2(to)-478.1(an)-474.2(increase)-472.9(in)]TJ
30.3542 78.0947 TD
[(dilator)-584.3(prostaglandin)-592(production)-585.9(in)-585.2(the)-584.5(air)-11.4(ways)-586.2(of)-583.7(these)]TJ
0 -1.3256 TD
[(gene-deficient)-247.5(mice)-249.1(\(Hansen)]TJ
/F3 1 Tf
13.49 0 TD
[(et)-244.2(al)]TJ
/F2 1 Tf
1.8411 0 TD
[(.,)-241.4(2000;)-252.8(Mehats)]TJ
/F3 1 Tf
7.304 0 TD
[(et)-244.2(al)]TJ
/F2 1 Tf
1.8344 0 TD
[(.,)-248.1(2003\).)]TJ
-24.4694 -1.3256 TD
[(However)39.4(,)-425.3(this)-420(effect)-422.4(was)-421.9(specific)-427.8(for)-426.3(methacholine)-422.8(because)]TJ
0 -1.3189 TD
[(the)-457.3(enhanced)-463.3(air)-11.4(way)-456.6(obstruction)-463.3(in)-458(response)-455.4(to)-458(serotonin)]TJ
0 -1.3256 TD
[(was)-542.4(unaffected)-535.4(by)-538.7(the)-537.6(removal)-545.7(of)-536.8(PDE4D)-537.9(\(Hansen)]TJ
/F3 1 Tf
25.5205 0 TD
[(et)-538.8(al)]TJ
/F2 1 Tf
2.1289 0 TD
(.,)Tj
-27.6495 -1.3256 TD
[(2000\).)-394.2(This)-381.9(study)-387.9(highlighted)-392.7(the)-383.7(potential)-388.9(complimentar)-17.6(y)]TJ
T*
[(role)-432.6(of)-429.7(PDE4)-435.2(isoforms)-433.4(in)-431.2(regulating)-435.6(allergic)-434.8(air)-11.4(way)-429.9(inflam-)]TJ
0 -1.3189 TD
[(mation,)-292.5(and)-285.2(the)-289.9(need)-283.9(to)-290.6(target)-286.4(more)-293(than)-286.7(one)-286.2(PDE4)-287.9(isoform)]TJ
0 -1.3256 TD
[(because)-448.2(inhibition)-448(of)-449.8(the)-443.9(inflammator)-14.5(y)-445.5(response,)-445.6(hyperre-)]TJ
T*
[(sponsiveness)-503.4(and)-499.5(air)-18.1(way)-496.8(remodelling)-510.3(in)-498.1(allergic)-501.8(wild-type)]TJ
0 -1.3189 TD
[(mice)-496.8(was)-488.8(obser)-16.7(ved)-486.3(following)-501(exposure)-492.1(to)-491.4(PDE4)-495.5(inhibitors)]TJ
0 -1.3256 TD
[(such)-258.4(as)-262.3(rolipram)-263.3(and)-265.2(roflumilast)-260(\(Kung)]TJ
/F3 1 Tf
18.4174 0 TD
[(et)-257.6(al)]TJ
/F2 1 Tf
1.8478 0 TD
[(.,)-261.5(2000;)-266.2(Kanehiro)]TJ
/F3 1 Tf
-20.2651 -1.3256 TD
[(et)-331.2(al)]TJ
/F2 1 Tf
1.9281 0 TD
[(.,)-335.2(2001;)-339.8(Kumar)]TJ
/F3 1 Tf
7.2906 0 TD
[(et)-337.9(al)]TJ
/F2 1 Tf
1.9281 0 TD
[(.,)-335.2(2003\).)]TJ
-10.1493 -1.3189 TD
[(The)-767.3(numerous)-761.1(preclinical)-769.2(studies)-759.6(reporting)-763.6(the)-765.2(anti-)]TJ
-0.9975 -1.3256 TD
[(inflammator)-14.5(y)-606.2(potential)-609.8(of)-603.8(PDE4)-609.3(inhibitors)-611.6(in)-605.3(models)-601.2(of)]TJ
T*
[(allergic)-300.9(inflammation)-301.8(and)-298.6(in)-297.3(human)-299(cells)]TJ
/F3 1 Tf
19.7697 0 TD
[(in)-301.9(vitro)]TJ
/F2 1 Tf
3.421 0 TD
[(have)-292.5(been,)]TJ
-23.1907 -1.3189 TD
[(to)-411.1(some)-412.6(degree,)-407.8(corroborated)-418.3(in)-411.1(clinical)-410.5(trials)-411.3(in)-411.1(asthmatic)]TJ
0 -1.3256 TD
[(patients.)-402.8(T)31.6(wice)-405.1(daily)-401.2(treatment)-404.6(for)-399.5(9.5)-406(days)-405(with)-396.6(the)-403.7(PDE4)]TJ
T*
[(inhibitor)-589.2(CDP840)-583.6(inhibited)-583.7(the)-584.5(development)-585(of)-583.7(the)-584.5(late)]TJ
T*
[(phase)-537.4(response)-542.5(in)-538.3(asthmatic)-541.3(patients)-539.8(by)-538.7(30%)-540.8(\(Harbinson)]TJ
/F3 1 Tf
0 -1.3189 TD
[(et)-331.2(al)]TJ
/F2 1 Tf
1.9281 0 TD
[(.,)-335.2(1997\).)-333.9(A)-337.3(similar)-330.6(degree)-337.4(of)-336(inhibition)-334.2(of)-336(the)-330.1(late)-338.2(phase)]TJ
-1.9281 -1.3256 TD
[(response)-488.9(was)-488.8(obser)-10(ved)-486.3(following)-487.6(once)-493.4(daily)-481.6(treatment)-491.6(for)]TJ
T*
[(7ñ10)-294.5(days)-284.5(with)-289.4(roflumilas)-12.4(t)-287.8(\()-0.8(van)-283.7(Schalkwyk)]TJ
/F3 1 Tf
20.2651 0 TD
[(et)-291.1(al)]TJ
/F2 1 Tf
1.8812 0 TD
[(.,)-288.3(2005\).)-293.8(This)]TJ
-22.1463 -1.3189 TD
[(late)-659.5(phase)-657.9(response)-656.3(is)-661.1(used)-654.3(by)-659.2(clinicians)-660.6(to)-658.8(model)-659.1(the)]TJ
0 -1.3256 TD
[(inflammator)-14.5(y)-318.3(component)-317.5(following)-313.5(an)-313.5(allergic)-321(insult)-310.8(to)-317.4(the)]TJ
T*
[(air)-11.4(ways.)-275.1(In)-282.1(both)-276.7(studies,)-274.4(the)-276.5(effects)-277.5(of)-275.7(drug)-279.4(treatment)-277.4(on)-277.4(the)]TJ
0 -1.3189 TD
[(acute)-799(allergen)-802.8(bronchoconstriction)-807.3(was)-803.5(modest)-799.3(and)-800.7(is)]TJ
0 -1.3256 TD
[(consistent)-534.1(with)-530.5(the)-530.9(lack)-533.7(of)-530.1(demonstrable)-537.7(action)-532.8(of)-530.1(PDE4)]TJ
T*
[(inhibition)-327.5(on)-324.2(mast)-326(cell)-321.7(function)-326.8(\(T)58.3(able)-324.3(1\))-325.9(and)-325.4(highlight)-325.2(the)]TJ
T*
[(role)-379(of)-376.2(other)-376.4(PDE)-384.6(enzymes,)-379.5(namely)-372.4(PDE3)-381.7(in)-377.6(the)-377(context)-376.4(of)]TJ
0 -1.3189 TD
[(air)-11.4(way)-737.8(smooth)-734.6(muscle)-735.3(relaxation)-737.8(\(Boswell-Smith)]TJ
/F3 1 Tf
25.3264 0 TD
[(et)-732.9(al)]TJ
/F2 1 Tf
2.3231 0 TD
(.,)Tj
-27.6495 -1.3256 TD
[(2006b\).)-413.7(Bronchial)-406.9(hyperresponsiveness)-409.2(was)-408.5(not)-404.5(reduced)-407.7(by)]TJ
T*
[(these)-682.7(drugs,)-687(although)-683.6(a)-688.4(later)-682.9(study)-682.5(purported)-684.9(to)-685.6(show)]TJ
0 -1.3189 TD
[(modest)-250.3(protection)-252.7(against)-251.5(allergen-induced)-252.3(bronchial)-257.1(hyper-)]TJ
0 -1.3256 TD
[(responsiveness)-287.8(\(Louw)]TJ
/F3 1 Tf
10.3769 0 TD
[(et)-284.4(al)]TJ
/F2 1 Tf
1.8812 0 TD
[(.,)-281.6(2007\),)-287.1(which)-289.3(might)-282(suggest)-285.6(that)]TJ
-12.2582 -1.3256 TD
[(PDE4)-743.2(may)-735.8(not)-739.2(be)-731.3(a)-741.9(suitable)-739.5(target)-734.9(for)-741(this)-734.7(particular)]TJ
0 -1.3189 TD
[(phenomenon,)-417.4(or)-414.5(that)-413.7(higher)-411.1(doses)-416.5(are)-412.5(required)-414(to)-411.1(provide)]TJ
0 -1.3256 TD
[(complementar)-17.1(y)-271.5(and)-278.5(persistent)-274.3(inhibition)-280.7(of)-275.7(the)-276.5(enzyme)-273.2(and)]TJ
T*
[(hence)-325.4(attenuation)-321.4(of)-322.6(bronchial)-330.7(hyperresponsiveness.)-325.7(It)-322.1(is)-326.4(of)]TJ
0 -1.3189 TD
[(interest)-722(that)-728.4(roflumilast)-728.6(has)-724.3(a)-721.8(plasma)-727.7(half-life)-723.8(of)-724.3(16)-168.2(h)]TJ
0 -1.3256 TD
[(following)-521(a)-514.3(single)-513.2(p.o)-520.4(administration,)-514.9(and)-519.6(is)-513.8(metabolized)]TJ
T*
[(by)-572.1(CYP3A4)-577.9(to)-571.8(the)-571.1(active)-575.8(N-oxide)-572.8(metabolite,)-579.8(which)-577.2(has)]TJ
T*
[(considerably)-477.9(greater)-472.6(bioavailability)-483(with)-470.2(a)-474.1(half-life)-476.1(of)-469.9(20)-174.8(h)]TJ
0 -1.3189 TD
[(that)-313.3(would)-319.5(favour)-316.8(prolonged)-319.9(enzyme)-313.4(exposure)-318(\(David)]TJ
/F3 1 Tf
25.7414 0 TD
[(et)-317.8(al)]TJ
/F2 1 Tf
1.908 0 TD
(.,)Tj
-27.6495 -1.3256 TD
[(2004\).)-581.6(This)-576(favourable)-580.8(pharmacokinetic)-578.5(profile)-579.4(would)-580.6(be)]TJ
T*
[(anticipated)-604(to)-605.3(produce)-602.6(long)-602.6(periods)-606(of)-603.8(PDE4)-602.6(inhibition.)]TJ
0 -1.3189 TD
[(There)-357.6(was)-354.9(a)-353.6(significant)-356.6(reduction)-359(in)-350.9(the)-356.9(activity)-352.3(of)-356.1(circulat-)]TJ
0 -1.3256 TD
[(ing)-405.7(monocytes)-412(in)-411.1(patients)-405.9(maintained)-408.8(on)-411.3(roflumilast)-414(for)-406.2(4)]TJ
T*
[(weeks,)-541.6(whereas)-543.2(the)-537.6(magnitude)-544.3(of)-543.5(this)-540.6(change)-537.5(was)-542.4(small,)]TJ
0 -1.3189 TD
[(resulting)-625.3(in)-618.7(approximately)-628.1(1.3-fold)-624.4(reduction)-626.8(in)-618.7(tumour)]TJ
0 -1.3256 TD
[(necrosis)-490.6(factor)-9.6(-)]TJ
/F6 1 Tf
7.2705 0 TD
(a)Tj
/F2 1 Tf
1.0444 0 TD
[(production)-492.1(by)-491.8(monocytes)-492.3(in)-491.5(response)-495.6(to)]TJ
-8.3149 -1.3256 TD
[(endotoxin)-273.7(challenge)]TJ
/F3 1 Tf
9.8748 0 TD
[(in)-268.4(vitro)]TJ
/F2 1 Tf
3.3608 0 TD
[(\()5.9(Timmer)]TJ
/F3 1 Tf
4.3181 0 TD
[(et)-264.3(al)]TJ
/F2 1 Tf
1.8545 0 TD
[(.,)-268.2(2002\).)-273.7(Therefore,)]TJ
-19.4082 -1.3256 TD
[(it)-605.1(is)-600.9(questionable)-609(whether)-602.3(total)-599.9(PDE4)-609.3(inhibition)-602(can)-607.8(be)]TJ
0 -1.3189 TD
[(achieved)-442.7(in)-444.6(cells)-437.9(within)-446.1(the)-437.2(air)-11.4(way)-443.2(tissue)-446.4(compartment)-440.7(at)]TJ
0 -1.3256 TD
[(the)-336.8(dose)-333.8(used)-332.9(in)-330.8(clinical)-343.5(studies.)]TJ
0.9975 -1.3256 TD
[(Side)-688.2(effects)-685.8(most)-684.9(commonly)-688.4(reported)-679.9(were)-682.6(headache,)]TJ
-0.9975 -1.3189 TD
[(nausea)-927.9(and)-921.2(diarrhoea)-927.4(of)-925.1(a)-929.4(mild-to-moderate)-928.4(severity)]TJ
0 -1.3256 TD
0.0001 Tc
(\(Harbinson)Tj
/F3 1 Tf
5.8178 0 TD
0 Tc
[(et)-552.2(al)]TJ
/F2 1 Tf
2.1423 0 TD
[(.,)-556.1(1997;)-560.7(van)-551.5(Schalkwyk)]TJ
/F3 1 Tf
12.0171 0 TD
[(et)-558.9(al)]TJ
/F2 1 Tf
2.149 0 TD
[(.,)-556.1(2005\))-558(and)]TJ
-22.1263 -1.3256 TD
[(suggest)-439.6(that)-433.8(unless)-439.9(the)-437.2(risk/benefit)-434.9(ratio)-435.9(can)-440.4(be)-436.7(improved,)]TJ
0 -1.3189 TD
[(then)-383.7(this)-386.6(may)-381(well)-387.9(hamper)-381.2(the)-383.7(use)-388(of)-382.8(this)-379.9(drug)-386.5(in)-384.3(asthma.)]TJ
ET
1 i 
50.797 749.367 239.131 -0.227 re
f
BT
/F1 1 Tf
5.9774 0 0 7.9702 179.1496 761.8392 Tm
-0.0001 Tc
[(PDE4)-332.8(inhibitors)-325.8(and)-335.3(respiratory)-326.4(disease)]TJ
/F9 1 Tf
15.1373 -1.2519 TD
[(D)-337.9(Spina)]TJ
7.0982 0 0 9.4646 50.7968 751.8612 Tm
0.0001 Tc
(310)Tj
ET
50.797 40.932 239.131 -0.283 re
f
BT
/F4 1 Tf
6.0123 0 0 8.4682 50.7968 31.2378 Tm
[(British)-331.9(J)0.1(ournal)-324.5(of)-334.4(Pharmacology)-320.4(\(2008\))]TJ
/F1 1 Tf
17.6049 0 TD
(155)Tj
/F4 1 Tf
2.0462 0 TD
(308ñ315)Tj
ET

 Q
q
q 1 0 0 1 0 0 cm /Xi3 Do Q
Q


Q

q
0.0 0.0 595 794 re
W
n
1 0 0 1 0 0 cm
BT
/F1-0 12 Tf
14.4 TL
ET
1 0 0 RG
n
49 716 242 12 re
S
1 0 0 RG
n
49 706 241 10 re
S
1 0 0 RG
n
49 694 241 11 re
S
1 0 0 RG
n
49 683 241 11 re
S
1 0 0 RG
n
48 671 243 11 re
S
1 0 0 RG
n
48 659 243 13 re
S
1 0 0 RG
n
48 649 243 12 re
S
1 0 0 RG
n
48 638 243 11 re
S
1 0 0 RG
n
49 627 242 11 re
S
1 0 0 RG
n
48 615 243 11 re
S
1 0 0 RG
n
48 603 243 13 re
S
1 0 0 RG
n
49 593 242 11 re
S
1 0 0 RG
n
48 581 243 12 re
S
1 0 0 RG
n
49 571 136 10 re
S
1 0 0 RG
n
49 538 72 10 re
S
1 0 0 RG
n
48 526 242 12 re
S
1 0 0 RG
n
49 515 241 10 re
S
1 0 0 RG
n
48 503 243 11 re
S
1 0 0 RG
n
48 492 242 12 re
S
1 0 0 RG
n
48 481 242 11 re
S
1 0 0 RG
n
48 469 243 12 re
S
1 0 0 RG
n
49 459 242 10 re
S
1 0 0 RG
n
49 447 242 12 re
S
1 0 0 RG
n
48 436 243 11 re
S
1 0 0 RG
n
48 425 243 11 re
S
1 0 0 RG
n
48 413 243 12 re
S
1 0 0 RG
n
48 403 243 11 re
S
1 0 0 RG
n
49 391 242 11 re
S
1 0 0 RG
n
49 380 242 11 re
S
1 0 0 RG
n
48 369 243 11 re
S
1 0 0 RG
n
49 357 242 12 re
S
1 0 0 RG
n
48 347 243 10 re
S
1 0 0 RG
n
49 335 242 12 re
S
1 0 0 RG
n
49 325 242 10 re
S
1 0 0 RG
n
48 313 243 11 re
S
1 0 0 RG
n
49 302 208 11 re
S
1 0 0 RG
n
57 290 233 12 re
S
1 0 0 RG
n
49 279 242 11 re
S
1 0 0 RG
n
49 268 242 11 re
S
1 0 0 RG
n
49 257 242 11 re
S
1 0 0 RG
n
49 245 242 12 re
S
1 0 0 RG
n
49 234 242 11 re
S
1 0 0 RG
n
48 223 243 12 re
S
1 0 0 RG
n
49 213 242 10 re
S
1 0 0 RG
n
49 200 242 12 re
S
1 0 0 RG
n
48 189 243 13 re
S
1 0 0 RG
n
48 178 243 12 re
S
1 0 0 RG
n
49 168 242 10 re
S
1 0 0 RG
n
49 156 242 11 re
S
1 0 0 RG
n
48 145 243 11 re
S
1 0 0 RG
n
49 134 242 11 re
S
1 0 0 RG
n
49 123 242 10 re
S
1 0 0 RG
n
48 111 243 12 re
S
1 0 0 RG
n
48 100 243 11 re
S
1 0 0 RG
n
48 89 243 11 re
S
1 0 0 RG
n
48 77 243 12 re
S
1 0 0 RG
n
48 67 243 10 re
S
1 0 0 RG
n
48 55 243 11 re
S
1 0 0 RG
n
306 716 242 12 re
S
1 0 0 RG
n
305 704 243 13 re
S
1 0 0 RG
n
306 694 241 10 re
S
1 0 0 RG
n
307 683 240 10 re
S
1 0 0 RG
n
306 671 241 12 re
S
1 0 0 RG
n
306 659 242 14 re
S
1 0 0 RG
n
306 649 241 11 re
S
1 0 0 RG
n
306 638 241 11 re
S
1 0 0 RG
n
305 626 242 12 re
S
1 0 0 RG
n
306 614 242 13 re
S
1 0 0 RG
n
306 604 242 11 re
S
1 0 0 RG
n
306 593 241 10 re
S
1 0 0 RG
n
306 581 130 12 re
S
1 0 0 RG
n
314 570 235 12 re
S
1 0 0 RG
n
305 558 244 12 re
S
1 0 0 RG
n
305 547 243 12 re
S
1 0 0 RG
n
305 536 244 12 re
S
1 0 0 RG
n
304 524 245 13 re
S
1 0 0 RG
n
305 513 244 13 re
S
1 0 0 RG
n
304 503 174 11 re
S
1 0 0 RG
n
498 503 51 11 re
S
1 0 0 RG
n
304 490 245 15 re
S
1 0 0 RG
n
304 479 245 13 re
S
1 0 0 RG
n
305 469 244 12 re
S
1 0 0 RG
n
305 456 244 14 re
S
1 0 0 RG
n
304 445 245 14 re
S
1 0 0 RG
n
306 436 243 10 re
S
1 0 0 RG
n
305 423 244 13 re
S
1 0 0 RG
n
305 413 244 11 re
S
1 0 0 RG
n
305 401 244 13 re
S
1 0 0 RG
n
305 390 244 12 re
S
1 0 0 RG
n
304 378 245 14 re
S
1 0 0 RG
n
304 365 245 17 re
S
1 0 0 RG
n
305 356 244 13 re
S
1 0 0 RG
n
305 345 243 12 re
S
1 0 0 RG
n
303 333 246 14 re
S
1 0 0 RG
n
304 322 245 14 re
S
1 0 0 RG
n
305 311 244 13 re
S
1 0 0 RG
n
305 300 244 12 re
S
1 0 0 RG
n
305 289 244 12 re
S
1 0 0 RG
n
305 279 223 10 re
S
1 0 0 RG
n
305 267 244 12 re
S
1 0 0 RG
n
304 255 245 13 re
S
1 0 0 RG
n
304 244 224 13 re
S
1 0 0 RG
n
305 234 242 12 re
S
1 0 0 RG
n
305 222 244 12 re
S
1 0 0 RG
n
305 210 244 14 re
S
1 0 0 RG
n
305 199 244 12 re
S
1 0 0 RG
n
304 189 245 11 re
S
1 0 0 RG
n
305 177 243 12 re
S
1 0 0 RG
n
305 166 244 12 re
S
1 0 0 RG
n
305 155 63 12 re
S
1 0 0 RG
n
374 155 175 12 re
S
1 0 0 RG
n
304 143 245 14 re
S
1 0 0 RG
n
305 132 244 12 re
S
1 0 0 RG
n
305 120 244 14 re
S
1 0 0 RG
n
305 110 133 12 re
S
1 0 0 RG
n
314 100 234 12 re
S
1 0 0 RG
n
305 88 243 13 re
S
1 0 0 RG
n
306 77 242 12 re
S
1 0 0 RG
n
305 65 243 13 re
S
1 0 0 RG
n
306 55 241 11 re
S
0 1 0 RG
n
479 504 19 10 re
S
0 1 0 RG
n
528 280 19 10 re
S
0 1 0 RG
n
528 247 19 10 re
S
0 1 0 RG
n
368 157 6 9 re
S
0.619608 0.619608 0.619608 RG
n
49 28 144 12 re
S
0.619608 0.619608 0.619608 RG
n
48 748 18 14 re
S
0.619608 0.619608 0.619608 RG
n
177 759 114 12 re
S
0.619608 0.619608 0.619608 RG
n
267 749 24 12 re
S
Q


endstream
endobj
156 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
157 0 obj
<<
/BBox [ 0 0 595 794 ]
/Filter /FlateDecode
/FormType 1
/Matrix [ 1 0 0 1 0 0 ]
/Resources <<
/Font <<
/F1 120 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Subtype /Form
/Type /XObject
/Length 286
>>
stream
xúuP=o¬0›Û+ﬁ¯#)$¥SKÀÑƒ–HJ'π£ƒéÏ ‚ﬂ◊.jßvy:›È}‹{*æëX∞eõÃ%$˘ä»ÛÇ…pËì	‰]æ\dÖú!¢ò!õ·Ÿ^LgUCZg{∆q˜úWÉNïg÷t⁄Pß+ß‹ï]tGWV€û7Vs)òY¡´„¿¢ ÀDéÍäµ≠N¬&`M3ºEvﬂRÿﬁ¥`ﬁÂíãOEö}0ºa<JrΩá2M2çµ5˚…O≤ˇçë6¥y˝K€O£Õüˆ≠upßé<lãìßÏ°‹®Î∏Séiœ‰L(&ºs©aËt≠™é∞v§F}ÉÌ˚o´k2û¶Â1â’‹0¥˛R&_¸TÑ∏
endstream
endobj
158 0 obj
<<
/BitsPerComponent 8
/ColorSpace 62 0 R
/Filter /FlateDecode
/Height 99
/Width 74
/Length 380
>>
stream
Hâ‰W[Ñ0Û˛‰:˚±3;Ö	µùÂKm	R@ëˇ≥K[ÈÕuúÉµ“©œvqíÊ¢_◊O™Í‚]+’ŒÅñî•.t"Ó≥Éú¶«â„‘ÌÆ"mNÇÑ”∑< w„‘‰€íx+€‚‘|∞ÍiëPÖSU÷ˆÈ™2Lq&ˆ√–àœ*ß.NZu∑ıÅïŒÀuâêàﬁ"ù∫¸|ùôäêÀ\_ÈD@P˜˚D'âQßﬁíÀÊ“±, Ì” lY3qÚrS@EÎ,í]œ®ÀªU=5?≈q˛Ì¡ˇ$ÎÍ ßyÍx$]∫kÁË,ùQs,™7ÒHSÂ•>«‘â˘Hy%AÚ\¢€¬‰eÅ∑1üüLx‡‘É≤`
í?EC§p ;ß|äQó∏⁄ÆÓn•„jf≠ƒÁÆˇ€X'5®nÈú6N+’±úÄ:tüË¡>YNÎ‚‰ª‚¶≈XøáÈeÍ§UÅ˛TgV›ôJ7œﬁÕ˛]ˆ ıÄcı
endstream
endobj
159 0 obj
<<
/Annots [ 160 0 R 161 0 R 162 0 R 163 0 R 164 0 R 165 0 R 166 0 R 167 0 R 168 0 R 169 0 R 170 0 R 171 0 R 172 0 R 173 0 R 174 0 R 175 0 R 176 0 R 177 0 R 178 0 R 179 0 R 180 0 R 181 0 R 182 0 R 183 0 R ]
/Contents 184 0 R
/CropBox [ 0 0 595 794 ]
/MediaBox [ 0 0 595 794 ]
/Resources <<
/ExtGState <<
/GS1 25 0 R
>>
/Font <<
/F1 26 0 R
/F1-0 185 0 R
/F2 30 0 R
/F3 33 0 R
/F4 36 0 R
/F6 42 0 R
/F7 45 0 R
/F9 55 0 R
>>
/XObject <<
/Xi4 186 0 R
>>
/ProcSet [ /ImageB /ImageC /ImageI /PDF /Text ]
>>
/Rotate 0
/Thumb 187 0 R
/Type /Page
/Parent 2 0 R
>>
endobj
160 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib12)
/Rect [ 54 683 137 691 ]
/Subtype /Link
/Type /Annot
>>
endobj
161 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib6)
/Rect [ 145 492 204 501 ]
/Subtype /Link
/Type /Annot
>>
endobj
162 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137tbl1)
/Rect [ 54 448 82 456 ]
/Subtype /Link
/Type /Annot
>>
endobj
163 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib42)
/Rect [ 84 414 161 422 ]
/Subtype /Link
/Type /Annot
>>
endobj
164 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib4)
/Rect [ 138 358 214 366 ]
/Subtype /Link
/Type /Annot
>>
endobj
165 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib4)
/Rect [ 54 313 123 322 ]
/Subtype /Link
/Type /Annot
>>
endobj
166 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib26)
/Rect [ 180 246 262 254 ]
/Subtype /Link
/Type /Annot
>>
endobj
167 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib75)
/Rect [ 266 246 290 254 ]
/Subtype /Link
/Type /Annot
>>
endobj
168 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib75)
/Rect [ 51 235 94 243 ]
/Subtype /Link
/Type /Annot
>>
endobj
169 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib3)
/Rect [ 54 123 133 131 ]
/Subtype /Link
/Type /Annot
>>
endobj
170 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib55)
/Rect [ 190 67 287 75 ]
/Subtype /Link
/Type /Annot
>>
endobj
171 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib50)
/Rect [ 51 55 129 64 ]
/Subtype /Link
/Type /Annot
>>
endobj
172 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib64)
/Rect [ 311 672 374 680 ]
/Subtype /Link
/Type /Annot
>>
endobj
173 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib66)
/Rect [ 378 672 456 680 ]
/Subtype /Link
/Type /Annot
>>
endobj
174 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib15)
/Rect [ 460 672 541 680 ]
/Subtype /Link
/Type /Annot
>>
endobj
175 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137tbl1)
/Rect [ 513 582 541 591 ]
/Subtype /Link
/Type /Annot
>>
endobj
176 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib30)
/Rect [ 381 537 483 546 ]
/Subtype /Link
/Type /Annot
>>
endobj
177 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib24)
/Rect [ 311 526 389 535 ]
/Subtype /Link
/Type /Annot
>>
endobj
178 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137tbl1)
/Rect [ 360 403 389 411 ]
/Subtype /Link
/Type /Annot
>>
endobj
179 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib64)
/Rect [ 311 347 378 355 ]
/Subtype /Link
/Type /Annot
>>
endobj
180 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib15)
/Rect [ 383 347 468 355 ]
/Subtype /Link
/Type /Annot
>>
endobj
181 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib66)
/Rect [ 370 313 457 322 ]
/Subtype /Link
/Type /Annot
>>
endobj
182 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib17)
/Rect [ 311 111 400 120 ]
/Subtype /Link
/Type /Annot
>>
endobj
183 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib17)
/Rect [ 445 67 541 75 ]
/Subtype /Link
/Type /Annot
>>
endobj
184 0 obj
<<
/Length 20479
>>
stream
q
q

BT
/F2 1 Tf
8.4682 0 0 8.4682 50.7968 718.7526 Tm
0 0 0 rg
/GS1 gs
0 Tc
0 Tw
[(This)-288.1(is)-286.2(a)-286.7(worthy)-283.1(aim)-286.3(to)-290.6(pursue)-284.5(in)-283.9(the)-283.2(light)-287.7(of)-289.1(a)-286.7(clinical)-283.3(study)]TJ
0 -1.3256 TD
[(reporting)-502.5(comparable)-498.3(clinical)-504.2(efficacy)-498.8(between)-500(roflumilast)]TJ
T*
[(and)-700.3(beclomethasone)-708(diproprionate)-703.4(in)-705.7(persistent)-702.7(asthma)]TJ
0 -1.3189 TD
0.0001 Tc
(\(Bousquet)Tj
/F3 1 Tf
5.0144 0 TD
0 Tc
[(et)-331.2(al)]TJ
/F2 1 Tf
1.9281 0 TD
[(.,)-335.2(2006\).)]TJ
/F3 1 Tf
-6.9425 -5.2956 TD
[(COPD)-337.4(and)-334.3(PDE4)]TJ
/F2 1 Tf
0 -1.3256 TD
[(Chronic)-621.9(obstructive)-626.8(pulmonar)-11.6(y)-619.6(disease)-618.1(unlike)-622.2(asthma)-619.4(is)]TJ
T*
[(caused)-880.4(by)-880.1(cigarette)-879.9(smoking,)-883.6(although)-884.4(in)-879.7(developing)]TJ
T*
[(countries)-369.6(smoke)-376(derived)-365.6(from)-369.7(burning)-370.1(biomass)-373.5(fuels)-368.9(is)-366.5(also)]TJ
0 -1.3189 TD
[(a)-735.2(predisposing)-738.1(factor)70.8(.)-733.3(The)-740.5(nature)-735.7(of)-731(the)-738.5(inflammator)-14.5(y)]TJ
0 -1.3256 TD
[(response)-555.8(is)-560.7(distinct)-554.7(from)-557.1(asthma)-559.2(and)-559.7(is)-554(characterized)-558.4(by)]TJ
T*
[(the)-283.2(activation)-276.6(of)-282.4(macrophages,)-282.6(air)-18.1(way)-275.9(epithelial)-286.5(cells,)-280.8(which)]TJ
0 -1.3189 TD
[(in)-397.7(turn,)-403.7(secrete)-399.8(a)-393.8(range)-400.5(of)-396.2(chemokines)-400.7(and)-399.1(lipid)-399.9(mediators)]TJ
0 -1.3256 TD
[(resulting)-725.8(in)-719.1(the)-718.4(recruitment)-728.1(of)-717.6(neutrophils)-725.9(and)-720.4(CD8)]TJ
/F7 1 Tf
6.351 0 0 5.6449 283.9747 554.3432 Tm
()Tj
/F2 1 Tf
8.4682 0 0 8.4682 50.7968 539.3763 Tm
[(T)-423.7(lymphocytes.)-430.9(The)-425.8(secretion)-423.3(of)-429.7(a)-420.6(range)-427.2(of)-429.7(proteases)-420.6(from)]TJ
0 -1.3189 TD
[(neutrophils)-424.6(\(elastase,)-428.4(MMP9,)-424.7(cathepsins\))-422.3(and)-425.8(macrophages)]TJ
0 -1.3256 TD
[(\(MMP12\))-312.7(is)-313(thought)-313.8(to)-310.7(contribute)-312.9(towards)-312.5(air)-11.4(way)-316(fibrosis)-315.2(of)]TJ
T*
[(the)-243.1(small)-244.4(air)-18.1(ways,)-241.6(increased)-243.8(mucus)-250.5(secretion)-242.6(and)-245.1(destruction)]TJ
T*
[(of)-677.4(the)-671.5(alveolar)-684.1(wall)-679.2(\(Barnes,)-674.8(2006b\))-677.9(These)-671.3(pathological)]TJ
0 -1.3189 TD
[(changes)-807.7(give)-806.3(rise)-807.1(to)-799.4(the)-805.4(symptoms)-806.8(of)-804.6(cough,)-812.6(mucus)]TJ
0 -1.3256 TD
[(secretion,)-386.7(difficult)-379.7(breathing)-389.1(and)-379(emphysema.)-386.5(Many)-376.7(of)-382.8(the)]TJ
T*
[(cell)-502.5(types)-501.9(implicated)-497.7(in)-504.8(this)-500.4(disease)-497.6(process)-499.8(express)-503.1(PDE4)]TJ
0 -1.3189 TD
0.0002 Tc
[(\(T)58.5(able)-330.8(1\).)]TJ
1.0042 -1.3256 TD
0 Tc
[(The)-459.3(expression)-468.5(of)-463.2(PDE4AñD)-462.2(in)-464.7(peripheral)-467.1(blood)-461.4(neutro-)]TJ
-1.0042 -1.3256 TD
[(phils)-501.6(and)-492.8(CD8T)-433.8(cells)-498.2(is)-493.7(not)-498.2(altered)-496(in)-498.1(patients)-499.6(with)-490.3(mild)]TJ
0 -1.3189 TD
0.0001 Tc
[(COPD)-697.6(\(Jones)]TJ
/F3 1 Tf
7.1634 0 TD
0 Tc
[(et)-699.4(al)]TJ
/F2 1 Tf
2.2896 0 TD
[(.,)-696.7(2007\).)-702.1(However)39.4(,)-693.1(the)-698.3(expression)-702.8(of)]TJ
-9.453 -1.3256 TD
[(PDE4A4)-354.4(and)-345.5(total)-352.1(cyclic)-349.5(AMP)-347(PDE)-351.2(activity)-345.6(was)-348.2(significantly)]TJ
T*
[(increased)-638.8(in)-632(macrophages)-640.5(purified)-637.3(from)-637.5(bronchoalveolar)]TJ
0 -1.3189 TD
[(lavage)-643.2(fluid)-640.1(from)-644.2(patients)-640.2(with)-644.3(mild-to-moderate)-647.2(COPD)]TJ
0 -1.3256 TD
[(compared)-529.5(with)-530.5(healthy)-522.7(patients)-526.4(or)-528.3(smokers)-529(who)-524(did)-528.6(not)]TJ
T*
[(present)-503.7(with)-497(COPD)-503.5(\(Barber)]TJ
/F3 1 Tf
13.798 0 TD
[(et)-498.6(al)]TJ
/F2 1 Tf
2.0955 0 TD
[(.,)-495.8(2004\).)-501.3(Of)-498.6(the)-504.2(12)-496.2(PDE4)]TJ
-15.8934 -1.3256 TD
[(variants)-290.6(analysed,)-284.9(only)-290.4(the)-283.2(activity)-292(of)-282.4(PDE4A4)-294.2(was)-288(increased)]TJ
0 -1.3189 TD
[(and)-312(suggested)-313(that)-306.6(local)-314.5(events/processes)-310.1(within)-312.2(the)-310(lung)-313.8(of)]TJ
0 -1.3256 TD
[(patients)-620.1(with)-617.5(COPD)-617.4(specifically)-616.3(upregulated)-620(this)-614.2(variant)]TJ
T*
0.0001 Tc
(\(Barber)Tj
/F3 1 Tf
3.5951 0 TD
0 Tc
[(et)-257.6(al)]TJ
/F2 1 Tf
1.8478 0 TD
[(.,)-261.5(2004\).)-260.3(However)32.7(,)-258(the)-256.5(functional)-261.3(consequence)-265.8(of)]TJ
-5.4429 -1.3189 TD
[(this)-473.6(change)-477.3(remains)-474.8(to)-471.4(be)-476.9(established)-472.8(in)-471.4(light)-475.1(of)-476.6(findings)]TJ
0 -1.3256 TD
[(showing)-342.9(that)-340.1(PDE4)-341.5(inhibition)-347.6(has)-336(modest)-344(effect)-342(in)-337.5(suppres-)]TJ
T*
[(sing)-762.8(tumour)-763.2(necrosis)-765.1(factor-)]TJ
/F6 1 Tf
14.5143 0 TD
(a)Tj
/F2 1 Tf
1.3122 0 TD
[(production)-766.6(from)-764.7(human)]TJ
-15.8265 -1.3189 TD
[(macrophages)-633.8(derived)-626.7(from)-624.1(cultur)-9.3(ed)-623.2(monocytes,)-629.8(and)-626.7(the)]TJ
0 -1.3256 TD
[(contribution)-490.4(of)-476.6(PDE3)-488.8(and)-479.4(PDE7)-482.1(in)-484.8(regulating)-482.4(function)-487.5(in)]TJ
T*
[(this)-259.4(cell)-261.5(type)-258.5(cannot)-262.4(be)-255.9(ignored)-265.1(\(Gantner)]TJ
/F3 1 Tf
19.3948 0 TD
[(et)-264.3(al)]TJ
/F2 1 Tf
1.8545 0 TD
[(.,)-261.5(1997a;)-264.9(Smith)]TJ
/F3 1 Tf
-21.2492 -1.3189 TD
[(et)-337.9(al)]TJ
/F2 1 Tf
1.9281 0 TD
[(.,)-335.2(2004\).)]TJ
-0.9239 -1.3256 TD
[(There)-283.9(are)-292(a)-286.7(limited)-293.2(number)-291.5(of)-289.1(preclinical)]TJ
/F3 1 Tf
19.455 0 TD
[(in)-288.5(vivo)]TJ
/F2 1 Tf
3.1867 0 TD
[(models)-293.2(of)]TJ
-23.646 -1.3256 TD
[(COPD.)-681.1(However)39.4(,)-673(the)-678.2(recruitment)-681.2(of)-677.4(neutrophils)-679(to)-678.9(the)]TJ
T*
[(air)-11.4(ways)-639.8(can)-634.6(be)-637.5(readily)-640.9(induced)-639.4(using)-637.5(the)-631.4(bacterial)-643.2(wall)]TJ
0 -1.3189 TD
[(component,)-542(endotoxin,)-545(although)-543(it)-538.1(is)-540.6(widely)-544.1(appreciated)]TJ
0 -1.3256 TD
[(that)-293.2(this)-292.8(stimulus)-291.8(can)-293.1(only)-290.3(model)-297.5(neutrophil)-295(recruitment)-292.9(to)]TJ
T*
[(the)-330.1(air)-11.4(ways.)-335.3(The)-332.1(recruitment)-333.1(of)-336(these)-327.9(cells)-330.8(to)-330.8(the)-336.8(air)-11.4(ways)-331.8(of)]TJ
0 -1.3189 TD
[(wild-type)-356.7(mice)-356.2(was)-348.2(inhibited)-356.1(by)-357.9(around)-353.5(50%)-353.4(in)-350.9(PDE4B)-356.8(and)]TJ
0 -1.3256 TD
[(PDE4D-deficient)-264.4(mice,)-259.3(and)-258.5(a)-259.9(greater)-258.4(degree)-257(of)-255.6(inhibition)-267.3(was)]TJ
T*
[(obser)-16.7(ved)-459.5(when)-463.1(wild-type)-470.5(mice)-463.3(were)-461.7(treated)-466.5(with)-463.5(rolipram)]TJ
0 -1.3189 TD
0.0001 Tc
(\(Ariga)Tj
/F3 1 Tf
3.6152 0 TD
0 Tc
[(et)-819.9(al)]TJ
/F2 1 Tf
2.4101 0 TD
[(.,)-823.9(2004\).)-829.3(This)-817(once)-821.4(again)-825(highlighted)-827.9(the)]TJ
-6.0253 -1.3256 TD
[(complimentar)-17.6(y)-947.6(roles)-950.5(of)-951.9(PDE4)-950.7(isoforms)-955.6(in)-946.7(regulating)]TJ
T*
[(neutrophil)-509.3(recruitment)-513.8(to)-504.8(the)-504.2(air)-11.4(ways.)-509.4(Similarly)71.7(,)-512.4(smoking)]TJ
T*
[(induced)-512.2(neutrophil)-516(recruitment)-513.8(to)-511.5(the)-510.9(air)-18.1(ways,)-509.4(release)-515.4(of)]TJ
0 -1.3189 TD
[(chemokines)-387.3(and)-379(emphysem)-9.3(atous)-380.7(changes)-385.9(to)-377.6(the)-383.7(lung)-380.8(were)]TJ
0 -1.3256 TD
[(attenuated)-718.2(by)-706(PDE4)-716.4(inhibitors)-718.8(\(Martorana)]TJ
/F3 1 Tf
22.0526 0 TD
[(et)-712.8(al)]TJ
/F2 1 Tf
2.303 0 TD
[(.,)-716.8(2005;)]TJ
-24.3556 -1.3256 TD
(Leclerc)Tj
/F3 1 Tf
3.7357 0 TD
[(et)-498.6(al)]TJ
/F2 1 Tf
2.0955 0 TD
[(.,)-495.8(2006\).)-501.3(T)65(ogether)35.4(,)-492.3(these)-501.9(studies)-498.5(highlight)-499.2(the)]TJ
24.523 78.0947 TD
[(utility)-502(of)-503.3(inhibiting)-506.7(PDE4)-508.9(in)-498.1(cell)-502.5(types)-501.9(implicated)-511.1(in)-498.1(this)]TJ
0 -1.3256 TD
(disease.)Tj
0.9975 -1.3256 TD
[(A)-558.2(number)-559.3(of)-556.9(phase)-550.8(III)-558.1(clinical)-557.8(trials)-558.6(have)-553.6(assessed)-559.9(the)]TJ
-0.9975 -1.3189 TD
[(potential)-241.6(utility)-240.9(of)-235.6(PDE4)-241.1(inhibitors)-243.4(in)-237(the)-236.4(treatment)-243.9(of)-235.6(COPD)]TJ
0 -1.3256 TD
0.0002 Tc
(\(Rabe)Tj
/F3 1 Tf
2.8319 0 TD
0 Tc
[(et)-244.2(al)]TJ
/F2 1 Tf
1.8344 0 TD
[(.,)-248.1(2005;)-252.8(Rennard)]TJ
/F3 1 Tf
7.853 0 TD
[(et)-250.9(al)]TJ
/F2 1 Tf
1.8411 0 TD
[(.,)-248.1(2006;)-246.1(Calverley)]TJ
/F3 1 Tf
8.2681 0 TD
[(et)-244.2(al)]TJ
/F2 1 Tf
1.8411 0 TD
[(.,)-248.1(2007\).)]TJ
-24.4694 -1.3256 TD
[(All)-248.8(three)-248.4(studies)-257.5(report)-250.9(modest)-250.3(but)-248.9(significant)-249.5(improvements)]TJ
T*
[(in)-752.5(spirometr)-18.5(y)-753.5(over)-755(placebo,)-757.3(quality)-757.8(of)-757.8(life)-755.6(scores)-755.7(and)]TJ
0 -1.3189 TD
[(reduction)-513(in)-504.8(the)-510.9(number)-505.8(of)-510(exacerbations)-511(in)-511.5(the)-504.2(severest)]TJ
0 -1.3256 TD
[(group)-469.7(of)-463.2(COPD)-470.1(patients.)-469.7(The)-466(mechanism)-468.2(of)-463.2(the)-470.7(improve-)]TJ
T*
[(ment)-481(in)-478.1(spirometr)-11.8(y)-479(i)0(s)-480.4(unlikely)-474.5(to)-478.1(be)-483.6(due)-477.8(to)-478.1(relaxation)-476.7(of)]TJ
0 -1.3189 TD
[(air)-11.4(way)-597.2(smooth)-600.7(muscle)-594.8(because)-602.2(this)-594.1(drug)-600.8(class)-595(has)-597.1(weak)]TJ
0 -1.3256 TD
[(bronchodilator)-331.3(activity)69.5(.)-324.9(I)0(t)-322.1(i)0(s)-326.4(possible)-327.5(that)-326.7(this)-326.3(improvement)]TJ
T*
[(is)-306.3(due)-297.1(to)-304(an)-306.8(anti-inflammator)-17.6(y)-304.9(action)-305.2(of)-302.5(the)-303.3(drugs)-301.9(\(T)58.3(able)-297.5(1\),)]TJ
0 -1.3189 TD
[(although)-489.4(no)-484.9(biomarker)-488.2(of)-483.3(inflammation)-489.3(was)-488.8(measured)-488(in)]TJ
0 -1.3256 TD
[(these)-696.1(studies.)-696.2(However)39.4(,)-693.1(separate)-695.3(studies)-692.6(have)-694.1(addressed)]TJ
T*
[(whether)-515.2(PDE4)-508.9(inhibitors)-517.9(are)-513(anti-inflammator)-17.6(y)-512.5(i)0(n)-511.5(COPD.)]TJ
0 -1.3189 TD
[(Both)-446.5(roflumilast)-447.4(\(Grootendorst)]TJ
/F3 1 Tf
15.2976 0 TD
[(et)-445(al)]TJ
/F2 1 Tf
2.0352 0 TD
[(.,)-442.3(2007\))-450.9(and)-439.2(cilomilast)]TJ
-17.3328 -1.3256 TD
0.0001 Tc
(\(Gamble)Tj
/F3 1 Tf
4.3851 0 TD
0 Tc
[(et)-391.5(al)]TJ
/F2 1 Tf
1.9817 0 TD
[(.,)-388.7(2003\))-390.6(reduced)-394.4(the)-383.7(number)-392(of)-389.5(inflammator)-14.5(y)]TJ
-6.3667 -1.3256 TD
[(cells)-411.1(such)-412.4(as)-409.5(neutrophils)-417.9(and)-412.4(lymphocytes)-413.9(recruited)-415.1(to)-411.1(the)]TJ
T*
[(air)-11.4(ways)-459(and)-452.6(the)-457.3(levels)-450.6(of)-456.5(two)-456.9(biochemical)-462.6(markers)-452.2(of)-456.5(this)]TJ
0 -1.3189 TD
[(disease,)-467.6(namely)-459.4(interleukin-8)-468.2(and)-466(neutrophil)-462.4(elastase.)-467.8(The)]TJ
0 -1.3256 TD
[(magnitude)-330.1(of)-322.6(the)-323.4(change)-323.3(in)-324.1(the)-323.4(number)-331.7(of)-322.6(these)-321.2(inflamma-)]TJ
T*
[(tor)-12.7(y)-452.2(cells)-451.3(and)-445.9(concentration)-453.6(of)-456.5(mediators)-449.1(was)-455.3(between)-446.5(30)]TJ
0 -1.3189 TD
[(and)-419.1(50%)-413.6(and)-419.1(might)-415.9(underlie)-414.9(their)-416.4(beneficial)-416.9(action)-419(in)-417.8(the)]TJ
0 -1.3256 TD
[(phase)-430.3(III)-437.6(clinical)-430.6(trials.)-434.9(However)39.4(,)-432(the)-430.5(biomarker)-441.3(study)-428.1(also)]TJ
T*
[(highlights)-274(a)-273.3(recurring)-278.6(theme)-268.8(that)-273.1(complementar)-17.1(y)-271.5(inhibition)]TJ
0 -1.3189 TD
[(of)-496.7(PDE4)-495.5(was)-502.2(not)-491.5(achievable)-498.6(because)-501.8(of)-496.7(dose-limiting)-498.2(side)]TJ
0 -1.3256 TD
[(effects;)-515.3(or)-514.9(alternatively)67(,)-512.4(other)-510.3(PDE)-518.5(isoforms)-513.7(\(for)-514.1(example,)]TJ
T*
[(PDE3,)-365.1(7,)-368.8(see)-361.4(T)65(able)-364.5(1\))-366.1(in)-364.3(these)-361.3(same)-361.7(inflammator)-21.2(y)-358.5(processes)]TJ
T*
[(may)-240.4(also)-240.9(require)-234.7(targeting)-243.5(for)-238.8(a)-239.8(full)-239.9(anti-inflammator)-17.6(y)-238(action)]TJ
0 -1.3189 TD
[(to)-337.5(be)-329.6(revealed)-334.5(in)-337.5(this)-333(disease.)]TJ
0.9975 -1.3256 TD
[(The)-479.4(most)-477.3(common)-481.3(side)-480.9(effect)-475.9(reported)-479.1(with)-476.9(roflumilas)-12.4(t)]TJ
-0.9975 -1.3256 TD
[(included)-494.8(diarrhoea)-492.3(\(9%\),)-495.4(headache)-488.8(\(6%\))-491.8(and)-492.8(nausea)-492.7(\(5%\))]TJ
0 -1.3189 TD
0.0002 Tc
(\(Rabe)Tj
/F3 1 Tf
2.9792 0 TD
0 Tc
[(et)-391.5(al)]TJ
/F2 1 Tf
1.9883 0 TD
[(.,)-388.7(2005;)-400.1(Calverley)]TJ
/F3 1 Tf
8.7099 0 TD
[(et)-391.5(al)]TJ
/F2 1 Tf
1.9884 0 TD
[(.,)-395.4(2007\),)-394.2(which)-396.4(was)-395.1(of)-396.2(the)]TJ
-15.6658 -1.3256 TD
[(same)-455.4(order)-451.8(of)-456.5(magnitude)-457.3(as)-449.7(that)-453.9(reported)-452.3(with)-456.8(cilomilast,)]TJ
T*
[(although)-409.1(abdominal)-415.6(pain)-408.4(and)-405.8(vomiting)-411.6(were)-408.1(also)-408.3(reported)]TJ
0 -1.3189 TD
[(for)-600.4(this)-607.5(drug)-600.8(\(Rennard)]TJ
/F3 1 Tf
11.9234 0 TD
[(et)-605.7(al)]TJ
/F2 1 Tf
2.1959 0 TD
[(.,)-603(2006\).)-608.4(The)-599.9(adverse)-606.6(effects)]TJ
-14.1193 -1.3256 TD
[(appeared)-348.7(to)-350.9(disappear)-358.3(with)-349.7(continued)-349.1(use)-354.5(but)-342.6(were)-354.5(a)-346.9(m)-0.1(ajor)]TJ
T*
[(reason)-310.7(why)-303.9(patients)-312.2(discontinued)-305.7(with)-309.5(the)-310(study)-307.6(during)-308.9(the)]TJ
0 -1.3189 TD
[(first)-548.9(3ñ4)-551.8(weeks)-551.4(of)-550.2(treatment.)-555.4(No)-550.8(cardiovascular)-559.1(liabilities)]TJ
0 -1.3256 TD
[(were)-334.5(noted.)]TJ
/F3 1 Tf
0 -3.97 TD
[(PDE4)-339.1(inhibitors:)-337.9(unwanted)-335.5(effects)]TJ
/F2 1 Tf
0 -1.3256 TD
[(Nausea)-431.3(is)-426.8(a)-427.3(commonly)-427.3(reported)-432.2(side)-427.4(effect)-422.4(associated)-436.4(with)]TJ
T*
[(theophylline)-298.3(and)-291.9(therefore)-301.9(not)-290.6(surprisingly)69.2(,)-298.1(PDE4)-294.6(inhibitors)]TJ
T*
[(also)-254.3(produce)-261.2(a)-253.2(similar)-243.6(constellation)-264.1(of)-255.6(adverse)-251.8(events)-257.9(and)-251.8(are)]TJ
0 -1.3189 TD
[(a)-286.7(major)-285.6(drawback)-295.6(for)-285.7(the)-283.2(therapeutic)-290(use)-287.5(of)-289.1(these)-287.7(drugs.)-285.3(The)]TJ
0 -1.3256 TD
[(mechanism)-361.1(responsible)-359.7(for)-352.7(this)-359.8(side)-353.7(effect)-355.4(has)-356(been)-351.8(investi-)]TJ
T*
[(gated)-288.4(in)-290.6(an)-293.4(attempt)-290.5(to)-290.6(discover)-289.5(non-emetic)-295.9(PDE4)-294.6(inhibitors.)]TJ
0.9975 -1.3189 TD
[(The)-399(direct)-394.4(recording)-395.2(of)-389.5(neuronal)-399.9(activity)-392.4(within)-392.6(the)-397(area)]TJ
-0.9975 -1.3256 TD
[(postrema)-312.6(conclusively)-311.7(demonstrated)-313.1(that)-313.3(substances)-310.2(known)]TJ
T*
[(to)-612(cause)-607.4(nausea)-606.5(\(for)-614.6(example,)-610.8(apomorphine\))-609.8(caused)-612.6(the)]TJ
0 -1.3189 TD
[(excitation)-547.8(of)-543.5(neurones)-543.5(within)-546.5(the)-537.6(area)-545.2(postrema)-546.9(of)-543.5(dogs)]TJ
0 -1.3256 TD
0.0001 Tc
(\(Carpenter)Tj
/F3 1 Tf
5.4763 0 TD
0 Tc
[(et)-465.1(al)]TJ
/F2 1 Tf
2.062 0 TD
[(.,)-462.4(1988\).)-474.5(Neuronal)-465.7(activity)-466.1(within)-472.9(the)-464(area)]TJ
-7.5383 -1.3256 TD
[(postrema)-386.2(was)-381.7(also)-381.5(increased)-384.4(following)-387.1(the)-383.7(systemic)-384.5(admin-)]TJ
T*
[(istration)-481(of)-476.6(8-bromo)-479.3(cyclic)-476.7(AMP)-480.9(or)-474.7(following)-480.9(elevation)-476.6(of)]TJ
0 -1.3189 TD
[(endogenous)-810.6(levels)-805.5(of)-804.6(cyclic)-804.7(AMP)-809(within)-807.6(neurones)-804.6(by)]TJ
0 -1.3256 TD
[(forskolin,)-758.6(an)-755.4(activator)-752.5(of)-757.8(AC)-749.8(\(Carpenter)]TJ
/F3 1 Tf
21.6108 0 TD
[(et)-753(al)]TJ
/F2 1 Tf
2.3499 0 TD
[(.,)-750.2(1988\).)]TJ
-23.9606 -1.3256 TD
[(Elevated)-634(levels)-631.4(of)-637.2(cyclic)-630.6(AMP)-634.9(within)-633.6(the)-638.1(area)-632.3(postrema)]TJ
ET
1 i 
307.842 749.367 239.131 -0.227 re
f
BT
/F1 1 Tf
5.9774 0 0 7.9702 307.8424 761.8392 Tm
-0.0001 Tc
[(PDE4)-332.8(inhibitors)-335.3(and)-325.8(respiratory)-335.9(disease)]TJ
/F9 1 Tf
0 -1.2519 TD
[(D)-328.5(Spina)]TJ
7.0982 0 0 9.4646 534.1038 751.8612 Tm
0.0001 Tc
(311)Tj
ET
307.842 40.932 239.131 -0.283 re
f
BT
/F4 1 Tf
6.0123 0 0 8.4682 405.2408 31.2378 Tm
[(British)-322.5(J)0.1(ournal)-334(of)-334.4(Pharmacolog)18.7(y)-339.1(\(2008\))]TJ
/F1 1 Tf
17.5955 0 TD
(155)Tj
/F4 1 Tf
2.0462 0 TD
(308ñ315)Tj
ET

 Q
q
q 1 0 0 1 0 0 cm /Xi4 Do Q
Q


Q

q
0.0 0.0 595 794 re
W
n
1 0 0 1 0 0 cm
BT
/F1-0 12 Tf
14.4 TL
ET
1 0 0 RG
n
48 716 243 13 re
S
1 0 0 RG
n
48 705 243 12 re
S
1 0 0 RG
n
48 694 242 12 re
S
1 0 0 RG
n
50 683 93 10 re
S
1 0 0 RG
n
49 638 67 11 re
S
1 0 0 RG
n
50 627 241 11 re
S
1 0 0 RG
n
48 614 243 13 re
S
1 0 0 RG
n
49 604 241 11 re
S
1 0 0 RG
n
48 592 243 12 re
S
1 0 0 RG
n
48 581 242 13 re
S
1 0 0 RG
n
49 571 241 11 re
S
1 0 0 RG
n
48 559 243 12 re
S
1 0 0 RG
n
48 549 215 10 re
S
1 0 0 RG
n
49 537 241 11 re
S
1 0 0 RG
n
48 525 243 12 re
S
1 0 0 RG
n
49 514 242 12 re
S
1 0 0 RG
n
48 503 243 12 re
S
1 0 0 RG
n
48 492 243 12 re
S
1 0 0 RG
n
49 481 242 11 re
S
1 0 0 RG
n
48 470 243 11 re
S
1 0 0 RG
n
48 459 243 11 re
S
1 0 0 RG
n
49 447 40 12 re
S
1 0 0 RG
n
58 436 232 11 re
S
1 0 0 RG
n
48 425 243 11 re
S
1 0 0 RG
n
49 414 242 11 re
S
1 0 0 RG
n
48 402 242 12 re
S
1 0 0 RG
n
48 391 243 12 re
S
1 0 0 RG
n
48 380 243 11 re
S
1 0 0 RG
n
49 369 242 11 re
S
1 0 0 RG
n
48 358 243 11 re
S
1 0 0 RG
n
48 346 243 11 re
S
1 0 0 RG
n
50 335 241 11 re
S
1 0 0 RG
n
48 324 243 11 re
S
1 0 0 RG
n
50 313 241 10 re
S
1 0 0 RG
n
48 301 243 13 re
S
1 0 0 RG
n
48 290 243 12 re
S
1 0 0 RG
n
48 279 124 11 re
S
1 0 0 RG
n
179 279 111 11 re
S
1 0 0 RG
n
48 268 243 11 re
S
1 0 0 RG
n
48 256 243 11 re
S
1 0 0 RG
n
48 245 243 12 re
S
1 0 0 RG
n
48 234 53 11 re
S
1 0 0 RG
n
58 224 233 10 re
S
1 0 0 RG
n
49 212 242 12 re
S
1 0 0 RG
n
49 201 242 10 re
S
1 0 0 RG
n
49 189 242 11 re
S
1 0 0 RG
n
48 178 243 12 re
S
1 0 0 RG
n
49 167 242 11 re
S
1 0 0 RG
n
49 156 163 11 re
S
1 0 0 RG
n
232 156 59 11 re
S
1 0 0 RG
n
48 144 243 13 re
S
1 0 0 RG
n
49 133 241 12 re
S
1 0 0 RG
n
49 122 242 12 re
S
1 0 0 RG
n
48 110 243 13 re
S
1 0 0 RG
n
48 99 243 12 re
S
1 0 0 RG
n
48 89 243 11 re
S
1 0 0 RG
n
49 77 242 12 re
S
1 0 0 RG
n
49 67 242 10 re
S
1 0 0 RG
n
48 55 243 11 re
S
1 0 0 RG
n
306 716 242 13 re
S
1 0 0 RG
n
306 704 33 13 re
S
1 0 0 RG
n
315 694 233 11 re
S
1 0 0 RG
n
305 683 244 11 re
S
1 0 0 RG
n
306 671 242 12 re
S
1 0 0 RG
n
306 660 242 11 re
S
1 0 0 RG
n
306 649 243 11 re
S
1 0 0 RG
n
306 638 242 11 re
S
1 0 0 RG
n
305 626 244 12 re
S
1 0 0 RG
n
305 616 244 10 re
S
1 0 0 RG
n
306 604 242 11 re
S
1 0 0 RG
n
306 593 242 11 re
S
1 0 0 RG
n
305 581 243 13 re
S
1 0 0 RG
n
306 571 242 11 re
S
1 0 0 RG
n
306 559 242 12 re
S
1 0 0 RG
n
306 548 242 12 re
S
1 0 0 RG
n
306 537 242 12 re
S
1 0 0 RG
n
306 525 242 12 re
S
1 0 0 RG
n
306 515 242 11 re
S
1 0 0 RG
n
306 503 242 11 re
S
1 0 0 RG
n
306 492 242 11 re
S
1 0 0 RG
n
305 481 244 11 re
S
1 0 0 RG
n
306 470 242 11 re
S
1 0 0 RG
n
306 459 18 10 re
S
1 0 0 RG
n
344 459 204 10 re
S
1 0 0 RG
n
306 446 242 12 re
S
1 0 0 RG
n
306 436 242 10 re
S
1 0 0 RG
n
306 425 242 11 re
S
1 0 0 RG
n
305 413 243 13 re
S
1 0 0 RG
n
306 402 242 12 re
S
1 0 0 RG
n
306 390 242 12 re
S
1 0 0 RG
n
306 380 120 11 re
S
1 0 0 RG
n
315 369 233 10 re
S
1 0 0 RG
n
306 357 81 12 re
S
1 0 0 RG
n
406 357 49 12 re
S
1 0 0 RG
n
473 357 54 12 re
S
1 0 0 RG
n
307 346 241 11 re
S
1 0 0 RG
n
306 335 241 11 re
S
1 0 0 RG
n
306 324 242 11 re
S
1 0 0 RG
n
306 313 242 11 re
S
1 0 0 RG
n
306 301 242 12 re
S
1 0 0 RG
n
306 290 242 11 re
S
1 0 0 RG
n
306 280 242 10 re
S
1 0 0 RG
n
306 269 49 9 re
S
1 0 0 RG
n
306 233 129 13 re
S
1 0 0 RG
n
306 223 241 11 re
S
1 0 0 RG
n
306 212 242 11 re
S
1 0 0 RG
n
306 200 242 12 re
S
1 0 0 RG
n
305 189 243 11 re
S
1 0 0 RG
n
306 179 242 10 re
S
1 0 0 RG
n
306 167 242 11 re
S
1 0 0 RG
n
315 156 233 11 re
S
1 0 0 RG
n
305 144 243 13 re
S
1 0 0 RG
n
305 133 243 11 re
S
1 0 0 RG
n
306 121 242 13 re
S
1 0 0 RG
n
306 110 242 12 re
S
1 0 0 RG
n
305 100 243 10 re
S
1 0 0 RG
n
306 89 242 11 re
S
1 0 0 RG
n
306 77 242 12 re
S
1 0 0 RG
n
306 66 242 11 re
S
1 0 0 RG
n
306 55 241 12 re
S
0 1 0 RG
n
263 549 26 11 re
S
0 1 0 RG
n
172 280 6 8 re
S
0 1 0 RG
n
212 157 19 10 re
S
0 1 0 RG
n
324 460 20 10 re
S
0 1 0 RG
n
387 358 19 10 re
S
0 1 0 RG
n
455 358 18 10 re
S
0 1 0 RG
n
527 358 19 10 re
S
0.619608 0.619608 0.619608 RG
n
404 29 143 11 re
S
0.619608 0.619608 0.619608 RG
n
531 748 18 14 re
S
0.619608 0.619608 0.619608 RG
n
306 759 113 13 re
S
0.619608 0.619608 0.619608 RG
n
305 749 25 12 re
S
0.619608 0.619608 0.619608 RG
n
577 402 8 371 re
S
Q


endstream
endobj
185 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
186 0 obj
<<
/BBox [ 0 0 595 794 ]
/Filter /FlateDecode
/FormType 1
/Matrix [ 1 0 0 1 0 0 ]
/Resources <<
/Font <<
/F1 120 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Subtype /Form
/Type /XObject
/Length 286
>>
stream
xúuP=o¬0›Û+ﬁ¯#)$¥SKÀÑƒ–HJ'π£ƒéÏ ‚ﬂ◊.jßvy:›È}‹{*æëX∞eõÃ%$˘ä»ÛÇ…pËì	‰]æ\dÖú!¢ò!õ·Ÿ^LgUCZg{∆q˜úWÉNïg÷t⁄Pß+ß‹ï]tGWV€û7Vs)òY¡´„¿¢ ÀDéÍäµ≠N¬&`M3ºEvﬂRÿﬁ¥`ﬁÂíãOEö}0ºa<JrΩá2M2çµ5˚…O≤ˇçë6¥y˝K€O£Õüˆ≠upßé<lãìßÏ°‹®Î∏Séiœ‰L(&ºs©aËt≠™é∞v§F}ÉÌ˚o´k2û¶Â1â’‹0¥˛R&_¸TÑ∏
endstream
endobj
187 0 obj
<<
/BitsPerComponent 8
/ColorSpace 62 0 R
/Filter /FlateDecode
/Height 99
/Width 74
/Length 374
>>
stream
HâÏóQ¬0DΩˇπéÍH	ªÑ&–é#µÈfﬂö“D‰_èc-*ëõÁ=ŸZÿQ ®Îû¢—EâŒ«ãô*ÈL—Ág:0oQÍ»Èå'˘RG
ÛâJ-µÓ·_5˙2JÚv™,ñ¢‘50Wìì¬pP^p∫1/'˝[/ÅŒ\∫®›˘\ûí7Ôg``π4'r‚	”±ÒÕx˚<’*Ÿ∑Ö≠∑⁄ú‹÷îXôÆño¶[ıydßLΩv/Ûûjsä∂±æ'ãÉEØ¢ã∂p!ùÌúdØ(A;Oe˘ú¿g€s=Kw‰º¡*p}1ki•∫·©`èäï:s¢&KrÍ¢Àt_ãb⁄@^IØ@˝.éáØÜöwﬂß¥Ø¢π.:x1Ë“ap=ü)œŸÔ›ÿˆÓÿ.ˇ"Äë≥J›9≠”Ò˚RKÁÆlÔΩ≥}~§©hü∏-ÒíòÚû˝ù˛¿V”ygòt;(1EÜ\B◊W0°ü†Î≠Á ∫[˛}
endstream
endobj
188 0 obj
<<
/Annots [ 189 0 R 190 0 R 191 0 R 192 0 R 193 0 R 194 0 R 195 0 R 196 0 R 197 0 R 198 0 R 199 0 R 200 0 R 201 0 R 202 0 R 203 0 R 204 0 R 205 0 R 206 0 R 207 0 R 208 0 R 209 0 R 210 0 R 211 0 R 212 0 R 213 0 R 214 0 R 215 0 R 216 0 R 217 0 R 218 0 R 219 0 R 220 0 R ]
/Contents 221 0 R
/CropBox [ 0 0 595 794 ]
/MediaBox [ 0 0 595 794 ]
/Resources <<
/ExtGState <<
/GS1 25 0 R
>>
/Font <<
/F1 26 0 R
/F1-0 222 0 R
/F2 30 0 R
/F3 33 0 R
/F4 36 0 R
/F5 39 0 R
/F6 42 0 R
/F7 45 0 R
/F9 55 0 R
>>
/XObject <<
/Im2 223 0 R
/Xi5 224 0 R
>>
/ProcSet [ /ImageB /ImageC /ImageI /PDF /Text ]
>>
/Rotate 0
/Thumb 225 0 R
/Type /Page
/Parent 2 0 R
>>
endobj
189 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib17)
/Rect [ 80 672 168 680 ]
/Subtype /Link
/Type /Annot
>>
endobj
190 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib70)
/Rect [ 114 649 212 658 ]
/Subtype /Link
/Type /Annot
>>
endobj
191 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib70)
/Rect [ 101 593 214 602 ]
/Subtype /Link
/Type /Annot
>>
endobj
192 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib19)
/Rect [ 54 537 147 546 ]
/Subtype /Link
/Type /Annot
>>
endobj
193 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib80)
/Rect [ 153 537 238 546 ]
/Subtype /Link
/Type /Annot
>>
endobj
194 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib61)
/Rect [ 243 537 290 546 ]
/Subtype /Link
/Type /Annot
>>
endobj
195 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib61)
/Rect [ 51 526 93 535 ]
/Subtype /Link
/Type /Annot
>>
endobj
196 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib48)
/Rect [ 97 526 191 535 ]
/Subtype /Link
/Type /Annot
>>
endobj
197 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib61)
/Rect [ 147 481 240 490 ]
/Subtype /Link
/Type /Annot
>>
endobj
198 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib68)
/Rect [ 54 414 169 422 ]
/Subtype /Link
/Type /Annot
>>
endobj
199 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib68)
/Rect [ 54 380 147 389 ]
/Subtype /Link
/Type /Annot
>>
endobj
200 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib68)
/Rect [ 120 324 209 333 ]
/Subtype /Link
/Type /Annot
>>
endobj
201 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib69)
/Rect [ 54 257 149 266 ]
/Subtype /Link
/Type /Annot
>>
endobj
202 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib23)
/Rect [ 157 190 226 198 ]
/Subtype /Link
/Type /Annot
>>
endobj
203 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib2)
/Rect [ 84 156 172 165 ]
/Subtype /Link
/Type /Annot
>>
endobj
204 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137fig1)
/Rect [ 125 123 157 131 ]
/Subtype /Link
/Type /Annot
>>
endobj
205 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib1)
/Rect [ 179 78 243 86 ]
/Subtype /Link
/Type /Annot
>>
endobj
206 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib67)
/Rect [ 248 78 290 86 ]
/Subtype /Link
/Type /Annot
>>
endobj
207 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib67)
/Rect [ 51 67 97 75 ]
/Subtype /Link
/Type /Annot
>>
endobj
208 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137fig1)
/Rect [ 349 448 385 456 ]
/Subtype /Link
/Type /Annot
>>
endobj
209 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib31)
/Rect [ 496 436 547 445 ]
/Subtype /Link
/Type /Annot
>>
endobj
210 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib31)
/Rect [ 308 425 327 434 ]
/Subtype /Link
/Type /Annot
>>
endobj
211 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib77)
/Rect [ 494 324 541 333 ]
/Subtype /Link
/Type /Annot
>>
endobj
212 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib51)
/Rect [ 426 313 502 322 ]
/Subtype /Link
/Type /Annot
>>
endobj
213 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib59)
/Rect [ 371 246 436 254 ]
/Subtype /Link
/Type /Annot
>>
endobj
214 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib56)
/Rect [ 311 223 400 232 ]
/Subtype /Link
/Type /Annot
>>
endobj
215 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib13)
/Rect [ 479 134 547 142 ]
/Subtype /Link
/Type /Annot
>>
endobj
216 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib13)
/Rect [ 308 123 327 131 ]
/Subtype /Link
/Type /Annot
>>
endobj
217 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib35)
/Rect [ 333 123 454 131 ]
/Subtype /Link
/Type /Annot
>>
endobj
218 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib70)
/Rect [ 308 582 391 590 ]
/Subtype /Link
/Type /Annot
>>
endobj
219 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib69)
/Rect [ 510 519 547 527 ]
/Subtype /Link
/Type /Annot
>>
endobj
220 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib69)
/Rect [ 308 511 355 519 ]
/Subtype /Link
/Type /Annot
>>
endobj
221 0 obj
<<
/Length 22118
>>
stream
q
q

BT
/F2 1 Tf
8.4682 0 0 8.4682 50.7968 718.7526 Tm
0 0 0 rg
/GS1 gs
0 Tc
0 Tw
[(enhanced)-777.9(the)-778.7(emetogenic)-779.4(response.)-780.3(Dogs)-778.6(treated)-781.1(with)]TJ
0 -1.3256 TD
[(theophylline)-378.6(and)-365.6(the)-370.3(PDE4)-375(selective)-372(inhibitor)33.4(,)-365.1(4-\(3-butoxy-)]TJ
T*
[(4-methoxyphenyl\)methyl-2-imi)-16.9(dazolidone)-1154.3(\(Ro)-1149.4(20ñ1724\))]TJ
0 -1.3189 TD
[(reduced)-494.8(the)-484.1(emetic)-492.1(threshold)-493.7(of)-490(the)-490.8(D2)-488(agonist,)-493.4(apomor-)]TJ
0 -1.3256 TD
0.0001 Tc
[(phine)-405(\(Carpenter)]TJ
/F3 1 Tf
8.5559 0 TD
0 Tc
[(et)-404.9(al)]TJ
/F2 1 Tf
1.995 0 TD
[(.,)-408.8(1988\).)-407.6(Similarly)65.1(,)-405.3(the)-403.7(i.c.v)67.2(.)-405.3(adminis-)]TJ
-10.551 -1.3256 TD
[(tration)-275.2(of)-275.7(highly)-271.4(potent)-277.7(PDE4)-274.5(inhibitors)-276.9(also)-274.4(induced)-277.9(emesis)]TJ
T*
[(in)-705.7(the)-705(ferret)-712(\()5.9(Robichaud)]TJ
/F3 1 Tf
13.1686 0 TD
[(et)-706.1(al)]TJ
/F2 1 Tf
2.2963 0 TD
[(.,)-710.1(1999\),)-708.8(and)-707(the)-705(emetic)]TJ
-15.465 -1.3189 TD
[(response)-602.7(to)-605.3(systemically)-606.5(administered)-603.6(PDE4)-602.6(inhibitors)-604.9(is)]TJ
0 -1.3256 TD
[(reduced)-447.9(by)-438.2(anti-emetic)-448.3(agents)-439.6(including)-444.6(the)-443.9(5HT3-antago-)]TJ
T*
[(nist,)-497.2(ondansetron,)-503(and)-499.5(the)-490.8(neurokinin)-501.2(1)-499.2(antagonist,)-498.8(\()]TJ
/F7 1 Tf
26.6118 0 TD
()Tj
/F2 1 Tf
0.9373 0 TD
(\)-)Tj
-27.549 -1.3189 TD
(\(2)Tj
/F3 1 Tf
0.9306 0 TD
(S)Tj
/F2 1 Tf
0.4753 0 TD
(,3)Tj
/F3 1 Tf
0.8636 0 TD
(S)Tj
/F2 1 Tf
0.482 0 TD
(\)-3-\(2-[)Tj
6.351 0 0 5.6449 101.0834 610.4125 Tm
0.0001 Tc
(11)Tj
8.4682 0 0 8.4682 108.3968 606.6707 Tm
0 Tc
(C]methoxybenzylamino\)-2-phenylpiperidine)Tj
-6.8019 -1.3256 TD
[(\(CP-99994\))-344.4(\(Robichaud)]TJ
/F3 1 Tf
11.2405 0 TD
[(et)-337.9(al)]TJ
/F2 1 Tf
1.9281 0 TD
[(.,)-335.2(1999,)-339.8(2001\).)]TJ
-12.1644 -1.3256 TD
[(Many)-363.3(studies)-364.6(have)-366.1(documented)-364(the)-363.6(expression)-368.1(of)-369.5(PDE4D)]TJ
-1.0042 -1.3189 TD
[(within)-707.2(the)-711.7(area)-705.9(postrema,)-704.5(nucleus)-713.6(tractus)-708.8(solitaris)-707(and)]TJ
0 -1.3256 TD
[(nodose)-731.7(ganglion)-732.6(neurones)-737.7(in)-725.8(various)-731.8(species)-732.8(including)]TJ
T*
[(man)-477.8(and)-479.4(implicated)-484.3(this)-473.6(isoform)-484.6(in)-478.1(nausea)-479.3(and)-479.4(vomiting)]TJ
0 -1.3189 TD
[(\(Cherr)-12.8(y)-304.9(and)-305.3(Davis,)-307.8(1999;)-306.3(T)65(akahashi)]TJ
/F3 1 Tf
16.978 0 TD
[(et)-304.4(al)]TJ
/F2 1 Tf
1.9013 0 TD
[(.,)-301.7(1999;)-313(Perez-T)64.9(orres)]TJ
/F3 1 Tf
-18.8793 -1.3256 TD
[(et)-244.2(al)]TJ
/F2 1 Tf
1.8344 0 TD
[(.,)-248.1(2000;)-246.1(Lamontagne)]TJ
/F3 1 Tf
9.761 0 TD
[(et)-244.2(al)]TJ
/F2 1 Tf
1.8344 0 TD
[(.,)-248.1(2001\).)-246.9(However)39.4(,)-237.9(i)0(t)-243.6(should)-242.6(also)]TJ
-13.4297 -1.3256 TD
[(be)-369.7(recognized)-374.6(that)-373.5(detectable)-373.3(transcript)-369.9(for)-372.7(PDE4B)-376.9(was)-368.3(also)]TJ
T*
[(found)-309.7(within)-298.8(the)-303.3(nucleus)-305.2(tractus)-307.1(solitaris)-305.3(and)-305.3(area)-304.2(postrema)]TJ
0 -1.3189 TD
[(in)-330.8(humans)-328.1(and)-332.1(rodents,)-333.9(respectively)71.2(,)-331.6(and)-325.4(could)-333.6(be)-329.6(involved)]TJ
0 -1.3256 TD
[(in)-324.1(the)-323.4(emetic)-318(response)-328.2(\(Perez-T)64.9(orres)]TJ
/F3 1 Tf
17.2257 0 TD
[(et)-317.8(al)]TJ
/F2 1 Tf
1.9147 0 TD
[(.,)-321.8(2000\).)-320.5(As)-326.3(rodents)]TJ
-19.1404 -1.3256 TD
[(do)-336.1(not)-330.8(possess)-334.2(an)-326.9(emetic)-338.1(reflex,)-330.5(it)-330.6(is)-333.1(not)-330.8(possible)-334.2(to)-330.8(directly)]TJ
0 -1.3189 TD
[(investigate)-356.8(the)-350.2(role)-352.3(of)-349.4(different)-353.5(isoforms)-353(of)-349.4(PDE4)-354.9(in)-350.9(emesis.)]TJ
0 -1.3256 TD
[(However)39.4(,)-385.2(a)-387.1(surrogate)-390.6(biological)-390.2(response)-388.5(that)-386.9(measures)-391.4(the)]TJ
T*
[(reversal)-339.5(of)-342.7(anaesthesia)-335.9(induced)-344.8(by)]TJ
/F6 1 Tf
16.4424 0 TD
(a)Tj
/F2 1 Tf
0.549 0 TD
[(2-adrenoceptor)-345.3(agonists)]TJ
-16.9914 -1.3189 TD
[(has)-362.7(been)-351.8(used)-359.7(to)-357.6(study)-361.1(the)-356.9(role)-359(of)-362.8(PDE4)-354.9(subtypes)-365(in)-357.6(emesis)]TJ
0 -1.3256 TD
0.0001 Tc
(\(Robichaud)Tj
/F3 1 Tf
5.6236 0 TD
0 Tc
[(et)-264.3(al)]TJ
/F2 1 Tf
1.8545 0 TD
[(.,)-268.2(2001,)-266.2(2002a\).)-272.5(It)-261.8(was)-267.9(previously)-264.5(shown)-265.4(that)]TJ
-7.4781 -1.3256 TD
[(the)-664.8(ability)-672.5(of)-664(PDE4)-669.5(inhibitors)-671.9(to)-665.5(induce)-667.7(emesis)-671.3(in)-665.5(the)]TJ
T*
[(ferret)-504.5(was)-508.9(inhibited)-503.4(by)-505.2(the)]TJ
/F6 1 Tf
13.6975 0 TD
(a)Tj
/F2 1 Tf
0.549 0 TD
[(2-selective)-511.3(agonist,)-506.8(clonidine)]TJ
-14.2465 -1.3189 TD
0.0001 Tc
(\(Robichaud)Tj
/F3 1 Tf
5.8713 0 TD
0 Tc
[(et)-512(al)]TJ
/F2 1 Tf
2.1089 0 TD
[(.,)-509.2(2001\))-517.8(and)-519.6(suggested)-513.8(that)-514.1(raising)-513.1(cyclic)]TJ
-7.9802 -1.3256 TD
[(AMP)-855.8(within)-854.5(central)-856.7(noradrenergic)-861.4(terminals)-852.2(by)-853.3(PDE4)]TJ
T*
[(inhibitors)-497.8(promoted)-493.5(emesis,)-487.4(and)-492.8(this)-493.7(could)-494.3(be)-490.2(attenuated)]TJ
0 -1.3189 TD
(by)Tj
/F6 1 Tf
1.4996 0 TD
(a)Tj
/F2 1 Tf
0.549 0 TD
[(2-adrenoceptor-mediated)-366.5(inhibition)-367.7(of)-362.8(AC.)-358.3(The)-358.9(hypno-)]TJ
-2.0486 -1.3256 TD
[(tic)-430.7(action)-439.1(of)-429.7(xylazine)-436(was)-428.6(reversed)-432.4(in)-431.2(rodents)-437.5(treated)-433(with)]TJ
T*
[(PDE4)-354.9(inhibitors)-357.2(\(Robichaud)]TJ
/F3 1 Tf
13.5101 0 TD
[(et)-351.3(al)]TJ
/F2 1 Tf
1.9482 0 TD
[(.,)-355.3(2001\))-357.2(and)-352.2(therefore)-355.4(used)]TJ
-15.4583 -1.3189 TD
[(as)-309.1(a)-300.1(surrogate)-310.2(for)-305.8(emesis.)-306.6(Deletion)-309.1(of)-309.2(PDE4D)-303.6(and)-305.3(not)-304(PDE4B)]TJ
0 -1.3256 TD
[(reduced)-514.9(the)-510.9(duration)-516.7(of)-510(anaesthesia)-516.7(induced)-512.2(by)-511.9(xylazine,)]TJ
T*
[(compared)-482.6(with)-470.2(wild-type)-477.2(mice,)-480.2(and)-472.7(second,)-477.7(the)-477.4(ability)-478.3(of)]TJ
0 -1.3189 TD
[(PDE4)-656.2(inhibitors)-651.8(to)-652.1(shorten)-653.3(xylazine-induced)-655.3(anaesthesia)]TJ
0 -1.3256 TD
[(was)-642.8(impaired)-639.4(in)-638.7(PDE4D)-645(but)-637.2(not)-638.8(PDE4B)-644.7(knockout)-643.8(mice)]TJ
T*
0.0001 Tc
(\(Robichaud)Tj
/F3 1 Tf
5.7374 0 TD
0 Tc
[(et)-384.8(al)]TJ
/F2 1 Tf
1.9817 0 TD
[(.,)-382(2002b\).)-386.9(T)65(ogether)35.4(,)-385.2(these)-381.4(studies)-384.7(suggested)]TJ
-7.7191 -1.3256 TD
[(that)-527.5(PDE4)-522.3(inhibito)-10.2(rs)-521.2(with)-523.8(low)-526.6(affinity)-526.7(for)-526.7(PDE4D)-531.2(should)]TJ
0 -1.3189 TD
[(have)-332.6(reduced)-340.8(emetic)-331.4(potential.)]TJ
1.0042 -1.3256 TD
[(However)39.4(,)-264.7(i)0(t)-263.6(i)0(s)-259.4(not)-263.9(entirely)-270.7(clear)-274.3(whether)-260.8(PDE4D)-270.1(inhibition)]TJ
-1.0042 -1.3256 TD
[(alone)-240.7(is)-239.3(the)-236.4(sole)-237.5(basis)-239.9(of)-242.3(emesis)-236.1(as)-235.5(there)-241.7(are)-238.5(examples)-241.4(of)-235.6(PDE4)]TJ
0 -1.3189 TD
[(inhibitors)-370.6(that)-366.8(document)]TJ
/F3 1 Tf
12.392 0 TD
[(in)-368.8(vivo)]TJ
/F2 1 Tf
3.3541 0 TD
[(anti-inflammator)-17.6(y)-365.2(activity)]TJ
-15.7461 -1.3256 TD
[(but)-536.8(are)-533.1(not)-538.4(emetogenic)-538.4(\(Gale)]TJ
/F3 1 Tf
15.157 0 TD
[(et)-532.1(al)]TJ
/F2 1 Tf
2.1289 0 TD
[(.,)-536(2002\))-537.9(and)-532.9(there)-536.3(are)]TJ
-17.2859 -1.3256 TD
[(examples)-589.6(of)-590.4(PDE4)-589.2(inhibitors)-591.6(that)-587.8(have)-587(little)-592.3(emetogenic)]TJ
0 -1.3189 TD
[(activity)-352.3(but)-349.3(potent)-351.4(anti-inflammator)-17.6(y)-351.8(activity)-352.3(in)-350.9(preclinical)]TJ
0 -1.3256 TD
[(studies)-311(\()5.9(Aoki)]TJ
/F3 1 Tf
6.3333 0 TD
[(et)-304.5(al)]TJ
/F2 1 Tf
1.8946 0 TD
[(.,)-308.4(2000,)-306.3(2001\).)-313.8(Similarly)71.7(,)-304.8(the)-303.3(emetic)-311.3(profile)]TJ
-8.2279 -1.3256 TD
[(of)-322.6(various)-330.1(PDE4)-321.4(inhibitors)-330.5(in)-317.4(the)-323.4(ferret)-323.7(cannot)-329.3(be)-322.9(explained)]TJ
T*
[(by)-485.1(their)-483.3(selectivity)-483.2(for)-486.5(PDE4D)-484.3(or)-481.4(to)-484.7(differences)-485(in)-484.8(PDE4D)]TJ
0 -1.3189 TD
[(inhibitor)-247.8(potency)-247.7(\(Figure)-241(1\).)-249.1(One)-241.2(possible)-247.2(explanation)-244.3(might)]TJ
0 -1.3256 TD
[(be)-316.2(that)-320(some)-318.9(PDE4)-314.7(inhibitors)-323.8(preferentially)-321.3(partition)-316.5(within)]TJ
T*
[(the)-370.3(CNS)-366.7(and)-365.6(hence)-372.2(the)-363.6(degree)-370.8(of)-369.5(PDE4D)-370.5(inhibition)-367.7(in)-370.9(area)]TJ
0 -1.3189 TD
[(postrema)-607.2(neurones)-603.8(might)-610(explain)-604.3(the)-604.6(differences)-605.5(in)-605.3(the)]TJ
0 -1.3256 TD
[(emetic)-304.6(potential)-295.2(of)-302.5(these)-301.1(drugs)-295.2(\(Aoki)]TJ
/F3 1 Tf
17.5805 0 TD
[(et)-297.8(al)]TJ
/F2 1 Tf
1.8946 0 TD
[(.,)-295(2001;)-306.3(Robichaud)]TJ
/F3 1 Tf
-19.4751 -1.3256 TD
[(et)-250.9(al)]TJ
/F2 1 Tf
1.8478 0 TD
[(.,)-248.1(2002a\).)-259.1(However)39.4(,)-251.3(the)-249.8(concentration)-252.8(of)-255.6(the)-249.8(ëlow)-252.3(emeticí)]TJ
-1.8478 -1.3189 TD
[(PDE4)-328.1(inhibitor)33.4(,)-324.9(C)0(T)60.9(-2450)-324.6(within)-325.6(the)-330.1(CNS)-326.5(was)-321.5(comparable)-331(to)]TJ
30.3542 47.6468 TD
[(that)-507.4(achieved)-502.9(by)-505.2(the)-504.2(most)-510.8(potent)-505.4(emetic)-505.4(PDE4)-508.9(inhibitor)40.1(,)]TJ
0 -1.3256 TD
[(PMNPQ)-793.8(\(Figure)-796.6(1\).)-791.4(Second,)-798.8(the)-792(area)-792.9(postrema)-794.6(is)-795(not)]TJ
T*
[(completely)-633.5(behind)-625.4(the)-631.4(bloodñbrain)-628.4(barrier)-628.7(\(Gross)]TJ
/F3 1 Tf
25.4335 0 TD
[(et)-625.8(al)]TJ
/F2 1 Tf
2.216 0 TD
(.,)Tj
-27.6495 -1.3189 TD
[(1990\),)-668.7(and)-660.1(therefore)-663.4(accessible)-667.9(to)-665.5(free)-662(drug)-661(within)-667(the)]TJ
0 -1.3256 TD
[(circulation.)-492.9(It)-502.8(would)-500.2(seem)-498.9(unlikely)-501.3(that)-500.7(differential)-504.9(parti-)]TJ
T*
[(tioning)-712.3(of)-710.9(these)-709.5(inhibitors)-712.1(within)-713.9(the)-705(CNS)-708.1(is)-714.7(a)-708.5(likely)]TJ
T*
[(explanation)-445.2(for)-446.4(their)-443.1(ability)-451.5(to)-437.9(induce)-446.7(emesis.)-447.2(However)39.4(,)-445.4(i)0(t)]TJ
0 -1.3189 TD
[(remains)-427.9(to)-424.5(be)-430(established)-425.9(whether)-428.2(the)-423.8(magnitude)-430.5(of)-423(PDE4)]TJ
0 -1.3256 TD
[(inhibition)-615.4(within)-606.8(the)-611.3(area)-612.2(postrema)-613.9(differs)-608.3(between)-613.8(the)]TJ
T*
[(various)-336.8(PDE4)-334.8(inhibitors.)]TJ
0.9975 -1.3189 TD
[(A)-243.6(number)-244.7(of)-242.3(preclinical)-247(studies)-244.1(have)-238.9(highlighted)-245.4(a)-246.5(number)]TJ
-0.9975 -1.3256 TD
[(of)-242.3(disadvantages)-242(to)-243.7(targeting)-243.5(PDE4,)-244.6(include)-241.9(the)-236.4(developmen)-9.3(t)]TJ
T*
[(of)-382.8(mesenteric)-386(vasculitis,)-388.3(immunosuppression)-386.3(\(Spina,)-387.2(2004\),)]TJ
0 -1.3189 TD
[(heart)-285.3(failure)-284.2(and)-285.2(arrhythmia)-288.5(\(Lehnart)]TJ
/F3 1 Tf
17.8952 0 TD
[(et)-284.4(al)]TJ
/F2 1 Tf
1.8812 0 TD
[(.,)-281.6(2005\).)-287.1(However)39.4(,)]TJ
-19.7764 -1.3256 TD
[(none)-420.1(of)-416.3(these)-414.9(events)-418.5(appear)-415(to)-417.8(be)-416.6(realized)-419(in)-417.8(phase)-416.9(II)-416.7(and)]TJ
T*
[(phase)-711.5(III)-705.4(clinical)-711.8(trials)-712.6(undertaken)-713.2(with)-711.2(cilomilast)-714(and)]TJ
0 -1.3189 TD
[(roflumilast.)-571.5(Similarly)65(,)-565.9(slow)-569.2(release)-569(theophylline)-566.1(has)-570.3(been)]TJ
0 -1.3256 TD
[(used)-326.2(for)-325.9(decades)-330.1(in)-324.1(the)-330.1(treatment)-324.2(of)-329.3(asthma)-324.9(and)-325.4(COPD)-329.5(and)]TJ
T*
[(has)-362.7(not)-364.3(been)-365.2(associated)-369.5(with)-363.1(a)-367(number)-365.2(of)-369.5(these)-361.3(potentially)]TJ
T*
[(adverse)-305.3(events)-298(\(Ohta)]TJ
/F3 1 Tf
10.0623 0 TD
[(et)-304.5(al)]TJ
/F2 1 Tf
1.8946 0 TD
[(.,)-301.7(2004\).)-307.1(It)-302(has)-302.5(been)-304.9(suggested)-299.6(that)]TJ
-11.9569 -1.3189 TD
[(PDE4)-843.6(inhibitors)-846(may)-836.2(have)-841.4(proinflammator)-19.1(y)-840.5(properties)]TJ
0 -1.3256 TD
0.0001 Tc
(\(McCluskie)Tj
/F3 1 Tf
5.6504 0 TD
0 Tc
[(et)-404.9(al)]TJ
/F2 1 Tf
2.0017 0 TD
[(.,)-408.8(2006\).)-407.6(This)-415.4(conclusion)-409.7(was)-408.5(based)-409.6(on)-411.3(the)]TJ
-7.6521 -1.3256 TD
[(finding)-666.4(that)-668.1(roflumilast)-668.4(at)-661.5(ver)-15.7(y)-659.8(high)-666.8(doses)-670.9(\(100)-166(mg/kg\))]TJ
0 -1.3189 TD
[(promoted)-312.8(the)-303.3(recruitment)-313(of)-309.2(neutrophils)-310.8(to)-304(the)-310(air)-11.4(ways)-305(and)]TJ
0 -1.3256 TD
[(this)-821.7(correlated)-829.8(with)-818.3(the)-825.5(release)-823.4(of)-824.7(interleukin-8)-823.1(from)]TJ
T*
[(cultured)-445.1(endothelial)-447.4(cells)]TJ
/F3 1 Tf
12.5728 0 TD
[(in)-442.5(vitro)]TJ
/F2 1 Tf
3.2671 0 TD
[(,)-438.7(although)-449.3(the)-437.2(concentra-)]TJ
-15.8399 -1.3189 TD
[(tions)-516.6(required)-521.1(to)-511.5(achieve)-517.8(these)-515.3(effects)-518.5(were)-521.9(at)-514.2(least)-514.6(1000)]TJ
0 -1.3256 TD
[(times)-492.6(greater)-499.4(than)-494.2(the)-490.8(ED)]TJ
6.351 0 0 5.6449 416.2393 156.926 Tm
0.0001 Tc
(50)Tj
8.4682 0 0 8.4682 427.6912 158.3433 Tm
0 Tc
[(and)-492.8(EC)]TJ
6.351 0 0 5.6449 457.9652 156.926 Tm
0.0001 Tc
(50)Tj
8.4682 0 0 8.4682 469.4172 158.3433 Tm
0 Tc
[(values)-493.4(reported)-499.2(for)]TJ
-19.0801 -1.3256 TD
[(roflumilast)-440.8(against)-432.2(several)]TJ
/F3 1 Tf
12.8942 0 TD
[(in)-435.8(vivo)]TJ
/F2 1 Tf
3.4813 0 TD
[(biomarkers)-437(of)-436.4(inflamma-)]TJ
-16.3754 -1.3189 TD
[(tion)-273.2(and)-265.2(cell)-274.9(function)]TJ
/F3 1 Tf
10.4439 0 TD
[(in)-268.4(vitro)]TJ
/F2 1 Tf
3.093 0 TD
[(,)-264.7(respectively)-270.3(\(Bundschuh)]TJ
/F3 1 Tf
12.2515 0 TD
[(et)-271(al)]TJ
/F2 1 Tf
1.8612 0 TD
(.,)Tj
-27.6495 -1.3256 TD
[(2001;)-333.1(Hatzelmann)-335.9(and)-325.4(Schudt,)-333.7(2001\).)-333.9(It)-328.8(is)-333.1(unlikely)-327.2(that)-333.4(the)]TJ
T*
[(plasma)-480(concentrations)-482.8(required)-474.2(to)-478.1(produce)-482.1(this)-473.6(purported)]TJ
T*
[(proinflammator)-19.1(y)-271.5(effect)-268.4(could)-273.4(be)-269.3(achieved)-275.3(even)-269(with)-269.4(chronic)]TJ
0 -1.3189 TD
[(dosing.)-740.9(Similarly)71.7(,)-733.3(another)-736.7(study)-736(has)-737.6(shown)-734(that)-735.1(PDE4)]TJ
0 -1.3256 TD
[(inhibitors,)-708.9(at)-701.6(concentrations)-710.4(that)-701.6(are)-700.4(pharmacologically)]TJ
T*
[(relevant,)-585.1(delay)-581.4(apoptosis)-591.1(of)-577(neutrophils)-592(and)-579.8(eosinophils,)]TJ
0 -1.3189 TD
[(an)-313.5(effect)-308.6(that)-313.3(increased)-310.8(when)-309.1(combined)-316.8(with)]TJ
/F6 1 Tf
21.5974 0 TD
(b)Tj
/F2 1 Tf
0.5557 0 TD
(2-adrenocep-)Tj
ET
q
1 i 
309.43 725.953 235.899 -119.792 re
W n
0 g
q
236.1588 0 0 119.8074 309.4412 606.1475 cm
/Im2 Do
Q
Q
BT
/F1 1 Tf
7.9702 0 0 7.9702 307.8424 593.2345 Tm
[(Figure)-519(1)]TJ
/F4 1 Tf
5.0361 0 TD
[(Line)-514.9(graph)-524.8(drawn)-514.6(from)-523.7(data)-518(presented)-516.5(in)-529.5(Table)-515.2(2)-523.4(o)0(f)]TJ
-5.0361 -1.1239 TD
(Robichaud)Tj
/F5 1 Tf
4.9934 0 TD
[(et)-311.5(al)]TJ
/F4 1 Tf
1.8708 0 TD
[(.)-313.6(\(1999\))-311.5(showing)-311.2(the)-313.8(number)-309.4(of)-310.6(retches)-310.9(\()]TJ
/F1 1 Tf
18.5084 0 TD
(a)Tj
/F4 1 Tf
0.5406 0 TD
[(\))-314.6(and)-308.5(the)]TJ
-25.9132 -1.1239 TD
[(percentage)-370.6(of)-381.8(animals)-379(who)-375.7(retch)-380.9(\()]TJ
/F1 1 Tf
15.5991 0 TD
(b)Tj
/F4 1 Tf
0.626 0 TD
[(\))-385.8(i)0(n)-380.1(response)-372.5(to)-379.6(increasing)-375.6(p.o)]TJ
-16.2251 -1.131 TD
[(doses)-336.1(of)-339.1(PDE4)-336.7(inhibitors,)-334.2(PMNPQ)-331.1(\(open)-339.8(circles\),)-329.9(R-rolipram)-334.4(\(closed)]TJ
0 -1.1239 TD
[(circles\))-336.4(and)-344.1(CT-2450.)]TJ
5.9774 0 0 5.3127 386.5322 560.9196 Tm
(1)Tj
7.9702 0 0 7.9702 389.9338 557.3479 Tm
[(Inhibitory)-339.9(potency)-339.2(\(IC)]TJ
5.9774 0 0 5.3127 468.1133 556.0439 Tm
-0.0001 Tc
(50)Tj
7.9702 0 0 7.9702 474.9731 557.3479 Tm
0 Tc
[(\))-343.1(for)-344.6(these)-336.3(inhibitors)]TJ
-20.9695 -1.1239 TD
[(against)-605.5(human)-608.4(cloned)-608.9(PDE4)-607(subtype)10.7(s.)]TJ
5.9774 0 0 5.3127 457.7385 551.9621 Tm
(2)Tj
7.9702 0 0 7.9702 461.1967 548.3904 Tm
[(Concentra)12.2(tion)-610.3(of)-616.5(PDE4)]TJ
-19.241 -1.1239 TD
[(inhibitors)-362.1(measured)-365.1(in)-373(homoge)12.1(nates)-367.7(of)-367.5(whole)-366.4(brain)-366.7(and)-365.4(in)-373(plasma)]TJ
T*
[(1)-167.8(h)-398.6(following)-386.3(systemic)-396.6(administra)10.9(tion)-396.9(of)-396(drug.)]TJ
5.9774 0 0 5.3127 476.3337 533.9904 Tm
(3)Tj
7.9702 0 0 7.9702 479.792 530.4755 Tm
(IC)Tj
5.9774 0 0 5.3127 487.3322 529.1149 Tm
-0.0001 Tc
(50)Tj
7.9702 0 0 7.9702 497.3101 530.4755 Tm
0 Tc
[(values)-399.1(against)]TJ
-23.7721 -1.1239 TD
[(whole)-259.7(blood)-254.8(tumour)-259.4(necrosis)-259.6(factor-)]TJ
/F6 1 Tf
15.9334 0 TD
(a)Tj
/F4 1 Tf
0.818 0 TD
[(\(referenc)11(es)-264.4(cited)-254.4(in)-259.2(Robichaud)]TJ
/F5 1 Tf
-16.7514 -1.131 TD
[(et)-581.8(al)]TJ
/F4 1 Tf
2.1411 0 TD
[(.)-583.9(2002b\).)-578.1(CT-2450)12(,)-583.9(\(R\)-)]TJ
/F5 1 Tf
11.2957 0 TD
(N)Tj
/F4 1 Tf
0.7327 0 TD
[(-\(4-[1-3-cycl)12.1(opentyloxy-)8.6(4-methoxy-)]TJ
-14.1694 -1.1239 TD
[(phenyl\)-2-)12.2(\(4-pyridyl\)eth)10.1(yl]phenyl\)-)]TJ
/F5 1 Tf
15.3928 0 TD
(N)Tj
/F7 1 Tf
5.5789 0 0 5.5789 436.4219 506.4377 Tm
()Tj
/F4 1 Tf
7.9702 0 0 7.9702 438.4062 503.5463 Tm
[(-ethylurea;)-546.6(PMNPQ;)-552.2(6-\(4-pyr-)]TJ
-16.3815 -1.1239 TD
[(idylmethyl)10.6(\)-8-\(3-nitro)8.9(phenyl\)quino)10.3(line.)]TJ
ET
1 i 
50.797 749.367 239.131 -0.227 re
f
BT
/F1 1 Tf
5.9774 0 0 7.9702 179.1496 761.8392 Tm
-0.0001 Tc
[(PDE4)-332.8(inhibitors)-325.8(and)-335.3(respiratory)-326.4(disease)]TJ
/F9 1 Tf
15.1373 -1.2519 TD
[(D)-337.9(Spina)]TJ
7.0982 0 0 9.4646 50.7968 751.8612 Tm
0.0001 Tc
(312)Tj
ET
50.797 40.932 239.131 -0.283 re
f
BT
/F4 1 Tf
6.0123 0 0 8.4682 50.7968 31.2378 Tm
[(British)-331.9(J)0.1(ournal)-324.5(of)-334.4(Pharmacology)-320.4(\(2008\))]TJ
/F1 1 Tf
17.6049 0 TD
(155)Tj
/F4 1 Tf
2.0462 0 TD
(308ñ315)Tj
ET

 Q
q
q 1 0 0 1 0 0 cm /Xi5 Do Q
Q


Q

q
0.0 0.0 595 794 re
W
n
1 0 0 1 0 0 cm
BT
/F1-0 12 Tf
14.4 TL
ET
1 0 0 RG
n
50 717 240 10 re
S
1 0 0 RG
n
48 704 243 13 re
S
1 0 0 RG
n
49 694 241 11 re
S
1 0 0 RG
n
48 682 242 13 re
S
1 0 0 RG
n
49 671 241 11 re
S
1 0 0 RG
n
49 661 242 10 re
S
1 0 0 RG
n
48 649 243 11 re
S
1 0 0 RG
n
48 638 243 11 re
S
1 0 0 RG
n
49 626 241 12 re
S
1 0 0 RG
n
49 616 221 10 re
S
1 0 0 RG
n
49 604 48 12 re
S
1 0 0 RG
n
117 604 170 12 re
S
1 0 0 RG
n
49 593 171 11 re
S
1 0 0 RG
n
58 582 233 11 re
S
1 0 0 RG
n
48 570 243 12 re
S
1 0 0 RG
n
49 559 242 11 re
S
1 0 0 RG
n
48 547 243 13 re
S
1 0 0 RG
n
48 536 243 13 re
S
1 0 0 RG
n
48 526 243 10 re
S
1 0 0 RG
n
49 514 242 11 re
S
1 0 0 RG
n
48 503 243 11 re
S
1 0 0 RG
n
49 492 242 11 re
S
1 0 0 RG
n
49 481 242 10 re
S
1 0 0 RG
n
49 469 241 11 re
S
1 0 0 RG
n
49 459 242 10 re
S
1 0 0 RG
n
49 447 242 11 re
S
1 0 0 RG
n
48 435 140 12 re
S
1 0 0 RG
n
199 435 92 12 re
S
1 0 0 RG
n
48 424 243 13 re
S
1 0 0 RG
n
49 413 242 11 re
S
1 0 0 RG
n
48 402 243 12 re
S
1 0 0 RG
n
48 391 116 11 re
S
1 0 0 RG
n
176 391 115 11 re
S
1 0 0 RG
n
48 379 243 13 re
S
1 0 0 RG
n
48 369 243 11 re
S
1 0 0 RG
n
49 357 242 11 re
S
1 0 0 RG
n
49 346 12 11 re
S
1 0 0 RG
n
73 346 218 11 re
S
1 0 0 RG
n
49 335 242 11 re
S
1 0 0 RG
n
49 325 242 9 re
S
1 0 0 RG
n
48 313 243 11 re
S
1 0 0 RG
n
48 301 243 13 re
S
1 0 0 RG
n
49 290 242 11 re
S
1 0 0 RG
n
49 279 242 11 re
S
1 0 0 RG
n
49 268 242 11 re
S
1 0 0 RG
n
49 257 242 10 re
S
1 0 0 RG
n
49 246 242 11 re
S
1 0 0 RG
n
49 234 125 11 re
S
1 0 0 RG
n
58 223 232 11 re
S
1 0 0 RG
n
49 212 241 12 re
S
1 0 0 RG
n
49 200 241 12 re
S
1 0 0 RG
n
49 190 242 10 re
S
1 0 0 RG
n
49 177 242 13 re
S
1 0 0 RG
n
49 167 242 11 re
S
1 0 0 RG
n
49 156 241 10 re
S
1 0 0 RG
n
49 145 241 10 re
S
1 0 0 RG
n
49 134 242 10 re
S
1 0 0 RG
n
48 122 243 11 re
S
1 0 0 RG
n
48 110 243 12 re
S
1 0 0 RG
n
48 99 243 12 re
S
1 0 0 RG
n
48 89 243 10 re
S
1 0 0 RG
n
49 78 242 10 re
S
1 0 0 RG
n
49 67 241 10 re
S
1 0 0 RG
n
48 55 243 11 re
S
1 0 0 RG
n
306 590 243 12 re
S
1 0 0 RG
n
306 581 242 12 re
S
1 0 0 RG
n
306 572 243 11 re
S
1 0 0 RG
n
306 563 242 12 re
S
1 0 0 RG
n
305 554 151 12 re
S
1 0 0 RG
n
478 554 71 12 re
S
1 0 0 RG
n
305 545 244 12 re
S
1 0 0 RG
n
306 537 243 11 re
S
1 0 0 RG
n
305 528 169 11 re
S
1 0 0 RG
n
495 528 54 11 re
S
1 0 0 RG
n
306 519 127 11 re
S
1 0 0 RG
n
439 519 109 11 re
S
1 0 0 RG
n
305 509 243 12 re
S
1 0 0 RG
n
305 500 124 13 re
S
1 0 0 RG
n
438 500 111 13 re
S
1 0 0 RG
n
306 491 141 12 re
S
1 0 0 RG
n
305 458 243 13 re
S
1 0 0 RG
n
306 447 242 12 re
S
1 0 0 RG
n
306 435 242 13 re
S
1 0 0 RG
n
306 425 242 12 re
S
1 0 0 RG
n
307 415 240 10 re
S
1 0 0 RG
n
305 402 244 13 re
S
1 0 0 RG
n
306 391 243 11 re
S
1 0 0 RG
n
306 381 242 10 re
S
1 0 0 RG
n
305 369 243 11 re
S
1 0 0 RG
n
306 358 100 11 re
S
1 0 0 RG
n
315 346 233 11 re
S
1 0 0 RG
n
307 335 240 11 re
S
1 0 0 RG
n
306 324 241 11 re
S
1 0 0 RG
n
306 312 241 12 re
S
1 0 0 RG
n
306 302 242 10 re
S
1 0 0 RG
n
306 291 242 11 re
S
1 0 0 RG
n
306 279 242 11 re
S
1 0 0 RG
n
306 268 242 11 re
S
1 0 0 RG
n
305 256 243 12 re
S
1 0 0 RG
n
306 245 242 12 re
S
1 0 0 RG
n
305 233 244 14 re
S
1 0 0 RG
n
306 223 242 11 re
S
1 0 0 RG
n
306 212 193 12 re
S
1 0 0 RG
n
306 201 242 10 re
S
1 0 0 RG
n
306 190 242 10 re
S
1 0 0 RG
n
306 179 242 10 re
S
1 0 0 RG
n
306 168 242 10 re
S
1 0 0 RG
n
305 156 97 11 re
S
1 0 0 RG
n
424 156 20 11 re
S
1 0 0 RG
n
466 156 82 11 re
S
1 0 0 RG
n
306 145 242 10 re
S
1 0 0 RG
n
306 133 242 12 re
S
1 0 0 RG
n
306 123 242 11 re
S
1 0 0 RG
n
306 110 242 12 re
S
1 0 0 RG
n
305 100 243 10 re
S
1 0 0 RG
n
306 89 242 11 re
S
1 0 0 RG
n
305 77 242 12 re
S
1 0 0 RG
n
306 66 242 11 re
S
1 0 0 RG
n
305 54 243 14 re
S
0 1 0 RG
n
270 616 16 10 re
S
0 1 0 RG
n
97 605 20 11 re
S
0 1 0 RG
n
188 437 11 10 re
S
0 1 0 RG
n
165 393 11 9 re
S
0 1 0 RG
n
61 347 11 10 re
S
0 1 0 RG
n
456 556 21 9 re
S
0 1 0 RG
n
474 529 20 10 re
S
0 1 0 RG
n
434 521 5 7 re
S
0 1 0 RG
n
429 503 9 8 re
S
0 1 0 RG
n
500 212 46 11 re
S
0 1 0 RG
n
403 156 21 11 re
S
0 1 0 RG
n
445 156 20 11 re
S
1 0.8 0 RG
n
309 605 236 124 re
S
0.619608 0.619608 0.619608 RG
n
49 28 144 12 re
S
0.619608 0.619608 0.619608 RG
n
48 748 17 14 re
S
0.619608 0.619608 0.619608 RG
n
177 759 114 13 re
S
0.619608 0.619608 0.619608 RG
n
267 749 25 13 re
S
Q


endstream
endobj
222 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
223 0 obj
<<
/BitsPerComponent 1
/DecodeParms <<
/Columns 984
/K -1
>>
/Filter /CCITTFaxDecode
/Height 500
/ImageMask true
/Subtype /Image
/Type /XObject
/Width 984
/Length 4993
>>
stream
ö2»HPÉ à˘Ù”OÈ#[Ëè)$ﬂ≠M˙◊¯Ëà¸†|ú%˝Êåœô¿ìÅâˇ˛jÎØöú_>9Õ“/ˇn-ÙEæ«˜˘–[hKësÒzÌ&“Èøó–OÜ)äÎ“€æ¥˛¯%[ÌD¬Cùè˝˚ˇA}ê£ˇËü^'˛˚Æ#˙»HÚ‹ b◊iØ˝èﬁ¬¸∑0‚π	ïÕAÎ·˝tcø‰ú.Aæ±/L<ØoMoÒˇ"Qªˇßˇ§xˇÙ≥®ÜÀˇ~©ˇ√YŒ|˙≠&ˇ‚9Ôˇàˇ"ô≈.>H˙k∑Î˝/∂”ˇˇ∑ˇ˛ÎjˇÇ#ˇ˝Ü€ùR∂ó˝à–¶+Û Ff|4kÛ!]4Û#AëXï—˝Q°£C¬aÙõIæ”NLˇ∫M”Ëú4”ˇˇ˙:i»ún¸ ëªˇÍÔ§ˇ≠ˇÊÇnáßˇOˇ_øˇ	?˚Îı˛“ˇÛ£Ωêq•µ˝øˇ˝*ÏWÏR_˛Zj◊Ó∏m&“–™j?¥“qLVI©=ÏG5¢VëpaS’1–BêçòAôY·$©7†”ÙíÔßp∞ÇKÆâ√Z–I[KA9‹∆J≈{`∑§∂∫p®Ç-¬	(Î¢>æÇJv>pø@±¬IHînTˆ’'“K¶®÷ˇ™2»‚¬	-#ΩPMÌ§ìIß§óI‡à˛˙AÑÅ√xA%øˇ◊jØ“JiljóÂK%´o–UI6íK˝&·$¥åÒø“uÿm¯A%nµ<‘È}∏Ùí∑ÁA#ıÎä–Ibî”Làd“¸¬ICP©¶õKK\tíààÌëÙøØ$ªZ_ô@§îû6Ö≠/◊$©Ÿ®á2	Îæí–"<⁄zi~eHıÑZoF«Èu§˙	.˝7ô?ˇ¬I[ˇ⁄K^≤)Å4äüGjJ√oﬂ“˛˝pÇR ãLE0”ˇ≠¥à◊0äIp“ ¿WKˆ)/$∏˛ó·Ø#⁄K7c˛∏¨^ÇOy8OKÙ•√4%˝NëøÎÆ∂’/Ë¿√ø_Ãé{pÇˇSΩ˝/’!rCAˆˇˇF¯Iı∑ˇ•ˇ¯J£∑∑˙˝µ]ó07Æª—úñÇK∏1__∂ìùïòI,–ZıÎáWk4íè•˙àËBKìÁ?Ø«D›%÷…Iü/_ÙÉ	%§Ë4˛øÈ§Ωh˘F∑ÎÆdAt⁄UºtõÙø	Î•ﬂÈˇz—π˛óo3Fˇ˝%Ùõ›R[øÂt°Ÿ[ØΩ.’‰ô™yk⁄Iqoˇ“È[KcJ¨Ü¸‘˛ΩäÈ%ö'ˇ“4“K¶‡Ù±ÆX·%TCÈ*i~wÅ‘tÖ.ûöÜ“ÙìÙí·ò,SˇFEBÙó¶öÙΩ=R[íf#ÈëhæzIqOıÍÙí™>?KÈ˝.OI7ı´~í^Ô^Ø“K†DyΩ}/ê!VíKIΩ¥øıÙæ˚È MGH%V˝Ø´˝$ªºx˛åîˇIq@…s"¶ôPŸiÑóº5Æ"=ß§UG•˙ﬁsüí_Ø≠È7Èrüˇ€¸é˜“U˙^¨kˇK©ÚHÎi˝4î∏˘ÒO¶ízˆö¶˝£®-=‘EˇtæµÈÎC˘!•≠ˇøÃÅcãˇkÙ√!ÒkÍù˙È=Q√!ti˛È Eˆ»M[KJªÛ„GÁ˙ı|S§◊Jı–im·¶º0é÷¡;Ô¯Cø“dN7ˇ•”øKÈ⁄˘@à±÷ìÎ7Î_tø⁄kØ^ﬁ˝&ù:“ˇ¯%·îÙÉJ@µ/€tèQÎın4∫ÊAoØ‡≈SiiRÈYMu! WÀ*&$´Iá«kJ©Œ»ÖÈ‘GKMÑõzH>EKKAµﬁí/W”◊M¶§:ﬁÇL>±Áe!Ñ¥Û±uH6∫ØËtía˝˝-?“Ià}s≤÷óˇI˚Óóπz§ˆ◊“ÈI …ÊL˛ªÔÈ?Ù∫…[˝'„ıøYÿ≥“K˛ñ¬¸'§ó»òOKk˘ÌÈ%ıÙ∂æˇ“¸Ê}-¸âˇ§î“◊Û∫ﬂÈo◊ˇ`ÿØK»BHA◊¸‘∞mi$5–iÓD»‡M$≥ô”KˇV&ñí_DÏW˙d{;IOéa/†öˇ<Ïªø§ï≤û/k¸å¯A∞}œID(ä}ë`zÁ∏?h"•Ùl~óÈ»0è.–J/M˙˘ŸNE˙[ní_˚˛4«$.Hi%"A(+˘tæA/“ˇ´¯˝bÇÙííø˛øˆX· óIˇ¡/¸e»tPí“	Œ¨ˇÍB@ØJˇ·,ˇÌi%_@øˇ“JDÇvñ/ˇ˙KI±X@øˇ’(Ìa˛?“J#Ç˜Ø§R&ºãÉÂè“Æ/ﬂÙíŒgÛΩÈ%@ºjh-˜§ïº øÎ.È[¬öÎ§ñ@à–`§˙H(D)$_ÎèI_W˛°(·µØI.#/¡O“JRF´/“∂ñ&=$Üñ"∏´5Ü4í∂ñzA(1X ≠ØKX@äÂ ÊªI(·_I.'Ùí‡Ç“ùúÅzH*y20ÙÇThx@óÙ®&ÙôK¡$ªËõÂ”ßÇó˙úË◊“2°o’&Ù“˘8ã˘ÿ®=7À«_≠ˇ˝'óˇ◊ˇÁƒßˇ∞µˆΩ%ˇ‚›xˇˇ˝_ÒˆìU˚_±Lq˝¨p”¥õ	q'm&)‚,SUh0Ü#ˇÛ≥ 3⁄tÃìÅò(™y`À ø.À≥9cñ9á,df¬‡–X‰8C_ód‡–g0Ê∞eê_óe¡nXÙ˚’?µ”˝u3ò~Ù◊˝=Sª≥ñ\¥ÂŸp[ñ9còs-˘v\ÂéCÉ-˘v\ÂéCÉ-˘vMÀr«Û±ŸxÏDv^≠›ˇ˝›ﬂôÃ=ﬂ~§QÓ˚_,ˇﬂ˜iØ˙ˆ∑Ÿ›[”]ˇÒ≈¨Zi¶áki≠¶á|E¢%iÈﬂŒ∆Gc!‚"#ˇƒDGŒ≈åêfy32;’÷èô›ÁÃ˘”MST’5M:5¥{jçmUQÒËˆ—Òù©åúè‰»ä#≤3∞Û√;<Gäì&›&››&ÙõJ”	™j™ö¶û¥ùÈΩˇtûù7=õ˙67‹—˘ˇˇˇˇæû∑IΩﬁùÈ∫oˇˇˇˇˇˇøˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇˇØˇˇˇˇ›	µÌ#ˇ€[_ˇˇˇ˛⁄V⁄J⁄Wkl0ñ⁄M•ˇÎˇˆïˆ+b≠ä”M6)6)äm @õKm#û⁄[≠•jö⁄™jö⁄iä∂4ÿÆ”MäMäb•†!”[Zˆ“¥‘µˇ¸∑>m<èëÆ3U˛öZ[xi~ﬁq√ØÚn"1ì<èë˝v…±ä¥∂¯lŒ>g,„>fÉ#«ç,†€É	}¥’?M8¥¸ÊÉÁ_øl#CFåÒÙxh˜ûÌ5§çˇ˙nÖI“˙™““Ø€3åŸ∆ñr3dËº^<idÜﬂ˝ÉI/ˇˇ◊	Ü”T¶öi•úA6ˇÌ–Kˇˇ˙ãˇm⁄;Áè†EÙhlŒgh—ÙÁáˇ√lWˇˇÈAˇ›&“˝&–ZUIih$üÎ´¬˚ˇˇJzˇº:_ØÎÎ\%ˇA6ëèHﬂÌ•Ø˙ˇØ˛H øˇˇ‚ˇ±±Q±˚«˜˜_·Ω/ˇˇ“Ç#ﬂÿM4◊¥¡˙⁄`Åkvè•Ø∑øˇˇJÎƒD[DGƒGÙ≠#£∂∫ˇ≠mˇa¯ÈE1Q‡æƒ(˛ÿˇç+j©$–i†≈{AÇ#ˇLKm“π â4*–Ka4i±i¨DZÒgÒBê§(DDlGm4”käIDD6íIT≥Kå´"¨´UCˇ˘ bxˇñuS;9hUdêÂC:ô”*nT3ª ï2qúâ¬e3å–!§pär8…¬fÑFÛ4id.≤ÂãyqÈé`è#b)C3.ÛΩ¡⁄kpÌn·⁄Ö∏v∞·¡YIÉWÉ˛ú4¨.Ê}œØôÛéÊ◊3π·√ü\œô›Õ¶·Û;ˇô˚ÁÎy˘Q˝3–ﬂAπ‡?\7Ü¥√s8~ìXy‡:î>xw√c•·ΩA^¸RÎ™nˇ∑£èø√zˇ·Ω#ÈÌÎ·º7˛ˇ¡÷ˇ‘d[ø˝º‹∫Gˇo1N?]wÃ5ˇﬂ7/∑πÊxœ©ºéŒººG< øŒ√/ë¬?ˇ#ëœ“áÔ¬ÔZ^ª≈ØÆªqu•Æã˝ˆ¬(O’Oã·zÈÖB”˛w|a__óºVﬂÙ±]ÈqQ[ÎÒ]ıÌÓç[¥hÒRc¬.<õ˘ò≠(∑…é[¬.9}∑Û¿˝*øıÚSZ≠|îˇ_%5’|î◊ˇΩ5Ø◊__ı˝u]{]7Õ4◊’ÎÁ@∏∫¯$.ÎÁ@æætˇ≠ÉÆ5_^=u¡◊◊èﬂ_ˆ?˘œıDü˝œnzWOÇ˝=uˆ.k„ˇ¸Ï?ˇˆ?ˇı˛ñ_•÷ˇÔû^ñ÷ó˘˙µˇˇ˛zˇˇØ£Ÿéø˙ÊΩo◊5Z¯K5ˆü•öÌt≠K™•ıˇˇ˚»˚ˇÔˇ∂∂≠§˛*BQ”ÒRòÆ9	K«!)äçäBÿÆ+bˇˇé?‚ˇ}¥Àß68¶4Ω~˛˝m}tˇT◊”øˇÌë«˚Ôn±MR‹0ÉM5M	⁄aaÑ÷MM0ÉL ÷¬¶è”M{[-””Mg^”MÖt&kñÖ\≠˘ﬂ«f1∞¡`¬∞“ﬂ´•-Eø& 3(R∫Œv_TŒƒÛ"»Å–•ƒ>E¬2£=€©À–“5Áìzµ†ümÈ.È*m“iôÛ–Ì[Í∂Î˝i=⁄M˚È.È{Qà{üÀø˜9òÀ≥œÕ£∆FEˇ˙∫Ó÷è˙Ëi÷öÖA˘‰qZéûóÕé◊o®µ]$¡Uµª@à˙›˝*o‰ﬂ˜ﬂ&9oFáZH∏Àz4„˝U}]p°ik^Ù?ˆø¸≠∆ﬁ=•÷¡Ø˙3äˇ˝ØˇˇÎﬁ†ﬂˇ[ÛŸç^øØˇÙ¶Ôˇˇ˝µ¥≠}_ˇÌ}ájC‹¬≥Íµˆ¡é8ÿØ›¥Øˆ:›é4ÿ“}UÓæ&}/øÏ±“ÓÃÛXk‚˜]ùÊ÷∂"#–à¯à≠ •ı∏à•„“N¢#VL5	*L5JÙÈ/Nı,Åbïc
¢?Œ¬ÄÃåíÄÃˇˇˇÕfhè#˘:0dÊUY8©GHÑ≤:eÇGH–ÃáŒ Y´3éÕc¶fé¬GX‡Jkw¶iÑÏ&Pö®L&T‘&T¬a?w}⁄ißIß¶™öi®MSMU4Î4=oö7¥h£\ûFåˆÊ
4=Q£=πØÕ{h÷’Q≠Õmãm˝˚§⁄∑∑JW¢9§ÿm^ú:M†D~Ω¡√Óì—ˇ˜˝tÈk]\CﬂI“Ì}◊ø´[à}SÇ#Ûø’[≠Ùø˙_ˇÿØÎJøˆø•G˛Ô÷øˇ˛]ø“ˇﬂı¬ˇˇÀ∑äçooäˇÙøÎˇˇ◊˙Îˇ˛üPDrˆ˙ˇˇ¸“øÙh™†øˇ«ÕEæﬂ7≥üÎ◊ˇ¸Cˇß˝iˇˇ˛ˇæ’µı¥ª_÷◊˝t≠~“µ^µxc€m&Î’øÀÈuìÕÔﬂ∂ë”Æø˙/◊ﬂﬂa≈Zò€I&“7∂î5mLKVëΩ¥µÌL^⁄FÙˆ“7∂ïÖ˚æ˚≈q\lS†ˆ+çä6+‰D°·0Éèçä’wOákjö√L&´⁄√L-ßÈ≠Ë5ÜòQ⁄¢Uò·∏à›ÌGî•5ª†Û›ôòáf°ƒ+,Õî¨…^vÕYÛ&lË 3∫ô—ÊwÿMu¬j°5	¶Biˆˆ≠˜¥’S[M5¥˚yü=ÁﬂõSôéh˙.;+5¥kË—F∑‹£/yéGe9|]îÂéY:ëŒE°Œ.ÅÙ⁄G«›≠#Ì;_‚”Ó„	ƒZ±p·•ØÓñ©XÎé?X"<èÊwGëüG¡)qìåúARØ•K÷ïRÎZˇOZO3Ö§ìt›6êTø◊K¬•ÑÇ‚çé™øﬁ´ZmÆ∫¡–_˝`˛Ç›$èˇ„ˇ∂8„∂í˛Î∑È*§ñ«ˇ˛øﬂˆ“BjÑ6˝$!§ñgˇ◊∑ˇˇKˇ€J¥í·Ω¥øK◊Û\ß%&íG‰ä≠TvkÌ§tÕ’È∫Æ¸≈ˇi;¥¨(#ª[[Ó‘≈∂≠§o¸üÙÌ0∫™`àˇ[≈1\S"-BlW≈1\ÑûDºÑÿπﬁdÃˆaÌ5∞ö⁄kñùaøˇè Ã∏!îfƒ>»ª$3æd·I&u À'e∆}ùÅ3°ü3±ÛÆpCΩY8ê∏MS	Ñ”	®U	·0òL&iÖPù’í&≠&ò@àÚ,v…é∞í,vÃ:¥—cª’&ì¨—?å˜ÁAØ5‡õ†„K
É§e]5·9ØFŒÇFÿ√^}Ö§8∫GÚ9•j⁄∫M–:I\â$Rm[˝Rëv_"Ï≠-Wãﬁ∑˝UiÌ~µmgP˚˙U…ª˙◊Ø—W…ƒ%˛	F∫"Ÿ7¨∑t∞´¬˜˝.”i´U√†ÿJÉAW_˝Öˇöﬂ÷ˇÉ¢«kÕö“ØÁÜí„ˇ±^óO„ﬂ˚tÈuéÇ˙HCıµ`à˝≠køﬁÙËC˝/„_˜èˇÆ⁄ˇÌ^©UŒ}≥∂ì§a$⁄F“π≈j⁄F—â#(æõH⁄7*‰“Sµ/%ì¢Ú„‰Sÿ®„¥£∫
¨U≠«ÿ[Tÿ¶uccë-∂	ZÔi¶≥÷®>ò¨4”ƒ.òØ¶ΩäÜV¬h5I5M5Üö¶M;A¶a¶Ï)êå¥ú7  

endstream
endobj
224 0 obj
<<
/BBox [ 0 0 595 794 ]
/Filter /FlateDecode
/FormType 1
/Matrix [ 1 0 0 1 0 0 ]
/Resources <<
/Font <<
/F1 120 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Subtype /Form
/Type /XObject
/Length 286
>>
stream
xúuP=o¬0›Û+ﬁ¯#)$¥SKÀÑƒ–HJ'π£ƒéÏ ‚ﬂ◊.jßvy:›È}‹{*æëX∞eõÃ%$˘ä»ÛÇ…pËì	‰]æ\dÖú!¢ò!õ·Ÿ^LgUCZg{∆q˜úWÉNïg÷t⁄Pß+ß‹ï]tGWV€û7Vs)òY¡´„¿¢ ÀDéÍäµ≠N¬&`M3ºEvﬂRÿﬁ¥`ﬁÂíãOEö}0ºa<JrΩá2M2çµ5˚…O≤ˇçë6¥y˝K€O£Õüˆ≠upßé<lãìßÏ°‹®Î∏Séiœ‰L(&ºs©aËt≠™é∞v§F}ÉÌ˚o´k2û¶Â1â’‹0¥˛R&_¸TÑ∏
endstream
endobj
225 0 obj
<<
/BitsPerComponent 8
/ColorSpace 62 0 R
/Filter /FlateDecode
/Height 99
/Width 74
/Length 426
>>
stream
HâÏWQrÖ Ù˛Ãu:”÷˜í∞õê⁄Nõd≥ªB@ëøáç“»µœ¡GÈ'Sı§∫™·g€ÿE≈… uhàæÓ|dË˜1bpD@|˙|¶P±„jÿaÔÕèØ/‚‡òG‚9Â•àT»ËÙ¯,≥ÜOÂÚ‚F®ÔØu„‰+¨Bµô?CèæI&îE§€îMŒÈE5©
sHZÇ–7ÀÏ·˙AÙ§ü…Õ=èî˙êıO#ë÷∆~òrÆr¢{ıEu-§qR¨iF¢ÈRµ¨ãí·ËÖI$ÌòZoÍÆäƒ∂†'|B°˜•≠ïËMÍDÂ°í´Î√å:—ÍH∑ÏŸ•V˙d¥kæé|¢˚›.-H]$ ≤&,ÅÆ.G‚cüöaŒÍ\%KlUó%∑màt	+ù:ñ©gg¡íS4J~n®ôÖöêAÖb«÷Y† âuüOT] âév’Ù˝hR˜©3«∂Iq7˛#ÄG=Ë>ü∏∫‡‡ü L]@™édÎ¸Nã}"”πhÇ-ˇ7®õ‡ƒŒ´‘m∑02uˇ±.> ∑Ø.k
endstream
endobj
226 0 obj
<<
/Annots [ 227 0 R 228 0 R 229 0 R 230 0 R 231 0 R 232 0 R 233 0 R 234 0 R 235 0 R 236 0 R 237 0 R 238 0 R 239 0 R 240 0 R 241 0 R 242 0 R 243 0 R ]
/Contents 244 0 R
/CropBox [ 0 0 595 794 ]
/MediaBox [ 0 0 595 794 ]
/Resources <<
/ExtGState <<
/GS1 25 0 R
>>
/Font <<
/F1 26 0 R
/F1-0 245 0 R
/F10 246 0 R
/F2 30 0 R
/F3 33 0 R
/F4 36 0 R
/F7 45 0 R
/F9 55 0 R
>>
/XObject <<
/Xi6 249 0 R
>>
/ProcSet [ /ImageB /ImageC /ImageI /PDF /Text ]
>>
/Rotate 0
/Thumb 250 0 R
/Type /Page
/Parent 2 0 R
>>
endobj
227 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib60)
/Rect [ 108 717 204 725 ]
/Subtype /Link
/Type /Annot
>>
endobj
228 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib24)
/Rect [ 54 661 131 669 ]
/Subtype /Link
/Type /Annot
>>
endobj
229 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib30)
/Rect [ 136 661 236 669 ]
/Subtype /Link
/Type /Annot
>>
endobj
230 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib29)
/Rect [ 147 492 287 501 ]
/Subtype /Link
/Type /Annot
>>
endobj
231 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib40)
/Rect [ 115 481 246 490 ]
/Subtype /Link
/Type /Annot
>>
endobj
232 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib47)
/Rect [ 54 392 117 400 ]
/Subtype /Link
/Type /Annot
>>
endobj
233 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib63)
/Rect [ 183 392 258 400 ]
/Subtype /Link
/Type /Annot
>>
endobj
234 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib84)
/Rect [ 263 392 290 400 ]
/Subtype /Link
/Type /Annot
>>
endobj
235 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib84)
/Rect [ 51 380 97 389 ]
/Subtype /Link
/Type /Annot
>>
endobj
236 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib58)
/Rect [ 270 291 290 299 ]
/Subtype /Link
/Type /Annot
>>
endobj
237 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib58)
/Rect [ 51 279 123 288 ]
/Subtype /Link
/Type /Annot
>>
endobj
238 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137tbl1)
/Rect [ 54 235 84 243 ]
/Subtype /Link
/Type /Annot
>>
endobj
239 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib6)
/Rect [ 169 201 226 209 ]
/Subtype /Link
/Type /Annot
>>
endobj
240 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib35)
/Rect [ 123 179 250 187 ]
/Subtype /Link
/Type /Annot
>>
endobj
241 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib75)
/Rect [ 240 123 290 131 ]
/Subtype /Link
/Type /Annot
>>
endobj
242 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib75)
/Rect [ 51 111 70 120 ]
/Subtype /Link
/Type /Annot
>>
endobj
243 0 obj
<<
/Border [ 0 0 0 ]
/Dest (bm\137bib11)
/Rect [ 86 55 194 64 ]
/Subtype /Link
/Type /Annot
>>
endobj
244 0 obj
<<
/Length 22618
>>
stream
q
q

BT
/F2 1 Tf
8.4682 0 0 8.4682 50.7968 718.7526 Tm
0 0 0 rg
/GS1 gs
0 Tc
0 Tw
[(tor)-621.9(agonists)-619.4(\(Parkkonen)]TJ
/F3 1 Tf
12.3519 0 TD
[(et)-619.1(al)]TJ
/F2 1 Tf
2.2093 0 TD
[(.,)-623(2007\).)-621.8(However)39.4(,)-619.5(t)0(o)-618.6(what)]TJ
-14.5612 -1.3256 TD
[(extent)-302.3(these)-294.4(findings)-300.5(translate)-302.4(into)-300(the)-296.6(clinic,)-298.8(particularly)64.7(,)-298.1(i)0(f)]TJ
T*
[(combined)-437.3(with)-436.7(bronchodilator)-438.4(drugs,)-439.3(remains)-434.6(to)-437.9(be)-430(estab-)]TJ
0 -1.3189 TD
[(lished.)-440.3(The)-439.2(clinical)-444(evidence)-439.3(suggests)-441.9(that)-440.5(PDE4)-435.2(inhibitors)]TJ
0 -1.3256 TD
[(suppress)-506.8(and)-506.2(not)-504.9(exacerbate)-505.3(inflammation)-509.4(in)-504.8(the)-504.2(air)-11.4(ways)]TJ
T*
0.0001 Tc
(\(Gamble)Tj
/F3 1 Tf
4.3382 0 TD
0 Tc
[(et)-331.2(al)]TJ
/F2 1 Tf
1.9214 0 TD
[(.,)-335.2(2003;)-339.8(Grootendorst)]TJ
/F3 1 Tf
10.4305 0 TD
[(et)-337.9(al)]TJ
/F2 1 Tf
1.9281 0 TD
[(.,)-335.2(2007\).)]TJ
/F3 1 Tf
-18.6182 -3.97 TD
[(PDE4)-339.1(inhibitors)-341(and)-334.3(the)-335(future)]TJ
/F2 1 Tf
0 -1.3256 TD
[(Although)-794.4(there)-784(is)-788.3(cause)-788.1(for)-787.8(optimism)-786(concernin)-10.4(g)-784.6(the)]TJ
T*
[(potential)-710.3(therapeutic)-705.1(utility)-709.5(of)-704.2(PDE4)-703(inhibito)-10.2(rs)-701.9(for)-707.5(the)]TJ
0 -1.3189 TD
[(treatment)-324.2(of)-315.9(respirator)-16.9(y)-318.3(diseases)-319.2(such)-318.7(as)-322.5(asthma)-318.2(and)-318.7(COPD,)]TJ
0 -1.3256 TD
[(it)-337.3(is)-333.1(clear)-334.5(that)-333.4(further)-337(improvements)-339.2(are)-332.2(requi)-8.4(red.)-328.8(Strategies)]TJ
T*
[(at)-433.8(improving)-433.5(the)-437.2(risk)-427(to)-437.9(benefit)-433.1(ratio)-429.2(will)-435.3(be)-430(important,)-441.5(if)]TJ
0 -1.3189 TD
[(this)-312.9(drug)-312.9(class)-313.8(is)-313(to)-310.7(be)-309.5(widely)-316.4(used.)-309.7(The)-312(therapeutic)-316.8(window)]TJ
0 -1.3256 TD
[(for)-359.3(anti-inflammator)-17.6(y)-358.5(action)-358.7(of)-356.1(these)-354.6(drugs)-362.1(and)-352.2(side)-360.4(effects)]TJ
T*
[(such)-358.9(as)-356(nausea)-352.1(and)-358.9(emesis)-356.6(is)-353.1(probably)-356.6(not)-357.6(wide)-357(enough)-356.3(for)]TJ
0 -1.3189 TD
[(cilomilast,)-402.9(and)-392.4(may)-401.1(limit)-399.7(the)-390.4(use)-394.7(of)-396.2(roflumilas)-12.4(t)-394.9(i)0(n)-391(asthma.)]TJ
0 -1.3256 TD
[(There)-906.5(are)-901.3(PDE4)-903.9(inhibitors)-906.2(currently)-900.2(in)-906.5(development,)]TJ
T*
[(which)-965.5(appear)-957.3(to)-966.8(lack)-962.1(significant)-959.1(emet)-7.7(ic)-959.7(action)-961.3(\(for)]TJ
T*
[(example,)-825.1(oglemilast\))-829.6(\(Glenmark)-823.1(Pharmaceuticals,)-824.9(2005\))]TJ
0 -1.3189 TD
[(and)-285.2(IPL512602)-291.7(\()5.9(Inflazyme)-291.9(pharmaceuticals,)-284(2005\),)-287.1(although)]TJ
0 -1.3256 TD
[(the)-336.8(molecular)-338.8(basis)-333.6(for)-332.6(this)-339.7(has)-329.3(not)-337.5(been)-331.7(published.)]TJ
1.0042 -1.3256 TD
[(Most)-292.3(PDE4)-294.6(inhibitors)-297(under)-300.4(development)-297.1(are)-292(designed)-295.4(for)]TJ
-1.0042 -1.3189 TD
[(p.o)-801.6(administration,)-809.5(however)40.6(,)-800.2(the)-798.7(inhaled)-801.5(route)-800(would)]TJ
0 -1.3256 TD
[(deliver)-570.6(PDE4)-569.1(inhibitor)-569.1(directly)-568.1(to)-571.8(target)-567.6(cells)-571.8(within)-566.6(the)]TJ
T*
[(lung)-782.5(and)-774(thereby)-773.7(minimize)-781.1(systemic)-779.5(absorption)-780.5(as)-777.8(in)]TJ
0 -1.3189 TD
[(the)-584.5(case)-585.4(of)-583.7(A)77.8(W)-0.1(D)-583.8(12-281)-589.4(\(N-\(3,5-dichloropyrid-4-yl\)-[1-\(4-)]TJ
0 -1.3256 TD
[(fluorobenzyl\)-5-hydroxy-indol)-18.8(e-3-yl]-glyoxylic)-851.7(acid)-843.2(amide)]TJ
T*
0.0002 Tc
(\(Kuss)Tj
/F3 1 Tf
2.7516 0 TD
0 Tc
[(et)-304.4(al)]TJ
/F2 1 Tf
1.9013 0 TD
[(.,)-301.7(2003\))-310.3(or)-300.7(UK-500001)-311(\(Phillips)]TJ
/F3 1 Tf
14.7888 0 TD
[(et)-304.5(al)]TJ
/F2 1 Tf
1.8946 0 TD
[(.,)-308.4(2007;)-306.3(V)55.2(estbo)]TJ
/F3 1 Tf
-21.3363 -1.3189 TD
[(et)-491.9(al)]TJ
/F2 1 Tf
2.0888 0 TD
[(.,)-489.2(2007\),)-494.6(although)-496.1(clinical)-497.5(trials)-491.6(in)-491.4(respirator)-16.9(y)-492.4(disease)]TJ
-2.0888 -1.3256 TD
[(have)-312.5(thus)-312.2(far)-315.1(been)-311.6(disappointing.)-320.2(Nonetheless,)-313.5(the)-310(develop-)]TJ
T*
[(ment)-434.1(of)-429.7(a)-434(potent,)-435.3(long)-428.6(acting)-437.5(PDE4)-435.2(inhibitor)-428.5(through)-437.7(the)]TJ
T*
[(inhaled)-366.3(route)-358.1(would)-366.3(offer)-359.8(a)-360.3(solution)-363.3(to)-357.5(the)-363.6(issues)-361.9(of)-362.8(emesis)]TJ
0 -1.3189 TD
[(and)-285.2(nausea.)-282(Another)-285.2(approach)-288.3(might)-282(be)-282.7(the)-283.2(use)-280.8(of)-282.4(antisense)]TJ
0 -1.3256 TD
[(oligodeoxynucleotides)-827.6(targeting)-825.9(PDE4,)-820.4(which)-824.9(could)-822.3(be)]TJ
T*
[(delivered)-397.1(by)-398.1(the)-397(inhaled)-399.8(route,)-395.1(and)-399.1(in)-397.7(view)-395.6(of)-402.9(the)-390.4(positi)-8.9(ve)]TJ
0 -1.3189 TD
[(results)-329.2(obtained)-332.2(in)-324.1(the)-323.4(successful)-334.8(targeting)-330.5(of)-322.6(the)-330.1(adenosine)]TJ
0 -1.3256 TD
[(A1)-280.8(receptor)-279.4(in)-270.5(a)-280(rabbit)-277.9(model)-277.5(of)-275.7(allergic)-280.8(inflammation)-281.8(\(Nyce)]TJ
T*
[(and)-245.1(Metzger)38.3(,)-237.9(1997\),)-246.9(illustrates)-246.1(the)-243.1(potential)-241.6(of)-242.3(this)-246(approach.)]TJ
1.0042 -1.3189 TD
[(Another)-412.4(reason)-411.1(why)-411.1(targeting)-417.5(PDE4)-408.4(alone)-414.8(may)-414.4(not)-411.2(fully)]TJ
-1.0042 -1.3256 TD
[(resolve)-300.1(air)-11.4(way)-296(inflammation)-308.5(is)-292.9(the)-296.6(fact)-298.1(that)-299.9(other)-296(PDE)-304.3(types)]TJ
T*
[(exist)-720.4(in)-719.1(structural)-723.3(and)-720.4(inflammator)-21.2(y)-720(cells)-719.1(in)-719.1(the)-718.4(lung)]TJ
0 -1.3189 TD
[(\(T)58.3(able)-578.7(1\))-580.3(and)-579.8(therefore,)-579.9(targeting)-584.9(multiple)-583(PDE)-578.8(enzymes)]TJ
0 -1.3256 TD
[(may)-414.4(be)-409.9(required)-414(for)-412.9(optimal)-417.3(anti-inflammator)-17.6(y)-412(action.)-415.8(For)]TJ
T*
[(example,)-356.4(the)-350.2(macrophage)-357(is)-353.2(viewed)-356.1(as)-349.3(a)-353.6(critical)-350.7(cell)-355.2(type)-352.3(in)]TJ
T*
[(the)-544.3(pathogenesis)-548.5(of)-543.5(COPD)-543.7(\(Barnes,)-540.9(2006b\);)-547.6(however)40.6(,)-545.8(the)]TJ
0 -1.3189 TD
[(activity)-372.4(of)-376.1(these)-368(cells)-371(is)-373.2(only)-370.7(inhibited)-376.2(to)-370.9(a)-373.7(small)-371.6(degree)-370.8(by)]TJ
0 -1.3256 TD
[(PDE4)-549(inhibitors)-544.7(\(Hatzelmann)-543.5(and)-546.3(Schudt,)-541.3(2001\))-544.6(and)-546.3(the)]TJ
T*
[(potential)-261.7(functional)-261.3(involvement)-264.2(of)-255.6(PDE3)-261.2(and)-258.5(PDE7)-261.2(in)-257.1(these)]TJ
0 -1.3189 TD
[(cells)-478.1(cannot)-476.6(be)-470.2(completely)-479.6(ignored.)-476.1(The)-479.4(inhibitor)-13.4(y)-472.3(action)]TJ
0 -1.3256 TD
[(of)-831.4(PDE4)-836.9(inhibitors)-832.6(on)-833(the)-832.2(cellular)-830.4(activity)-834.3(of)-831.4(CD8)]TJ
/F7 1 Tf
6.351 0 0 5.6449 283.918 150.8598 Tm
()Tj
/F2 1 Tf
8.4682 0 0 8.4682 50.7968 135.8929 Tm
[(T)-309.9(lymphocytes)-313.5(and)-312(macrophages)-312.5(was)-314.8(significantly)-316(increased)]TJ
0 -1.3189 TD
[(in)-491.4(the)-484.1(presence)-492.2(of)-490(PDE7)-488.8(selective)-492.5(inhibitors)-491.1(\(Smith)]TJ
/F3 1 Tf
25.5741 0 TD
[(et)-485.2(al)]TJ
/F2 1 Tf
2.0821 0 TD
(.,)Tj
-27.6562 -1.3256 TD
[(2004\).)-481.2(Similarly)65(,)-472.2(combined)-477.5(PDE3)-482.1(and)-479.4(PDE4)-475.4(inhibitor)-482.1(in)-471.4(a)]TJ
T*
[(single)-245.4(molecule)-251.8(offers)-248.4(the)-243.1(advantage)-242.8(of)-248.9(delivering)-246.5(a)-246.5(broncho-)]TJ
T*
[(dilator)-631.2(and)-626.7(anti-inflammator)-17.6(y)-633(substance.)-626(Moreover)34.3(,)-626.2(i)0(t)-625.2(i)0(s)]TJ
0 -1.3189 TD
[(likely)-291.8(that)-293.2(retention)-294(of)-289.1(the)-289.9(inhibitor)-301.3(within)-292.1(the)-296.6(lung)-287(may)-293.9(be)]TJ
0 -1.3256 TD
[(required)-387.2(to)-391(maintain)-388.1(anti-inflammator)-17.6(y)-385.3(activity)-392.4(within)-385.9(the)]TJ
T*
[(air)-11.4(ways)-338.5(\(Boswell-Smith)]TJ
/F3 1 Tf
11.1602 0 TD
[(et)-331.2(al)]TJ
/F2 1 Tf
1.9281 0 TD
[(.,)-335.2(2006b\).)]TJ
/F1 1 Tf
9.9626 0 0 9.9626 307.8424 718.7526 Tm
[(Conclu)-11.9(sion)]TJ
/F2 1 Tf
8.4682 0 0 8.4682 307.8424 696.5857 Tm
[(A)-511.4(number)-505.8(of)-510(clinical)-510.9(trials)-511.7(assessing)-509.7(the)-504.2(efficacy)-512.2(of)-510(PDE4)]TJ
0 -1.3256 TD
[(inhibitors)-437.6(for)-439.7(the)-430.5(treatment)-438.1(of)-436.4(respirator)-10.2(y)-438.8(diseases)-433(such)-439.2(as)]TJ
T*
[(asthma)-539.1(and)-539.6(COPD)-543.7(have)-533.5(been)-539.3(moderately)-539.5(successful.)-545.9(The)]TJ
0 -1.3189 TD
[(dose)-487.8(limiting)-490.7(side)-480.9(effects)-491.7(of)-483.3(nausea,)-489.5(emesis)-483.8(and)-486.1(headache)]TJ
0 -1.3256 TD
[(potentially)-435.4(limit)-439.9(the)-430.5(utility)-441.7(of)-436.4(these)-428.3(drugs.)-439.3(However)39.4(,)-438.7(there)]TJ
T*
[(are)-399.2(examples)-408.8(of)-396.2(PDE4)-408.4(inhibitors)-404.1(that)-400.3(have)-399.6(low)-399.4(emetogenic)]TJ
T*
[(potential,)-285.3(although)-288.6(the)-276.5(molecular)-291.9(basis)-280.1(of)-282.4(this)-286.2(phenomenon)]TJ
0 -1.3189 TD
[(remains)-253.8(to)-243.7(be)-249.2(established.)-248.7(Other)-251.1(strategies)-249(including)-250.4(deliver)-14.9(y)]TJ
0 -1.3256 TD
[(through)-277.1(the)-269.8(inhaled)-272.6(route,)-274.6(development)-277(of)-269(subtype)-275.6(selective)]TJ
T*
[(PDE4)-435.2(inhibitors,)-441.1(use)-434.8(of)-436.4(mixed)-432.4(PDE)-438.2(inhibitors,)-434.4(interference)]TJ
0 -1.3189 TD
[(with)-282.7(PDE4)-274.5(activation,)-286.9(targeting)-276.9(proteins)-286.1(that)-273.1(are)-278.7(involved)-283.8(in)]TJ
0 -1.3256 TD
[(locating)-369.3(PDE4)-368.3(to)-364.2(specific)-360.9(microcellular)-373.8(domains)-370.3(and)-358.9(finally)]TJ
T*
[(the)-885.8(potential)-884.3(of)-885(antisense)-887.4(oligonucleotides)-890.4(may)-889.8(offer)]TJ
0 -1.3189 TD
[(another)-462.2(solution)-463.7(to)-458(the)-457.3(problem)-460.9(of)-463.2(targeting)-464.4(PDE4)-462(in)-458(the)]TJ
0 -1.3256 TD
[(context)-336.2(of)-336(respirator)-16.9(y)-331.7(diseases,)-336.1(is)-333.1(a)-333.5(cause)-332.9(for)-339.3(optimism.)]TJ
/F1 1 Tf
9.9626 0 0 9.9626 307.8424 502.2424 Tm
[(Confli)-10.3(ct)-336.7(of)-333.7(intere)-9(st)]TJ
/F2 1 Tf
8.4682 0 0 8.4682 307.8424 480.0755 Tm
[(The)-332.1(author)-341.5(is)-333.1(a)-333.5(consultant)-336.1(for)-332.6(V)48.5(eronapharma)-338.1(plc.)]TJ
/F1 1 Tf
9.9626 0 0 9.9626 307.8424 444.9826 Tm
[(Refer)-8.4(ences)]TJ
/F2 1 Tf
7.4718 0 0 7.4718 307.8424 425.0834 Tm
0.0001 Tc
[(Aoki)-321.7(M,)-321.4(Fukun)-10.4(aga)-320.5(M,)-321.4(Sugimoto)-327.5(T)75.4(,)-315.9(H)0(irano)-330.6(Y)98.8(,)-323.5(Kobayashi)-325.5(M)0(,)-329(Honda)-324.9(K)]TJ
/F3 1 Tf
1.1988 -1.1988 TD
0 Tc
[(et)-552.6(al.)]TJ
/F2 1 Tf
2.9971 0 TD
0.0001 Tc
[(\(2001\).)-559.5(Studies)-550.7(on)-556.7(mechani)-11.6(s)0.1(ms)-555(of)-551(low)-557.3(e)0.1(metogenic)-11.5(ity)-551.5(of)]TJ
-2.9971 -1.2064 TD
[(YM976)-11.6(,)-429.7(a)-423.2(novel)-436.9(phosphodie)-10.3(sterase)-430.7(type)-427.1(4)-429.5(inhibit)-10.8(o)0(r)75.2(.)]TJ
/F3 1 Tf
25.3879 0 TD
0 Tc
[(J)-433.3(Pharmacol)]TJ
-25.3879 -1.1988 TD
0.0001 Tc
[(Exp)-337.8(Ther)]TJ
/F10 1 Tf
4.287 0 TD
(298)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-331.1(1142ñ)-11.5(1149.)]TJ
-7.2689 -1.1988 TD
0 Tc
[(Aoki)-344.5(M,)-344.3(Kobayashi)-348.3(M)-0.1(,)-344.3(Ishika)-9.6(w)-0.1(a)-337.8(J)0(,)-348.9(S)0(aita)-342.3(Y)91.1(,)-338.8(T)60.1(erai)-349.1(Y)98.7(,)-346.4(T)60.1(akayama)-347.4(K)]TJ
/F3 1 Tf
29.7735 0 TD
[(et)-340.2(al.)]TJ
/F2 1 Tf
-28.5747 -1.1988 TD
0.0001 Tc
[(\(2000\).)-498.8(A)-496.6(novel)-497.6(phosphodie)-10.3(sterase)-491.4(type)-495.4(4)-497.7(inhibitor)34.1(,)-490.4(YM976)-497.2(\()0.1(4-)]TJ
T*
0 Tc
[(\(3-chloroph)-14.2(enyl\)-1,7-dieth)-12.4(ylpyrido[2,3-d]pyrimi)-18.9(d)-0.1(in-2\(1H\)-one\),)]TJ
T*
[(with)-278.7(little)-272.2(emetogenic)-277.2(activity)62.9(.)]TJ
/F3 1 Tf
14.5377 0 TD
[(J)-274(Pharmacol)-275.3(Exp)-277.2(Ther)]TJ
/F10 1 Tf
9.6817 0 TD
0.0001 Tc
(295)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-278(255ñ260.)]TJ
-27.2013 -1.1988 TD
0 Tc
[(Ariga)-440.5(M,)-442.9(Neitzert)-444.1(B,)-445.5(Nakae)-437.4(S,)-445.7(Mottin)-441.1(G,)-443(Bertrand)-439.7(C,)-441.9(Pruni)-10.2(aux)-443.6(M)-0.1(P)]TJ
/F3 1 Tf
1.1988 -1.2064 TD
[(et)-476.7(al.)]TJ
/F2 1 Tf
2.8302 0 TD
0.0001 Tc
[(\(2004\).)-476(Nonredun)-11(dant)-472.4(function)-476.2(o)0(f)-475.1(phosphodie)-10.3(sterases)-472.3(4)0(D)]TJ
-2.8302 -1.1988 TD
0 Tc
[(and)-506.2(4)-0.1(B)-498.4(i)0(n)-504(n)-0.1(eutrophil)-501.1(recruit)-12.7(ment)-496.1(to)-503.9(the)-502.4(site)-501.1(of)-498(inflammat)-11.9(i)0(on.)]TJ
/F3 1 Tf
T*
0.0001 Tc
[(J)-334.6(I)0.1(mmunol)]TJ
/F10 1 Tf
4.9622 0 TD
(173)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(7531ñ7538.)]TJ
-7.9442 -1.1988 TD
[(Barber)-368.8(R,)-371.3(Baillie)-367.6(GS,)-367.8(B)-8.1(ergmann)-372.3(R)0(,)-363.7(S)0.1(hepherd)-374.7(MC,)-363.9(Seppe)-8(r)-366.1(R)0(,)-363.7(Hou)-9.1(slay)]TJ
1.1988 -1.1988 TD
(MD)Tj
/F3 1 Tf
2.079 0 TD
0 Tc
[(et)-332.6(al.)]TJ
/F2 1 Tf
2.5494 0 TD
[(\(2004\).)-339.6(D)-0.1(ifferential)-338.4(express)-10.8(ion)-335.8(o)-0.1(f)-331.1(PDE4)-340.6(cAMP)-336.4(phospho-)]TJ
-4.6284 -1.1988 TD
[(diesterase)-357.7(isoforms)-354.7(i)0(n)-344.6(i)0(nflammat)-11.9(ory)-359.2(cells)-348.2(of)-346.2(smokers)-353.5(with)-354.6(COPD,)]TJ
0 -1.2064 TD
0.0001 Tc
[(smokers)-391.3(without)-388.4(COPD,)-386(and)-384.7(nonsmo)-10.7(kers.)]TJ
/F3 1 Tf
20.4029 0 TD
0 Tc
[(Am)-378.6(J)-387.8(Physiol)-386.6(Lung)-387.7(Cell)]TJ
-20.4029 -1.1988 TD
[(Mol)-334.6(P)0(hysiol)]TJ
/F10 1 Tf
5.463 0 TD
0.0001 Tc
(287)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(L332ñL343.)]TJ
-8.4449 -1.1988 TD
0 Tc
[(Barnes)-836.3(PJ)-834.3(\(2006a\).)-838.7(How)-833.7(corticosteroids)-838.2(c)0(ontrol)-838.2(i)0(nflammat)-11.9(i)0(on:)]TJ
1.1988 -1.1988 TD
[(Quintiles)-344.2(Prize)-335(Lecture)-343.3(2005.)]TJ
/F3 1 Tf
13.908 0 TD
0.0001 Tc
[(Br)-336.9(J)-334.6(Pharmacol)]TJ
/F10 1 Tf
6.9578 0 TD
(148)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-331.1(245ñ254)-13.1(.)]TJ
-23.8476 -1.1988 TD
0 Tc
[(Barnes)-555.6(PJ)-561.1(\(2006b\).)-560.8(Novel)-559.9(signal)-555.8(transduction)-565(modulato)-11.7(r)0(s)-552(for)-560.6(the)]TJ
1.1988 -1.1988 TD
[(treatment)-338.9(o)-0.1(f)-338.7(air)-14.5(way)-332.1(d)-0.1(isease)-9.2(s.)]TJ
/F3 1 Tf
13.9231 0 TD
[(Pharmacol)-343.6(Ther)]TJ
/F10 1 Tf
7.3144 0 TD
0.0001 Tc
(109)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(238ñ245.)]TJ
-24.2194 -1.2064 TD
0 Tc
[(Barnes)-760.5(PJ,)-755.7(Adcock)-758.9(I)0(M,)-756.6(Ito)-749.3(K)-752.9(\()0(2005)-13.4(\).)-751.1(Histone)-756.5(acetylati)-10.2(on)-754(and)]TJ
1.1988 -1.1988 TD
[(deacetyla)-10.5(tion:)-640.9(impo)-9.8(rtance)-643.3(in)-640.5(inflammat)-11.9(ory)-655.1(l)0(ung)-638.7(disease)-9.2(s.)]TJ
/F3 1 Tf
29.3183 0 TD
0.0001 Tc
(Eur)Tj
-29.3183 -1.1988 TD
0 Tc
[(Respir)-339.3(J)]TJ
/F10 1 Tf
3.6193 0 TD
0.0001 Tc
(25)Tj
/F2 1 Tf
1.1912 0 TD
[(:)-331.1(552ñ563)-13.1(.)]TJ
-6.0093 -1.1988 TD
0 Tc
[(Bender)-428.3(A)26.9(T)82.9(,)-422.2(Beavo)-425.2(JA)-423.4(\(2006\).)-430.6(Cyclic)-430.1(nucleoti)-10.7(de)-421(phosphodie)-10.4(sterases:)]TJ
1.1988 -1.1988 TD
[(molecul)-11.3(a)0(r)-334.1(regulation)-338.4(t)0(o)-337(clinical)-340.8(use.)]TJ
/F3 1 Tf
17.3299 0 TD
[(Pharmacol)-343.6(Rev)]TJ
/F10 1 Tf
6.8364 0 TD
0.0001 Tc
(58)Tj
/F2 1 Tf
1.1912 0 TD
[(:)-331.1(4)0(88ñ5)-11.5(20.)]TJ
-26.5564 -1.1988 TD
0 Tc
[(Boolell)-474(M,)-465.7(Gepi-)-9.2(A)-0.1(ttee)-468.8(S,)-460.9(Gingell)-475.7(JC,)-467.3(A)-0.1(llen)-469.2(MJ)-471(\(1996\).)-468.6(Sild)-9.5(enafil,)-467.4(a)]TJ
1.1988 -1.1988 TD
[(novel)-292.8(effective)-289.2(o)-0.1(ral)-286.4(therapy)-287.4(f)0(or)-287.5(male)-287.8(erecti)-11(le)-280.6(dysfuncti)-11.5(on.)]TJ
/F3 1 Tf
27.0875 0 TD
0.0001 Tc
[(Br)-283.8(J)-281.5(U)0(rol)]TJ
/F10 1 Tf
-27.0875 -1.2064 TD
(78)Tj
/F2 1 Tf
1.1912 0 TD
[(:)-331.1(257ñ2)-11.5(6)0(1.)]TJ
-2.3901 -1.1988 TD
0 Tc
[(Boswell-Smit)-13.8(h)-269.7(V)133.8(,)-270.5(C)-0.1(azzola)-276.9(M,)-268.4(Page)-274.5(CP)-274.7(\(2006a\).)-277.2(A)-0.1(re)-271.7(phosphod)-10.7(iesterase)]TJ
1.1988 -1.1988 TD
[(4)-422(i)0(nhibitors)-425(just)-425(more)-420.1(t)0(heophyllin)-10.5(e?)]TJ
/F3 1 Tf
17.899 0 TD
[(J)-418.2(A)-0.1(llergy)-427.2(Clin)-421.7(Immunol)]TJ
/F10 1 Tf
10.8274 0 TD
0.0001 Tc
(117)Tj
/F2 1 Tf
1.7831 0 TD
0 Tc
(:)Tj
-30.5095 -1.1988 TD
0.0001 Tc
[(1237ñ)-11.5(1243.)]TJ
-1.1988 -1.1988 TD
[(Boswell-Smit)-13.7(h)-724.8(V)133.9(,)-725.6(S)0.1(pina)-725.9(D,)-726.1(Oxf)-10.3(ord)-724.4(A)80.1(W)96.1(,)-725.6(Comer)-728.1(MB,)-731.7(Seeds)-729.6(EA,)]TJ
1.1988 -1.1988 TD
[(Page)-911.8(CP)-904.4(\(2006b\).)-917.3(The)-908.2(pharmacolog)-12.9(y)-904.7(of)-907.6(two)-911.6(n)0(ovel)-907.3(long-)]TJ
0 -1.2064 TD
0 Tc
[(acting)-1092.7(phosphod)-10.7(iesterase)-1090.7(3/4)-1088.6(i)0(nhibitors,)-1090(RPL55)-13.2(4)-1082.1([)0(9,10)-12(-di-)]TJ
0 -1.1988 TD
[(metho)21(xy-2\()15.9(2,4)16.2(,6-t)15.7(rimet)15.3(hyl)17.8(pheny)16.7(lim)15.6(ino\)-)17.4(3)-0.1(-\()14.7(n-ca)15.4(rbamo)21.1(y)-0.1(l-2)16.4(-ami)15.6(no-)]TJ
T*
[(ethyl\))-1249.4(-)0(3,4,)-12.2(6,7-tetrahydro-2H-p)-15.2(y)-0.1(rimido[6,1-a]is)-15(oquinolin-4-one])]TJ
T*
0.0001 Tc
[(and)-1317.9(RPL565)-1322.7([6,7-dihydro-2-\(2,6-diisop)-19.5(r)0.1(opylphenox)-12.1(y\)-9,10-di-)]TJ
T*
0 Tc
[(metho)-9.3(xy-4H-pyrimido[6,1-a]i)-438.9(soquinolin-4)-15.5(-one].)]TJ
/F3 1 Tf
23.3544 0 TD
0.0001 Tc
[(J)-425.7(Pharmac)-11.6(o)0.1(l)-422.9(Exp)]TJ
-23.3544 -1.1988 TD
(Ther)Tj
/F10 1 Tf
2.337 0 TD
(318)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-331.1(840ñ8)-11.5(48.)]TJ
-5.3189 -1.1988 TD
[(Bo)23.5(us)33.8(qu)26.9(et)-240.2(J)20.2(,)-255.2(Au)26.5(bi)30.2(er)-237.8(M,)-238(Sa)23.8(s)19.1(t)0.1(r)24.1(e)-251.1(J,)-235(Iz)25.4(qu)26.9(i)16.2(e)0.1(r)27.8(d)0(o)-236.9(J)0.1(L)23.2(,)-247.6(Ad)24(l)16.2(e)0.1(r)-237.8(L)0(M)27.8(,)-255.2(Ho)29.4(f)16.8(b)0(a)23.3(u)0(e)29.1(r)-252.2(P)]TJ
/F3 1 Tf
29.9101 0 TD
-0.0173 Tc
[(et)-268.5(a)-17.4(l)10.5(.)]TJ
/F2 1 Tf
-28.7113 -1.2064 TD
0 Tc
[(\(2)23.1(0)18.1(0)-0.1(6)28.7(\))0(.)-295.8(C)18.2(om)22.5(pa)29(ri)29.3(so)27.8(n)-307.6(o)16.3(f)-309.5(r)0(o)29.6(f)16.7(lu)23.1(mi)29.9(l)16.1(a)-0.1(s)28.3(t)0(,)-297.6(a)16.8(n)-307.6(o)16.3(ra)30.1(l)-310.2(a)16.8(nt)29.5(i)16.1(-)0(i)22.9(n)18.6(fl)25.3(a)16.8(m)-0.1(m)27.6(a)0(t)27.7(o)-0.1(r)14.4(y)89.2(,)-308.4(w)-0.1(ith)]TJ
ET
1 i 
307.842 749.367 239.131 -0.227 re
f
BT
/F1 1 Tf
5.9774 0 0 7.9702 307.8424 761.8392 Tm
-0.0001 Tc
[(PDE4)-332.8(inhibitors)-335.3(and)-325.8(respiratory)-335.9(disease)]TJ
/F9 1 Tf
0 -1.2519 TD
[(D)-328.5(Spina)]TJ
7.0982 0 0 9.4646 534.1038 751.8612 Tm
0.0001 Tc
(313)Tj
ET
307.842 40.932 239.131 -0.283 re
f
BT
/F4 1 Tf
6.0123 0 0 8.4682 405.2408 31.2378 Tm
[(British)-322.5(J)0.1(ournal)-334(of)-334.4(Pharmacolog)18.7(y)-339.1(\(2008\))]TJ
/F1 1 Tf
17.5955 0 TD
(155)Tj
/F4 1 Tf
2.0462 0 TD
(308ñ315)Tj
ET

 Q
q
q 1 0 0 1 0 0 cm /Xi6 Do Q
Q


Q

q
0.0 0.0 595 794 re
W
n
1 0 0 1 0 0 cm
BT
/F1-0 12 Tf
14.4 TL
ET
1 0 0 RG
n
49 717 242 11 re
S
1 0 0 RG
n
49 705 242 11 re
S
1 0 0 RG
n
49 694 242 11 re
S
1 0 0 RG
n
48 683 243 12 re
S
1 0 0 RG
n
48 670 243 13 re
S
1 0 0 RG
n
49 660 193 11 re
S
1 0 0 RG
n
48 626 118 13 re
S
1 0 0 RG
n
49 615 241 12 re
S
1 0 0 RG
n
48 604 243 11 re
S
1 0 0 RG
n
49 593 241 10 re
S
1 0 0 RG
n
48 581 243 12 re
S
1 0 0 RG
n
48 570 243 11 re
S
1 0 0 RG
n
48 559 243 12 re
S
1 0 0 RG
n
48 548 243 12 re
S
1 0 0 RG
n
49 537 241 11 re
S
1 0 0 RG
n
49 526 242 11 re
S
1 0 0 RG
n
49 515 241 11 re
S
1 0 0 RG
n
49 503 242 11 re
S
1 0 0 RG
n
48 492 242 11 re
S
1 0 0 RG
n
48 481 242 11 re
S
1 0 0 RG
n
49 470 210 11 re
S
1 0 0 RG
n
57 459 233 11 re
S
1 0 0 RG
n
48 448 242 10 re
S
1 0 0 RG
n
48 436 242 11 re
S
1 0 0 RG
n
48 424 242 12 re
S
1 0 0 RG
n
48 414 243 11 re
S
1 0 0 RG
n
48 402 243 12 re
S
1 0 0 RG
n
49 391 241 11 re
S
1 0 0 RG
n
48 380 243 12 re
S
1 0 0 RG
n
48 368 242 12 re
S
1 0 0 RG
n
48 357 243 12 re
S
1 0 0 RG
n
49 347 242 10 re
S
1 0 0 RG
n
49 335 242 11 re
S
1 0 0 RG
n
49 324 242 11 re
S
1 0 0 RG
n
49 313 241 10 re
S
1 0 0 RG
n
48 301 243 11 re
S
1 0 0 RG
n
49 290 241 11 re
S
1 0 0 RG
n
49 279 241 11 re
S
1 0 0 RG
n
57 267 233 12 re
S
1 0 0 RG
n
48 256 243 13 re
S
1 0 0 RG
n
48 244 243 14 re
S
1 0 0 RG
n
48 233 243 14 re
S
1 0 0 RG
n
48 223 243 11 re
S
1 0 0 RG
n
49 212 242 11 re
S
1 0 0 RG
n
49 200 241 12 re
S
1 0 0 RG
n
48 188 243 13 re
S
1 0 0 RG
n
48 178 243 11 re
S
1 0 0 RG
n
48 167 243 11 re
S
1 0 0 RG
n
49 155 241 12 re
S
1 0 0 RG
n
48 144 215 13 re
S
1 0 0 RG
n
48 133 243 12 re
S
1 0 0 RG
n
48 122 243 12 re
S
1 0 0 RG
n
48 111 243 11 re
S
1 0 0 RG
n
48 100 243 11 re
S
1 0 0 RG
n
49 89 242 11 re
S
1 0 0 RG
n
48 77 243 12 re
S
1 0 0 RG
n
48 66 243 11 re
S
1 0 0 RG
n
49 55 151 10 re
S
1 0 0 RG
n
306 716 55 14 re
S
1 0 0 RG
n
306 694 241 11 re
S
1 0 0 RG
n
306 683 241 11 re
S
1 0 0 RG
n
306 672 241 11 re
S
1 0 0 RG
n
306 661 241 10 re
S
1 0 0 RG
n
305 649 244 12 re
S
1 0 0 RG
n
306 638 241 11 re
S
1 0 0 RG
n
306 626 241 12 re
S
1 0 0 RG
n
305 614 242 13 re
S
1 0 0 RG
n
306 604 242 11 re
S
1 0 0 RG
n
306 593 242 11 re
S
1 0 0 RG
n
306 582 242 11 re
S
1 0 0 RG
n
306 571 241 10 re
S
1 0 0 RG
n
306 560 242 11 re
S
1 0 0 RG
n
306 548 242 11 re
S
1 0 0 RG
n
306 537 223 11 re
S
1 0 0 RG
n
306 499 92 14 re
S
1 0 0 RG
n
306 476 201 15 re
S
1 0 0 RG
n
306 442 54 14 re
S
1 0 0 RG
n
306 422 243 11 re
S
1 0 0 RG
n
314 413 235 11 re
S
1 0 0 RG
n
314 403 235 13 re
S
1 0 0 RG
n
314 395 94 11 re
S
1 0 0 RG
n
306 386 242 11 re
S
1 0 0 RG
n
315 377 233 11 re
S
1 0 0 RG
n
315 368 227 11 re
S
1 0 0 RG
n
314 359 234 11 re
S
1 0 0 RG
n
306 350 242 11 re
S
1 0 0 RG
n
315 341 233 11 re
S
1 0 0 RG
n
315 333 232 11 re
S
1 0 0 RG
n
314 324 100 11 re
S
1 0 0 RG
n
305 314 243 11 re
S
1 0 0 RG
n
315 305 233 11 re
S
1 0 0 RG
n
315 297 232 10 re
S
1 0 0 RG
n
314 287 234 12 re
S
1 0 0 RG
n
314 279 102 10 re
S
1 0 0 RG
n
306 269 242 11 re
S
1 0 0 RG
n
314 261 209 10 re
S
1 0 0 RG
n
306 253 242 9 re
S
1 0 0 RG
n
316 243 209 10 re
S
1 0 0 RG
n
306 234 242 10 re
S
1 0 0 RG
n
315 225 233 10 re
S
1 0 0 RG
n
314 216 76 11 re
S
1 0 0 RG
n
306 207 242 10 re
S
1 0 0 RG
n
315 199 228 9 re
S
1 0 0 RG
n
306 189 242 11 re
S
1 0 0 RG
n
315 180 233 10 re
S
1 0 0 RG
n
315 171 49 11 re
S
1 0 0 RG
n
305 162 243 11 re
S
1 0 0 RG
n
315 153 233 10 re
S
1 0 0 RG
n
315 144 43 11 re
S
1 0 0 RG
n
306 135 242 11 re
S
1 0 0 RG
n
314 125 234 12 re
S
1 0 0 RG
n
314 117 234 11 re
S
1 0 0 RG
n
315 108 233 11 re
S
1 0 0 RG
n
315 98 233 13 re
S
1 0 0 RG
n
313 89 236 13 re
S
1 0 0 RG
n
314 80 235 13 re
S
1 0 0 RG
n
316 73 69 10 re
S
1 0 0 RG
n
305 63 138 12 re
S
1 0 0 RG
n
454 63 94 12 re
S
1 0 0 RG
n
316 54 232 11 re
S
0 1 0 RG
n
263 146 26 10 re
S
0 1 0 RG
n
443 65 10 9 re
S
0.619608 0.619608 0.619608 RG
n
404 29 143 11 re
S
0.619608 0.619608 0.619608 RG
n
305 760 114 11 re
S
0.619608 0.619608 0.619608 RG
n
305 749 25 12 re
S
0.619608 0.619608 0.619608 RG
n
531 749 18 13 re
S
Q


endstream
endobj
245 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
246 0 obj
<<
/BaseFont /DJCOIN+AdvStoneS-SB
/Encoding /WinAnsiEncoding
/FirstChar 32
/FontDescriptor 247 0 R
/LastChar 177
/Subtype /Type1
/Type /Font
/Widths [ 291 312 406 593 593 947 791 218 375 375 427 593 291 333 291 458 593 593 593 593 593 593 593 593 593 593 291 291 593 593 593 479 791 718 677 739 812 625 541 791 833 395 385 697 625 979 791 812 625 812 687 541 645 791 739 1072 781 697 625 354 572 354 593 500 385 552 625 520 645 520 385 572 687 343 312 625 343 1000 687 614 645 625 427 427 395 645 593 864 625 593 510 354 333 354 593 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 593 593 0 0 0 0 0 0 0 0 0 0 0 0 0 593 ]
>>
endobj
247 0 obj
<<
/Ascent 735
/CapHeight 700
/CharSet (\057eight\057zero\057one\057nine\057two\057three\057four\057five\057six\057seven)
/Descent -249
/Flags 34
/FontBBox [ -187 -250 1312 770 ]
/FontFile3 248 0 R
/FontName /DJCOIN+AdvStoneS-SB
/ItalicAngle 0
/StemV 0
/Type /FontDescriptor
/XHeight 500
>>
endobj
248 0 obj
<<
/Filter /FlateDecode
/Subtype /Type1C
/Length 1036
>>
stream
HâTíoLS≈˚
ÂΩ	÷Å<≤ˆëægD«ëLhAç¸Q
(ÖJ˚äƒ“÷∂Caòç@©•$[Hòôâ‚Ñ	õÇòH‹òl!ÆnSßì∏)∆9ô∑Ïíl∑/˚r>ú‰ú‹_Ó!D˛bA°ô9€≥Ûc“Ù5Ev≥â/ä+J_Ú„|·˚¬É¬p;∂ÜK∏Öâ¢ã¯€Ì˛WÉHh[˝ÎbàHL«∫3ÃñZkUÂ^;©ã‚÷´î…±Ç™^i"ó¶7W\Q≠ÕŒW€∏lìŒlµò≠Z;ØèÁ∏4£ë+\ ⁄∏Bﬁ∆[k7[ì¡Ω∫â´≤qZŒ WV	Y+ØÁÏV≠ûØ÷Z˜qfÉ–$ò&≠Ω l“9M≠Ö7hu<óÒ_Ω`«ˇNDàÇ_
Ù"?—fë]4NºEºO|#ÊƒoãG¸ñsR˘ÄÜ$ a-4@¥
q'+±£±H\ÿÛ˛∫¯6òÖÎø∂˛ÊƒÎ8Á‘±Rüt°å∆Q˙ã«%Éù„«ÛÂã*“‡ÆwZNªŒµ≈A}Ø˜êõ€yèÛ’|∆˝ÒÄ\ÍÎ5]`7X2Ùå=>uïÚNA»<Pr'‹@:!UóU¢@ˇAÚ≈±…˛IÊ √î âî2Ö-€≥´‹PNe˘J»IPK§êœÈHÈBu§&k[iÂŸ^˚é∑πΩ—’– 3◊46π∑6 ˙íN˙¡rÀ%ÉHˇÎ"aWtPÚœ.ÔDÀ3
¸kz1à…›˙û©îUíü◊IÓı\8}ôπ4Vû˙fÓNt
‘öÖ4$£w„©Úçùo¿ŸïÓCŒ˝
Áªº+Ωô2¬ìr˜—*èÛ y⁄›Ÿ/üz¸s,â/√∆>ÉòÈ)
ØëR(™"pN%‡∑ó≠/“®3≠Ωg≤Eø4‘‰p8d’˚ö=M≠M≤ÅXI˝…ÔÍn3¡@Ú’äŸë¿ÅÄ˛ß©ØeÈ'Í∞ µN4Rò. ¢ƒ1˝¯êa!ÍHÏÕUÃñ=’’l7$Ã=Í√~ø®¢Ô^π<uoPïæ7qcJÒO∞≤]!ıe˘—kpÜa=á)¨Ätòª9◊ Ñ∫¥òáÎŒêc_πzaH©ÙÃPIfñ°T{ÄM>ØûñOçÃ(p’b3}ªoËÍ9≈è∫˘äxyJq°jSæ˜Æ8_7çÀ10Ei„;ÓT∞yˆÿ2î»ëzæ	!$^XÅë£Iü)<‰p«‹ËÔÚ£®ê>v{¢
¿‹
&
ÚZqŸdLåYç“£ZûdÕ3∑æ¸Ù\ÎqÌ«uÇÍx}*Z©)…M÷›y:”˜˛ÕâTu∞≥°/È ¬!·π

endstream
endobj
249 0 obj
<<
/BBox [ 0 0 595 794 ]
/Filter /FlateDecode
/FormType 1
/Matrix [ 1 0 0 1 0 0 ]
/Resources <<
/Font <<
/F1 120 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Subtype /Form
/Type /XObject
/Length 286
>>
stream
xúuP=o¬0›Û+ﬁ¯#)$¥SKÀÑƒ–HJ'π£ƒéÏ ‚ﬂ◊.jßvy:›È}‹{*æëX∞eõÃ%$˘ä»ÛÇ…pËì	‰]æ\dÖú!¢ò!õ·Ÿ^LgUCZg{∆q˜úWÉNïg÷t⁄Pß+ß‹ï]tGWV€û7Vs)òY¡´„¿¢ ÀDéÍäµ≠N¬&`M3ºEvﬂRÿﬁ¥`ﬁÂíãOEö}0ºa<JrΩá2M2çµ5˚…O≤ˇçë6¥y˝K€O£Õüˆ≠upßé<lãìßÏ°‹®Î∏Séiœ‰L(&ºs©aËt≠™é∞v§F}ÉÌ˚o´k2û¶Â1â’‹0¥˛R&_¸TÑ∏
endstream
endobj
250 0 obj
<<
/BitsPerComponent 8
/ColorSpace 62 0 R
/Filter /FlateDecode
/Height 99
/Width 74
/Length 575
>>
stream
HâÏV	nƒ0‰ˇ‰;≠n;Ïm¢JK’UŒ	3‡¡àﬂ áHãõ˚9≈8»Òâ“•¯,ãµûü´ÕÔ˝‰[è≥É$#óSÇ·<Bê˜qÚÿ£Q◊i	€H€ﬂ,Á4>´akè'˝Ñ·‰ßÀ>πÕ.Úƒ· €Ï2w*z¡ı‡îÛ“$'ÂyùíŒÏ ˝IÚEv©	óë®uíJêkÊçX◊ÆìÌ‰ΩHÿuÄd€fÖŸÿÀç ¢=zyw8Uå\id~◊èﬂ=ﬁËcH9ÒÈ u‘€áR
»SèÆ]Ëå›4©¢{é‘…}Öƒä_=Aö2µfw øÊt‚BUŸI÷ÆÉ˘5_∫%éB!’Oa˙:¢˙2Ç2CÈ÷;ìÅ*e$ëñ≥Ö;§±i°xn3q¨êB}Y"”…t1U˝Í] ¢ê7Ô¥≠@<ΩÊ‹£YNvıõ¶dcÇ€.Xêsµ,I>«¥=ÄBL÷rS'˝cé”◊ÏlN§êéÜj˛s ¶ú©Ï±Gam≥í∫ÄÙ≤c™˚”±fÄ±Ù¶'¢ûC¡<;^e÷ﬂd¯∑Áﬂ∏Öhè;îùÅ8Å⁄V®›Ωâwß˘íùc$^k‡“ó9’ä+%ıWtr’∞ß‚te'e◊ZÏ–$ãÏRà±≤IJàfì°√‹#¿åƒ˜ntÒ<'∑3ÿù≈ã5&•◊y≠âVev¢Sd‹Ù≠¨'^Ta7êEv9”ù“…Dò|ãd »˝ﬂQ®Ì7äÒ3 Çkhî
endstream
endobj
251 0 obj
<<
/Contents 252 0 R
/CropBox [ 0 0 595 794 ]
/MediaBox [ 0 0 595 794 ]
/Resources <<
/ExtGState <<
/GS1 25 0 R
>>
/Font <<
/F1 26 0 R
/F1-0 253 0 R
/F10 246 0 R
/F2 30 0 R
/F3 33 0 R
/F4 36 0 R
/F7 45 0 R
/F9 55 0 R
>>
/XObject <<
/Xi7 254 0 R
>>
/ProcSet [ /ImageB /ImageC /ImageI /PDF /Text ]
>>
/Rotate 0
/Thumb 255 0 R
/Type /Page
/Annots [ ]
/Parent 2 0 R
>>
endobj
252 0 obj
<<
/Length 32032
>>
stream
q
q

BT
/F2 1 Tf
7.4718 0 0 7.4718 59.7543 718.7526 Tm
0 0 0 rg
/GS1 gs
0 Tc
0 Tw
[(beclom)-12.9(ethasone)-750.7(dipropio)-14.1(n)-0.1(ate)-751.1(in)-754.3(the)-752.8(treatment)-756.2(o)-0.1(f)-756(p)-0.1(ersiste)-9.6(nt)]TJ
0 -1.2064 TD
0.0001 Tc
[(asthma)-10(.)]TJ
/F3 1 Tf
4.0366 0 TD
0 Tc
(Allergy)Tj
/F10 1 Tf
3.3309 0 TD
0.0001 Tc
(61)Tj
/F2 1 Tf
1.1837 0 TD
0 Tc
[(:)-338.8(7)-0.1(2ñ78.)]TJ
-9.75 -1.1988 TD
[(Bundschu)-13(h)-330.4(DS,)-332.4(E)-0.1(ltze)-329.8(M,)-336.7(Barsig)-335.1(J,)-326.2(W)73.2(o)-0.1(llin)-333.9(L,)-335.8(Hatzelmann)-341.2(A)-0.1(,)-327(B)-0.1(eume)-337.8(R)]TJ
1.1988 -1.1988 TD
0.0001 Tc
(\(2001\).)Tj
/F3 1 Tf
3.7786 0 TD
0 Tc
[(In)-475.9(vivo)]TJ
/F2 1 Tf
3.6117 0 TD
[(efficacy)-483.1(in)-481.2(airw)-12.6(ay)-478.2(disease)-479.6(models)-484.6(of)-475.2(roflumi)-14.3(last,)]TJ
-7.3903 -1.1988 TD
[(a)-468.8(novel)-474.9(o)-0.1(rally)-469.5(active)-471.3(PDE4)-469.5(inhibit)-10.9(o)-0.1(r)75.1(.)]TJ
/F3 1 Tf
18.2556 0 TD
[(J)-471.3(Pharmacol)-472.6(Exp)-474.5(Ther)]TJ
/F10 1 Tf
10.4708 0 TD
0.0001 Tc
(297)Tj
/F2 1 Tf
1.7831 0 TD
0 Tc
(:)Tj
-30.5095 -1.1988 TD
0.0001 Tc
[(280ñ2)-11.5(90.)]TJ
-1.1988 -1.1988 TD
0 Tc
[(Butcher)-486.7(R)20.4(W)96(,)-482.9(S)0(utherl)-11.4(and)-483.4(E)0(W)-477.7(\()0(1962\).)-491.3(Adenosine)-487.9(3)]TJ
/F7 1 Tf
5.2302 0 0 5.2302 229.6062 667.6723 Tm
()Tj
/F2 1 Tf
7.4718 0 0 7.4718 231.4771 664.951 Tm
(,5)Tj
/F7 1 Tf
5.2302 0 0 5.2302 237.9401 667.6723 Tm
()Tj
/F2 1 Tf
7.4718 0 0 7.4718 239.8676 664.951 Tm
[(-phosph)-9.8(ate)-481.4(in)]TJ
-24.1056 -1.1988 TD
[(biologic)-12.9(a)0(l)-551.3(m)-0.1(aterials.)-558(I.)-546.2(Purification)-558.6(a)0(nd)-551.7(proper)-9.3(ties)-546.6(of)-551.1(cycl)-9.2(ic)-549.6(3)]TJ
/F7 1 Tf
5.2302 0 0 5.2302 285.7889 658.6581 Tm
()Tj
/F2 1 Tf
7.4718 0 0 7.4718 287.7165 655.9935 Tm
(,)Tj
-30.5095 -1.2064 TD
(5)Tj
/F7 1 Tf
5.2302 0 0 5.2302 64.063 649.7007 Tm
()Tj
/F2 1 Tf
7.4718 0 0 7.4718 65.9905 646.9794 Tm
[(-nucleotide)-789.2(phosphodie)-10.4(sterase)-779.8(and)-786.9(u)-0.1(se)-778.9(of)-786.3(this)-785.1(enzyme)-785.1(t)0(o)]TJ
-0.8346 -1.1988 TD
[(charac)-11(terize)-585.9(ad)-8.9(enosine)-587.8(3)]TJ
/F7 1 Tf
5.2302 0 0 5.2302 150.0661 640.7432 Tm
()Tj
/F2 1 Tf
7.4718 0 0 7.4718 151.9937 638.0219 Tm
(,5)Tj
/F7 1 Tf
5.2302 0 0 5.2302 158.4566 640.7432 Tm
()Tj
/F2 1 Tf
7.4718 0 0 7.4718 160.3275 638.0219 Tm
[(-phos)-10.3(phate)-587.1(in)-595(human)-592.6(u)-0.1(rine.)]TJ
/F3 1 Tf
14.7198 0 TD
[(J)-592.7(B)-0.1(iol)]TJ
-28.1801 -1.1988 TD
0.0001 Tc
(Chem)Tj
/F10 1 Tf
2.8984 0 TD
(237)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(1244ñ1250.)]TJ
-5.8803 -1.1988 TD
0 Tc
[(Calverley)-1222.1(PM,)-1213.9(Sanchez-T)60(oril)-1220.4(F)102.7(,)-1211.3(McIvor)-1213.7(A,)-1214.7(T)60.1(eichmann)-1214.7(P)124.3(,)]TJ
1.1988 -1.1988 TD
[(Breden)-11(broeker)-523.1(D,)-528.9(Fabbri)-521.2(L)-0.1(M)-526.2(\()0(2007\).)-529.3(E)-0.1(ffect)-534.2(of)-520.8(1-year)-531.8(treatment)]TJ
T*
[(wit)-9.1(h)-315.2(roflumilast)-323.2(in)-321.9(severe)-320.8(chronic)-327.3(obstructive)-324.1(pulmonar)-14.6(y)-320.6(disease.)]TJ
/F3 1 Tf
0 -1.2064 TD
[(Am)-340.6(J)-334.7(R)-0.1(espir)-331.8(Crit)-339.7(Care)-337.2(Med)]TJ
/F10 1 Tf
12.0718 0 TD
0.0001 Tc
(176)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(154ñ161.)]TJ
-15.0537 -1.1988 TD
[(Card)-303.6(GL,)-310.9(England)-306.6(B)0(P)123.9(,)-300.7(Suzuki)-308.5(Y)91.2(,)-300.7(Fong)-307.4(D,)-301.2(Powe)-9.7(ll)-301.6(B,)-301.3(Lee)-301.9(B)]TJ
/F3 1 Tf
26.215 0 TD
0 Tc
[(et)-302.2(al.)]TJ
/F2 1 Tf
2.4963 0 TD
0.0001 Tc
(\(2004\).)Tj
-27.5124 -1.1988 TD
0 Tc
[(Structur)-10.9(a)0(l)-513.4(b)-0.1(asis)-514.3(for)-507.5(t)0(h)-8.5(e)-509.1(activity)-513.8(of)-513.2(drugs)-515.2(t)0(hat)-511.9(i)0(nhibit)-519.2(phospho-)]TJ
T*
[(diestera)-11.8(ses.)]TJ
/F3 1 Tf
5.5389 0 TD
(Structure)Tj
/F10 1 Tf
4.1428 0 TD
0.0001 Tc
(12)Tj
/F2 1 Tf
1.1837 0 TD
[(:)-338.7(2233ñ2247.)]TJ
-12.0642 -1.1988 TD
[(Carpent)-9.2(e)0.1(r)-328.9(DO,)-331.3(Briggs)-334.3(D)-8(B)0(,)-331.6(Knox)-335.3(AP)128.6(,)-331.1(Stromin)-10.2(ger)-334.1(N)-331.9(\()0.1(1988\).)-331.9(E)0.1(xcitat)-11.8(ion)]TJ
1.1988 -1.1988 TD
0 Tc
[(of)-490.4(are)-8.6(a)-484(postrema)-497.7(n)-0.1(eurones)-492.5(b)-0.1(y)-496.3(transmitters,)-495.5(peptides)-495.4(and)-491(c)0(yclic)]TJ
T*
[(nucleot)-11.7(i)0(des.)]TJ
/F3 1 Tf
6.0017 0 TD
[(J)-327.1(N)-0.1(eur)-8.6(ophysiol)]TJ
/F10 1 Tf
6.6619 0 TD
0.0001 Tc
(59)Tj
/F2 1 Tf
1.1837 0 TD
[(:)-338.7(358ñ369.)]TJ
-15.0461 -1.2064 TD
[(Chan)-580(S)0.1(C,)-571.5(Reifsny)-10(d)0(er)-574.6(D,)-574.3(Beavo)-576.8(JA,)-579.9(H)0(anifin)-574.2(JM)-577.2(\(1993\).)-582.3(I)0.1(mmuno-)]TJ
1.1988 -1.1988 TD
0 Tc
[(che)-9(m)-0.1(ical)-449.6(characterization)-456.5(o)-0.1(f)-444.9(t)0(he)-449.3(distinct)-446.6(m)-9(onocyte)-445.2(cycl)-9.2(ic)-443.3(AMP-)]TJ
T*
[(phos)-9.5(phodiesterase)-401.4(from)-402.7(p)-0.1(atien)-9.5(ts)-395(with)-400.1(atopic)-402.2(d)-0.1(ermat)-9.7(itis.)]TJ
/F3 1 Tf
27.0799 0 TD
[(J)-395.4(A)-0.1(llergy)]TJ
-27.0799 -1.1988 TD
0.0001 Tc
[(Clin)-338.2(Immunol)]TJ
/F10 1 Tf
6.4949 0 TD
(91)Tj
/F2 1 Tf
1.1912 0 TD
[(:)-338.7(1179ñ1188.)]TJ
-8.885 -1.1988 TD
0 Tc
[(Cherr)-13.2(y)-608.9(J)0(A,)-602.7(Davis)-602.8(R)-0.1(L)-606.4(\()0(1999\).)-612.7(Cyclic)-604.6(AMP)-605.4(phosphod)-10.7(iesterases)-608.8(are)]TJ
1.1988 -1.1988 TD
[(loc)-9.6(alized)-336.4(in)-329.4(regions)-339.8(of)-338.7(the)-327.9(mouse)-339(b)-0.1(rain)-338.5(associated)-340.3(with)-331.8(reinfo)-10.6(rce-)]TJ
0 -1.2064 TD
[(ment,)-341.7(movement)-339.5(and)-339.2(affect.)]TJ
/F3 1 Tf
13.8169 0 TD
[(J)-334.7(C)-0.1(omp)-339(N)-0.1(eurol)]TJ
/F10 1 Tf
6.806 0 TD
0.0001 Tc
(407)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(287ñ301.)]TJ
-23.6048 -1.1988 TD
0 Tc
[(David)-640(M)-0.1(,)-640.2(Z)-0.1(ech)-637.5(K,)-643.9(Seiberling)-641.6(M)-0.1(,)-640.2(W)80.8(eimar)-646.4(C,)-639.2(Bethke)-634.5(TD)-638.4(\(2004\).)]TJ
1.1988 -1.1988 TD
[(Ro)-8.7(flumilast,)-471.6(a)-461.2(novel,)-464.6(oral,)-465.8(selective)-469.6(PDE4)-469.6(inhibitor)34(,)-460.2(shows)-471.1(high)]TJ
T*
[(abso)-9.6(lute)-331(bioavai)-11.8(lability)73.9(.)]TJ
/F3 1 Tf
11.442 0 TD
[(J)-334.7(A)-0.1(llergy)-336.1(Clin)-338.3(Immunol)]TJ
/F10 1 Tf
10.486 0 TD
0.0001 Tc
(113)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(S)0.1(220ñS221.)]TJ
-24.9099 -1.1988 TD
0 Tc
[(Dunker)-9.6(n)-262.1(TR,)-265.7(Feurstein)-269(D,)-263.3(Rossi)-265.5(GA,)-271.9(Sabatini)-263.1(F)102.7(,)-262.9(H)-0.1(atzelman)-10.8(n)-262.1(A)-261.4(\(2007)-13.4(\).)]TJ
1.1988 -1.1988 TD
[(Inhibi)-10(tion)-431.2(o)-0.1(f)-429.7(TGF)-9.7(-beta)-430.3(induced)-439.4(lung)-433.9(fibroblast)-438.5(to)-428.1(myofibrobla)-15.1(st)]TJ
T*
[(conve)-9.6(rsion)-386.9(b)-0.1(y)-390(phosphod)-10.7(iesterase)-392.6(inhibiting)-391(d)-0.1(rugs)-393.8(and)-392.3(activators)]TJ
0 -1.2064 TD
[(of)-338.7(soluble)-336.9(g)0(uany)-10.1(lyl)-333.8(cyclase.)]TJ
/F3 1 Tf
13.2099 0 TD
0.0001 Tc
[(Eur)-335.2(J)-334.6(Pharmac)-11.6(o)0.1(l)]TJ
/F10 1 Tf
7.4661 0 TD
(572)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(12ñ22.)]TJ
-23.658 -1.1988 TD
[(Fuhrm)-11.4(a)0.1(nn)-241.6(M,)-253.1(Jahn)-244.2(H)0(-U,)-251.1(Seybold)-255.6(J)0.1(,)-242.6(N)0(eurohr)-256.3(C,)-244.5(Barnes)-252(PJ,)-247.2(H)0(ippensti)-11.4(el)]TJ
1.1988 -1.1988 TD
0 Tc
(S)Tj
/F3 1 Tf
0.9864 0 TD
[(et)-484.3(al.)]TJ
/F2 1 Tf
2.8529 0 TD
[(\(1999\).)-491.3(I)0(dentification)-490.4(a)0(nd)-491(function)-491.4(o)-0.1(f)-482.8(c)0(yclic)-490.5(nucleotide)]TJ
-3.8393 -1.1988 TD
[(phos)-9.5(phodiesterase)-606.2(isoenzymes)-608.2(in)-595(air)-14.5(way)-605.2(e)0(pithelial)-599.2(cell)-10.6(s.)]TJ
/F3 1 Tf
28.3243 0 TD
0.0001 Tc
[(Am)-606.1(J)]TJ
-28.3243 -1.1988 TD
0 Tc
[(Respi)-10.5(r)-328.9(C)-0.1(ell)-339.1(Mol)-334.6(B)-0.1(iol)]TJ
/F10 1 Tf
9.0519 0 TD
0.0001 Tc
(20)Tj
/F2 1 Tf
1.1912 0 TD
[(:)-331.1(292ñ302)-13.1(.)]TJ
-11.442 -1.1988 TD
0 Tc
[(Gale)-421.1(DD,)-415.5(Landel)-9.7(l)0(s)-412.5(L)-0.1(J,)-414.2(Spina)-422.5(D)-0.1(,)-415.1(M)-0.1(iller)-422.7(AJ,)-413(S)0(mith)-419.3(K,)-416.3(Nichol)-10.7(s)-413.5(T)]TJ
/F3 1 Tf
29.6976 0 TD
[(et)-416(al.)]TJ
/F2 1 Tf
-28.4988 -1.2064 TD
[(\(2002\).)-324.4(Pharmacoki)-12.4(netic)-315.9(and)-308.9(pharmac)-11.1(odynamic)-321.6(p)-0.1(rofile)-319.6(following)]TJ
0 -1.1988 TD
[(oral)-597.5(administration)-596(o)-0.1(f)-596.6(t)0(he)-585.8(phosphod)-10.7(iesterase)-589.9(\(PDE\)4)-596.1(i)0(nhibit)-10.9(o)-0.1(r)]TJ
T*
0.0001 Tc
[(V1129)-13.5(4A)-334.2(in)-329.3(heal)-9.7(thy)-328.9(voluntee)-10(rs.)]TJ
/F3 1 Tf
15.342 0 TD
0 Tc
[(Br)-329.4(J)-334.7(C)-0.1(lin)-338.3(Pharmac)-11.7(ol)]TJ
/F10 1 Tf
9.1506 0 TD
0.0001 Tc
(54)Tj
/F2 1 Tf
1.1912 0 TD
[(:)-331.1(478ñ4)-11.5(84.)]TJ
-26.8827 -1.1988 TD
[(Gamble)-279.4(E)0(,)-267.4(G)0(roote)-10.1(ndorst)-273.6(DC,)-267.7(Bri)-9(g)0.1(htling)-271.4(CE,)-271.9(T)52.6(r)0.1(oy)-275.6(S,)-271.1(Qiu)-272.5(Y)91.2(,)-270.4(Zhu)-268.9(J)]TJ
/F3 1 Tf
29.8494 0 TD
0 Tc
[(et)-264.3(al.)]TJ
/F2 1 Tf
-28.6506 -1.1988 TD
[(\(2003\).)-817.6(Antiinfl)-11.5(ammator)-12(y)-813.8(effects)-814.8(of)-809.1(the)-813.5(phosphodiestera)-11.9(se-4)]TJ
T*
[(inhibit)-10.9(o)-0.1(r)-615.3(cilomilast)-636.7(\(Ariflo\))-628(i)0(n)-625.4(c)0(hroni)-12(c)-626.4(obstructive)-627.6(pulmo)-10.3(nar)-11.9(y)]TJ
T*
[(disease)-9.2(.)]TJ
/F3 1 Tf
3.8696 0 TD
[(Am)-333.1(J)-334.7(R)-0.1(espi)-10.5(r)-328.9(C)-0.1(rit)-339.8(Care)-337.2(Med)]TJ
/F10 1 Tf
12.0718 0 TD
0.0001 Tc
(168)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(976ñ982.)]TJ
-18.9233 -1.2064 TD
0 Tc
[(Gantne)-9.6(r)-404.1(F)102.7(,)-407.1(Gotz)-413.3(C)-0.1(,)-411.6(G)-0.1(ekeler)-412.8(V)133.8(,)-407.1(Schudt)-411.3(C,)-411.6(W)73.2(e)0(ndel)-409.7(A)-0.1(,)-410.5(H)-0.1(atzelman)-10.8(n)-406.3(A)]TJ
1.1988 -1.1988 TD
[(\(1998\).)-385.1(P)-0.1(h)-8.7(o)-0.1(sphodiesterase)-388.7(profile)-380.3(of)-384.2(human)-380.2(B)-380(lymphocyt)-10.8(es)-376.3(from)]TJ
T*
0.0001 Tc
[(norma)-12(l)-332.8(a)0.1(nd)-339.1(atopic)-341.4(donors)-344(a)0.1(nd)-339.1(the)-342.9(effects)-344.2(of)-338.6(PDE)-335.9(inhibit)-10.8(i)0.1(on)-335.7(on)-344.2(B)]TJ
T*
0 Tc
[(cell)-336.9(proliferat)-13.1(ion.)]TJ
/F3 1 Tf
8.4677 0 TD
0.0001 Tc
[(Br)-336.9(J)-334.6(P)0.1(harmacol)]TJ
/F10 1 Tf
6.9578 0 TD
(123)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-331.1(1)0.1(031ñ10)-13.1(38.)]TJ
-18.4074 -1.1988 TD
[(Gantne)-9.5(r)-479.9(F)102.8(,)-482.8(Kupferschmidt)-488.6(R,)-485.1(Schudt)-487.1(C,)-479.8(W)73.3(e)0.1(ndel)-485.5(A)0(,)-478.6(H)0(a)-8.1(tzelmann)-484.7(A)]TJ
1.1988 -1.1988 TD
[(\(1997a)-11.7(\).)]TJ
/F3 1 Tf
4.2642 0 TD
0 Tc
[(In)-460.7(vitro)]TJ
/F2 1 Tf
3.7862 0 TD
[(differentiation)-469.5(o)-0.1(f)-460.1(human)-456(m)-9(onocytes)-456.5(to)-466(macro-)]TJ
-8.0504 -1.2064 TD
[(phages:)-346.2(change)-342.9(of)-338.6(PDE)-343.5(profile)-342.4(and)-346.8(its)-333.4(relati)-11.1(onship)-338.9(t)0(o)-337(s)0(upp)-10.2(ression)]TJ
0 -1.1988 TD
[(of)-513.2(tumour)-515.9(necrosis)-509.3(factor-al)-11.7(pha)-506.1(release)-513.6(by)-511.4(PDE)-510.5(inhibitors.)]TJ
/F3 1 Tf
28.992 0 TD
0.0001 Tc
[(Br)-511.4(J)]TJ
-28.992 -1.1988 TD
[(Pharmac)-11.6(o)0.1(l)]TJ
/F10 1 Tf
4.985 0 TD
(121)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(221ñ231.)]TJ
-7.9669 -1.1988 TD
[(Gantne)-9.5(r)-358.5(F)102.8(,)-361.4(T)60.2(enor)-362(H,)-363.6(Gekeler)-367.2(V)141.4(,)-361.4(Sch)-8.9(udt)-356.8(C,)-365.9(W)73.3(e)0.1(ndel)-364.1(A)0(,)-357.2(H)0(atzelman)-10.7(n)-360.6(A)]TJ
1.1988 -1.1988 TD
0 Tc
[(\(1997b\).)-651.8(Phosphodiesterase)-647.7(profiles)-642(of)-642.2(highly)-643.1(purified)-643(human)]TJ
T*
0.0001 Tc
[(periphera)-12.6(l)-416.3(b)0(lood)-418(leukocyte)-421.7(populations)-422.2(from)-425.4(normal)-420.7(a)0.1(nd)-415(atopic)]TJ
0 -1.2064 TD
[(individual)-14.4(s)0.1(:)-623.1(a)-628(comparative)-633.9(study)70.2(.)]TJ
/F3 1 Tf
17.072 0 TD
0 Tc
[(J)-623(A)-0.1(llerg)-10.9(y)-621.2(C)-0.1(lin)-634.2(Immunol)]TJ
/F10 1 Tf
11.6545 0 TD
0.0001 Tc
(100)Tj
/F2 1 Tf
1.7831 0 TD
0 Tc
(:)Tj
-30.5095 -1.1988 TD
0.0001 Tc
[(527ñ5)-11.5(35.)]TJ
-1.1988 -1.1988 TD
0 Tc
[(Glenmar)-11.1(k)-1041.4(Pharm)-10.3(aceuticals)-1051.9(\(2005\).)-1052.8(GRC3886.)-1052.5(Report.)-1047.8(http://)]TJ
1.1988 -1.1988 TD
[(www)66.5(.glenmarkp)-12.8(h)-0.1(arma.com/research/clinical.html.)]TJ
-1.1988 -1.1988 TD
[(Groote)-10.2(ndorst)-554.5(DC,)-556.2(Gauw)-564.1(SA,)-555.4(V)50.3(erhoosel)-554.1(RM,)-559(Sterk)-555.9(PJ,)-558.4(Hospers)-560.3(JJ,)]TJ
1.1988 -1.1988 TD
[(Breden)-11(broker)-272(D)]TJ
/F3 1 Tf
7.5951 0 TD
[(et)-279.5(al.)]TJ
/F2 1 Tf
2.4356 0 TD
0.0001 Tc
[(\(2007\).)-278.8(R)0(educ)-10.6(tion)-271.8(i)0.1(n)-276.2(s)0.1(putum)-279(neutroph)-9.7(il)-271.2(and)]TJ
-10.0307 -1.1988 TD
0 Tc
[(eosinoph)-12.1(il)-316.8(number)-9.8(s)-314.8(by)-321.8(the)-320.3(PDE)-9.7(4)-315.7(i)0(nhibitor)-330.2(r)0(oflumilast)-330.8(in)-314.3(patien)-9.5(ts)]TJ
0 -1.2064 TD
0.0001 Tc
[(wit)-9(h)-330.3(COPD.)]TJ
/F3 1 Tf
6.0093 0 TD
0 Tc
(Thorax)Tj
/F10 1 Tf
3.4675 0 TD
0.0001 Tc
(62)Tj
/F2 1 Tf
1.1912 0 TD
[(:)-338.7(1081ñ1087.)]TJ
-11.8669 -1.1988 TD
0 Tc
[(Gross)-635.9(PM,)-629.6(W)80.8(all)-633.8(KM,)-626.7(Pang)-634.5(JJ,)-624.7(Shaver)-629.8(SW)95.2(,)-627.1(W)73.2(ainman)-635(D)-0.1(S)-623.4(\()0(1990)-13.4(\).)]TJ
1.1988 -1.1988 TD
[(Microv)-11.3(ascular)-1311.1(specializations)-1315.1(promotin)-11.3(g)-1302.8(rapid)-1310.3(interstitial)]TJ
T*
[(sol)-9.1(u)-0.1(te)-430.6(dispersion)-441.8(i)0(n)-428.1(nucleus)-437.7(tractus)-442.2(s)0(olitarius.)]TJ
/F3 1 Tf
22.4364 0 TD
[(Am)-431.7(J)-433.3(P)-0.1(hysiol)]TJ
/F10 1 Tf
6.2901 0 TD
0.0001 Tc
(259)Tj
/F2 1 Tf
1.7831 0 TD
0 Tc
(:)Tj
-30.5095 -1.1988 TD
0.0001 Tc
[(R1131)-13.1(ñR1138.)]TJ
-1.1988 -1.1988 TD
[(Haddad)-387(JJ,)-381.8(Land)-381.7(SC,)-381.8(T)60.2(arnow-Mordi)-389.5(WO,)-379(Zembala)-384.7(M,)-382.1(Kowalczyk)-385.4(D,)]TJ
1.1988 -1.2064 TD
0 Tc
[(Lauter)-10.5(bach)-341.6(R)-343.8(\()0(2002\).)-347.2(I)0(mmunopharmacol)-17.6(ogical)-346.1(potential)-345.5(of)-338.7(selec-)]TJ
0 -1.1988 TD
[(tive)-613(phosphodie)-10.4(sterase)-605.3(inhibition)-12.8(.)-604.3(I.)-606.9(Differential)-619.2(regulation)-611.5(o)-0.1(f)]TJ
34.4019 87.6058 TD
[(lipopolysa)-12.1(ccharide-medi)-12.7(a)-0.1(ted)-780.3(proinflamm)-12.9(a)-0.1(tor)-11(y)-783.4(cytokine)-788.8(\(inter-)]TJ
0 -1.2064 TD
[(leukin-6)-306.7(a)0(nd)-301.3(tumor)-302.9(nec)-9(r)0(osis)-303.1(factor-alpha\))-308(b)-0.1(iosynthesis)-304.9(in)-299.1(alveola)-11.3(r)]TJ
0 -1.1988 TD
[(epitheli)-10(al)-331.3(cells.)]TJ
/F3 1 Tf
7.3827 0 TD
[(J)-334.7(Pharmacol)-343.6(Exp)-337.9(T)-0.1(her)]TJ
/F10 1 Tf
9.9397 0 TD
0.0001 Tc
(300)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-331.1(559ñ566.)]TJ
-20.3043 -1.1988 TD
0 Tc
[(Hansen)-293.9(G,)-298.9(Jin)-286.5(S,)-294(Umetsu)-299.5(DT)82.4(,)-293.2(Conti)-291.5(M)-293.9(\(2000\).)-301.6(Absence)-291.1(of)-293.1(m)-9(u)-0.1(scarinic)]TJ
1.1988 -1.1988 TD
[(choliner)-11.8(gic)-691.4(air)-14.5(way)-696.3(responses)-695.6(in)-693.6(mice)-695.8(deficient)-696.4(i)0(n)-693.6(t)0(he)-692.1(cycl)-9.2(i)0(c)]TJ
T*
0.0001 Tc
[(nucleoti)-10.6(de)-390.6(phosphod)-10.6(iesterase)-392.5(PDE4D.)]TJ
/F3 1 Tf
18.3391 0 TD
0 Tc
[(Proc)-396.2(Natl)-396.6(A)-0.1(cad)-394.6(Sci)-399.7(USA)]TJ
/F10 1 Tf
10.9792 0 TD
(97)Tj
/F2 1 Tf
1.1912 0 TD
(:)Tj
-30.5095 -1.1988 TD
0.0001 Tc
[(6751ñ)-11.5(6756.)]TJ
-1.1988 -1.1988 TD
0 Tc
[(Harbinson)-461(P)-0.1(L,)-461.8(MacLeo)-12.1(d)-450.7(D)-0.1(,)-460.6(H)-0.1(awksw)-9.8(orth)-456.8(R,)-454.9(OíT)53(oole)-460.2(S)0(,)-453.3(Sullivan)-465.6(PJ,)]TJ
1.1988 -1.2064 TD
[(Heath)-373.9(P)]TJ
/F3 1 Tf
4.158 0 TD
[(et)-378.1(al.)]TJ
/F2 1 Tf
2.6329 0 TD
[(\(1997\).)-377.5(The)-369.6(effect)-378.6(of)-369(a)-370.2(novel)-376.3(orally)-378.4(active)-372.7(selective)]TJ
-6.7908 -1.1988 TD
0.0001 Tc
[(PDE4)-727.4(isoenzyme)-725.8(i)0.1(nhibit)-10.8(o)0(r)-721.5(\()0.1(CDP840\))-726.5(on)-723.6(allergen-in)-13(duced)-724.5(re-)]TJ
T*
0 Tc
[(sponses)-343.9(in)-329.4(asthma)-10.1(tic)-333.9(subjects.)]TJ
/F3 1 Tf
14.4543 0 TD
0.0001 Tc
[(Eur)-335.2(Respir)-339.2(J)]TJ
/F10 1 Tf
5.4327 0 TD
(10)Tj
/F2 1 Tf
1.1837 0 TD
[(:)-338.7(1008ñ1014.)]TJ
-22.2694 -1.1988 TD
[(Hatzelman)-10.7(n)-421.3(A)0(,)-433.1(Schudt)-426.4(C)-429.4(\()0.1(2001\).)-430.5(Anti-i)-10.7(nflammator)-21(y)-419.1(and)-430.2(i)0.1(mmuno)-12.7(-)]TJ
1.1988 -1.1988 TD
[(modul)-10.2(ator)-10.9(y)-593.6(potential)-595.8(of)-596.5(the)-593.3(novel)-596.2(PDE)-9.6(4)-588.8(i)0.1(nhibitor)-603.3(r)0.1(oflumilast)]TJ
/F3 1 Tf
T*
0 Tc
[(in)-335.8(vitro)]TJ
/F2 1 Tf
3.164 0 TD
(.)Tj
/F3 1 Tf
0.6222 0 TD
0.0001 Tc
[(J)-334.6(Pharmacol)-343.5(Exp)-337.8(Ther)]TJ
/F10 1 Tf
9.9321 0 TD
(297)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(267ñ279.)]TJ
-16.7002 -1.2064 TD
[(Heystek)-546.5(HC,)-542.7(Thierr)-15.8(y)-548.1(AC,)-543.9(Soulard)-548.6(P)124.4(,)-543.5(Moulon)-545.4(C)-543.2(\()0.1(2003\).)-551.9(Phospho-)]TJ
1.1988 -1.1988 TD
0 Tc
[(diesterase)-334.9(4)-338.5(i)0(nhibitors)-333.9(reduce)-337.3(human)-334.6(dendritic)-337.9(cell)-336.9(inflammator)-20.2(y)]TJ
T*
0.0001 Tc
[(cytoki)-9.9(ne)-300.6(production)-313.4(a)0.1(nd)-308.8(Th1-polarizing)-316.7(capacity)70.4(.)]TJ
/F3 1 Tf
23.5138 0 TD
[(Int)-302.1(I)0.1(mmunol)]TJ
/F10 1 Tf
5.8045 0 TD
0 Tc
(15)Tj
/F2 1 Tf
1.1912 0 TD
(:)Tj
-30.5095 -1.1988 TD
0.0001 Tc
[(827ñ8)-11.5(35.)]TJ
-1.1988 -1.1988 TD
0 Tc
[(Holgate)-365.3(ST)-365.5(\(2007\).)-369.9(E)0(pithelium)-372.5(d)-0.1(ysfuncti)-11.5(on)-359.5(in)-367.4(asthma.)]TJ
/F3 1 Tf
26.086 0 TD
[(J)-357.5(A)-0.1(llerg)-10.9(y)-363.2(C)-0.1(lin)]TJ
-24.8871 -1.1988 TD
0.0001 Tc
(Immunol)Tj
/F10 1 Tf
4.2945 0 TD
(120)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(1233ñ1244.)]TJ
-7.2765 -1.1988 TD
0 Tc
[(Houslay)-490.1(MD,)-481.3(Baillie)-489.1(GS,)-489.3(M)-0.1(aurice)-488.3(DH)-480.7(\(2007\).)-491.3(c)0(AMP-Specific)-490.6(phos)-9.5(-)]TJ
1.1988 -1.2064 TD
[(phod)-8.8(iesterase-4)-238.7(enzymes)-242.5(i)0(n)-238.4(t)0(he)-236.8(cardiovascular)-248.3(system:)-240.6(a)-233.6(molecular)]TJ
0 -1.1988 TD
[(toolb)-9.8(o)-0.1(x)-458.7(f)0(or)-454.4(genera)-11.1(ting)-452.8(c)0(ompa)-13.2(rtmentalized)-459.4(cAMP)-465.4(signaling.)]TJ
/F3 1 Tf
29.0375 0 TD
(Circ)Tj
-29.0375 -1.1988 TD
0.0001 Tc
(Res)Tj
/F10 1 Tf
1.7831 0 TD
(100)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(950ñ966.)]TJ
-4.765 -1.1988 TD
0 Tc
[(Houslay)-915(MD,)-913.8(Schafer)-918.9(P)124.3(,)-915.4(Zhang)-913.4(KY)-912.1(\(2005\).)-923.8(K)-0.1(eynote)-915.1(review:)]TJ
1.1988 -1.1988 TD
[(phosphod)-10.7(iesterase-4)-557.4(as)-555.9(a)-559.8(t)0(herapeutic)-559.9(target.)]TJ
/F3 1 Tf
22.0418 0 TD
0.0001 Tc
[(Drug)-559.3(Discov)-552.1(T)60.9(o)0.1(day)]TJ
/F10 1 Tf
-22.0418 -1.1988 TD
(10)Tj
/F2 1 Tf
1.1912 0 TD
[(:)-331.1(1503ñ)-11.5(1519.)]TJ
-2.3901 -1.2064 TD
0 Tc
[(Inflazyme)-1313.8(pharmac)-11.1(euticals)-1307.4(\(2005\).)-1310.8(I)0(PL512,)-15.3(602.)-1308.6(http://www)64.9(.)]TJ
1.1988 -1.1988 TD
0.0001 Tc
[(inflazy)-10.7(me.com/IPL512)-15.9(602.php.)]TJ
-1.1988 -1.1988 TD
0 Tc
[(Jones)-434.8(NA,)-431.2(Boswell-Smit)-13.8(h)-429(V)133.8(,)-429.8(L)-0.1(ever)-434.8(R,)-432.1(Page)-433.8(CP)-434.1(\(2005\).)-438.2(The)-430.3(effec)-10(t)-429.3(o)-0.1(f)]TJ
1.1988 -1.1988 TD
[(selective)-454.5(phosphod)-10.7(iesterase)-453.3(isoenzyme)-452.7(i)0(nhibition)-460.4(o)-0.1(n)-450.6(n)-0.1(eutrophil)]TJ
T*
0.0001 Tc
[(functi)-10.5(on)]TJ
/F3 1 Tf
4.378 0 TD
0 Tc
[(in)-335.8(vitro)]TJ
/F2 1 Tf
3.164 0 TD
(.)Tj
/F3 1 Tf
0.6222 0 TD
0.0001 Tc
[(Pulm)-340.9(Pharmacol)-335.9(The)-9.9(r)]TJ
/F10 1 Tf
9.9245 0 TD
(18)Tj
/F2 1 Tf
1.1912 0 TD
[(:)-331.1(93ñ10)-11.5(1.)]TJ
-20.4788 -1.1988 TD
[(Jones)-260.2(NA,)-256.6(Leport)-256.1(M)0(,)-253.1(Holand)-263.3(T)83(,)-247.6(V)50.4(os)-260.4(T)83(,)-255.2(Morgan)-256.6(M,)-253.1(Fink)-258.8(M)]TJ
/F3 1 Tf
26.3136 0 TD
0 Tc
[(et)-256.7(al.)]TJ
/F2 1 Tf
2.3901 0 TD
0.0001 Tc
(\(2007\).)Tj
-27.5048 -1.1988 TD
0 Tc
[(Phosph)-10.6(odiesterase)-508.2(\(PDE\))-508(7)-505.4(i)0(n)-504(i)0(nflammat)-11.9(ory)-511(c)0(ells)-507.5(from)-508.9(p)-0.1(atients)]TJ
0 -1.2064 TD
0.0001 Tc
[(with)-339.3(asthma)-336.3(and)-339.1(COPD.)]TJ
/F3 1 Tf
11.8593 0 TD
[(Pulm)-333.3(Pharmac)-11.6(ol)-331.8(Ther)]TJ
/F10 1 Tf
9.9245 0 TD
(20)Tj
/F2 1 Tf
1.1837 0 TD
[(:)-338.7(60ñ68.)]TJ
-24.1663 -1.1988 TD
[(Kanehir)-9.7(o)-302.2(A,)-311.7(Ikemura)-310.7(T)83(,)-300.7(M)0(akela)-314.8(MJ,)-308.8(L)0(ahn)-306.9(M)0(,)-306.3(J)0.1(oetham)-313.7(A,)-304.1(Dakhama)-313.7(A)]TJ
/F3 1 Tf
1.1988 -1.1988 TD
0 Tc
[(et)-347.7(al.)]TJ
/F2 1 Tf
2.5798 0 TD
[(\(2001\).)-354.7(I)0(nhibition)-350.1(o)-0.1(f)-346.2(phosphod)-10.7(iesterase)-347.1(4)-346.1(attenua)-10.7(tes)-342.7(air)-14.5(way)]TJ
-2.5798 -1.1988 TD
[(hyperres)-10.3(ponsiveness)-645.5(and)-642.7(air)-14.5(way)-643.2(i)0(nflammat)-11.9(i)0(on)-646.9(in)-640.5(a)-643.3(model)-647.9(o)-0.1(f)]TJ
T*
[(secondar)-22.2(y)-601.3(allergen)-608.6(challenge.)]TJ
/F3 1 Tf
15.0233 0 TD
[(Am)-613.8(J)-600.3(R)-0.1(espir)-612.5(Crit)-605.3(Care)-610.3(M)-0.1(ed)]TJ
/F10 1 Tf
13.7031 0 TD
0.0001 Tc
(163)Tj
/F2 1 Tf
1.7831 0 TD
0 Tc
(:)Tj
-30.5095 -1.1988 TD
0.0001 Tc
[(173ñ1)-11.5(84.)]TJ
-1.1988 -1.2064 TD
[(Kohyama)-338.1(T)83(,)-323.5(Liu)-330.4(X)0(,)-329.8(Zhu)-329.6(YK)-9.1(,)-323.5(W)73.3(en)-331(FQ,)-326.8(W)73.3(ang)-333.8(HJ,)-328.3(F)0(ang)-329.7(Q)]TJ
/F3 1 Tf
26.1618 0 TD
0 Tc
[(et)-332.6(al.)]TJ
/F2 1 Tf
2.5418 0 TD
0.0001 Tc
(\(2002\).)Tj
-27.5048 -1.1988 TD
0 Tc
[(Phosph)-10.6(odiesterase)-910.3(4)-900(i)0(nhibitor)-899.3(cilomilast)-909.8(inhibit)-10.8(s)-899.1(fibroblast-)]TJ
T*
[(media)-10(ted)-562(col)-9.6(lagen)-569(gel)-566.6(degra)-9.2(d)-0.1(ation)-569(i)0(nduced)-576(by)-564.6(tumor)-576(necrosis)]TJ
T*
[(factor-al)-11.7(pha)-346.8(and)-354.4(n)-0.1(eutroph)-9.8(il)-347.2(elastase.)]TJ
/F3 1 Tf
17.6334 0 TD
[(Am)-348.2(J)-349.9(R)-0.1(espi)-10.5(r)-344.1(Cell)-354.3(Mol)-349.8(B)-0.1(iol)]TJ
/F10 1 Tf
11.6848 0 TD
(27)Tj
/F2 1 Tf
1.1912 0 TD
(:)Tj
-30.5095 -1.1988 TD
0.0001 Tc
[(487ñ4)-11.5(94.)]TJ
-1.1988 -1.1988 TD
[(Kumar)-337.6(RK,)-342.6(Herbert)-339.3(C,)-335.6(Thomas)-340.5(PS,)-336.4(W)73.3(ollin)-341.4(L,)-335.7(Beume)-337.7(R,)-333.4(Y)76(a)0.1(ng)-333.8(M)]TJ
/F3 1 Tf
29.7811 0 TD
0 Tc
[(et)-332.6(al.)]TJ
/F2 1 Tf
-28.5823 -1.1988 TD
[(\(2003\).)-278.9(I)0(nhibition)-274.3(o)-0.1(f)-270.4(i)0(nflammat)-11.9(ion)-267.5(and)-270.9(remodeling)-279.5(b)-0.1(y)-268.6(r)0(oflumilast)]TJ
0 -1.2064 TD
0.0001 Tc
[(and)-430.2(d)0(examethas)-11.4(one)-428.4(in)-428(murine)-424.9(c)0.1(hroni)-12(c)-421.4(a)0(sthma)-10(.)]TJ
/F3 1 Tf
23.3469 0 TD
[(J)-425.7(Pharm)-12.7(acol)-429.4(Exp)]TJ
-23.3469 -1.1988 TD
(Ther)Tj
/F10 1 Tf
2.337 0 TD
(307)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-331.1(349ñ3)-11.5(55.)]TJ
-5.3189 -1.1988 TD
[(Kung)-489.4(TT)82.4(,)-490.4(C)0(rawley)-490(Y)91.2(,)-490.4(Luo)-489.5(B,)-491(Y)83.6(oung)-494.2(S,)-483.6(Kreut)-9.1(n)0(er)-484.7(W)96.1(,)-490.4(Chapman)-491.5(R)20.5(W)]TJ
1.1988 -1.1988 TD
[(\(2000\).)-293.9(I)0.1(nhibi)-9.9(tion)-286.9(o)0(f)-293(pulmonar)-14.5(y)-290.1(eosinophilia)-295.9(and)-293.6(airw)-12.5(ay)-288.4(hyperre-)]TJ
T*
0 Tc
[(sponsiven)-11.3(ess)-827.6(in)-837.8(allergic)-834.6(mice)-832.4(by)-837.7(rolipram:)-835.3(i)0(nvolvemen)-11.6(t)-831.4(o)-0.1(f)]TJ
T*
[(endogenous)-12(ly)-539.7(released)-546.9(corticosterone)-549(and)-544.1(c)0(atecholam)-13.3(ines.)]TJ
/F3 1 Tf
28.9616 0 TD
0.0001 Tc
[(Br)-541.8(J)]TJ
-28.9616 -1.2064 TD
0 Tc
[(Pharmac)-11.7(ol)]TJ
/F10 1 Tf
4.985 0 TD
0.0001 Tc
(130)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-331.1(457ñ4)-11.5(63.)]TJ
-7.9669 -1.1988 TD
0 Tc
[(Kuss)-426.9(H)-0.1(,)-416.8(Hoefgen)-427.5(N,)-420.3(Johanssen)-422.2(S,)-423(Kronbach)-431.5(T)82.9(,)-414.6(Rund)-9.9(feldt)-415.3(C)-421.9(\(2003\).)]TJ
/F3 1 Tf
1.1988 -1.1988 TD
[(In)-377.3(vivo)]TJ
/F2 1 Tf
3.4144 0 TD
[(efficacy)-376.9(in)-375(air)-14.5(way)-377.6(d)-0.1(isease)-381(models)-378.4(of)-384.2(N-\(3,5-dichloropyr)-16.7(i)0(d-)]TJ
-3.4144 -1.1988 TD
[(4-yl\)-)-9.8([1-\(4-fluorobenzyl\))-16(-)0(5-hydroxy-indole-3)-18(-yl]-glyo)-1078.2(xylic)-1078.6(acid)]TJ
T*
[(amide)-472.9(\()0(A)85(W)-0.1(D)-465.9(12ñ28)-11.6(1\),)-467.3(a)-468.8(selective)-469.6(phosphod)-10.7(iesterase)-468.5(4)-467.5(i)0(nhibitor)]TJ
T*
[(for)-340.6(i)0(nhaled)-334.5(administra)-13.1(tion.)]TJ
/F3 1 Tf
13.1416 0 TD
[(J)-334.7(Pharmacol)-336(Exp)-337.9(Ther)]TJ
/F10 1 Tf
9.9321 0 TD
0.0001 Tc
(307)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(373ñ385.)]TJ
-26.0556 -1.2064 TD
[(Lamontagne)-361.2(S)0.1(,)-347(M)0(eadows)-357(E,)-350.9(Luk)-348.4(P)124.4(,)-353.8(Normandin)-357.5(D)0(,)-354.3(Muise)-350.9(E,)-350.8(Boulet)-352.9(L)]TJ
/F3 1 Tf
1.1988 -1.1988 TD
0 Tc
[(et)-370.5(al.)]TJ
/F2 1 Tf
2.6253 0 TD
[(\(2001\).)-369.9(Local)-12.5(ization)-370.3(o)-0.1(f)-369(phosphod)-10.7(iesterase-4)-375.3(isoforms)-369.9(i)0(n)-375(t)0(he)]TJ
-2.6253 -1.1988 TD
[(medulla)-442.1(and)-430.3(nodose)-441.5(ganglion)-438.8(o)-0.1(f)-429.7(t)0(h)-8.5(e)-425.7(squirr)-10.1(el)-432.3(monkey)67.2(.)]TJ
/F3 1 Tf
26.5412 0 TD
[(Brain)-442.8(Res)]TJ
/F10 1 Tf
-26.5412 -1.1988 TD
0.0001 Tc
(920)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(84ñ96.)]TJ
-2.9819 -1.1988 TD
0 Tc
[(Landells)-1127.9(LJ,)-1119.9(Szilagyi)-1121.1(C,)-1124.8(Orr)-1119.1(LM,)-1122.8(Petersen)-1121.1(B)-0.1(,)-1120.8(A)-0.1(llen)-1121.7(J)0(M,)]TJ
1.1988 -1.1988 TD
0.0001 Tc
[(OíConn)-10.9(or)-516.6(BJ)]TJ
/F3 1 Tf
6.7301 0 TD
0 Tc
[(et)-514.7(al.)]TJ
/F2 1 Tf
2.9212 0 TD
[(\(2000\).)-521.7(I)0(dentifi)-11.2(cation)-517.1(and)-521.3(quanti)-9.3(fication)-522.2(of)]TJ
-9.6513 -1.1988 TD
0.0001 Tc
[(phosphod)-10.6(iesterase)-286.3(\(PDE\)4)-292.5(s)0.1(ubtypes)-292(i)0.1(n)-283.8(CD4)-290.3(and)-286(CD8)-282.7(lym)-9.8(phocytes)]TJ
0 -1.2064 TD
0 Tc
[(from)-463.4(h)-0.1(ealthy)-460.1(and)-453(asthmatic)-465.3(subjects.)]TJ
/F3 1 Tf
18.4605 0 TD
[(Am)-454.5(J)-456.1(R)-0.1(espir)-460.7(Crit)-453.6(Care)-458.6(M)-0.1(ed)]TJ
/F10 1 Tf
-18.4605 -1.1988 TD
0.0001 Tc
(161)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(A200.)]TJ
-2.9819 -1.1988 TD
0 Tc
[(Leclerc)-273.4(O,)-277.9(Lagent)-9.8(e)-281.5(V)141.3(,)-285.7(Planquois)-284.2(J)0(M,)-278.6(Bertheli)-10.5(er)-275.8(C,)-282.6(Artola)-286.6(M,)-276(Eichholtz)]TJ
1.1988 -1.1988 TD
(T)Tj
/F3 1 Tf
1.0243 0 TD
[(et)-469.1(al.)]TJ
/F2 1 Tf
2.8226 0 TD
0.0001 Tc
[(\(2006\).)-476(I)0.1(nvolvem)-10.2(ent)-471.9(o)0(f)-467.5(MMP-12)-480.9(a)0.1(nd)-468.1(phosphod)-10.6(iesterase)]TJ
-3.8469 -1.1988 TD
0 Tc
[(type)-579(4)-581.3(in)-579.8(cigarett)-10.6(e)-577.4(s)0(moke-induced)-590.8(inflammation)-590.5(i)0(n)-579.8(m)-0.1(ice.)]TJ
/F3 1 Tf
29.3183 0 TD
0.0001 Tc
(Eur)Tj
-29.3183 -1.1988 TD
0 Tc
[(Respir)-339.3(J)]TJ
/F10 1 Tf
3.6193 0 TD
0.0001 Tc
(27)Tj
/F2 1 Tf
1.1912 0 TD
[(:)-331.1(1102ñ11)-13.1(09.)]TJ
-6.0093 -1.2064 TD
0 Tc
[(Lehnart)-382.3(SE,)-382(W)73.2(ehrens)-379.4(XH,)-385.2(Reiken)-380.6(S,)-377.4(W)73.2(arrier)-383.3(S,)-377.4(Belevych)-384.8(AE,)-384.7(H)-0.1(ar)-10.1(vey)]TJ
1.1988 -1.1988 TD
0.0001 Tc
(RD)Tj
/F3 1 Tf
2.2914 0 TD
0 Tc
[(et)-878.9(al.)]TJ
/F2 1 Tf
3.6344 0 TD
[(\(2005\).)-878.3(Phosph)-10.6(odiesterase)-880(4D)-870.1(deficienc)-13.3(y)-874.5(in)-868.2(the)]TJ
ET
1 i 
50.797 749.367 239.131 -0.227 re
f
BT
/F1 1 Tf
5.9774 0 0 7.9702 179.1496 761.8392 Tm
-0.0001 Tc
[(PDE4)-332.8(inhibitors)-325.8(and)-335.3(respiratory)-326.4(disease)]TJ
/F9 1 Tf
15.1373 -1.2519 TD
[(D)-337.9(Spina)]TJ
7.0982 0 0 9.4646 50.7968 751.8612 Tm
0.0001 Tc
(314)Tj
ET
50.797 40.932 239.131 -0.283 re
f
BT
/F4 1 Tf
6.0123 0 0 8.4682 50.7968 31.2378 Tm
[(British)-331.9(J)0.1(ournal)-324.5(of)-334.4(Pharmacology)-320.4(\(2008\))]TJ
/F1 1 Tf
17.6049 0 TD
(155)Tj
/F4 1 Tf
2.0462 0 TD
(308ñ315)Tj
ET

 Q
q
q 1 0 0 1 0 0 cm /Xi7 Do Q
Q


Q

q
0.0 0.0 595 794 re
W
n
1 0 0 1 0 0 cm
BT
/F1-0 12 Tf
14.4 TL
ET
1 0 0 RG
n
57 715 234 12 re
S
1 0 0 RG
n
55 707 98 11 re
S
1 0 0 RG
n
48 698 244 12 re
S
1 0 0 RG
n
57 688 234 12 re
S
1 0 0 RG
n
57 680 234 10 re
S
1 0 0 RG
n
57 671 39 10 re
S
1 0 0 RG
n
48 661 175 12 re
S
1 0 0 RG
n
239 661 53 12 re
S
1 0 0 RG
n
57 652 222 12 re
S
1 0 0 RG
n
287 652 4 12 re
S
1 0 0 RG
n
65 643 226 12 re
S
1 0 0 RG
n
57 634 87 12 re
S
1 0 0 RG
n
160 634 132 12 re
S
1 0 0 RG
n
57 627 84 9 re
S
1 0 0 RG
n
47 616 245 14 re
S
1 0 0 RG
n
57 608 234 12 re
S
1 0 0 RG
n
57 599 234 12 re
S
1 0 0 RG
n
57 590 144 12 re
S
1 0 0 RG
n
49 581 242 12 re
S
1 0 0 RG
n
57 571 234 12 re
S
1 0 0 RG
n
57 563 131 12 re
S
1 0 0 RG
n
48 553 244 14 re
S
1 0 0 RG
n
57 544 234 12 re
S
1 0 0 RG
n
57 536 144 12 re
S
1 0 0 RG
n
49 527 242 12 re
S
1 0 0 RG
n
57 518 234 12 re
S
1 0 0 RG
n
56 507 235 16 re
S
1 0 0 RG
n
57 500 108 12 re
S
1 0 0 RG
n
47 491 245 13 re
S
1 0 0 RG
n
57 482 234 12 re
S
1 0 0 RG
n
57 473 206 12 re
S
1 0 0 RG
n
48 464 158 12 re
S
1 0 0 RG
n
216 464 75 12 re
S
1 0 0 RG
n
57 455 234 12 re
S
1 0 0 RG
n
57 446 224 12 re
S
1 0 0 RG
n
50 438 239 10 re
S
1 0 0 RG
n
57 428 234 12 re
S
1 0 0 RG
n
57 419 234 12 re
S
1 0 0 RG
n
57 411 198 11 re
S
1 0 0 RG
n
47 401 244 12 re
S
1 0 0 RG
n
56 392 235 12 re
S
1 0 0 RG
n
56 383 237 13 re
S
1 0 0 RG
n
56 375 118 12 re
S
1 0 0 RG
n
48 366 243 12 re
S
1 0 0 RG
n
57 356 234 13 re
S
1 0 0 RG
n
55 347 237 13 re
S
1 0 0 RG
n
57 339 233 12 re
S
1 0 0 RG
n
48 330 243 13 re
S
1 0 0 RG
n
57 321 234 12 re
S
1 0 0 RG
n
57 311 234 12 re
S
1 0 0 RG
n
57 304 172 10 re
S
1 0 0 RG
n
49 295 242 10 re
S
1 0 0 RG
n
57 285 234 12 re
S
1 0 0 RG
n
57 276 235 12 re
S
1 0 0 RG
n
55 267 180 12 re
S
1 0 0 RG
n
49 258 243 12 re
S
1 0 0 RG
n
57 249 234 12 re
S
1 0 0 RG
n
57 240 234 12 re
S
1 0 0 RG
n
57 231 235 12 re
S
1 0 0 RG
n
55 222 93 13 re
S
1 0 0 RG
n
49 213 243 12 re
S
1 0 0 RG
n
57 204 234 12 re
S
1 0 0 RG
n
57 195 234 12 re
S
1 0 0 RG
n
57 186 234 12 re
S
1 0 0 RG
n
57 177 36 12 re
S
1 0 0 RG
n
47 167 245 15 re
S
1 0 0 RG
n
57 159 183 12 re
S
1 0 0 RG
n
49 151 242 12 re
S
1 0 0 RG
n
58 143 233 9 re
S
1 0 0 RG
n
55 131 237 15 re
S
1 0 0 RG
n
57 124 130 12 re
S
1 0 0 RG
n
49 114 242 12 re
S
1 0 0 RG
n
56 104 236 14 re
S
1 0 0 RG
n
57 96 234 12 re
S
1 0 0 RG
n
57 89 54 10 re
S
1 0 0 RG
n
48 78 243 12 re
S
1 0 0 RG
n
57 69 234 12 re
S
1 0 0 RG
n
58 62 233 9 re
S
1 0 0 RG
n
314 715 234 12 re
S
1 0 0 RG
n
314 706 235 12 re
S
1 0 0 RG
n
313 697 184 13 re
S
1 0 0 RG
n
306 689 243 12 re
S
1 0 0 RG
n
314 679 235 12 re
S
1 0 0 RG
n
314 671 234 12 re
S
1 0 0 RG
n
315 662 44 10 re
S
1 0 0 RG
n
306 653 242 12 re
S
1 0 0 RG
n
315 645 233 9 re
S
1 0 0 RG
n
314 635 234 12 re
S
1 0 0 RG
n
313 626 208 11 re
S
1 0 0 RG
n
306 616 242 12 re
S
1 0 0 RG
n
314 607 235 13 re
S
1 0 0 RG
n
313 599 158 12 re
S
1 0 0 RG
n
306 590 242 12 re
S
1 0 0 RG
n
315 581 232 10 re
S
1 0 0 RG
n
316 572 231 10 re
S
1 0 0 RG
n
313 562 37 14 re
S
1 0 0 RG
n
306 554 242 12 re
S
1 0 0 RG
n
313 545 95 12 re
S
1 0 0 RG
n
306 536 242 12 re
S
1 0 0 RG
n
315 528 232 9 re
S
1 0 0 RG
n
314 517 234 12 re
S
1 0 0 RG
n
314 510 67 10 re
S
1 0 0 RG
n
306 500 243 12 re
S
1 0 0 RG
n
314 491 234 12 re
S
1 0 0 RG
n
314 482 58 13 re
S
1 0 0 RG
n
306 473 242 12 re
S
1 0 0 RG
n
313 464 115 13 re
S
1 0 0 RG
n
304 456 245 11 re
S
1 0 0 RG
n
314 446 234 12 re
S
1 0 0 RG
n
315 438 178 10 re
S
1 0 0 RG
n
304 429 244 11 re
S
1 0 0 RG
n
314 419 235 12 re
S
1 0 0 RG
n
315 412 201 10 re
S
1 0 0 RG
n
306 401 243 12 re
S
1 0 0 RG
n
313 391 236 15 re
S
1 0 0 RG
n
313 383 237 13 re
S
1 0 0 RG
n
314 374 235 12 re
S
1 0 0 RG
n
315 366 36 10 re
S
1 0 0 RG
n
306 357 242 12 re
S
1 0 0 RG
n
314 348 234 12 re
S
1 0 0 RG
n
314 339 233 13 re
S
1 0 0 RG
n
315 331 232 10 re
S
1 0 0 RG
n
314 321 37 12 re
S
1 0 0 RG
n
306 313 241 10 re
S
1 0 0 RG
n
314 302 235 12 re
S
1 0 0 RG
n
313 292 236 15 re
S
1 0 0 RG
n
315 286 70 10 re
S
1 0 0 RG
n
306 276 243 12 re
S
1 0 0 RG
n
314 267 233 12 re
S
1 0 0 RG
n
315 258 235 12 re
S
1 0 0 RG
n
314 249 236 12 re
S
1 0 0 RG
n
313 240 93 12 re
S
1 0 0 RG
n
306 231 242 12 re
S
1 0 0 RG
n
314 222 234 12 re
S
1 0 0 RG
n
314 213 234 12 re
S
1 0 0 RG
n
314 204 234 12 re
S
1 0 0 RG
n
314 195 226 12 re
S
1 0 0 RG
n
306 186 243 12 re
S
1 0 0 RG
n
315 178 233 10 re
S
1 0 0 RG
n
314 168 235 12 re
S
1 0 0 RG
n
313 159 47 13 re
S
1 0 0 RG
n
304 150 245 13 re
S
1 0 0 RG
n
314 142 235 12 re
S
1 0 0 RG
n
315 132 234 12 re
S
1 0 0 RG
n
314 123 235 12 re
S
1 0 0 RG
n
315 116 42 9 re
S
1 0 0 RG
n
306 105 243 12 re
S
1 0 0 RG
n
314 96 235 12 re
S
1 0 0 RG
n
313 87 237 13 re
S
1 0 0 RG
n
314 78 85 12 re
S
1 0 0 RG
n
306 69 242 12 re
S
1 0 0 RG
n
314 60 235 13 re
S
0 1 0 RG
n
223 663 16 10 re
S
0 1 0 RG
n
280 655 7 8 re
S
0 1 0 RG
n
58 647 7 7 re
S
0 1 0 RG
n
144 636 16 10 re
S
0 1 0 RG
n
207 466 9 9 re
S
0.619608 0.619608 0.619608 RG
n
49 28 144 12 re
S
0.619608 0.619608 0.619608 RG
n
48 749 18 13 re
S
0.619608 0.619608 0.619608 RG
n
177 759 114 12 re
S
0.619608 0.619608 0.619608 RG
n
267 749 24 13 re
S
Q


endstream
endobj
253 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
254 0 obj
<<
/BBox [ 0 0 595 794 ]
/Filter /FlateDecode
/FormType 1
/Matrix [ 1 0 0 1 0 0 ]
/Resources <<
/Font <<
/F1 120 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Subtype /Form
/Type /XObject
/Length 286
>>
stream
xúuP=o¬0›Û+ﬁ¯#)$¥SKÀÑƒ–HJ'π£ƒéÏ ‚ﬂ◊.jßvy:›È}‹{*æëX∞eõÃ%$˘ä»ÛÇ…pËì	‰]æ\dÖú!¢ò!õ·Ÿ^LgUCZg{∆q˜úWÉNïg÷t⁄Pß+ß‹ï]tGWV€û7Vs)òY¡´„¿¢ ÀDéÍäµ≠N¬&`M3ºEvﬂRÿﬁ¥`ﬁÂíãOEö}0ºa<JrΩá2M2çµ5˚…O≤ˇçë6¥y˝K€O£Õüˆ≠upßé<lãìßÏ°‹®Î∏Séiœ‰L(&ºs©aËt≠™é∞v§F}ÉÌ˚o´k2û¶Â1â’‹0¥˛R&_¸TÑ∏
endstream
endobj
255 0 obj
<<
/BitsPerComponent 8
/ColorSpace 62 0 R
/Filter /FlateDecode
/Height 99
/Width 74
/Length 906
>>
stream
Hâ‰ïr„0˘ˇÍ;7M`)…Æ”IÊnzjÎ§éLÅ ÄåÒˇ≠ÍÎ•'/´˛√º^®ÙOÆz¸å«ﬂ◊Â´•„û>(Ì™z´óè5_ı¸=„∑Ñz…UÓ¢πGï/ﬁ™Â„†Á†«ÈPuø\zê¨
jCo˚ßjÇD>y=øé!L’æ†Áñ…Í —9xW3˜éj'é4ïﬂ	hüØ+©”på	∞Z]A˘˘íÜ’9ˆ√’9ΩsE$WGH_ì®⁄ÛÍQGí±Ì¿y;-a≥/“' ïfK«ƒúc≥C	ªÕpœ¿ÏêÈ©)FˆÖ'éq ΩCñ~¢ÆR!YiÛ•é9Õ◊ŒÓ⁄Ó}KSÈQ‹,}o≠<IÇ«{)¿_-≤ˇù&ùM;¶0Ä¿≈$Y¶ç™VÓ˘P·wÉ%“ö„Ti∞Uë¥ÊDK%}Ô)!ë∫›Q√ ª0`cvIì/1W⁄ﬁ§Ô€¸ï(iÛ∫ß•ëáÛÕ√g´'Wÿ(Ñ∆ŒTµÇÛ;dN9>e:Ñ¬∂\“∑πvIO˘”¥xYIbl°ör√V~=kìè5ßIr≤¯L¯™Ç√ì*±Åc	h?±4∫:1DÜ•¥Í4–û·¶zéÇ5UtÜdæÒp“7„™p∂fAÌHÀî≥Õ„ZŸµ√tûgJ[;…TL ÑÑÑ?úç”˙ÎÅîrÇEœõºf¶G„√ÆOÿk Ã±È.>aπ¶)õ$µ>ßna∑ºùv!û"j[Wûƒ‰=çõ˚≥ûøÁNI2ç1±9¸∞ûõ◊Ãƒîﬁe&¬2ØÜEìÂKfuKÒÆÁ-ô≤∑L˘ÿSW¨;É
¸m¶€xb∑gîË±QïmÁq≈õΩÔ∫D∞ﬂ4öÊ”<ŒñW¬-??è¡*o¶H±2-1∞ı›»|ˆL¢ÂÏ]æ<˛Ïò4îNµö∆¡u…¸Å1'
;à+ŸcTwÙìïôÀ-õı3}òˇ:Oó(i;&ÒX∑ûKQUı-DroÓœ≈DlÒ¨{‘Nê≠R¥°"_«ÿab¸¶°–lê=Á1ë
l∂1úãìÀ%3iëïJ≥3¸xsΩ xx6=Ø⁄°p©vßyªÂ¿âÒöÈèŸöxÉÉ_»‘B√U∆qT¶?'ù JO®€Ç∆}rKë∂(jayﬂàñ¨π∏jÓÓwØ∫^ﬁØZ œÇì’
endstream
endobj
256 0 obj
<<
/Contents 257 0 R
/CropBox [ 0 0 595 794 ]
/MediaBox [ 0 0 595 794 ]
/Resources <<
/ExtGState <<
/GS1 25 0 R
>>
/Font <<
/F1 26 0 R
/F1-0 258 0 R
/F10 246 0 R
/F2 30 0 R
/F3 33 0 R
/F4 36 0 R
/F7 45 0 R
/F9 55 0 R
>>
/XObject <<
/Xi8 259 0 R
>>
/ProcSet [ /ImageB /ImageC /ImageI /PDF /Text ]
>>
/Rotate 0
/Thumb 260 0 R
/Type /Page
/Annots [ ]
/Parent 2 0 R
>>
endobj
257 0 obj
<<
/Length 29314
>>
stream
q
q

BT
/F2 1 Tf
7.4718 0 0 7.4718 59.7543 718.7526 Tm
0 0 0 rg
/GS1 gs
0 Tc
0 Tw
[(r)-17.1(y)-0.1(anodine-receptor)-1247.8(c)0(omplex)-1256(promotes)-1249.3(heart)-1253.8(failure)-1250(and)]TJ
0 -1.2064 TD
[(arrhythm)-10.3(ias.)]TJ
/F3 1 Tf
6.3356 0 TD
(Cell)Tj
/F10 1 Tf
2.0486 0 TD
0.0001 Tc
(123)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(25ñ35.)]TJ
-11.3661 -1.1988 TD
[(Lim)-376.8(S)0.1(,)-377.3(Jatakanon)-374.8(A,)-380(Gordon)-376.3(D,)-377(Macdonald)-378.2(C,)-373.5(Chung)-375(KF)101.1(,)-376.6(B)0(arnes)-373.4(PJ)]TJ
1.1988 -1.1988 TD
0 Tc
[(\(2000\).)-673.4(Comparison)-673.6(o)-0.1(f)-664.9(h)-0.1(igh)-665(dose)-666.3(i)0(nhaled)-660.8(stero)-9.5(ids,)-663.1(low)-663.6(dose)]TJ
T*
[(inhaled)-281.4(steroids)-273.2(p)-0.1(lus)-279.4(l)0(ow)-276.7(dose)-271.8(t)0(heophy)-9.2(lline,)-272.4(and)-278.5(l)0(ow)-276.7(dose)-271.8(i)0(nhaled)]TJ
T*
[(stero)-9.5(ids)-407.9(alone)-418.3(in)-412.9(chroni)-12(c)-406.3(asthma)-419.9(in)-412.9(general)-419.8(practice.)]TJ
/F3 1 Tf
25.7749 0 TD
(Thorax)Tj
/F10 1 Tf
3.551 0 TD
0.0001 Tc
(55)Tj
/F2 1 Tf
1.1837 0 TD
0 Tc
(:)Tj
-30.5095 -1.1988 TD
0.0001 Tc
[(837ñ8)-11.5(41.)]TJ
-1.1988 -1.1988 TD
0 Tc
[(Louw)-700.1(C,)-692.3(W)20.1(illiams)-697.7(Z)-0.1(,)-694.2(V)50.3(enter)-694.7(L,)-692.4(Leichtl)-698.9(S,)-696.1(Schmid-W)14.6(irlitsch)-698.3(C,)]TJ
1.1988 -1.2064 TD
[(Breden)-11(broker)-401(D)]TJ
/F3 1 Tf
7.8531 0 TD
[(et)-400.9(al.)]TJ
/F2 1 Tf
2.686 0 TD
[(\(2007\).)-407.9(Roflumilast,)-411.9(a)-400.5(phosphodie)-10.4(sterase)-400.4(4)]TJ
-10.5391 -1.1988 TD
[(inhibit)-10.9(o)-0.1(r)44.8(,)-869.9(reduc)-10.3(es)-869.4(airw)-12.6(ay)-872.8(hyperresponsivene)-11(s)0(s)-864.8(aft)-8.7(er)-867.7(allergen)]TJ
T*
(challenge.)Tj
/F3 1 Tf
5.114 0 TD
(Respiration)Tj
/F10 1 Tf
5.1899 0 TD
0.0001 Tc
(74)Tj
/F2 1 Tf
1.1912 0 TD
[(:)-331.1(411ñ417)-13.1(.)]TJ
-12.694 -1.1988 TD
0 Tc
[(Marti)-9.2(n-Chouly)-567.6(CA,)-559.1(Astier)-567.1(A,)-562.2(Jacob)-566.5(C)-0.1(,)-563.3(P)-0.1(runiaux)-567.6(M)-0.1(P)118.8(,)-558.8(Bertrand)-568.7(C)-0.1(,)]TJ
1.1988 -1.1988 TD
[(Lagent)-9.7(e)-858.2(V)-852.6(\(2004\).)-863.1(Modulation)-868.8(o)-0.1(f)-854.6(m)-0.1(atrix)-867.1(metalloprotein)-13.5(ase)]TJ
T*
0.0001 Tc
[(produc)-11.2(tion)-598(from)-599.9(human)-600.1(l)0.1(ung)-600.7(fibroblasts)-601.4(by)-594.8(type)-601.6(4)-596.4(phospho-)]TJ
0 -1.2064 TD
0 Tc
[(diestera)-11.8(se)-330.7(inhibitors.)]TJ
/F3 1 Tf
10.0611 0 TD
[(Li)-9.5(fe)-332.6(Sci)]TJ
/F10 1 Tf
3.4827 0 TD
0.0001 Tc
(75)Tj
/F2 1 Tf
1.1912 0 TD
[(:)-331.1(823ñ8)-11.5(40.)]TJ
-15.9338 -1.1988 TD
[(Martor)-10.8(a)0.1(na)-281.4(P)48.6(A)0(,)-281.4(B)0(eume)-292.2(R,)-280.3(Lucattelli)-294.9(M,)-283.5(W)73.3(o)0(llin)-288.3(L,)-282.6(Lungarella)-292.5(G)-286.3(\()0.1(2005\).)]TJ
1.1988 -1.1988 TD
0 Tc
[(Ro)-8.7(flumilast)-868.8(fully)-863.9(preve)-8.2(nts)-861.9(e)0(mph)-9.1(ysema)-863.4(i)0(n)-868.2(m)-0.1(ice)-862.7(chronical)-13.6(ly)]TJ
T*
[(expos)-10.8(ed)-656.3(to)-663.3(cigarett)-10.6(e)-660.9(s)0(moke.)]TJ
/F3 1 Tf
14.6895 0 TD
[(Am)-666.9(J)-661(R)-0.1(espir)-665.6(Crit)-658.4(Care)-663.4(Me)-8.1(d)]TJ
/F10 1 Tf
14.0369 0 TD
0.0001 Tc
(172)Tj
/F2 1 Tf
1.7831 0 TD
0 Tc
(:)Tj
-30.5095 -1.1988 TD
0.0001 Tc
[(848ñ8)-11.5(53.)]TJ
-1.1988 -1.1988 TD
[(McClusk)-11.7(i)0.1(e)-394.3(K)0(,)-401(K)0(lein)-399.1(U,)-399.8(Linnevers)-407.6(C,)-396.3(Ji)-403.7(YH,)-401.5(Y)83.6(a)0.1(ng)-402.1(A,)-395.2(Husfeld)-409.7(C)]TJ
/F3 1 Tf
29.7204 0 TD
0 Tc
[(et)-393.3(al.)]TJ
/F2 1 Tf
-28.5216 -1.1988 TD
[(\(2006\).)-461(P)-0.1(h)-8.7(o)-0.1(sphodiesterase)-464.5(type)-450(4)-459.9(i)0(nhibitors)-455.3(cause)-462.7(proinflamma-)]TJ
0 -1.2064 TD
[(tor)-12.7(y)-335.7(effects)]TJ
/F3 1 Tf
5.5465 0 TD
[(in)-335.8(vivo)]TJ
/F2 1 Tf
2.9516 0 TD
(.)Tj
/F3 1 Tf
0.6298 0 TD
[(J)-334.7(Pharmacol)-336(Exp)-337.9(Ther)]TJ
/F10 1 Tf
9.9321 0 TD
0.0001 Tc
(319)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(4)0.1(68ñ476.)]TJ
-22.0418 -1.1988 TD
[(Meha)-8.6(ts)-341.8(C,)-350.8(Jin)-347.1(SL,)-344(W)73.3(ahlstrom)-352.9(J)0.1(,)-348.8(L)0(aw)-342.4(E,)-350.9(Umetsu)-352.5(DT)82.5(,)-346.3(Conti)-344.5(M)-347(\(2003\).)]TJ
1.1988 -1.1988 TD
0 Tc
[(PDE)-9.7(4D)-255.5(play)-9.8(s)-254.1(a)-263.9(critical)-268.1(role)-258.5(in)-261.2(the)-267.2(c)0(ontrol)-261.5(o)-0.1(f)-262.8(air)-14.5(way)-263.8(s)0(mooth)-261.4(musc)-9.8(l)0(e)]TJ
T*
[(contra)-11.6(ction.)]TJ
/F3 1 Tf
6.07 0 TD
-0.063 Tc
[(FA)-63.1(S)-63(E)-63.1(B)-404.4(J)]TJ
/F10 1 Tf
3.8393 0 TD
0.0001 Tc
(17)Tj
/F2 1 Tf
1.1837 0 TD
[(:)-338.7(1831ñ1841.)]TJ
-12.2918 -1.1988 TD
0 Tc
[(Nyce)-240(J)0(W)93.4(,)-232.5(Metzger)-241(WJ)-232.8(\(1997\).)-240.9(DNA)-237.2(antis)-9.5(ense)-236.9(therapy)-234.2(f)0(or)-242(asthma)-237.8(in)-238.4(an)]TJ
1.1988 -1.1988 TD
[(ani)-9(m)-0.1(al)-332.6(model.)]TJ
/F3 1 Tf
7.1778 0 TD
0.0001 Tc
(Nature)Tj
/F10 1 Tf
3.3006 0 TD
(385)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(7)0.1(21ñ725.)]TJ
-13.4603 -1.2064 TD
[(Ohta)-347.9(K)0(,)-347.9(F)0.1(ukuchi)-347.4(Y)91.2(,)-346.3(Grouse)-352.7(L)0(,)-343.3(M)0(izutani)-354.7(R)0(,)-341(R)0(abe)-351.5(K)0(F)101.1(,)-338.7(Renna)-9.4(rd)-346.3(SI)]TJ
/F3 1 Tf
29.7735 0 TD
0 Tc
[(et)-340.2(al.)]TJ
/F2 1 Tf
-28.5747 -1.1988 TD
[(\(2004\).)-301.6(A)-291.8(prospective)-294.3(clinical)-295.3(study)-294.1(of)-293.1(theophyllin)-10.5(e)-289.1(safety)-288.1(in)-291.5(3810)]TJ
T*
[(elderly)-340.2(with)-339.4(asthma)-336.4(or)-334.6(COPD.)]TJ
/F3 1 Tf
14.5681 0 TD
[(Respir)-339.3(Med)]TJ
/F10 1 Tf
5.1368 0 TD
0.0001 Tc
(98)Tj
/F2 1 Tf
1.1912 0 TD
[(:)-331.1(1016ñ)-11.5(1024.)]TJ
-22.0949 -1.1988 TD
0 Tc
[(Parkkon)-11.4(en)-323.5(J,)-333.8(Hasala)-333.8(H,)-325.8(Moilanen)-335.9(E,)-328.2(Giemby)-9.8(cz)-325.2(MA)-9(,)-323.6(K)-0.1(ankaa)-10.1(n)-0.1(ranta)-329.7(H)]TJ
1.1988 -1.1988 TD
[(\(2007\).)-498.9(Phosphodiestera)-13.5(se)-482.5(4)-490.3(i)0(nhibitors)-493.3(delay)-488.5(human)-494(e)0(osinophil)]TJ
T*
[(and)-840(n)-0.1(eutro)-10.4(phil)-832.2(a)0(p)-8.9(optosis)-838.4(in)-837.8(the)-836.2(a)0(bsence)-847.5(and)-832.4(p)-0.1(res)-9.3(ence)-836.8(of)]TJ
T*
[(sal)-8.7(butamol.)]TJ
/F3 1 Tf
5.7969 0 TD
[(Pulm)-341(Pharmacol)-343.6(Ther)]TJ
/F10 1 Tf
9.9321 0 TD
0.0001 Tc
(21)Tj
/F2 1 Tf
1.1837 0 TD
[(:)-338.7(499ñ506.)]TJ
-18.1115 -1.2064 TD
0 Tc
[(Perez-T)56.5(orres)-598.9(S,)-589.9(Miro)-597.2(X,)-595.4(Palacios)-597.8(J)0(M,)-597.3(Cortes)-598.3(R,)-591.5(Puigdomenec)-14.6(h)-588.4(P)124.3(,)]TJ
1.1988 -1.1988 TD
[(Mengod)-366.4(G)-362.3(\()0(2000\).)-369.9(Phosphodi)-11.3(esterase)-363.2(type)-358.9(4)-361.3(iso)-9.2(zymes)-359.1(express)-10.8(ion)]TJ
T*
[(in)-314.3(human)-319.5(b)-0.1(rain)-308.1(exami)-11.7(n)-0.1(ed)-311.3(by)]TJ
/F3 1 Tf
14.1052 0 TD
[(in)-313(situ)]TJ
/F2 1 Tf
3.073 0 TD
[(hybridiza)-10.8(tion)-309.8(h)-0.1(istochemi)-11.7(str)-10(y)]TJ
-17.1782 -1.1988 TD
[(and[3)-10.8(H)-0.1(]rolipram)-856.3(binding)-850.3(autoradiography)58.5(.)-847.1(Comparison)-855.7(w)-0.1(ith)]TJ
T*
0.0001 Tc
[(monkey)-342.4(a)0.1(nd)-331.5(rat)-338.4(brain.)]TJ
/F3 1 Tf
10.9261 0 TD
[(J)-334.6(Chem)-337.2(N)0(eur)-8.5(oanat)]TJ
/F10 1 Tf
8.4905 0 TD
(20)Tj
/F2 1 Tf
1.1912 0 TD
[(:)-331.1(349ñ374.)]TJ
-21.8066 -1.1988 TD
0 Tc
[(Peter)-391.7(D,)-384.7(Jin)-385.1(SL,)-382(Conti)-390.1(M)-0.1(,)-382.2(H)-0.1(atzelman)-10.8(n)-383.5(A)-0.1(,)-380.1(Z)-0.1(itt)-385.9(C)-384(\()0(2007\).)-392.7(D)-0.1(ifferential)]TJ
1.1988 -1.2064 TD
0.0001 Tc
[(express)-10.7(ion)-381.2(a)0.1(nd)-377.1(function)-385.1(o)0(f)-384.1(phosphodiestera)-11.8(se)-376.2(4)-376.3(\()0.1(PDE4\))-383.5(subt)-9.7(ypes)]TJ
0 -1.1988 TD
[(in)-473.5(human)-471.1(p)0(rimar)-13.1(y)-472.2(CD4)]TJ
/F7 1 Tf
11.7379 0 TD
0 Tc
()Tj
/F2 1 Tf
1.4037 0 TD
0.0001 Tc
[(T)-402.6(cells:)-474.3(predominant)-473.7(role)-470.9(of)-467.5(PDE)-9.6(4D.)]TJ
/F3 1 Tf
-13.1416 -1.1988 TD
[(J)-334.6(I)0.1(mmunol)]TJ
/F10 1 Tf
4.9623 0 TD
(178)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(4820ñ4831.)]TJ
-7.9442 -1.1988 TD
0 Tc
[(Phillips)-368.2(P)124.3(,)-361.5(B)-0.1(ennetts)-364(M,)-367.1(Banner)-366.3(K)-0.1(,)-355.6(W)73.2(ard)-367.5(J,)-356.5(W)73.2(essels)-360.7(D,)-362(Fuhr)-366.7(R)-359(\()0(2007)-13.4(\).)]TJ
1.1988 -1.1988 TD
0.0001 Tc
[(The)-604.7(PDE)-9.6(4)-596.4(i)0.1(nhibit)-10.8(o)0(r)-600.1(UK-500)-176(001)-605.6(does)-605.5(not)-598.9(signi)-11(ficantly)-601(inhibit)]TJ
T*
0 Tc
[(air)-14.5(way)-339.7(responses)-338.9(to)-337(allergen)-335.5(and)-339.2(h)-0.1(istamine.)]TJ
/F3 1 Tf
20.9796 0 TD
0.0001 Tc
[(Eur)-335.2(Resp)-339.4(J)]TJ
/F2 1 Tf
4.7877 0 TD
(490s.)Tj
-26.9661 -1.1988 TD
[(Rabe)-662.6(KF)101.1(,)-657.3(B)0(ateman)-660.1(ED,)-662.4(OíDonnell)-665.7(D,)-657.8(W)20.2(itte)-660.9(S,)-658.1(Bredenbroker)-662.2(D,)]TJ
1.1988 -1.2064 TD
0 Tc
[(Bethke)-497.9(TD)-486.7(\(2005\).)-498.9(Roflumilastñan)-501.2(oral)-491.3(anti-inflammator)-19.2(y)-495.1(treat-)]TJ
0 -1.1988 TD
[(ment)-503.7(for)-484.7(c)0(hronic)-501.8(obstructive)-498.6(pulmo)-10.3(nar)-11.9(y)-495.1(disease:)-499.7(a)-491.6(randomise)-10.9(d)]TJ
T*
[(contro)-12.1(lled)-335.7(trial.)]TJ
/F3 1 Tf
7.6862 0 TD
(Lancet)Tj
/F10 1 Tf
3.2019 0 TD
0.0001 Tc
(366)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-331.1(563ñ5)-11.5(71.)]TJ
-13.87 -1.1988 TD
0 Tc
[(Ren)23.2(n)-0.1(ar)18.4(d)-238.2(S)0(I)-231(\()0(2)15.5(0)-0.1(0)13.5(4)-0.1(\))15.5(.)-240.1(T)60.1(r)0(e)20.1(atm)18.7(ent)-221.6(o)-0.1(f)-232.4(sta)24(bl)14.9(e)-236(c)0(h)14.5(r)0(o)14.4(n)-0.1(ic)-227.3(ob)15.2(str)20.4(uc)18(tiv)17.5(e)-236(p)-0.1(u)19.2(l)0(mo)15.9(nary)]TJ
1.1988 -1.1988 TD
[(disease)-9.2(.)]TJ
/F3 1 Tf
3.8696 0 TD
(Lancet)Tj
/F10 1 Tf
3.2019 0 TD
0.0001 Tc
(364)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-331.1(7)0.1(91ñ8)-11.5(02.)]TJ
-10.0535 -1.1988 TD
0 Tc
[(Renna)-9.5(rd)-680.2(SI,)-675.9(Schachter)-690.2(N,)-678.2(Strek)-684.9(M,)-678.1(Ri)-9(ckard)-676.9(K,)-681.8(Amit)-683.5(O)-682.7(\(2006\).)]TJ
1.1988 -1.2064 TD
[(Cilomila)-14.4(st)-539.2(for)-545.4(COPD:)-553(results)-545.1(of)-551.1(a)-544.7(6)-0.1(-month,)-546.5(placebo-con)-13(trolled)]TJ
0 -1.1988 TD
[(stu)-8.6(dy)-262.8(of)-262.8(a)-263.9(poten)-10.9(t,)-259.6(selective)-272.4(i)0(nhibitor)-269.5(o)-0.1(f)-270.4(phosphodiestera)-11.9(se)-262.4(4.)]TJ
/F3 1 Tf
28.3546 0 TD
(Chest)Tj
/F10 1 Tf
-28.3546 -1.1988 TD
0.0001 Tc
(129)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(56ñ66.)]TJ
-2.9819 -1.1988 TD
0 Tc
[(Robichaud)-269.3(A)-0.1(,)-258.7(Savoie)-257.5(C,)-259.8(Stamatiou)-263.8(PB,)-260.4(Lachance)-261.2(N,)-260.9(Jolicoeu)-11.3(r)-252.4(P)124.3(,)-262.9(Rasori)]TJ
1.1988 -1.1988 TD
(R)Tj
/F3 1 Tf
0.956 0 TD
[(et)-325(al.)]TJ
/F2 1 Tf
2.5266 0 TD
[(\(2002)-13.4(a\).)-316.9(Assessing)-330.8(t)0(he)-320.3(emetic)-321.5(potential)-330.3(of)-323.5(PDE4)-325.4(inhibitors)]TJ
-3.4827 -1.1988 TD
[(in)-337(rats.)]TJ
/F3 1 Tf
3.6117 0 TD
0.0001 Tc
[(Br)-336.9(J)-327(Pharmac)-11.6(o)0.1(l)]TJ
/F10 1 Tf
6.9502 0 TD
(135)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(113ñ118.)]TJ
-13.5438 -1.2064 TD
0 Tc
[(Robichaud)-269.3(A)-0.1(,)-266.3(Savoie)-265.1(C)-0.1(,)-259.8(Stamatiou)-271.4(PB,)-260.4(T)60.1(attersall)-267.8(FD,)-266.8(Chan)-261.4(C)-0.1(C)-259.5(\()0(2001)-13.4(\).)]TJ
1.1988 -1.1988 TD
[(PDE)-9.7(4)-642(i)0(nhibitor)-11.6(s)-641.1(induce)-648.9(e)0(mesis)-654.2(in)-648.1(ferrets)-649.2(via)-644.2(a)-643.3(noradren)-12.8(ergic)]TJ
T*
0.0001 Tc
[(pathway)68.1(.)]TJ
/F3 1 Tf
4.5601 0 TD
0 Tc
[(Neuropharmac)-12.3(ology)]TJ
/F10 1 Tf
8.9685 0 TD
0.0001 Tc
(40)Tj
/F2 1 Tf
1.1837 0 TD
[(:)-338.7(262ñ269.)]TJ
-15.9111 -1.1988 TD
0 Tc
[(Robichaud)-603.2(A)-0.1(,)-585(Stama)-10.7(tiou)-587(PB,)-594.3(Jin)-597.6(SL,)-586.9(L)-0.1(achance)-602.7(N,)-587.2(Macdo)-9.8(n)-0.1(ald)-588.7(D,)]TJ
1.1988 -1.1988 TD
[(Lal)-9.6(i)0(berte)-501.2(F)]TJ
/F3 1 Tf
5.5844 0 TD
[(et)-507.1(al.)]TJ
/F2 1 Tf
2.8984 0 TD
[(\(2002b\).)-515.3(D)-0.1(eletion)-508(o)-0.1(f)-505.6(phosphodie)-10.4(sterase)-506.7(4D)-505.9(in)]TJ
-8.4829 -1.1988 TD
[(mice)-961.4(shortens)-954.6(alpha)-10.3(\(2\)-adrenoceptor-media)-18.3(ted)-948.9(anesthesi)-11.1(a,)-951.7(a)]TJ
T*
[(behavio)-11.6(ral)-333.2(correlate)-336.3(of)-338.6(emesis)-9.3(.)]TJ
/F3 1 Tf
14.6212 0 TD
[(J)-334.7(C)-0.1(lin)-338.3(Invest)]TJ
/F10 1 Tf
5.7514 0 TD
0.0001 Tc
(110)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(1045ñ1052.)]TJ
11.0475 77.9999 TD
[(Robichaud)-337.5(A,)-334.5(T)60.2(attersall)-336(FD,)-335(Choud)-10.8(hury)-342.2(I)0.1(,)-333.7(Rodger)-338.1(I)0.1(W)-331.4(\()0.1(1999\).)-339.5(Emesis)]TJ
1.1988 -1.2064 TD
0 Tc
[(induced)-651.8(by)-648(inhibitor)-11.6(s)-641.1(of)-649.7(type)-647.3(IV)-650.3(cyclic)-649.8(nucleot)-11.7(i)0(de)-647.7(phospho-)]TJ
0 -1.1988 TD
[(diesterase)-342.5(\(PDE)-338.5(IV\))-334.2(i)0(n)-337(t)0(he)-335.4(ferret.)]TJ
/F3 1 Tf
15.5013 0 TD
[(Neur)-8.6(opharmacology)]TJ
/F10 1 Tf
8.9685 0 TD
0.0001 Tc
(38)Tj
/F2 1 Tf
1.1912 0 TD
[(:)-331.1(289ñ2)-11.5(97.)]TJ
-26.8599 -1.1988 TD
0 Tc
[(Roth)-244.7(BL,)-245.3(Sheffler)-246.9(DJ,)-243.1(K)-0.1(roeze)-249(WK)-239.5(\(2004\).)-248.5(M)-0.1(agic)-247.6(shotguns)-244.5(versu)-8.8(s)-238.9(m)-0.1(agic)]TJ
1.1988 -1.1988 TD
[(bullets:)-552.2(selectively)-546.4(non-selective)-553.2(drugs)-545.5(for)-545.4(m)-0.1(ood)-548.2(d)-0.1(isorders)-546.9(and)]TJ
T*
[(schizoph)-11.6(renia.)]TJ
/F3 1 Tf
7.1854 0 TD
[(Nat)-338.6(R)-0.1(ev)-331.3(Drug)-339.4(Discov)]TJ
/F10 1 Tf
9.4996 0 TD
(3)Tj
/F2 1 Tf
0.5918 0 TD
0.0001 Tc
[(:)-338.7(353ñ359.)]TJ
-18.4757 -1.1988 TD
0 Tc
[(Sanz)-817.4(M)-0.1(J)-8.1(,)-816.8(Cortijo)-818.4(J,)-819.4(T)60.1(a)0(ha)-820.2(MA,)-818.1(Cerda-Nicola)-14.3(s)-815.6(M)-0.1(,)-814.7(S)0(chatton)-823.1(E,)]TJ
1.1988 -1.1988 TD
[(Burgbac)-11.9(her)-628.9(B)]TJ
/F3 1 Tf
7.1626 0 TD
[(et)-628.5(al.)]TJ
/F2 1 Tf
3.1488 0 TD
[(\(2007\).)-635.5(Roflumilast)-642.3(inhibits)-636.7(leukocyte-en-)]TJ
-10.3115 -1.2064 TD
[(dothelial)-370.6(cell)-367.2(inte)-8.2(ractions,)-368.2(e)0(xpressi)-9.8(on)-367.1(of)-361.4(adhes)-9.8(i)0(on)-366.1(molecules)-372.3(and)]TJ
0 -1.1988 TD
[(microvasc)-13.3(ular)-333.7(permeabili)-12(ty)77.2(.)]TJ
/F3 1 Tf
13.3085 0 TD
0.0001 Tc
[(Br)-329.3(J)-334.6(Pharmac)-11.6(ol)]TJ
/F10 1 Tf
6.9502 0 TD
(152)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(481ñ492.)]TJ
-23.2406 -1.1988 TD
0 Tc
[(Shichijo)-411.1(M,)-412.6(Inagaki)-411.6(N,)-405.1(Nakai)-412.9(N)-0.1(,)-405.1(K)-0.1(imata)-412.8(M,)-405(Nakahat)-10.8(a)-400.5(T)82.9(,)-407.1(S)-0.1(eriza)-10.8(wa)-406.1(I)]TJ
/F3 1 Tf
1.1988 -1.1988 TD
[(et)-325(al.)]TJ
/F2 1 Tf
2.5266 0 TD
[(\(1998\).)-324.4(The)-324(effects)-321.6(of)-323.5(anti-asthm)-10.9(a)-317(drugs)-325.5(on)-321.6(mediator)-326.2(release)]TJ
-2.5266 -1.1988 TD
[(from)-342(c)0(ultured)-340.5(human)-334.6(m)-0.1(ast)-341.6(cells.)]TJ
/F3 1 Tf
15.7897 0 TD
[(Clin)-338.3(Exp)-330.3(A)-0.1(llerg)-10.9(y)]TJ
/F10 1 Tf
7.4737 0 TD
0.0001 Tc
(28)Tj
/F2 1 Tf
1.1837 0 TD
[(:)-338.7(1228ñ1236)-14.7(.)]TJ
-25.6459 -1.1988 TD
0 Tc
[(Smith)-305.5(SJ,)-296.6(Brooke)-10.2(s-Fazakerley)-309.1(S,)-294(Donnelly)-311.6(LE,)-302.4(Barnes)-297.6(PJ,)-308(B)-0.1(arnette)-303.4(MS,)]TJ
1.1988 -1.2064 TD
0.0001 Tc
[(Giemby)-9.7(cz)-249.3(MA)-251.7(\(2003\).)-256(Ubiqui)-10.7(tous)-250.1(expressi)-9.7(on)-245.6(of)-255.1(phosphod)-10.6(iesterase)]TJ
0 -1.1988 TD
[(7A)-455.6(in)-450.7(human)-455.9(proi)-10.2(nflammator)-21(y)-449.5(and)-452.9(immune)-462.3(cells.)]TJ
/F3 1 Tf
24.9023 0 TD
0 Tc
[(Am)-454.5(J)-456.1(P)-0.1(hysiol)]TJ
-24.9023 -1.1988 TD
[(Lung)-342.1(Cell)-331.5(Mol)-334.6(Physiol)]TJ
/F10 1 Tf
10.008 0 TD
0.0001 Tc
(284)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(L279ñL289.)]TJ
-12.9899 -1.1988 TD
[(Smith)-715.2(SJ,)-721.4(Cieslinski)-720.3(LB,)-715.6(Newton)-717.2(R,)-720.3(Donnelly)-713.6(LE,)-719.7(Fenwick)-716.9(PS,)]TJ
1.1988 -1.1988 TD
[(Nichol)-10.6(son)-590.7(A)0(G)]TJ
/F3 1 Tf
7.4737 0 TD
0 Tc
[(et)-590.5(al.)]TJ
/F2 1 Tf
3.0654 0 TD
[(\(2004\).)-597.5(D)-0.1(iscover)-18.2(y)-586.1(o)-0.1(f)-589(B)-8.2(RL)-583.6(50481)-599.7([3-\(N,N-)]TJ
-10.5391 -1.1988 TD
[(dimethylsulf)-15.1(onamido\)-4-methyl)-15.9(-nitrobenzene],)-309.3(a)-301.9(selective)-310.3(inhibi-)]TJ
T*
[(tor)-361.7(o)-0.1(f)-353.8(phosphod)-10.7(iesterase)-362.3(7:)]TJ
/F3 1 Tf
13.2099 0 TD
[(in)-351(vitro)]TJ
/F2 1 Tf
3.5358 0 TD
[(studies)-356.5(in)-359.8(human)-357.4(mono)-10.6(cytes,)]TJ
-16.7457 -1.2064 TD
0.0001 Tc
[(lung)-327.5(macroph)-11.5(ages,)-323.9(and)-331.5(CD8)]TJ
/F7 1 Tf
13.5817 0 TD
0 Tc
()Tj
/F2 1 Tf
1.2595 0 TD
[(T)60.1(-lymph)-10.1(ocytes.)]TJ
/F3 1 Tf
7.5041 0 TD
[(Mol)-327(Pharmacol)]TJ
/F10 1 Tf
6.973 0 TD
(66)Tj
/F2 1 Tf
1.1912 0 TD
(:)Tj
-30.5095 -1.1988 TD
0.0001 Tc
[(1679ñ)-11.5(1689.)]TJ
-1.1988 -1.1988 TD
0 Tc
[(Spina)-399.7(D)-395.1(\(2003\).)-407.9(Phosphodiest)-12.5(erase-4)-397.8(inhibitors)-402.2(in)-397.7(the)-396.1(treat)-9.7(m)-0.1(ent)-397.5(o)-0.1(f)]TJ
1.1988 -1.1988 TD
[(inflammat)-11.9(ory)-344(l)0(ung)-335.2(disease)-9.2(.)]TJ
/F3 1 Tf
13.1264 0 TD
0.0001 Tc
(Drugs)Tj
/F10 1 Tf
2.8833 0 TD
(63)Tj
/F2 1 Tf
1.1837 0 TD
[(:)-338.7(2575ñ2594.)]TJ
-18.3922 -1.1988 TD
0 Tc
[(Spina)-589.4(D)-592.4(\(2004\).)-590(The)-589.6(potentia)-12.6(l)-583.3(o)-0.1(f)-589(PDE4)-591(inhibit)-10.9(o)-0.1(rs)-588.7(in)-587.4(respirator)-21.3(y)]TJ
1.1988 -1.1988 TD
[(disease)-9.2(.)]TJ
/F3 1 Tf
3.8696 0 TD
[(Curr)-338.5(D)-0.1(rug)-331.8(T)60.8(argets)-341.3(Inflamm)-341.8(A)-0.1(llergy)]TJ
/F10 1 Tf
15.6607 0 TD
(3)Tj
/F2 1 Tf
0.5918 0 TD
0.0001 Tc
[(:)-338.7(231ñ236.)]TJ
-21.321 -1.2064 TD
0 Tc
[(Spina)-680.5(D)-0.1(,)-680.6(H)-0.1(a)-8.2(rrison)-677.2(S)0(,)-680.9(P)-0.1(age)-684.2(C)-0.1(P)-684.5(\()0(1995\).)-681(Regulat)-10.6(ion)-677.2(b)-0.1(y)-686(phospho-)]TJ
1.1988 -1.1988 TD
[(diesterase)-1351.6(isoenzymes)-1351.8(o)-0.1(f)-1347.8(non-adrener)-10.8(gic)-1343.9(non-choli)-12.8(nergic)]TJ
T*
[(contracti)-11.6(on)-344.3(in)-352.2(guinea-pig)-349.9(iso)-9.2(lated)-346.9(main)-351.9(bronchus.)]TJ
/F3 1 Tf
24.1587 0 TD
0.0001 Tc
[(Br)-344.5(J)-349.8(Pharmacol)]TJ
/F10 1 Tf
-24.1587 -1.1988 TD
(116)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(2334ñ2340.)]TJ
-2.9819 -1.1988 TD
0 Tc
[(Sullivan)-336.6(P)124.3(,)-323.6(Bekir)-330.4(S,)-331.9(Jaffar)-331.8(Z,)-322.4(Page)-335.2(C,)-328.1(Jeffer)-10.4(y)-328.2(P)124.3(,)-331.2(Costello)-335.3(J)-321.3(\()0(1994\).)-339.6(Anti-)]TJ
1.1988 -1.1988 TD
[(inflammat)-11.9(ory)-670.3(effects)-663(of)-657.3(low-dose)-663(o)-0.1(ral)-658.2(theophy)-9.2(lline)-662.1(i)0(n)-655.7(atopic)]TJ
T*
[(asthma)-730.9([published)-728.3(erratum)-730(a)-0.1(ppears)-722.1(in)-724(Lancet)-729.5(1994)-724.1(Jun)-728(11;)]TJ
0 -1.2064 TD
0.0001 Tc
[(343\(8911\))-14.5(:1512].)]TJ
/F3 1 Tf
8.2704 0 TD
0 Tc
(Lancet)Tj
/F10 1 Tf
3.2019 0 TD
0.0001 Tc
(343)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-331.1(1)0(006ñ)-11.5(1008.)]TJ
-14.4543 -1.1988 TD
0 Tc
[(T)60.1(akahashi)-387.1(M)-0.1(,)-382.2(T)67.7(er)-17.9(williger)-381.6(R,)-379(Lane)-387.1(C,)-381.2(Mezes)-384.9(PS,)-382(Conti)-382.6(M)-0.1(,)-382.2(Duman)-384.1(R)-0.1(S)]TJ
1.1988 -1.1988 TD
[(\(1999\).)-847.9(Chronic)-843.6(a)0(ntidepressant)-848.6(a)0(dministration)-846.4(i)0(ncr)-9.2(eases)-834.2(the)]TJ
T*
[(expressi)-9.8(on)-556.8(of)-566.3(cAMP-specif)-12.3(ic)-557.1(phosphod)-10.7(iesterase)-559.6(4A)-569.5(and)-559.3(4)-0.1(B)-559.1(iso)-9.2(-)]TJ
T*
(forms.)Tj
/F3 1 Tf
3.3082 0 TD
[(J)-334.7(N)-0.1(eurosci)]TJ
/F10 1 Tf
4.7119 0 TD
0.0001 Tc
(19)Tj
/F2 1 Tf
1.1912 0 TD
[(:)-331.1(610ñ618.)]TJ
-10.4101 -1.1988 TD
0 Tc
[(Timmer)-604.4(W)96(,)-611.9(L)-0.1(eclerc)-607.2(V)133.8(,)-611.9(Birraux)-614(G,)-609.9(Neuha)-9.3(user)-613.9(M,)-609.9(Hatzelmann)-614.3(A)-0.1(,)]TJ
1.1988 -1.2064 TD
[(Bethke)-535.8(T)]TJ
/F3 1 Tf
4.8105 0 TD
[(et)-529.8(al.)]TJ
/F2 1 Tf
2.944 0 TD
0.0001 Tc
[(\(2002\).)-536.7(The)-528.8(new)-533.9(phosphodie)-10.3(sterase)-529.3(4)-528.1(i)0.1(nhibitor)]TJ
-7.7545 -1.1988 TD
0 Tc
[(roflumil)-13.4(ast)-347.8(is)-351.8(efficacious)-361.9(in)-352.2(exercise-induced)-349.6(asthma)-359.1(and)-354.4(l)0(eads)-353.8(to)]TJ
T*
[(suppressi)-11.7(on)-336.7(of)-346.2(LPS-stimulated)-351.5(TNF-alpha)]TJ
/F3 1 Tf
19.5986 0 TD
[(ex)-342.8(vivo)]TJ
/F2 1 Tf
3.0426 0 TD
(.)Tj
/F3 1 Tf
0.6298 0 TD
[(J)-342.3(C)-0.1(lin)-345.9(Pharmacol)]TJ
/F10 1 Tf
-23.271 -1.1988 TD
0.0001 Tc
(42)Tj
/F2 1 Tf
1.1912 0 TD
[(:)-331.1(297ñ3)-11.5(0)0(3.)]TJ
-2.3901 -1.1988 TD
0 Tc
[(T)60.1(o)-0.1(rphy)-320.7(TJ)-321.8(\(1998\).)-324.4(Phosphodiestera)-13.5(se)-315.6(isozymes:)-327.5(molecular)-322.6(targets)-322.1(for)]TJ
1.1988 -1.1988 TD
[(novel)-330.8(antiasthma)-334.6(agents.)]TJ
/F3 1 Tf
12.1477 0 TD
[(Am)-325.5(J)-327.1(R)-0.1(espir)-324.2(Crit)-332.2(Care)-329.6(Med)]TJ
/F10 1 Tf
12.0187 0 TD
0.0001 Tc
(157)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-331.1(351ñ370.)]TJ
-27.1482 -1.1988 TD
0 Tc
[(van)-247.1(Schalkwyk)-252.7(E,)-252.3(Str)-14.6(ydom)-247.8(K,)-249.4(W)20.1(illiams)-250(Z)-0.1(,)-246.5(V)50.3(enter)-254.6(L,)-244.7(Leichtl)-258.8(S)0(,)-240.9(S)0(ch)-9(mid-)]TJ
1.1988 -1.2064 TD
[(W)20.1(irlitsch)-857.6(C)]TJ
/F3 1 Tf
6.7226 0 TD
[(et)-848.5(al.)]TJ
/F2 1 Tf
3.5889 0 TD
[(\(2005\).)-855.5(Roflumilast,)-859.6(an)-852.2(oral,)-852.8(once-d)-11.5(aily)]TJ
-10.3115 -1.1988 TD
[(phosphod)-10.7(iesterase)-1128.6(4)-1120(i)0(nhibit)-10.9(o)-0.1(r)44.8(,)-1127.9(attenuates)-1127.2(allergen-induc)-13.2(ed)]TJ
T*
[(asthma)-10.1(tic)-333.9(reactions.)]TJ
/F3 1 Tf
9.7803 0 TD
[(J)-334.7(A)-0.1(llergy)-336.1(Clin)-338.3(Immu)-9.3(nol)]TJ
/F10 1 Tf
10.486 0 TD
0.0001 Tc
(116)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(292ñ298.)]TJ
-23.2482 -1.1988 TD
0 Tc
[(V)50.3(estbo)-244(J)0(,)-242.7(T)60.1(an)-237.6(L,)-244.7(Atkinson)-246.9(G)-240.9(\(2007\).)-248.5(A)-238.7(6)-239.9(w)-0.1(eek)-244.2(study)-241(of)-240(th)-8.5(e)-236(efficacy)-247.9(and)]TJ
1.1988 -1.1988 TD
0.0001 Tc
[(safety)-485.3(of)-482.7(UK-500)-168.4(001)-484.2(d)0(r)-12.4(y)-479.8(powder)-483.3(f)0.1(or)-477.1(inhala)-10.4(tion)-476.6(\()0.1(DPI)-10.1(\))-472.9(i)0.1(n)-481.1(a)0.1(dults)]TJ
T*
0 Tc
[(with)-392.5(chronic)-395.6(obstructive)-400(pulmonar)-14.6(y)-388.9(d)-0.1(isease)-396.2(\(COPD\).)]TJ
/F3 1 Tf
25.5928 0 TD
0.0001 Tc
[(Eur)-388.3(R)-8.1(espir)-391.8(J)]TJ
/F2 1 Tf
-25.5928 -1.2064 TD
(612s.)Tj
-1.1988 -1.1988 TD
[(W)73.3(ang)-364.2(H,)-363.6(Peng)-363.6(MS,)-360.1(Chen)-369.9(Y)98.8(,)-369(G)0(eng)-364.6(J)0.1(,)-356.4(R)0(o)-8.6(b)0(inson)-359.8(H)0(,)-363.6(Housla)-10.1(y)-358.4(M)0(D)]TJ
/F3 1 Tf
29.7507 0 TD
0 Tc
[(et)-362.9(al.)]TJ
/F2 1 Tf
-28.5519 -1.1988 TD
[(\(2007\).)-400.3(Structures)-394.7(of)-391.8(the)-388.5(f)0(our)-394.2(subfamilies)-399.7(of)-384.2(phos)-9.5(phodiesterase-4)]TJ
T*
[(provide)-425.6(insight)-421.7(i)0(nto)-416(t)0(he)-418.9(selectivity)-421(of)-414.5(th)-8.5(eir)-411.5(inhibit)-10.9(o)-0.1(rs.)]TJ
/F3 1 Tf
26.3743 0 TD
[(Biochem)-423(J)]TJ
/F10 1 Tf
-26.3743 -1.1988 TD
0.0001 Tc
(408)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(193ñ201.)]TJ
-2.9819 -1.1988 TD
0 Tc
[(W)73.2(einberger)-334.3(M,)-336.7(Hendeles)-332.9(L)-330.9(\()0(1996\).)-339.6(Theophyl)-12(line)-329.2(i)0(n)-337(asthma.)]TJ
/F3 1 Tf
28.347 0 TD
[(N)-332.6(E)-0.1(ngl)-337.6(J)]TJ
-27.1482 -1.2064 TD
0.0001 Tc
(Med)Tj
/F10 1 Tf
2.1928 0 TD
(334)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-331.1(1)0.1(380ñ13)-13.1(88.)]TJ
-5.1747 -1.1988 TD
[(W)73.3(eston)-466.8(MC,)-462.5(Anderson)-467.2(N)0(,)-465.7(P)0(eachell)-465.9(PT)-460.3(\(1997)-13.4(\).)-462.6(Effects)-461.9(of)-467.5(phospho-)]TJ
1.1988 -1.1988 TD
0 Tc
[(diesterase)-668.7(inhibit)-10.9(o)-0.1(rs)-664.5(on)-670.6(human)-668.5(lung)-669.1(mast)-667.9(cell)-663.1(and)-673.1(b)0(asophil)]TJ
T*
0.0001 Tc
[(functi)-10.5(on.)]TJ
/F3 1 Tf
4.6739 0 TD
[(Br)-336.9(J)-327(Pharm)-12.7(acol)]TJ
/F10 1 Tf
6.9502 0 TD
(121)Tj
/F2 1 Tf
1.7831 0 TD
[(:)-338.7(287ñ295.)]TJ
-14.606 -1.1988 TD
[(X)16.5(u)-334.3(RX)29.4(,)-331.1(H)0(a)29.9(s)0.1(s)30.6(e)0.1(l)30.6(l)-332.8(AM)29(,)-331.1(V)65.6(a)16.9(n)0(d)23.4(e)0.1(r)20.2(w)17.2(al)25.5(l)-332.8(D)0(,)-308.8(L)0(a)27.5(m)0(b)27.8(e)0.1(r)27.8(t)-330.5(MH)30.2(,)-331.1(H)0(o)29.4(l)0.1(m)22.4(e)0.1(s)-315.4(W)20.2(D,)-316.4(L)18.2(u)0(t)25.5(h)0(e)25.6(r)]TJ
1.1988 -1.1988 TD
(MA)Tj
/F3 1 Tf
2.4811 0 TD
[(et)-833.2(al)27.9(.)]TJ
/F2 1 Tf
3.5434 0 TD
[(\()20.3(2)0(0)21.2(0)18.2(0\))23.2(.)-847(A)0(t)30.3(o)16.4(mi)22.4(c)-846.3(s)0.1(t)30(r)0.1(u)27.9(c)0.1(t)29.5(u)0(r)28(e)-850.5(of)-839.3(P)18.2(D)0(E)25.4(4)0(:)-836.4(i)16.2(ns)30.3(ig)26.1(ht)29.6(s)-853.4(i)16.2(nt)29.6(o)]TJ
-6.0245 -1.1988 TD
[(ph)23.4(o)16.4(s)0.1(p)31.3(h)0(o)27.6(d)0(i)28.4(e)0.1(s)26(t)18.5(er)27.8(as)28.4(e)-273.8(m)0(e)28.3(c)18.7(ha)28(ni)27.3(sm)-255.4(a)-271.4(s)0.1(p)23.8(e)0.1(c)33.1(i)16.2(fi)25.4(ci)27.2(t)18.5(y)81.7(.)]TJ
/F3 1 Tf
20.0463 0 TD
-0.0162 Tc
[(Sc)-16.2(i)15.5(e)-16.2(n)11.6(c)-16.2(e)]TJ
/F10 1 Tf
3.2095 0 TD
0.0001 Tc
[(28)25.3(8)]TJ
/F2 1 Tf
1.7375 0 TD
-0.03 Tc
[(:)-300.5(1)-30.1(82)-30.1(2)-8.9(ñ)-30(18)-30.1(25)-30.1(.)]TJ
ET
1 i 
307.842 749.367 239.131 -0.227 re
f
BT
/F1 1 Tf
5.9774 0 0 7.9702 307.8424 761.8392 Tm
-0.0001 Tc
[(PDE4)-332.8(inhibitors)-335.3(and)-325.8(respiratory)-335.9(disease)]TJ
/F9 1 Tf
0 -1.2519 TD
[(D)-328.5(Spina)]TJ
7.0982 0 0 9.4646 534.1038 751.8612 Tm
0.0001 Tc
(315)Tj
ET
307.842 40.932 239.131 -0.283 re
f
BT
/F4 1 Tf
6.0123 0 0 8.4682 405.2408 31.2378 Tm
[(British)-322.5(J)0.1(ournal)-334(of)-334.4(Pharmacolog)18.7(y)-339.1(\(2008\))]TJ
/F1 1 Tf
17.5955 0 TD
(155)Tj
/F4 1 Tf
2.0462 0 TD
(308ñ315)Tj
ET

 Q
q
q 1 0 0 1 0 0 cm /Xi8 Do Q
Q


Q

q
0.0 0.0 595 794 re
W
n
1 0 0 1 0 0 cm
BT
/F1-0 12 Tf
14.4 TL
ET
1 0 0 RG
n
57 715 234 11 re
S
1 0 0 RG
n
56 707 110 12 re
S
1 0 0 RG
n
48 697 243 13 re
S
1 0 0 RG
n
56 689 236 11 re
S
1 0 0 RG
n
57 680 234 10 re
S
1 0 0 RG
n
57 671 234 10 re
S
1 0 0 RG
n
57 662 37 10 re
S
1 0 0 RG
n
49 654 241 10 re
S
1 0 0 RG
n
57 643 235 13 re
S
1 0 0 RG
n
57 634 234 13 re
S
1 0 0 RG
n
57 626 126 11 re
S
1 0 0 RG
n
48 617 243 12 re
S
1 0 0 RG
n
56 608 236 12 re
S
1 0 0 RG
n
56 598 235 12 re
S
1 0 0 RG
n
56 590 153 12 re
S
1 0 0 RG
n
48 580 243 13 re
S
1 0 0 RG
n
56 571 235 13 re
S
1 0 0 RG
n
56 562 235 13 re
S
1 0 0 RG
n
57 555 40 11 re
S
1 0 0 RG
n
48 546 242 11 re
S
1 0 0 RG
n
57 536 234 12 re
S
1 0 0 RG
n
57 528 195 10 re
S
1 0 0 RG
n
49 519 241 10 re
S
1 0 0 RG
n
57 509 235 12 re
S
1 0 0 RG
n
57 501 132 10 re
S
1 0 0 RG
n
49 492 242 10 re
S
1 0 0 RG
n
56 483 133 11 re
S
1 0 0 RG
n
47 473 244 13 re
S
1 0 0 RG
n
57 464 234 12 re
S
1 0 0 RG
n
57 456 205 11 re
S
1 0 0 RG
n
48 447 243 11 re
S
1 0 0 RG
n
56 437 235 13 re
S
1 0 0 RG
n
57 428 235 13 re
S
1 0 0 RG
n
57 420 166 11 re
S
1 0 0 RG
n
49 411 242 11 re
S
1 0 0 RG
n
57 401 235 12 re
S
1 0 0 RG
n
57 393 234 11 re
S
1 0 0 RG
n
57 383 235 12 re
S
1 0 0 RG
n
56 376 195 10 re
S
1 0 0 RG
n
48 366 243 11 re
S
1 0 0 RG
n
57 357 234 10 re
S
1 0 0 RG
n
57 348 71 11 re
S
1 0 0 RG
n
154 348 136 11 re
S
1 0 0 RG
n
57 340 99 10 re
S
1 0 0 RG
n
48 330 243 12 re
S
1 0 0 RG
n
57 321 234 13 re
S
1 0 0 RG
n
56 312 215 12 re
S
1 0 0 RG
n
49 304 242 10 re
S
1 0 0 RG
n
57 295 234 10 re
S
1 0 0 RG
n
57 284 234 13 re
S
1 0 0 RG
n
57 276 135 11 re
S
1 0 0 RG
n
47 266 244 13 re
S
1 0 0 RG
n
57 258 106 11 re
S
1 0 0 RG
n
49 250 241 10 re
S
1 0 0 RG
n
57 241 234 10 re
S
1 0 0 RG
n
57 230 235 13 re
S
1 0 0 RG
n
57 221 46 14 re
S
1 0 0 RG
n
47 214 244 11 re
S
1 0 0 RG
n
56 204 235 12 re
S
1 0 0 RG
n
57 196 132 11 re
S
1 0 0 RG
n
49 187 242 11 re
S
1 0 0 RG
n
56 177 235 13 re
S
1 0 0 RG
n
56 169 151 11 re
S
1 0 0 RG
n
49 160 122 10 re
S
1 0 0 RG
n
184 160 107 10 re
S
1 0 0 RG
n
57 152 234 10 re
S
1 0 0 RG
n
56 141 237 13 re
S
1 0 0 RG
n
57 133 214 11 re
S
1 0 0 RG
n
306 715 243 13 re
S
1 0 0 RG
n
314 706 233 13 re
S
1 0 0 RG
n
313 698 234 12 re
S
1 0 0 RG
n
304 688 245 14 re
S
1 0 0 RG
n
314 680 234 10 re
S
1 0 0 RG
n
314 671 169 10 re
S
1 0 0 RG
n
306 662 241 11 re
S
1 0 0 RG
n
315 653 232 11 re
S
1 0 0 RG
n
315 644 233 11 re
S
1 0 0 RG
n
313 635 206 12 re
S
1 0 0 RG
n
306 626 242 11 re
S
1 0 0 RG
n
315 617 233 11 re
S
1 0 0 RG
n
314 607 232 13 re
S
1 0 0 RG
n
306 599 241 11 re
S
1 0 0 RG
n
315 590 233 11 re
S
1 0 0 RG
n
314 580 235 13 re
S
1 0 0 RG
n
313 572 137 11 re
S
1 0 0 RG
n
306 563 241 11 re
S
1 0 0 RG
n
314 555 233 10 re
S
1 0 0 RG
n
316 546 231 9 re
S
1 0 0 RG
n
315 536 232 11 re
S
1 0 0 RG
n
314 526 85 13 re
S
1 0 0 RG
n
424 526 125 13 re
S
1 0 0 RG
n
316 520 42 8 re
S
1 0 0 RG
n
306 510 243 10 re
S
1 0 0 RG
n
313 500 178 12 re
S
1 0 0 RG
n
304 490 245 14 re
S
1 0 0 RG
n
314 483 191 11 re
S
1 0 0 RG
n
305 473 243 12 re
S
1 0 0 RG
n
314 464 234 11 re
S
1 0 0 RG
n
313 455 236 12 re
S
1 0 0 RG
n
315 447 61 11 re
S
1 0 0 RG
n
305 437 242 13 re
S
1 0 0 RG
n
313 428 236 14 re
S
1 0 0 RG
n
313 419 236 13 re
S
1 0 0 RG
n
314 411 147 11 re
S
1 0 0 RG
n
304 402 245 12 re
S
1 0 0 RG
n
314 393 234 11 re
S
1 0 0 RG
n
315 384 233 11 re
S
1 0 0 RG
n
315 375 108 11 re
S
1 0 0 RG
n
306 366 242 11 re
S
1 0 0 RG
n
314 358 233 11 re
S
1 0 0 RG
n
315 348 233 11 re
S
1 0 0 RG
n
313 339 236 12 re
S
1 0 0 RG
n
314 332 48 9 re
S
1 0 0 RG
n
306 321 242 11 re
S
1 0 0 RG
n
313 312 234 11 re
S
1 0 0 RG
n
306 304 241 11 re
S
1 0 0 RG
n
315 294 232 11 re
S
1 0 0 RG
n
313 284 236 13 re
S
1 0 0 RG
n
313 276 205 11 re
S
1 0 0 RG
n
306 268 46 10 re
S
1 0 0 RG
n
360 268 187 10 re
S
1 0 0 RG
n
314 258 234 11 re
S
1 0 0 RG
n
315 249 233 11 re
S
1 0 0 RG
n
314 241 23 11 re
S
1 0 0 RG
n
306 231 241 13 re
S
1 0 0 RG
n
316 222 232 11 re
S
1 0 0 RG
n
314 212 236 13 re
S
1 0 0 RG
n
314 204 55 11 re
S
1 0 0 RG
n
306 196 242 11 re
S
1 0 0 RG
n
314 187 79 11 re
S
1 0 0 RG
n
306 177 242 13 re
S
1 0 0 RG
n
314 167 234 13 re
S
1 0 0 RG
n
313 160 142 11 re
S
1 0 0 RG
n
304 151 245 12 re
S
1 0 0 RG
n
314 142 234 11 re
S
1 0 0 RG
n
315 135 231 10 re
S
0 1 0 RG
n
129 350 24 9 re
S
0 1 0 RG
n
172 161 11 9 re
S
0 1 0 RG
n
400 529 24 9 re
S
0 1 0 RG
n
352 269 8 9 re
S
0.619608 0.619608 0.619608 RG
n
404 28 143 12 re
S
0.619608 0.619608 0.619608 RG
n
305 759 115 12 re
S
0.619608 0.619608 0.619608 RG
n
305 749 25 13 re
S
0.619608 0.619608 0.619608 RG
n
531 749 18 13 re
S
Q


endstream
endobj
258 0 obj
<<
/BaseFont /Helvetica
/Encoding /WinAnsiEncoding
/Name /F1
/Subtype /Type1
/Type /Font
>>
endobj
259 0 obj
<<
/BBox [ 0 0 595 794 ]
/Filter /FlateDecode
/FormType 1
/Matrix [ 1 0 0 1 0 0 ]
/Resources <<
/Font <<
/F1 120 0 R
>>
/ProcSet [ /PDF /Text /ImageB /ImageC /ImageI ]
>>
/Subtype /Form
/Type /XObject
/Length 286
>>
stream
xúuP=o¬0›Û+ﬁ¯#)$¥SKÀÑƒ–HJ'π£ƒéÏ ‚ﬂ◊.jßvy:›È}‹{*æëX∞eõÃ%$˘ä»ÛÇ…pËì	‰]æ\dÖú!¢ò!õ·Ÿ^LgUCZg{∆q˜úWÉNïg÷t⁄Pß+ß‹ï]tGWV€û7Vs)òY¡´„¿¢ ÀDéÍäµ≠N¬&`M3ºEvﬂRÿﬁ¥`ﬁÂíãOEö}0ºa<JrΩá2M2çµ5˚…O≤ˇçë6¥y˝K€O£Õüˆ≠upßé<lãìßÏ°‹®Î∏Séiœ‰L(&ºs©aËt≠™é∞v§F}ÉÌ˚o´k2û¶Â1â’‹0¥˛R&_¸TÑ∏
endstream
endobj
260 0 obj
<<
/BitsPerComponent 8
/ColorSpace 62 0 R
/Filter /FlateDecode
/Height 99
/Width 74
/Length 830
>>
stream
HâÏUãn€@”ˇˇ†~gX{|ÈŒq⁄"+‰Ü%Æ}÷ë≈tøWÂ˙a•øèiÆ`¸W´QÎœèÖK|ª˙Â‘˛Øu“2ûYÎ€>K˝j<˛Û÷:¨Qi„gw÷U·¿•î:ÆÔr|Ò’¢—Õ¬‚‘Õ+µ(¯µ7ÔÛF©©≈Üá§˝4ù›±èù∆^1«∞Do~œCıæµß¿0∞XòIœ“›Ëê:œãó[ºCöÅX”T§Ë∞mó&ÜäâKq# lä´1M)m# wl<p'∫ctä q*kfõÌ:ûT3®Mv∞QKJ@øﬁk·»µW5w!ÕCqÇÈ˜ñ >-ç‹2*ØX˜àa]ÕÙ±7—uaZ”ÿv‹õ—)´Ö	€cœ¢Y·;¥üÆˆ∫ﬁ√ÃBKzÊaèCõÁ[!É]N“ ¡ﬂî˛B(á„Ò2ê’=@bÄk≤\x9Ä√)}^õÆ˙Õe™\Ù Ì$ûLŸÜ∞e‚õt£T[º∞Ö»Í˘√‹w“‘≠©KõÛ∫∂í%Hâ’ìﬁuDµ˝¯ÕÚÁÁÚÙµe≠N«e>ù†Ãz˚Yƒ"≠%È=Áo,B∑	%ìá¶d)7c4ΩÂ0®I∂g¡z◊- aÉ>≠hH´ÃÏÿÈÓ¥q≤	ò†Ùÿ∏&‰[FÚZîÀÆM#€¥≈ÜKo∏≠8ç¥/sÚ¯z2±·“(Å6ûÙ‹3◊*‡eoËã<^ﬁ∑2‰ÊπLQÛÙÛ¬_:(7:˘ÒÌTÆiD¢%eò¡Ú)Á
A ˛õ¡∫ù)LrëtìÄjf∫∑DŒ	∂(ÅI[ß±Î≤RÑÛ©%ôøÁç|†Lux"ﬂ⁄ËY¯íe]?˚#x3*.Ÿ…Ç4Ö¬&T]°ÑQYÙ¥^ |©…7g34∞^ËfB9ç x∂ÎÈ^◊öñ1K&lHÓùQ¥∞5∑†~áó“dü;‡ãÎ§SŸgÊÁ5Œ¯‚Éü¸%7H‘⁄o⁄\‚o®ï•äìÇsÉ∫äPåç3.YJì∞¥ÁúÕ"ˇÜ√vŸ{`H›àFcÑà⁄™»◊Üï"÷0†_0Ï{Ω◊{˝“™«Î∑·˝WÎœ ﬂ¢Ck
endstream
endobj
xref
0 261
0000000000 65535 f 
0000000015 00000 n 
0000000054 00000 n 
0000000168 00000 n 
0000000217 00000 n 
0000000765 00000 n 
0000000878 00000 n 
0000000991 00000 n 
0000001103 00000 n 
0000001216 00000 n 
0000001329 00000 n 
0000001443 00000 n 
0000001555 00000 n 
0000001668 00000 n 
0000001782 00000 n 
0000001896 00000 n 
0000002010 00000 n 
0000002123 00000 n 
0000002237 00000 n 
0000002351 00000 n 
0000002465 00000 n 
0000002577 00000 n 
0000002689 00000 n 
0000002800 00000 n 
0000003076 00000 n 
0000019500 00000 n 
0000019572 00000 n 
0000020231 00000 n 
0000020723 00000 n 
0000023158 00000 n 
0000023266 00000 n 
0000023936 00000 n 
0000024680 00000 n 
0000029907 00000 n 
0000030573 00000 n 
0000031059 00000 n 
0000034808 00000 n 
0000035471 00000 n 
0000036161 00000 n 
0000039586 00000 n 
0000040249 00000 n 
0000040645 00000 n 
0000042514 00000 n 
0000043051 00000 n 
0000043289 00000 n 
0000044471 00000 n 
0000044653 00000 n 
0000044723 00000 n 
0000044962 00000 n 
0000045262 00000 n 
0000045563 00000 n 
0000045738 00000 n 
0000045806 00000 n 
0000046036 00000 n 
0000046366 00000 n 
0000046652 00000 n 
0000047321 00000 n 
0000047791 00000 n 
0000050144 00000 n 
0000050489 00000 n 
0000050690 00000 n 
0000054960 00000 n 
0000055453 00000 n 
0000055504 00000 n 
0000055914 00000 n 
0000056685 00000 n 
0000056798 00000 n 
0000056909 00000 n 
0000057023 00000 n 
0000057135 00000 n 
0000057249 00000 n 
0000057363 00000 n 
0000057477 00000 n 
0000057591 00000 n 
0000057705 00000 n 
0000057819 00000 n 
0000057933 00000 n 
0000058047 00000 n 
0000058161 00000 n 
0000058275 00000 n 
0000058388 00000 n 
0000058502 00000 n 
0000058615 00000 n 
0000058729 00000 n 
0000058843 00000 n 
0000058957 00000 n 
0000059071 00000 n 
0000059185 00000 n 
0000059299 00000 n 
0000059413 00000 n 
0000059527 00000 n 
0000059641 00000 n 
0000059755 00000 n 
0000059869 00000 n 
0000059983 00000 n 
0000060097 00000 n 
0000060211 00000 n 
0000060325 00000 n 
0000060439 00000 n 
0000060553 00000 n 
0000060667 00000 n 
0000060782 00000 n 
0000060897 00000 n 
0000061012 00000 n 
0000061126 00000 n 
0000061241 00000 n 
0000061356 00000 n 
0000061471 00000 n 
0000061586 00000 n 
0000061701 00000 n 
0000061816 00000 n 
0000061931 00000 n 
0000062046 00000 n 
0000062161 00000 n 
0000062276 00000 n 
0000062391 00000 n 
0000062506 00000 n 
0000062621 00000 n 
0000083381 00000 n 
0000083490 00000 n 
0000084027 00000 n 
0000084128 00000 n 
0000084760 00000 n 
0000085385 00000 n 
0000085499 00000 n 
0000085614 00000 n 
0000085729 00000 n 
0000085844 00000 n 
0000085958 00000 n 
0000086072 00000 n 
0000086186 00000 n 
0000086300 00000 n 
0000086415 00000 n 
0000086530 00000 n 
0000086645 00000 n 
0000086760 00000 n 
0000086875 00000 n 
0000086990 00000 n 
0000087105 00000 n 
0000087220 00000 n 
0000087335 00000 n 
0000087450 00000 n 
0000087565 00000 n 
0000087680 00000 n 
0000087795 00000 n 
0000087910 00000 n 
0000088025 00000 n 
0000088139 00000 n 
0000088254 00000 n 
0000088369 00000 n 
0000088484 00000 n 
0000088599 00000 n 
0000088714 00000 n 
0000088829 00000 n 
0000088942 00000 n 
0000089055 00000 n 
0000110453 00000 n 
0000110562 00000 n 
0000111099 00000 n 
0000111613 00000 n 
0000112185 00000 n 
0000112299 00000 n 
0000112413 00000 n 
0000112525 00000 n 
0000112639 00000 n 
0000112753 00000 n 
0000112866 00000 n 
0000112981 00000 n 
0000113096 00000 n 
0000113209 00000 n 
0000113322 00000 n 
0000113435 00000 n 
0000113547 00000 n 
0000113662 00000 n 
0000113777 00000 n 
0000113892 00000 n 
0000114006 00000 n 
0000114121 00000 n 
0000114236 00000 n 
0000114350 00000 n 
0000114465 00000 n 
0000114580 00000 n 
0000114695 00000 n 
0000114810 00000 n 
0000114923 00000 n 
0000135457 00000 n 
0000135566 00000 n 
0000136103 00000 n 
0000136611 00000 n 
0000137271 00000 n 
0000137385 00000 n 
0000137500 00000 n 
0000137615 00000 n 
0000137729 00000 n 
0000137844 00000 n 
0000137959 00000 n 
0000138072 00000 n 
0000138186 00000 n 
0000138301 00000 n 
0000138415 00000 n 
0000138529 00000 n 
0000138644 00000 n 
0000138758 00000 n 
0000138873 00000 n 
0000138986 00000 n 
0000139100 00000 n 
0000139212 00000 n 
0000139325 00000 n 
0000139436 00000 n 
0000139550 00000 n 
0000139665 00000 n 
0000139780 00000 n 
0000139895 00000 n 
0000140010 00000 n 
0000140125 00000 n 
0000140240 00000 n 
0000140355 00000 n 
0000140470 00000 n 
0000140585 00000 n 
0000140700 00000 n 
0000140815 00000 n 
0000140930 00000 n 
0000163103 00000 n 
0000163212 00000 n 
0000168411 00000 n 
0000168948 00000 n 
0000169508 00000 n 
0000170026 00000 n 
0000170141 00000 n 
0000170255 00000 n 
0000170370 00000 n 
0000170485 00000 n 
0000170600 00000 n 
0000170714 00000 n 
0000170829 00000 n 
0000170944 00000 n 
0000171057 00000 n 
0000171172 00000 n 
0000171286 00000 n 
0000171398 00000 n 
0000171512 00000 n 
0000171627 00000 n 
0000171742 00000 n 
0000171855 00000 n 
0000171967 00000 n 
0000194640 00000 n 
0000194749 00000 n 
0000195412 00000 n 
0000195720 00000 n 
0000196848 00000 n 
0000197385 00000 n 
0000198094 00000 n 
0000198476 00000 n 
0000230563 00000 n 
0000230672 00000 n 
0000231209 00000 n 
0000232249 00000 n 
0000232631 00000 n 
0000262000 00000 n 
0000262109 00000 n 
0000262646 00000 n 
trailer
<<
/Size 261
/Root 3 0 R
/Info 1 0 R
>>
startxref
263610
%%EOF
